首页 » 细胞株Cell Lines 88及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net

细胞株Cell Lines 88及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net

  • 价  格:¥19200
  • 货  号:NTCC-CV88
  • 产  地:北京
点击询问我要采购
 竭诚为您服务!
BioVector NTCC典型培养物保藏中心
联系人:Dr.Xu, Biovector NTCC Inc.点击这里给我发消息

电话:+86-010-53513060. 工作QQ:1843439339

邮件:Biovector@163.com

手机:18901268599

地址:北京

已注册
 

细胞株Cell Lines-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心


http://www.biovector.net


ID   OU-AML-3

AC   CVCL_8393

DR   BioSample; SAMN03151869

RX   PubMed=10027306;

RX   PubMed=12592342;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a OCI-AML2 derivative (PubMed=12592342, PubMed=20143388).

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1619 ! OCI-AML2

SX   Male

CA   Cancer cell line

//

ID   OU-AML-4

AC   CVCL_8394

DR   BioSample; SAMN03151870

RX   PubMed=10027306;

RX   PubMed=12592342;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a OCI-AML2 derivative (PubMed=12592342, PubMed=20143388).

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1619 ! OCI-AML2

SX   Male

CA   Cancer cell line

//

ID   OU-AML-5

AC   CVCL_8395

DR   BioSample; SAMN03151871

RX   PubMed=10027306;

RX   PubMed=12592342;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a OCI-AML2 derivative (PubMed=12592342, PubMed=20143388).

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1619 ! OCI-AML2

SX   Male

CA   Cancer cell line

//

ID   OU-AML-6

AC   CVCL_8396

DR   BioSample; SAMN03151872

RX   PubMed=10027306;

RX   PubMed=12592342;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a OCI-AML2 derivative (PubMed=12592342, PubMed=20143388).

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1619 ! OCI-AML2

SX   Male

CA   Cancer cell line

//

ID   OU-AML-7

AC   CVCL_8397

DR   BioSample; SAMN03151873

RX   PubMed=10027306;

RX   PubMed=12592342;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a OCI-AML2 derivative (PubMed=12592342, PubMed=20143388).

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1619 ! OCI-AML2

SX   Male

CA   Cancer cell line

//

ID   OU-AML-8

AC   CVCL_8398

DR   BioSample; SAMN03151874

RX   PubMed=10027306;

RX   PubMed=12592342;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a OCI-AML2 derivative (PubMed=12592342, PubMed=20143388).

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1619 ! OCI-AML2

SX   Male

CA   Cancer cell line

//

ID   OU-LC-A1

AC   CVCL_DI01

RX   PubMed=10213231;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OU-LC-A2

AC   CVCL_DI02

RX   PubMed=10213231;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OU-LC-A3

AC   CVCL_DI03

RX   PubMed=10213231;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OU-LC-A4

AC   CVCL_DI04

RX   PubMed=10213231;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OU-LC-AS1

AC   CVCL_DI05

RX   PubMed=10213231;

CC   Derived from metastatic site: Supraclavicular lymph node.

DI   NCIt; C9133; Adenosquamous lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OU-LC-KI

AC   CVCL_DI06

RX   PubMed=10213231;

RX   PubMed=21048114;

RX   PubMed=22109656;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OU-LC-OK

AC   CVCL_DI07

RX   PubMed=21048114;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OU-LC-ON

AC   CVCL_DI08

RX   PubMed=21048114;

RX   PubMed=22109656;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OU-LC-KM

AC   CVCL_DI09

RX   PubMed=21048114;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OU-LC-SK

AC   CVCL_DI10

RX   PubMed=21048114;

RX   PubMed=22109656;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OUMS-21

AC   CVCL_9131

SY   Okayama University Medical School-21

RX   DOI=10.1007/978-1-4612-0411-4_32;

RX   PubMed=7683277;

CC   Characteristics: SV40-transformed but with a finite life span.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_9132 ! OUMS-22

CA   Finite cell line

//

ID   OUMS-22

AC   CVCL_9132

SY   Okayama University Medical School-22

RX   DOI=10.1007/978-1-4612-0411-4_32;

RX   PubMed=7683277;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_9131 ! OUMS-21

CA   Transformed cell line

//

ID   OUMS-23

AC   CVCL_3088

SY   OUMS23; Okayama University Medical School-23

DR   EFO; EFO_0006717

DR   BioSample; SAMN03470828

DR   BioSample; SAMN03472537

DR   CCLE; OUMS23_LARGE_INTESTINE

DR   Cosmic; 1187312

DR   Cosmic-CLP; 1298363

DR   GDSC; 1298363

DR   GEO; GSM827177

DR   GEO; GSM887479

DR   GEO; GSM888560

DR   GEO; GSM1448077

DR   JCRB; JCRB1022

DR   JCRB; NIHS0292

RX   PubMed=8576285;

RX   PubMed=22460905;

RX   PubMed=25926053;

RX   PubMed=25485619;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Stable (MSS) (PubMed=25926053).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: JCRB; NIHS0292; true.

ST   Source(s): JCRB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 12

ST   D16S539: 11

ST   D18S51: 16

ST   D21S11: 28,30

ST   D3S1358: 16,17

ST   D5S818: 11

ST   D7S820: 10 (JCRB)

ST   D7S820: 10,13 (PubMed=25877200)

ST   D8S1179: 13,16

ST   FGA: 23.2

ST   Penta D: 9,12

ST   Penta E: 5,9

ST   TH01: 7,9.3

ST   TPOX: 11

ST   vWA: 16

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OUMS-24

AC   CVCL_B369

SY   OUMS24; Okayama University Medical School-24

RX   PubMed=8985102;

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   OUMS-24/P6X

AC   CVCL_3089

SY   OUMS24/P6X

DR   JCRB; JCRB1051

DR   JCRB; NIHS0327

RX   PubMed=8985102;

CC   Transfected with: HGNC; 11998; TP53 (with H-273).

CC   Transformant: NCIt; C17262; X-Ray.

CC   Discontinued: JCRB; NIHS0327; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 12

ST   D16S539: 10,11

ST   D5S818: 11

ST   D7S820: 12

ST   TH01: 8,9

ST   TPOX: 8,12

ST   vWA: 16,19

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B369 ! OUMS-24

SX   Female

CA   Transformed cell line

//

ID   OUMS-24F

AC   CVCL_B370

SY   OUMS24F

RX   PubMed=8148305;

RX   PubMed=8557247;

RX   PubMed=9290701;

CC   Transformant: ChEBI; CHEBI:16907; 4-nitroquinoline N-oxide (4NQO).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B369 ! OUMS-24

SX   Female

CA   Transformed cell line

//

ID   OUMS-25

AC   CVCL_9133

SY   Okayama University Medical School-25

RX   PubMed=8168158;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: Donryu.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Transformed cell line

//

ID   OUMS-27

AC   CVCL_3090

SY   OUMS27; Okayama University Medical School-27

DR   BioSample; SAMN03472799

DR   CCLE; OUMS27_BONE

DR   Cosmic; 1602478

DR   Cosmic; 1992325

DR   GEO; GSM887480

DR   GEO; GSM888561

DR   IFO; IFO50488

RX   PubMed=9714054;

RX   PubMed=22057234;

RX   PubMed=22460905;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 12

ST   D16S539: 14

ST   D5S818: 10,11

ST   D7S820: 10,12

ST   TH01: 9

ST   TPOX: 11

ST   vWA: 14

DI   NCIt; C2946; Chondrosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OUMS-29

AC   CVCL_9130

SY   Okayama University Medical School-29

RX   PubMed=11513080;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   OUMS-31

AC   CVCL_9129

SY   Okayama University Medical School-31

RX   PubMed=10476912;

CC   Breed/subspecies: C3H/AnLCsb-Csb.

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_9134 ! OUMS-32

OI   CVCL_9135 ! OUMS-33

SX   Female

CA   Spontaneously immortalized cell line

//

ID   OUMS-32

AC   CVCL_9134

SY   Okayama University Medical School-32

RX   PubMed=10476912;

CC   Breed/subspecies: C3H/AnLCsb-Csb.

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_9129 ! OUMS-31

OI   CVCL_9135 ! OUMS-33

SX   Female

CA   Spontaneously immortalized cell line

//

ID   OUMS-33

AC   CVCL_9135

SY   Okayama University Medical School-33

RX   PubMed=10476912;

CC   Breed/subspecies: C3H/AnLCsb-Csb.

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_9129 ! OUMS-31

OI   CVCL_9134 ! OUMS-32

SX   Female

CA   Spontaneously immortalized cell line

//

ID   OUMS-34

AC   CVCL_9136

SY   Okayama University Medical School-34

RX   PubMed=10476912;

CC   Breed/subspecies: C3H/AnLCsa-Csa.

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_9137 ! OUMS-35

CA   Spontaneously immortalized cell line

//

ID   OUMS-35

AC   CVCL_9137

SY   Okayama University Medical School-35

RX   PubMed=10476912;

CC   Breed/subspecies: C3H/AnLCsa-Csa.

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_9136 ! OUMS-34

CA   Spontaneously immortalized cell line

//

ID   OUMS-36

AC   CVCL_3091

SY   Okayama University Medical School-36

DR   BioSample; SAMN03472528

DR   JCRB; JCRB1006.0

DR   JCRB; NIHS0291.0

CC   Discontinued: JCRB; NIHS0291.0; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,11

ST   D16S539: 9,10

ST   D5S818: 10,12

ST   D7S820: 11

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 18,20

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   OUMS-36T-1

AC   CVCL_3092

DR   JCRB; JCRB1006.1

DR   JCRB; NIHS0291.1

RX   DOI=10.11418/jtca1981.19.4_203;

CC   Transfected with: HGNC; 11730; TERT.

CC   Discontinued: JCRB; NIHS0291.1; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,11

ST   D16S539: 9,10

ST   D5S818: 10,12

ST   D7S820: 11

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 18,20

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3091 ! OUMS-36

CA   Telomerase immortalized cell line

//

ID   OUMS-36T-1F

AC   CVCL_3093

DR   JCRB; JCRB1006.1F

DR   JCRB; NIHS0291.1S

CC   Transfected with: HGNC; 11730; TERT.

CC   Discontinued: JCRB; NIHS0291.1S; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,11

ST   D16S539: 9,10

ST   D5S818: 10,12

ST   D7S820: 11

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 18,20

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3091 ! OUMS-36

CA   Telomerase immortalized cell line

//

ID   OUMS-36T-2

AC   CVCL_3094

DR   JCRB; JCRB1006.2

DR   JCRB; NIHS0291.2

RX   DOI=10.11418/jtca1981.19.4_203;

CC   Transfected with: HGNC; 11730; TERT.

CC   Discontinued: JCRB; NIHS0291.2; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,11

ST   D16S539: 9,10

ST   D5S818: 10,12

ST   D7S820: 11

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 18,20

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3091 ! OUMS-36

CA   Telomerase immortalized cell line

//

ID   OUMS-36T-2F

AC   CVCL_3095

DR   JCRB; JCRB1006.2F

DR   JCRB; NIHS0291.2S

CC   Transfected with: HGNC; 11730; TERT.

CC   Discontinued: JCRB; NIHS0291.2S; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,11

ST   D16S539: 9,10

ST   D5S818: 10,12

ST   D7S820: 11

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 18,20

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3091 ! OUMS-36

CA   Telomerase immortalized cell line

//

ID   OUMS-36T-3

AC   CVCL_3096

DR   JCRB; JCRB1006.3

DR   JCRB; NIHS0291.3

RX   DOI=10.11418/jtca1981.19.4_203;

CC   Transfected with: HGNC; 11730; TERT.

CC   Discontinued: JCRB; NIHS0291.3; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,11

ST   D16S539: 9,10

ST   D5S818: 10,12

ST   D7S820: 11

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 18,20

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3091 ! OUMS-36

CA   Telomerase immortalized cell line

//

ID   OUMS-36T-3F

AC   CVCL_3097

DR   JCRB; JCRB1006.3F

DR   JCRB; NIHS0291.3S

CC   Transfected with: HGNC; 11730; TERT.

CC   Discontinued: JCRB; NIHS0291.3S; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,11

ST   D16S539: 9,10

ST   D5S818: 10,12

ST   D7S820: 11

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 18,20

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3091 ! OUMS-36

CA   Telomerase immortalized cell line

//

ID   OUMS-36T-4

AC   CVCL_3098

DR   JCRB; JCRB1006.4

DR   JCRB; NIHS0291.4

RX   DOI=10.11418/jtca1981.19.4_203;

CC   Transfected with: HGNC; 11730; TERT.

CC   Discontinued: JCRB; NIHS0291.4; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,11

ST   D16S539: 9,10

ST   D5S818: 10,12

ST   D7S820: 11

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 18,20

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3091 ! OUMS-36

CA   Telomerase immortalized cell line

//

ID   OUMS-36T-4F

AC   CVCL_3099

DR   JCRB; JCRB1006.4F

DR   JCRB; NIHS0291.4S

CC   Transfected with: HGNC; 11730; TERT.

CC   Discontinued: JCRB; NIHS0291.4S; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,11

ST   D16S539: 9,10

ST   D5S818: 10,12

ST   D7S820: 11

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 18,20

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3091 ! OUMS-36

CA   Telomerase immortalized cell line

//

ID   OUMS-36T-5

AC   CVCL_3100

DR   JCRB; JCRB1006.5

DR   JCRB; NIHS0291.5

RX   DOI=10.11418/jtca1981.19.4_203;

CC   Transfected with: HGNC; 11730; TERT.

CC   Discontinued: JCRB; NIHS0291.5; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,11

ST   D16S539: 9,10

ST   D5S818: 10,12

ST   D7S820: 11

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 18,20

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3091 ! OUMS-36

CA   Telomerase immortalized cell line

//

ID   OUMS-36T-5F

AC   CVCL_3101

DR   BioSample; SAMN03472529

DR   JCRB; JCRB1006.5F

DR   JCRB; NIHS0291.5S

CC   Transfected with: HGNC; 11730; TERT.

CC   Discontinued: JCRB; NIHS0291.5S; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,11

ST   D16S539: 9,10

ST   D5S818: 10,12

ST   D7S820: 11

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 18,21

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3091 ! OUMS-36

CA   Telomerase immortalized cell line

//

ID   OUMS-36T-6

AC   CVCL_3102

DR   JCRB; JCRB1006.6

DR   JCRB; NIHS0291.6

RX   DOI=10.11418/jtca1981.19.4_203;

CC   Transfected with: HGNC; 11730; TERT.

CC   Discontinued: JCRB; NIHS0291.6; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,11

ST   D16S539: 9,10

ST   D5S818: 10,12

ST   D7S820: 11

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 18,20

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3091 ! OUMS-36

CA   Telomerase immortalized cell line

//

ID   OUMS-36T-6F

AC   CVCL_3103

DR   JCRB; JCRB1006.6F

DR   JCRB; NIHS0291.6S

CC   Transfected with: HGNC; 11730; TERT.

CC   Discontinued: JCRB; NIHS0291.6S; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,11

ST   D16S539: 9,10

ST   D5S818: 10,12

ST   D7S820: 11

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 18,20

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3091 ! OUMS-36

CA   Telomerase immortalized cell line

//

ID   OUMS-36T-7

AC   CVCL_3104

DR   JCRB; JCRB1006.7

DR   JCRB; NIHS0291.7

RX   DOI=10.11418/jtca1981.19.4_203;

CC   Transfected with: HGNC; 11730; TERT.

CC   Discontinued: JCRB; NIHS0291.7; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,11

ST   D16S539: 9,10

ST   D5S818: 10,12

ST   D7S820: 11

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 18,20

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3091 ! OUMS-36

CA   Telomerase immortalized cell line

//

ID   OUMS-36T-7F

AC   CVCL_3105

DR   JCRB; JCRB1006.7F

DR   JCRB; NIHS0291.7S

CC   Transfected with: HGNC; 11730; TERT.

CC   Discontinued: JCRB; NIHS0291.7S; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,11

ST   D16S539: 9,10

ST   D5S818: 10,12

ST   D7S820: 11

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 18,20

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3091 ! OUMS-36

CA   Telomerase immortalized cell line

//

ID   OUMS-36T-8

AC   CVCL_3106

DR   JCRB; JCRB1006.8

DR   JCRB; NIHS0291.8

RX   DOI=10.11418/jtca1981.19.4_203;

CC   Transfected with: HGNC; 11730; TERT.

CC   Discontinued: JCRB; NIHS0291.8; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,11

ST   D16S539: 9,10

ST   D5S818: 10,12

ST   D7S820: 11

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 18,20

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3091 ! OUMS-36

CA   Telomerase immortalized cell line

//

ID   OUMS-36T-8F

AC   CVCL_3107

DR   JCRB; JCRB1006.8F

DR   JCRB; NIHS0291.8S

CC   Transfected with: HGNC; 11730; TERT.

CC   Discontinued: JCRB; NIHS0291.8S; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,11

ST   D16S539: 9,10

ST   D5S818: 10,12

ST   D7S820: 11

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 18,20

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3091 ! OUMS-36

CA   Telomerase immortalized cell line

//

ID   OUMS-37

AC   CVCL_9128

SY   OUMS37; Okayama University Medical School-37

RX   PubMed=10548428;

CC   Breed/subspecies: Donryu.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Spontaneously immortalized cell line

//

ID   OUR-10

AC   CVCL_A416

SY   OUR10

DR   Cosmic; 849376

DR   TKG; TKG 0694

RX   PubMed=40693;

RX   PubMed=11146448;

CC   Doubling time: ~32 hours, at 50th passage (PubMed=40693).

ST   Source(s): TKG

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 11,12

ST   D16S539: 13

ST   D5S818: 9,13

ST   D7S820: 10,11

ST   TH01: 6,7,9.3

ST   TPOX: 11,12

ST   vWA: 14,17,18

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OUR-20

AC   CVCL_A417

SY   OUR20

DR   Cosmic; 849367

RX   PubMed=1958632;

RX   PubMed=11146448;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OUR-20P

AC   CVCL_A418

RX   PubMed=1958632;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_A417 ! OUR-20

CA   Cancer cell line

//

ID   OUR-20S

AC   CVCL_A419

RX   PubMed=1958632;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_A417 ! OUR-20

CA   Cancer cell line

//

ID   OUR-30

AC   CVCL_A420

RX   PubMed=1958632;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OUS-11

AC   CVCL_3108

SY   OUS11

DR   BTO; BTO:0003968

DR   BioSample; SAMN03472481

DR   JCRB; JCRB1034

DR   JCRB; NIHS0313

CC   Discontinued: JCRB; NIHS0313; true.

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 10,11

ST   D16S539: 10

ST   D5S818: 10,11

ST   D7S820: 10,11

ST   TH01: 7

ST   TPOX: 8,11

ST   vWA: 14,17

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   OV-1063

AC   CVCL_4366

SY   OV1063; 0V-1063

DR   ATCC; CRL-2183

DR   BioSample; SAMN03152024

DR   BioSample; SAMN03472561

DR   CCRID; 3111C0001CCC000361

DR   ChEMBL-Cells; CHEMBL3308411

DR   ChEMBL-Targets; CHEMBL614211

DR   Cosmic; 844352

DR   Cosmic; 849609

DR   Cosmic; 897432

DR   Cosmic; 948286

DR   Cosmic; 1044238

DR   Cosmic; 2582808

RX   PubMed=2412195;

RX   PubMed=20143388;

WW   http://www.atcc.org/Products/Cells_and_Microorganisms/Cell_Lines/Misidentified_Cell_Lines.aspx

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (PubMed=20143388).

CC   Discontinued: ATCC; CRL-2183; true.

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 12,14

ST   D16S539: 10,11,13

ST   D5S818: 10,13

ST   D7S820: 7,9,11

ST   TH01: 7

ST   TPOX: 11

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Undefined cell line type

//

ID   OV-1369(R2)

AC   CVCL_9T12

SY   OV1369(R2)

RX   PubMed=22931248;

CC   Derived from metastatic site: Ascites.

DI   NCIt; C105555; High grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_9T17 ! TOV-1369

SX   Female

CA   Cancer cell line

//

ID   OV-1847

AC   CVCL_D703

SY   Ovary 1847; Ovary1847; OVARY1847

DR   BioSample; SAMN03151864

DR   Cosmic; 1709260

DR   GEO; GSM851927

RX   PubMed=22328975;

RX   PubMed=22710073;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a OVCAR-8 derivative (PubMed=22710073).

CC   Omics: Transcriptome analysis.

DI   NCIt; C105555; High grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1629 ! OVCAR-8

SX   Female

CA   Cancer cell line

//

ID   OV-2295

AC   CVCL_9T13

SY   OV2295

RX   PubMed=22931248;

CC   Derived from metastatic site: Ascites.

DI   NCIt; C105555; High grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_9T14 ! OV-2295(R2)

OI   CVCL_9T18 ! TOV-2295(R)

SX   Female

CA   Cancer cell line

//

ID   OV-1946

AC   CVCL_4375

SY   OV1946

DR   Cosmic; 1122315

RX   PubMed=18507860;

WW   http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=OV-1946

CC   Derived from metastatic site: Ascites.

DI   NCIt; C105555; High grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_4062 ! TOV-1946

SX   Female

CA   Cancer cell line

//

ID   OV-2008

AC   CVCL_0473

AS   CVCL_4066

SY   OV2008; Ov2008; OV 2008; 2008; A2008

DR   BTO; BTO:0003792

DR   MCCL; MCC:0000371

DR   BioSample; SAMN03151841

DR   BioSample; SAMN03151843

DR   ChEMBL-Cells; CHEMBL3308015

DR   ChEMBL-Targets; CHEMBL612818

DR   Cosmic; 849613

DR   Cosmic; 948293

DR   Cosmic; 988874

DR   Cosmic; 1102825

DR   Cosmic; 1524359

DR   Cosmic; 1707563

DR   Cosmic; 2582806

DR   GEO; GSM184384

DR   GEO; GSM184385

DR   GEO; GSM659387

DR   GEO; GSM851907

DR   GEO; GSM851925

RX   PubMed=4118903;

RX   PubMed=9234707;

RX   PubMed=11314036;

RX   PubMed=22710073;

RX   PubMed=24023729;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/2/cell-lines-detail-62.html

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a ME-180 derivative (PubMed=22570425).

CC   Transformant: NCBI_TaxID; 45240; Human papillomavirus type 68 (HPV68).

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=22710073

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11,12

ST   D16S539: 12,13

ST   D18S51: 12

ST   D19S433: 13,15.2

ST   D21S11: 30,31

ST   D2S1338: 18

ST   D3S1358: 16

ST   D5S818: 12

ST   D7S820: 9,10

ST   D8S1179: 14

ST   FGA: 23

ST   TH01: 8,9.3

ST   TPOX: 8,10

ST   vWA: 15,17

DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1401 ! ME-180

SX   Female

CA   Cancer cell line

//

ID   OV-2295(R2)

AC   CVCL_9T14

SY   OV2295(R2)

RX   PubMed=22931248;

CC   Derived from metastatic site: Ascites.

DI   NCIt; C105555; High grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_9T13 ! OV-2295

OI   CVCL_9T18 ! TOV-2295(R)

SX   Female

CA   Cancer cell line

//

ID   OV-3133(R)

AC   CVCL_9T15

SY   OV3133(R)

RX   PubMed=22931248;

CC   Derived from metastatic site: Ascites.

DI   NCIt; C105555; High grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_9T16 ! OV-3133(R2)

OI   CVCL_9T19 ! TOV-3133D

OI   CVCL_4064 ! TOV-3133G

SX   Female

CA   Cancer cell line

//

ID   OV-3133(R2)

AC   CVCL_9T16

SY   OV3133(R2)

RX   PubMed=22931248;

CC   Derived from metastatic site: Ascites.

DI   NCIt; C105555; High grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_9T15 ! OV-3133(R)

OI   CVCL_9T19 ! TOV-3133D

OI   CVCL_4064 ! TOV-3133G

SX   Female

CA   Cancer cell line

//

ID   OV-4453

AC   CVCL_9T20

SY   OV4453

RX   PubMed=26622941;

CC   Doubling time: 2.44 +- 0.03 days (PubMed=26622941).

CC   Omics: Deep exome analysis.

CC   Omics: SNP array analysis.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C36101; BRCA2 syndrome

DI   NCIt; C105555; High grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV-4485

AC   CVCL_9T21

SY   OV4485

RX   PubMed=26622941;

CC   Doubling time: 1.85 +- 0.29 days (PubMed=26622941).

CC   Omics: Deep exome analysis.

CC   Omics: SNP array analysis.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C36100; BRCA1 syndrome

DI   NCIt; C105555; High grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV-866(2)

AC   CVCL_9T22

SY   OV866(2)

RX   PubMed=26622941;

CC   Doubling time: 1.77 +- 0.32 days (PubMed=26622941).

CC   Omics: Deep exome analysis.

CC   Omics: SNP array analysis.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C105555; High grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV-90

AC   CVCL_3768

SY   OV90

DR   BTO; BTO:0004852

DR   CLO; CLO_0008276

DR   EFO; EFO_0002311

DR   ATCC; CRL-11732

DR   BioSample; SAMN03471308

DR   CCLE; OV90_OVARY

DR   Cosmic; 1102815

DR   Cosmic; 1113283

DR   Cosmic; 1139219

DR   Cosmic; 1305311

DR   Cosmic; 1709257

DR   Cosmic; 2186586

DR   Cosmic-CLP; 1240197

DR   GDSC; 1240197

DR   GEO; GSM659389

DR   GEO; GSM784576

DR   GEO; GSM851926

DR   GEO; GSM887483

DR   GEO; GSM888564

DR   GEO; GSM1001427

DR   GEO; GSM1001428

DR   GEO; GSM1001492

DR   GEO; GSM1374800

DR   GEO; GSM1670314

DR   IGRhCellID; OV90

RX   Patent=US5710038;

RX   PubMed=10949993;

RX   PubMed=11641787;

RX   PubMed=22328975;

RX   PubMed=22460905;

RX   PubMed=22710073;

RX   PubMed=23839242;

RX   PubMed=24023729;

RX   PubMed=25230021;

RX   PubMed=25485619;

RX   PubMed=25984343;

RX   PubMed=27235858;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=OV-90

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: KuDOS 95 cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: OCCP ovarian cancer cell line panel.

CC   Doubling time: 40 hours (PubMed=25984343).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'TOV-90' in Cosmic 1139219.

CC   Derived from metastatic site: Ascites.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25230021; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12,13

ST   D13S317: 11,12

ST   D16S539: 11

ST   D18S51: 12

ST   D21S11: 30,30.2

ST   D3S1358: 18

ST   D5S818: 11,15

ST   D7S820: 10,10.1 (ATCC; PubMed=25230021; PubMed=25877200)

ST   D7S820: 10 (Cosmic-CLP)

ST   D8S1179: 12,14

ST   FGA: 21,22

ST   Penta D: 12,13

ST   Penta E: 11,13

ST   TH01: 9.3

ST   TPOX: 8,10

ST   vWA: 16,17

DI   NCIt; C7700; Ovarian adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV-MZ-1

AC   CVCL_X950

RX   PubMed=1500230;

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV-MZ-10

AC   CVCL_4003

DR   BTO; BTO:0004485

RX   PubMed=7510115;

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV-MZ-12

AC   CVCL_X965

RX   PubMed=11242531;

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV-MZ-14

AC   CVCL_X966

SY   OVMZ-14

RX   PubMed=11242531;

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV-MZ-15

AC   CVCL_4004

DR   BTO; BTO:0004486

DR   GEO; GSM313678

RX   PubMed=7510115;

RX   PubMed=11242531;

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV-MZ-16

AC   CVCL_X959

SY   OVMZ-16

RX   PubMed=11242531;

RX   PubMed=15153938;

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV-MZ-19

AC   CVCL_6863

RX   PubMed=9735390;

DI   NCIt; C5228; Ovarian cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV-MZ-1a

AC   CVCL_X962

SY   OVMZ-1a

RX   PubMed=11242531;

RX   PubMed=15153938;

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_X950 ! OV-MZ-1

SX   Female

CA   Cancer cell line

//

ID   OV-MZ-2

AC   CVCL_X951

RX   PubMed=1500230;

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV-MZ-20

AC   CVCL_X967

SY   OVMZ-20

RX   PubMed=11242531;

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV-MZ-21

AC   CVCL_X968

RX   PubMed=11242531;

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV-MZ-22

AC   CVCL_E117

RX   PubMed=11242531;

RX   PubMed=11733966;

RX   PubMed=15153938;

DI   NCIt; C9192; Ovarian carcinosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV-MZ-26

AC   CVCL_X969

RX   PubMed=11242531;

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV-MZ-27

AC   CVCL_X970

RX   PubMed=11242531;

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV-MZ-2a

AC   CVCL_X955

RX   PubMed=10741907;

RX   PubMed=11242531;

RX   PubMed=15153938;

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_X951 ! OV-MZ-2

SX   Female

CA   Cancer cell line

//

ID   OV-MZ-3

AC   CVCL_X952

RX   PubMed=1500230;

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV-MZ-30

AC   CVCL_X971

RX   PubMed=11242531;

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV-MZ-31

AC   CVCL_X972

RX   PubMed=11242531;

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV-MZ-32

AC   CVCL_X956

SY   OVMZ32

RX   PubMed=10741907;

RX   PubMed=11242531;

RX   PubMed=15153938;

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV-MZ-33

AC   CVCL_X973

RX   PubMed=11242531;

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV-MZ-35

AC   CVCL_X957

RX   PubMed=11242531;

RX   PubMed=15153938;

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV-MZ-36

AC   CVCL_X987

RX   PubMed=11242531;

RX   PubMed=15153938;

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV-MZ-37

AC   CVCL_X960

RX   PubMed=11242531;

RX   PubMed=15153938;

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV-MZ-38

AC   CVCL_X961

RX   PubMed=11242531;

RX   PubMed=15153938;

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV-MZ-4

AC   CVCL_X953

SY   OVMZ-4

RX   PubMed=1500230;

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV-MZ-5

AC   CVCL_X954

RX   PubMed=1500230;

RX   PubMed=11242531;

RX   PubMed=15153938;

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV-MZ-6

AC   CVCL_4005

SY   OVMZ-6

DR   BTO; BTO:0004487

RX   PubMed=1500230;

RX   PubMed=11242531;

RX   PubMed=15153938;

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV-MZ-6#8

AC   CVCL_X988

RX   PubMed=12297307;

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4005 ! OV-MZ-6

SX   Female

CA   Cancer cell line

//

ID   OV-MZ-7a

AC   CVCL_X974

SY   OVMZ-7a

RX   PubMed=11242531;

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV-MZ-8

AC   CVCL_X958

RX   PubMed=11242531;

RX   PubMed=15153938;

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV-MZ-9

AC   CVCL_X964

SY   OVMZ-9

RX   PubMed=11242531;

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV-TRL-12B

AC   CVCL_DH78

SY   OV-TRL 12B; OV-TRL12B; TRL-12B

DR   GEO; GSM313705

RX   PubMed=19222485;

DI   NCIt; C40093; Ovarian squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV-TRL-90T

AC   CVCL_DH79

SY   TRL-90T; TRL90T

DR   GEO; GSM313687

DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV-UL-2

AC   CVCL_X963

RX   PubMed=11242531;

RX   PubMed=15153938;

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV(hyg)CAR3

AC   CVCL_Y033

SY   Ov(hyg)CAR3

RX   PubMed=8824553;

CC   Selected for resistance to: ChEBI; CHEBI:16976; Hygromycin B.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C105555; High grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0465 ! OVCAR-3

SX   Female

CA   Cancer cell line

//

ID   OV1/ADR

AC   CVCL_8744

SY   OV1/DXR

RX   PubMed=2731146;

RX   PubMed=17934650;

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1304 ! IGROV-1

SX   Female

CA   Cancer cell line

//

ID   OV1/CDDP

AC   CVCL_8745

RX   PubMed=2731146;

RX   PubMed=17934650;

CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).

DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1304 ! IGROV-1

SX   Female

CA   Cancer cell line

//

ID   OV1/VCR

AC   CVCL_8746

RX   PubMed=2731146;

RX   PubMed=2925277;

RX   PubMed=17934650;

CC   Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).

DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1304 ! IGROV-1

SX   Female

CA   Cancer cell line

//

ID   OV167

AC   CVCL_A402

SY   Ov167; OV-167; OV 167

DR   Cosmic; 1523766

DR   GEO; GSM659385

RX   PubMed=9473353;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV176

AC   CVCL_6E73

SY   ov176

DR   Cosmic; 845143

RX   PubMed=9625810;

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV177

AC   CVCL_A403

SY   Ov177; ov177; OV 177

DR   Cosmic; 845144

DR   Cosmic; 1523767

DR   GEO; GSM659386

RX   PubMed=9473353;

RX   PubMed=9625810;

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV17R

AC   CVCL_2672

SY   OV-17R

DR   Cosmic-CLP; 1480361

DR   ECACC; 96020763

DR   GDSC; 1480361

DR   GEO; GSM1670311

RX   PubMed=7707437;

RX   PubMed=25230021;

RX   PubMed=27397505;

CC   Part of: OCCP ovarian cancer cell line panel.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): Cosmic-CLP; ECACC; PubMed=25230021

ST   Amelogenin: X

ST   CSF1PO: 11,14

ST   D13S317: 11,13

ST   D16S539: 9,13

ST   D18S51: 13,18

ST   D19S433: 14,16

ST   D21S11: 30

ST   D2S1338: 24,25

ST   D3S1358: 14,17

ST   D5S818: 11

ST   D7S820: 8,10

ST   D8S1179: 13,14

ST   FGA: 21,22

ST   Penta D: 10,13

ST   Penta E: 14

ST   TH01: 9 (Cosmic-CLP; ECACC)

ST   TH01: 9,9.3 (PubMed=25230021)

ST   TPOX: 8,10

ST   vWA: 14,18

DI   NCIt; C7700; Ovarian adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV202

AC   CVCL_4067

SY   Ov202; ov202; OV-202; OV 202

DR   BTO; BTO:0003504

DR   Cosmic; 845145

DR   Cosmic; 1523768

RX   PubMed=9473353;

RX   PubMed=9625810;

RX   PubMed=10690552;

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV202 hp

AC   CVCL_4068

SY   OV-202 hp; OV202 high passage

RX   PubMed=10690552;

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4067 ! OV202

SX   Female

CA   Cancer cell line

//

ID   OV207

AC   CVCL_A404

SY   Ov207; ov207; OV 207

DR   Cosmic; 845146

DR   Cosmic; 1223314

DR   Cosmic; 1328063

DR   Cosmic; 1434892

DR   Cosmic; 1523769

DR   Cosmic; 1708376

DR   Cosmic; 2074244

DR   GEO; GSM659388

RX   PubMed=9473353;

RX   PubMed=9625810;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

DI   NCIt; C40078; Ovarian clear cell adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV25R

AC   CVCL_X502

RX   PubMed=7707437;

DI   NCIt; C7700; Ovarian adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV266

AC   CVCL_A405

SY   Ov266; ov266; OV 266

DR   Cosmic; 845147

RX   PubMed=9473353;

RX   PubMed=9625810;

DI   NCIt; C7700; Ovarian adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV2944

AC   CVCL_E953

SY   OV 2944

CC   Breed/subspecies: C57BL/6N x C3H/He.

DI   NCIt; C30037; Mouse malignant ovarian neoplasm

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Cancer cell line

//

ID   OV2944-HM-1

AC   CVCL_E954

SY   HM-1

DR   CLO; CLO_0051455

DR   RCB; RCB1483

RX   PubMed=2502522;

CC   Breed/subspecies: C57BL/6N x C3H/He.

DI   NCIt; C30037; Mouse malignant ovarian neoplasm

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_E953 ! OV2944

SX   Female

CA   Cancer cell line

//

ID   OV2944-LM-1

AC   CVCL_E955

SY   LM-1

RX   PubMed=2502522;

CC   Breed/subspecies: C57BL/6N x C3H/He.

DI   NCIt; C30037; Mouse malignant ovarian neoplasm

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_E953 ! OV2944

SX   Female

CA   Cancer cell line

//

ID   OV2944-LM-3

AC   CVCL_E956

SY   LM-3

RX   PubMed=2502522;

CC   Breed/subspecies: C57BL/6N x C3H/He.

DI   NCIt; C30037; Mouse malignant ovarian neoplasm

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_E953 ! OV2944

SX   Female

CA   Cancer cell line

//

ID   OV3121

AC   CVCL_6547

DR   JCRB; JCRB1026

DR   JCRB; NIHS0255

RX   PubMed=7775256;

RX   PubMed=15541573;

CC   Discontinued: JCRB; NIHS0255; true.

CC   Breed/subspecies: C57BL/6N x C3H/He.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Cancer cell line

//

ID   OV3121-1

AC   CVCL_0474

DR   MCCL; MCC:0000372

RX   PubMed=7775256;

CC   Breed/subspecies: C57BL/6N x C3H/He.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6547 ! OV3121

SX   Female

CA   Cancer cell line

//

ID   OV3121-ras4

AC   CVCL_6548

SY   OV312ras4; OV-ras4

DR   JCRB; JCRB0186

RX   PubMed=7775256;

CC   Transfected with: UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).

CC   Breed/subspecies: C57BL/6N x C3H/He.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0474 ! OV3121-1

SX   Female

CA   Cancer cell line

//

ID   OV3121-ras7

AC   CVCL_6549

SY   OV312ras7; OV-ras7

DR   JCRB; JCRB0187

RX   PubMed=7775256;

CC   Transfected with: UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).

CC   Breed/subspecies: C57BL/6N x C3H/He.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0474 ! OV3121-1

SX   Female

CA   Cancer cell line

//

ID   OV56

AC   CVCL_2673

SY   OV-56

DR   EFO; EFO_0006458

DR   BioSample; SAMN03472428

DR   CCLE; OV56_OVARY

DR   Cosmic-CLP; 1480362

DR   ECACC; 96020759

DR   GDSC; 1480362

DR   GEO; GSM887481

DR   GEO; GSM888562

DR   GEO; GSM1670312

RX   PubMed=22460905;

RX   PubMed=23839242;

RX   PubMed=25230021;

RX   PubMed=25485619;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: OCCP ovarian cancer cell line panel.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Ascites.

ST   Source(s): Cosmic-CLP; ECACC; PubMed=25230021; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 8,9

ST   D16S539: 10,13

ST   D18S51: 14

ST   D19S433: 13,15

ST   D21S11: 28

ST   D2S1338: 20,24

ST   D3S1358: 16,17

ST   D5S818: 11,12

ST   D7S820: 10

ST   D8S1179: 8,14

ST   FGA: 21

ST   Penta D: 13,15

ST   Penta E: 12,20

ST   TH01: 6,9

ST   TPOX: 9,11

ST   vWA: 15,19

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV58

AC   CVCL_2674

SY   OV-58

DR   ECACC; 96020760

CC   Discontinued: ECACC; 96020760; probable.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV7

AC   CVCL_2675

SY   OV-7

DR   EFO; EFO_0006459

DR   BioSample; SAMN03473061

DR   CCLE; OV7_OVARY

DR   ECACC; 96020764

DR   Cosmic-CLP; 1480360

DR   GDSC; 1480360

DR   GEO; GSM887482

DR   GEO; GSM888563

DR   GEO; GSM1670313

RX   PubMed=7707437;

RX   PubMed=22460905;

RX   PubMed=25230021;

RX   PubMed=25485619;

RX   PubMed=25984343;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: OCCP ovarian cancer cell line panel.

CC   Doubling time: 110 hours (PubMed=25984343).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: shRNA library screening.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; ECACC; PubMed=25230021; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12,13

ST   D13S317: 8,11

ST   D16S539: 13

ST   D18S51: 12,14

ST   D19S433: 14

ST   D21S11: 30,31.2

ST   D2S1338: 20,24

ST   D3S1358: 16

ST   D5S818: 11,12

ST   D7S820: 9,11

ST   D8S1179: 10,14

ST   FGA: 23

ST   Penta D: 12,14

ST   Penta E: 10,12

ST   TH01: 7,9.3

ST   TPOX: 8,10

ST   vWA: 15

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OV90C-A

AC   CVCL_4Z23

RX   PubMed=22141344;

CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C7700; Ovarian adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3768 ! OV-90

SX   Female

CA   Cancer cell line

//

ID   OV90C-D

AC   CVCL_4Z24

RX   PubMed=22141344;

CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C7700; Ovarian adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3768 ! OV-90

SX   Female

CA   Cancer cell line

//

ID   OV90D-6

AC   CVCL_4Z25

RX   PubMed=22141344;

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C7700; Ovarian adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3768 ! OV-90

SX   Female

CA   Cancer cell line

//

ID   OV90D-7

AC   CVCL_4Z26

RX   PubMed=22141344;

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C7700; Ovarian adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3768 ! OV-90

SX   Female

CA   Cancer cell line

//

ID   OV90P-3

AC   CVCL_4Z27

RX   PubMed=22141344;

CC   Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C7700; Ovarian adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3768 ! OV-90

SX   Female

CA   Cancer cell line

//

ID   OV90P-7

AC   CVCL_4Z28

RX   PubMed=22141344;

CC   Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C7700; Ovarian adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3768 ! OV-90

SX   Female

CA   Cancer cell line

//

ID   OVAS

AC   CVCL_0V12

DR   Cosmic; 1889264

DR   BioSample; SAMN03472381

DR   JCRB; NIHS0403

DR   PRIDE; PXD000901

RX   PubMed=23430509;

CC   From: Minaguchi H.; Yokohama City University; Yokohama; Japan.

CC   Discontinued: JCRB; NIHS0403; true.

CC   Derived from metastatic site: Ascites.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 11,12,13

ST   D13S317: 11,13

ST   D16S539: 9,12

ST   D5S818: 6,9,10,12

ST   D7S820: 10,11,12

ST   TH01: 6,7

ST   TPOX: 10,11

ST   vWA: 16,17,18,19

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OVAS-21

AC   CVCL_A768

SY   OVAS21

DR   Cosmic; 945376

RX   CelloPub=CLPUB00096;

DI   NCIt; C40078; Ovarian clear cell adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OVB-3

AC   CVCL_3109

SY   OVB3

DR   CLO; CLO_0008277

DR   ATCC; HB-9147

RX   Patent=US4806494;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OVC1-PI 32

AC   CVCL_9U97

DR   NCBI_Iran; C442

RX   PubMed=24936210;

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OVCA-X

AC   CVCL_DH80

SY   OVCA X; OV-CAX

DR   Cosmic; 1609528

DR   GEO; GSM313716

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OVCA400

AC   CVCL_IQ31

SY   OVCA 400

RX   PubMed=7028788;

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OVCA420

AC   CVCL_3935

SY   OVCA 420; OvCa 420; OVCA-420; OVCAR-420; OVCAR 420; OVCAR420

DR   BTO; BTO:0002563

DR   EFO; EFO_0006720

DR   BioSample; SAMN03471874

DR   Cosmic; 924145

DR   Cosmic; 927566

DR   Cosmic-CLP; 1480364

DR   GDSC; 1480364

DR   GEO; GSM659390

DR   GEO; GSM851928

DR   GEO; GSM1670315

RX   PubMed=1536252;

RX   PubMed=6346879;

RX   PubMed=7028788;

RX   PubMed=10972993;

RX   PubMed=11793438;

RX   PubMed=12960427;

RX   PubMed=22115851;

RX   PubMed=22710073;

RX   PubMed=23415752;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; PubMed=22115851; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 8

ST   D13S317: 12,13

ST   D16S539: 9,12 (Cosmic-CLP; PubMed=25877200)

ST   D16S539: 9 (PubMed=22115851)

ST   D18S51: 14,17

ST   D21S11: 30.2

ST   D3S1358: 16,17

ST   D5S818: 13

ST   D7S820: 11 (Cosmic-CLP; PubMed=22115851)

ST   D7S820: 8,11 (PubMed=25877200)

ST   D8S1179: 14,15

ST   FGA: 22 (PubMed=22115851)

ST   FGA: 21,22 (PubMed=25877200)

ST   Penta D: 12

ST   Penta E: 5,8

ST   TH01: 6,9 (Cosmic-CLP)

ST   TH01: 6 (PubMed=25877200)

ST   TPOX: 8

ST   vWA: 16,18

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OVCA424

AC   CVCL_IQ30

SY   OVCA 424; OvCa 424

RX   PubMed=6346879;

RX   PubMed=7028788;

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OVCA429

AC   CVCL_3936

SY   OVCA 429; OvCA 429; OVCA-429; OVCAR-429; OVCAR 429; OVCAR429; OV429

DR   BTO; BTO:0002564

DR   EFO; EFO_0006721

DR   BioSample; SAMN03470937

DR   Cosmic; 924146

DR   Cosmic; 927567

DR   Cosmic; 1223315

DR   Cosmic; 1328064

DR   Cosmic; 1434898

DR   Cosmic; 2074245

DR   GEO; GSM95439

DR   GEO; GSM659391

DR   GEO; GSM851929

RX   PubMed=1536252;

RX   PubMed=6346879;

RX   PubMed=7028788;

RX   PubMed=10972993;

RX   PubMed=12080474;

RX   PubMed=12960427;

RX   PubMed=16382445;

RX   PubMed=22710073;

RX   PubMed=25485619;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Deep RNAseq analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12,13

ST   D13S317: 7,12

ST   D16S539: 12

ST   D18S51: 14

ST   D21S11: 30

ST   D3S1358: 15,16

ST   D5S818: 11,12

ST   D7S820: 11,12

ST   D8S1179: 14,15

ST   FGA: 24

ST   Penta D: 13,14

ST   Penta E: 12

ST   TH01: 9

ST   TPOX: 9,11

ST   vWA: 16,18

DI   NCIt; C5228; Ovarian cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OVCA429/T40

AC   CVCL_CZ99

SY   OVCA429T40

DR   GEO; GSM95441

RX   PubMed=16382445;

CC   Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).

DI   NCIt; C5228; Ovarian cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3936 ! OVCA429

SX   Female

CA   Cancer cell line

//

ID   OVCA429/TxT50

AC   CVCL_CZ98

SY   OVCA429TxT50; OV429 TxT50

DR   GEO; GSM95430

RX   PubMed=16382445;

CC   Selected for resistance to: ChEBI; CHEBI:4672; Docetaxel anhydrous (Taxotere).

DI   NCIt; C5228; Ovarian cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3936 ! OVCA429

SX   Female

CA   Cancer cell line

//

ID   OVCA432

AC   CVCL_3769

SY   OV-CA 432; OVCA 432; OvCA 432; OVCA-432; OVCAR-432; OVCAR 432; OVCAR432

DR   BTO; BTO:0002565

DR   CLO; CLO_0008278

DR   EFO; EFO_0006722

DR   CLDB; cl3778

DR   BioSample; SAMN03470830

DR   Cosmic; 924147

DR   Cosmic; 991322

DR   Cosmic; 1524354

DR   GDSC; 1480366

DR   GEO; GSM659392

DR   GEO; GSM851930

RX   PubMed=1536252;

RX   PubMed=6346879;

RX   PubMed=7028788;

RX   PubMed=7836420;

RX   PubMed=10972993;

RX   PubMed=11793438;

RX   PubMed=12960427;

RX   PubMed=22710073;

RX   PubMed=23415752;

RX   PubMed=25485619;

CC   Omics: Deep RNAseq analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 11,12

ST   D16S539: 12

ST   D18S51: 15,16

ST   D21S11: 29,31.2

ST   D3S1358: 16

ST   D5S818: 12,13

ST   D7S820: 8,10

ST   D8S1179: 10,14

ST   FGA: 20,24

ST   Penta D: 10,14

ST   Penta E: 13,19

ST   TH01: 10

ST   TPOX: 11

ST   vWA: 15,19

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IQ28 ! LAZ-446

SX   Female

CA   Cancer cell line

//

ID   OVCA433

AC   CVCL_0475

SY   OVCA 433; OvCa 433; OVCA-433; OVCAR-433; OVCAR 433; OVCAR433; SKOV-433; SK-OV-433; OV433

DR   BTO; BTO:0002566

DR   EFO; EFO_0006723

DR   MCCL; MCC:0000373

DR   BioSample; SAMN03473291

DR   Cosmic; 924148

DR   Cosmic; 927568

DR   Cosmic; 1175882

DR   Cosmic; 1524355

DR   Cosmic; 1709258

DR   Cosmic-CLP; 1480367

DR   GDSC; 1480367

DR   GEO; GSM95433

DR   GEO; GSM851931

DR   GEO; GSM1670316

RX   PubMed=1536252;

RX   PubMed=6346879;

RX   PubMed=7028788;

RX   PubMed=10972993;

RX   PubMed=11793438;

RX   PubMed=16382445;

RX   PubMed=22328975;

RX   PubMed=22710073;

RX   PubMed=23415752;

RX   PubMed=24434149;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=27561551;

WW   http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=OVCA433_Bast

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Exosome proteome analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12,13

ST   D13S317: 7,12

ST   D16S539: 12

ST   D18S51: 14

ST   D21S11: 30

ST   D3S1358: 15,16

ST   D5S818: 11,12

ST   D7S820: 11,12

ST   D8S1179: 14,15

ST   FGA: 24

ST   Penta D: 13,14

ST   Penta E: 7,12

ST   TH01: 9

ST   TPOX: 9,11

ST   vWA: 16,18

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IQ32 ! LAZ-444

SX   Female

CA   Cancer cell line

//

ID   OVCA433/T40

AC   CVCL_DA01

SY   OVCA433T40; 433T40

DR   GEO; GSM95451

RX   PubMed=16382445;

CC   Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0475 ! OVCA433

SX   Female

CA   Cancer cell line

//

ID   OVCA433/TxT50

AC   CVCL_DA00

SY   OVCA433TxT50; OV433TxT50

DR   GEO; GSM95432

RX   PubMed=16382445;

CC   Selected for resistance to: ChEBI; CHEBI:4672; Docetaxel anhydrous (Taxotere).

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0475 ! OVCA433

SX   Female

CA   Cancer cell line

//

ID   OVCA633

AC   CVCL_W776

RX   PubMed=11793438;

RX   PubMed=15571795;

CC   Omics: Transcriptome analysis.

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OVCA680

AC   CVCL_W781

RX   PubMed=12492109;

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OVCA702

AC   CVCL_W782

RX   PubMed=12492109;

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OVCA810

AC   CVCL_W783

RX   PubMed=12492109;

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OVCAR-10

AC   CVCL_4377

SY   NIH:OVCAR-10; OVCAR10

DR   Cosmic; 1102813

DR   GEO; GSM185131

DR   GEO; GSM185132

DR   GEO; GSM313703

DR   GEO; GSM851932

RX   PubMed=2307530;

RX   PubMed=9041185;

RX   PubMed=22710073;

RX   PubMed=23415752;

CC   Omics: Transcriptome analysis.

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OVCAR-2

AC   CVCL_3941

SY   NIH:OVCAR-2; OVCAR2; OVCAR 2

DR   BTO; BTO:0002560

DR   GEO; GSM185133

DR   GEO; GSM185134

DR   GEO; GSM851933

RX   PubMed=2307530;

RX   PubMed=9041185;

RX   PubMed=22710073;

CC   Omics: Transcriptome analysis.

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OVCAR-3

AC   CVCL_0465

SY   Ovcar-3; NIH:OVCAR-3; NIH:Ovcar-3; NIH:OVCAR3; NIH-OVCAR-3; NIHOVCAR3; OVCAR.3; OVCAR3; Ovcar3

DR   BTO; BTO:0000812

DR   CLO; CLO_0008171

DR   CLO; CLO_0008279

DR   CLO; CLO_0051451

DR   EFO; EFO_0003061

DR   MCCL; MCC:0000363

DR   CLDB; cl3712

DR   CLDB; cl3780

DR   CLDB; cl5237

DR   ATCC; HTB-161

DR   BCRC; 60551

DR   BCRJ; 0317

DR   BioSample; SAMN01821585

DR   BioSample; SAMN03471390

DR   CCLE; NIHOVCAR3_OVARY

DR   CCRID; 3111C0001CCC000362

DR   CCRID; 3131C0001000700108

DR   CCRID; 3142C0001000000122

DR   ChEMBL-Cells; CHEMBL3307564

DR   ChEMBL-Targets; CHEMBL614213

DR   CLS; 300307/p690_NIH:Ovcar-3

DR   Cosmic; 687926

DR   Cosmic; 688104

DR   Cosmic; 755845

DR   Cosmic; 809113

DR   Cosmic; 844347

DR   Cosmic; 845142

DR   Cosmic; 875859

DR   Cosmic; 897433

DR   Cosmic; 905933

DR   Cosmic; 906577

DR   Cosmic; 920357

DR   Cosmic; 924144

DR   Cosmic; 927564

DR   Cosmic; 949227

DR   Cosmic; 974296

DR   Cosmic; 991321

DR   Cosmic; 1044239

DR   Cosmic; 1092623

DR   Cosmic; 1102816

DR   Cosmic; 1139222

DR   Cosmic; 1175883

DR   Cosmic; 1218877

DR   Cosmic; 1305312

DR   Cosmic; 1312192

DR   Cosmic; 1312354

DR   Cosmic; 1436033

DR   Cosmic; 1482525

DR   Cosmic; 1524357

DR   Cosmic; 1709250

DR   Cosmic; 1998465

DR   Cosmic; 2186584

DR   Cosmic-CLP; 905933

DR   ENCODE; ENCBS419ENC

DR   GDSC; 905933

DR   GEO; GSM50219

DR   GEO; GSM50282

DR   GEO; GSM95463

DR   GEO; GSM185135

DR   GEO; GSM185136

DR   GEO; GSM313683

DR   GEO; GSM459733

DR   GEO; GSM459741

DR   GEO; GSM645843

DR   GEO; GSM659393

DR   GEO; GSM750817

DR   GEO; GSM784564

DR   GEO; GSM799362

DR   GEO; GSM799363

DR   GEO; GSM799425

DR   GEO; GSM799426

DR   GEO; GSM847106

DR   GEO; GSM844668

DR   GEO; GSM851934

DR   GEO; GSM887456

DR   GEO; GSM888536

DR   GEO; GSM1001493

DR   GEO; GSM1153434

DR   GEO; GSM1153435

DR   GEO; GSM1181276

DR   GEO; GSM1181278

DR   GEO; GSM1186813

DR   GEO; GSM1186814

DR   GEO; GSM1186815

DR   GEO; GSM1186816

DR   GEO; GSM1186827

DR   GEO; GSM1374771

DR   GEO; GSM1374772

DR   GEO; GSM1374773

DR   GEO; GSM1670317

DR   ICLC; HTL97004

DR   IGRhCellID; OVCAR3

DR   IZSLER; BS TCL 131

DR   KCB; KCB 2006106YJ

DR   KCLB; 30161

DR   NCBI_Iran; C430

DR   PRIDE; PXD003105

DR   RCB; RCB2135

DR   SKY/M-FISH/CGH; 2742

DR   TKG; TKG 0602

DR   TOKU-E; 2754

RX   PubMed=1892748;

RX   PubMed=2041050;

RX   PubMed=2307530;

RX   PubMed=2653399;

RX   PubMed=9041185;

RX   PubMed=11414198;

RX   PubMed=11793438;

RX   PubMed=12417041;

RX   PubMed=12960427;

RX   PubMed=16382445;

RX   PubMed=17088437;

RX   PubMed=18560578;

RX   PubMed=19372543;

RX   PubMed=22328975;

RX   PubMed=22336246;

RX   PubMed=22460905;

RX   PubMed=22710073;

RX   PubMed=23172893;

RX   PubMed=23415752;

RX   PubMed=23839242;

RX   PubMed=23856246;

RX   PubMed=23933261;

RX   PubMed=24023729;

RX   PubMed=24434149;

RX   PubMed=25230021;

RX   PubMed=25485619;

RX   PubMed=25984343;

RX   PubMed=26972028;

RX   PubMed=27141528;

RX   PubMed=27235858;

RX   PubMed=27397505;

RX   PubMed=27561551;

RX   PubMed=27807467;

RX   PubMed=28196595;

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=22

WW   http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=OVCAR-3

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/o/cell-lines-detail-239.html

WW   http://tcpaportal.org/mclp/

CC   Part of: AKT genetic alteration cell panel (ATCC TCP-1029).

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: ENCODE project common cell types; tier 3.

CC   Part of: JFCR39 cancer cell line panel.

CC   Part of: KuDOS 95 cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: NCI60 cancer cell line panel.

CC   Part of: OCCP ovarian cancer cell line panel.

CC   Doubling time: 64 hours (PubMed=25984343); 34.7 hours (DTP).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Exosome proteome analysis.

CC   Omics: GPI-anchored proteins analysis by proteomics.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: Secretome proteome analysis.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: Occasionally 'OVCA3'.

CC   Misspelling: Occasionally 'OVOCAR3'.

CC   Misspelling: 'OVCAK3' in GEO GSM459741.

CC   Discontinued: ICLC; HTL97004; true.

CC   Derived from metastatic site: Ascites.

ST   Source(s): ATCC; CLS; COG; Cosmic-CLP; KCLB; PubMed=19372543; PubMed=25230021; PubMed=25877200; RCB; TKG

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 12

ST   D16S539: 12

ST   D18S51: 13

ST   D19S433: 16.2

ST   D21S11: 29,31.2

ST   D2S1338: 17,21

ST   D3S1358: 17,18

ST   D5S818: 11,12

ST   D7S820: 10

ST   D8S1179: 10,15

ST   FGA: 21

ST   Penta D: 12,13

ST   Penta E: 7,13

ST   TH01: 9,9.3

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C105555; High grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OVCAR-3 SimpleCell O-GalNAc

AC   CVCL_S033

SY   OVCAR-3 SimpleCell; OVCAR-3 SC

RX   PubMed=23584533;

CC   Characteristics: Cell engineered to produce only truncated GalNAc or NeuAc-alpha-2-6-GalNAc O-glycans.

CC   Knockout cell: Method=ZFN; HGNC; 24338; C1GALT1C1.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C105555; High grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0465 ! OVCAR-3

SX   Female

CA   Cancer cell line

//

ID   OVCAR-3/CMV-Luc

AC   CVCL_4Y18

DR   JCRB; NIHS0732

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C105555; High grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0465 ! OVCAR-3

SX   Female

CA   Cancer cell line

//

ID   OVCAR-3/T40

AC   CVCL_DA03

SY   OVCAR-3T40

DR   GEO; GSM95435

RX   PubMed=16382445;

CC   Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C105555; High grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0465 ! OVCAR-3

SX   Female

CA   Cancer cell line

//

ID   OVCAR-3/TxT5

AC   CVCL_DA02

SY   OVCAR-3TxT5

DR   GEO; GSM95456

RX   PubMed=16382445;

CC   Selected for resistance to: ChEBI; CHEBI:4672; Docetaxel anhydrous (Taxotere).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C105555; High grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0465 ! OVCAR-3

SX   Female

CA   Cancer cell line

//

ID   OVCAR-4

AC   CVCL_1627

SY   NIH:OVCAR-4; NIH:OVCAR4; OVCAR.4; OVCAR4; Ovcar4

DR   BTO; BTO:0002561

DR   EFO; EFO_0005442

DR   BioSample; SAMN03472889

DR   CCLE; OVCAR4_OVARY

DR   ChEMBL-Cells; CHEMBL3307517

DR   ChEMBL-Targets; CHEMBL614051

DR   Cosmic; 688105

DR   Cosmic; 875860

DR   Cosmic; 897434

DR   Cosmic; 905990

DR   Cosmic; 974295

DR   Cosmic; 1044240

DR   Cosmic; 1092624

DR   Cosmic; 1175884

DR   Cosmic; 1305313

DR   Cosmic; 1312355

DR   Cosmic; 1436034

DR   Cosmic; 1998466

DR   Cosmic-CLP; 905990

DR   GDSC; 905990

DR   GEO; GSM50220

DR   GEO; GSM50284

DR   GEO; GSM185137

DR   GEO; GSM185138

DR   GEO; GSM186442

DR   GEO; GSM186443

DR   GEO; GSM750829

DR   GEO; GSM784572

DR   GEO; GSM799364

DR   GEO; GSM799427

DR   GEO; GSM847107

DR   GEO; GSM844669

DR   GEO; GSM844670

DR   GEO; GSM851935

DR   GEO; GSM887484

DR   GEO; GSM888565

DR   GEO; GSM1153436

DR   GEO; GSM1181279

DR   GEO; GSM1181286

DR   GEO; GSM1374801

DR   GEO; GSM1670318

DR   SKY/M-FISH/CGH; 2817

RX   PubMed=2041050;

RX   PubMed=2307530;

RX   PubMed=9041185;

RX   PubMed=12080474;

RX   PubMed=12960427;

RX   PubMed=17088437;

RX   PubMed=19372543;

RX   PubMed=22336246;

RX   PubMed=22460905;

RX   PubMed=23839242;

RX   PubMed=23856246;

RX   PubMed=23933261;

RX   PubMed=24023729;

RX   PubMed=25485619;

RX   PubMed=25984343;

RX   PubMed=27235858;

RX   PubMed=27397505;

RX   PubMed=27807467;

RX   PubMed=28196595;

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=23

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: JFCR39 cancer cell line panel.

CC   Part of: KuDOS 95 cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: NCI60 cancer cell line panel.

CC   Doubling time: 43 hours (PubMed=25984343); 41.4 hours (DTP).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; PubMed=19372543; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 9

ST   D16S539: 11

ST   D18S51: 15

ST   D19S433: 13,15

ST   D21S11: 28,31

ST   D2S1338: 23

ST   D3S1358: 15

ST   D5S818: 13

ST   D7S820: 10,11

ST   D8S1179: 13

ST   FGA: 21

ST   Penta D: 12,14

ST   Penta E: 11

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 14,18

DI   NCIt; C105555; High grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OVCAR-5

AC   CVCL_1628

SY   NIH:OVCAR-5; OVCAR.5; OVCAR5; Ovcar5; OVCA5

DR   BTO; BTO:0001870

DR   CLO; CLO_0008280

DR   EFO; EFO_0005443

DR   CLDB; cl3781

DR   BioSample; SAMN03472888

DR   ChEMBL-Cells; CHEMBL3307565

DR   ChEMBL-Targets; CHEMBL614214

DR   Cosmic; 875861

DR   Cosmic; 897435

DR   Cosmic; 905969

DR   Cosmic; 974297

DR   Cosmic; 1044241

DR   Cosmic; 1092625

DR   Cosmic; 1102824

DR   Cosmic; 1175885

DR   Cosmic; 1305314

DR   Cosmic; 1312356

DR   Cosmic; 1436035

DR   Cosmic; 1523763

DR   Cosmic; 1707573

DR   Cosmic; 1709255

DR   Cosmic; 1995605

DR   Cosmic; 1998467

DR   Cosmic; 2186583

DR   Cosmic-CLP; 905969

DR   GDSC; 905969

DR   GEO; GSM50221

DR   GEO; GSM50285

DR   GEO; GSM185139

DR   GEO; GSM185140

DR   GEO; GSM659394

DR   GEO; GSM750830

DR   GEO; GSM784573

DR   GEO; GSM799365

DR   GEO; GSM799428

DR   GEO; GSM847108

DR   GEO; GSM844671

DR   GEO; GSM851936

DR   GEO; GSM1153437

DR   GEO; GSM1181280

DR   GEO; GSM1181287

DR   GEO; GSM1374802

DR   GEO; GSM1670319

DR   SKY/M-FISH/CGH; 2818

RX   PubMed=2041050;

RX   PubMed=2307530;

RX   PubMed=9041185;

RX   PubMed=12417041;

RX   PubMed=12960427;

RX   PubMed=17088437;

RX   PubMed=19372543;

RX   PubMed=22328975;

RX   PubMed=22336246;

RX   PubMed=22710073;

RX   PubMed=23415752;

RX   PubMed=23856246;

RX   PubMed=23933261;

RX   PubMed=24023729;

RX   PubMed=24434149;

RX   PubMed=25485619;

RX   PubMed=27235858;

RX   PubMed=27397505;

RX   PubMed=27561551;

RX   PubMed=27807467;

RX   PubMed=28196595;

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=24

WW   http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=OVCA5

WW   http://tcpaportal.org/mclp/

CC   Part of: JFCR39 cancer cell line panel.

CC   Part of: KuDOS 95 cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: NCI60 cancer cell line panel.

CC   Doubling time: 48.8 hours (DTP).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Exosome proteome analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; PubMed=19372543; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 10,13

ST   D16S539: 11

ST   D18S51: 12

ST   D19S433: 13,14

ST   D21S11: 31

ST   D2S1338: 17,23

ST   D3S1358: 15,16

ST   D5S818: 11,13

ST   D7S820: 10

ST   D8S1179: 13,14

ST   FGA: 23

ST   Penta D: 12

ST   Penta E: 9,16

ST   TH01: 7,9.3

ST   TPOX: 8,11

ST   vWA: 16

DI   NCIt; C105555; High grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OVCAR-7

AC   CVCL_DG79

SY   OVCAR7

DR   GEO; GSM185141

DR   GEO; GSM185142

RX   PubMed=2307530;

RX   PubMed=9041185;

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OVCAR-8

AC   CVCL_1629

SY   NIH:OVCAR-8; OVCAR8; Ovcar8; OVCAR.8; OVCA8

DR   BTO; BTO:0003054

DR   EFO; EFO_0005444

DR   BioSample; SAMN03472794

DR   CCLE; OVCAR8_OVARY

DR   ChEMBL-Cells; CHEMBL3307975

DR   ChEMBL-Targets; CHEMBL612555

DR   Cosmic; 688106

DR   Cosmic; 875862

DR   Cosmic; 905991

DR   Cosmic; 974298

DR   Cosmic; 1044242

DR   Cosmic; 1092626

DR   Cosmic; 1312357

DR   Cosmic; 1305315

DR   Cosmic; 1436036

DR   Cosmic; 1523764

DR   Cosmic; 1526923

DR   Cosmic; 1998468

DR   Cosmic; 2186582

DR   Cosmic-CLP; 905991

DR   GDSC; 905991

DR   GEO; GSM50222

DR   GEO; GSM50286

DR   GEO; GSM185143

DR   GEO; GSM185144

DR   GEO; GSM322534

DR   GEO; GSM322535

DR   GEO; GSM322536

DR   GEO; GSM459646

DR   GEO; GSM459647

DR   GEO; GSM750819

DR   GEO; GSM750831

DR   GEO; GSM784574

DR   GEO; GSM799366

DR   GEO; GSM799429

DR   GEO; GSM847109

DR   GEO; GSM844672

DR   GEO; GSM844673

DR   GEO; GSM851937

DR   GEO; GSM887485

DR   GEO; GSM888566

DR   GEO; GSM1153438

DR   GEO; GSM1181299

DR   GEO; GSM1181339

DR   GEO; GSM1374803

DR   GEO; GSM1670320

DR   SKY/M-FISH/CGH; 1437

RX   DOI=10.4172/2157-7145.S2-005;

RX   PubMed=2041050;

RX   PubMed=2307530;

RX   PubMed=9041185;

RX   PubMed=12417041;

RX   PubMed=12960427;

RX   PubMed=17088437;

RX   PubMed=19372543;

RX   PubMed=22336246;

RX   PubMed=22460905;

RX   PubMed=22710073;

RX   PubMed=23415752;

RX   PubMed=23839242;

RX   PubMed=23856246;

RX   PubMed=23933261;

RX   PubMed=24023729;

RX   PubMed=25485619;

RX   PubMed=25984343;

RX   PubMed=27235858;

RX   PubMed=27397505;

RX   PubMed=27807467;

RX   PubMed=28196595;

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=25

WW   http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=OVCA8

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: JFCR39 cancer cell line panel.

CC   Part of: KuDOS 95 cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: NCI60 cancer cell line panel.

CC   Doubling time: 25 hours (PubMed=25984343); 26.1 hours (DTP).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'OVACAR8' in Cosmic 1526923.

CC   Misspelling: Occasionally 'OVOCAR-8'.

CC   Misspelling: Occasionally 'OVOCAR8'.

ST   Source(s): Cosmic-CLP; DOI=10.4172/2157-7145.S2-005; PubMed=19372543; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 12

ST   D16S539: 13

ST   D18S51: 14

ST   D19S433: 14,16

ST   D21S11: 28

ST   D2S1338: 19,23

ST   D3S1358: 16,18

ST   D5S818: 12

ST   D7S820: 12

ST   D8S1179: 10

ST   FGA: 20

ST   Penta D: 12

ST   Penta E: 10

ST   TH01: 7

ST   TPOX: 8

ST   vWA: 16,17

DI   NCIt; C105555; High grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OVCAR-8 RIA

AC   CVCL_IM65

DR   GEO; GSM322537

DR   GEO; GSM322538

DR   GEO; GSM322539

RX   PubMed=18822129;

CC   Transfected with: HGNC; 9388; PRKAR1A.

CC   Omics: Transcriptome analysis.

DI   NCIt; C105555; High grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1629 ! OVCAR-8

SX   Female

CA   Cancer cell line

//

ID   OVCAR-8 RIIB

AC   CVCL_IM66

DR   GEO; GSM322540

DR   GEO; GSM322541

DR   GEO; GSM322542

RX   PubMed=18822129;

CC   Transfected with: HGNC; 9392; PRKAR2B.

CC   Omics: Transcriptome analysis.

DI   NCIt; C105555; High grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1629 ! OVCAR-8

SX   Female

CA   Cancer cell line

//

ID   OVCAR3-533533-R1

AC   CVCL_DH37

SY   533533-R1

DR   GEO; GSM1186817

DR   GEO; GSM1186822

DR   GEO; GSM1186828

RX   PubMed=24004674;

CC   Selected for resistance to: ChEBI; CHEBI:132239; PHA-533533.

DI   NCIt; C105555; High grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0465 ! OVCAR-3

SX   Female

CA   Cancer cell line

//

ID   OVCAR3-533533-R3

AC   CVCL_DH38

DR   GEO; GSM1186818

DR   GEO; GSM1186823

DR   GEO; GSM1186829

RX   PubMed=24004674;

CC   Selected for resistance to: ChEBI; CHEBI:132239; PHA-533533.

DI   NCIt; C105555; High grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0465 ! OVCAR-3

SX   Female

CA   Cancer cell line

//

ID   OVCAR3-533533-R5

AC   CVCL_DH39

DR   GEO; GSM1186819

DR   GEO; GSM1186824

DR   GEO; GSM1186830

RX   PubMed=24004674;

CC   Selected for resistance to: ChEBI; CHEBI:132239; PHA-533533.

DI   NCIt; C105555; High grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0465 ! OVCAR-3

SX   Female

CA   Cancer cell line

//

ID   OVCAR3-533533-R6

AC   CVCL_DH40

SY   533533-R6

DR   GEO; GSM1186820

DR   GEO; GSM1186825

DR   GEO; GSM1186831

RX   PubMed=24004674;

CC   Selected for resistance to: ChEBI; CHEBI:132239; PHA-533533.

DI   NCIt; C105555; High grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0465 ! OVCAR-3

SX   Female

CA   Cancer cell line

//

ID   OVCAR3-533533-R7

AC   CVCL_DH41

DR   GEO; GSM1186821

DR   GEO; GSM1186826

DR   GEO; GSM1186832

RX   PubMed=24004674;

CC   Selected for resistance to: ChEBI; CHEBI:132239; PHA-533533.

DI   NCIt; C105555; High grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0465 ! OVCAR-3

SX   Female

CA   Cancer cell line

//

ID   OVHS-1

AC   CVCL_A769

SY   OVHS1

DR   Cosmic; 991319

DR   Cosmic; 1524356

DI   NCIt; C40078; Ovarian clear cell adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OVI-P

AC   CVCL_W129

SY   OVI/p; OVIP; OV1-P; OV1/p

DR   Cosmic; 688107

DR   Cosmic; 1609527

RX   PubMed=15677628;

CC   Microsatellite instability: Instable (MSI) (PubMed=15677628).

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OVISE

AC   CVCL_3116

DR   BTO; BTO:0003498

DR   EFO; EFO_0006724

DR   BioSample; SAMN03472858

DR   CCLE; OVISE_OVARY

DR   CGH-DB; 330-2

DR   Cosmic; 1223316

DR   Cosmic; 1328065

DR   Cosmic; 1434893

DR   Cosmic; 1708377

DR   Cosmic; 1995606

DR   Cosmic; 2074246

DR   Cosmic-CLP; 1240198

DR   GDSC; 1240198

DR   GEO; GSM659395

DR   GEO; GSM827222

DR   GEO; GSM888567

DR   GEO; GSM1176280

DR   GEO; GSM1670321

DR   JCRB; JCRB1043

DR   JCRB; NIHS0296

DR   JCRB; NIHS0338

DR   PRIDE; PXD000901

DR   PRIDE; PXD003105

RX   DOI=10.5795/jjscc.31.966;

RX   PubMed=9328139;

RX   PubMed=15677628;

RX   PubMed=17671176;

RX   PubMed=22460905;

RX   PubMed=23839242;

RX   PubMed=24023729;

RX   PubMed=25485619;

RX   PubMed=25984343;

RX   PubMed=26972028;

RX   PubMed=27141528;

RX   PubMed=27397505;

RX   PubMed=27561551;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: 48 hours (PubMed=25984343).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: GPI-anchored proteins analysis by proteomics.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Discontinued: JCRB; NIHS0296; true.

CC   Discontinued: JCRB; NIHS0338; true.

CC   Derived from metastatic site: Innominate bone.

ST   Source(s): Cosmic-CLP; JCRB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 9,11

ST   D13S317: 11,12

ST   D16S539: 9

ST   D18S51: 19

ST   D21S11: 28,30

ST   D3S1358: 14,15

ST   D5S818: 10

ST   D7S820: 11,12

ST   D8S1179: 15,16

ST   FGA: 19,23

ST   Penta D: 9,11

ST   Penta E: 14

ST   TH01: 9,9.3

ST   TPOX: 8

ST   vWA: 18

DI   NCIt; C40078; Ovarian clear cell adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OVISE-3

AC   CVCL_U211

RX   PubMed=7882618;

DI   NCIt; C40078; Ovarian clear cell adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3116 ! OVISE

SX   Female

CA   Cancer cell line

//

ID   OVK18

AC   CVCL_3770

SY   OVK-18; OVK#18

DR   CLO; CLO_0051452

DR   BioSample; SAMN03472087

DR   CCLE; OVK18_OVARY

DR   Cosmic; 1066216

DR   Cosmic; 1708385

DR   Cosmic-CLP; 1480371

DR   GDSC; 1480371

DR   GEO; GSM887486

DR   GEO; GSM888568

DR   GEO; GSM1670322

DR   RCB; RCB1903

DR   TKG; TKG 0323

RX   PubMed=6584390;

RX   PubMed=22460905;

RX   PubMed=23839242;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Instable (MSI-high) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; RCB; TKG

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 8,12

ST   D16S539: 9,11

ST   D5S818: 8,13

ST   D7S820: 8 (RCB)

ST   D7S820: 8,13,14 (Cosmic-CLP; TKG)

ST   TH01: 7

ST   TPOX: 8,11

ST   vWA: 17,18

DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OVK18#102

AC   CVCL_7171

DR   CLO; CLO_0051453

DR   BioSample; SAMN03471921

DR   Cosmic; 1066217

DR   RCB; RCB2535

DR   TKG; TKG 0357

ST   Source(s): RCB; TKG

ST   Amelogenin: X

ST   CSF1PO: 10,12 (RCB)

ST   CSF1PO: 10 (TKG)

ST   D13S317: 9,12

ST   D16S539: 9,11

ST   D5S818: 8,11 (RCB)

ST   D5S818: 8,11,12 (TKG)

ST   D7S820: 8 (RCB)

ST   D7S820: 8,13 (TKG)

ST   TH01: 7

ST   TPOX: 8,11

ST   vWA: 17,18

DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3770 ! OVK18

SX   Female

CA   Cancer cell line

//

ID   OVKATE

AC   CVCL_3110

DR   BTO; BTO:0003503

DR   EFO; EFO_0006725

DR   BioSample; SAMN03472859

DR   CCLE; OVKATE_OVARY

DR   CGH-DB; 338-2

DR   Cosmic; 1995607

DR   Cosmic-CLP; 1240199

DR   GDSC; 1240199

DR   GEO; GSM659396

DR   GEO; GSM887487

DR   GEO; GSM888569

DR   GEO; GSM1670323

DR   JCRB; JCRB1044

DR   JCRB; NIHS0297

DR   JCRB; NIHS0339

RX   PubMed=9328139;

RX   PubMed=15677628;

RX   PubMed=17671176;

RX   PubMed=22460905;

RX   PubMed=23839242;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=27561551;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: JCRB; NIHS0297; true.

CC   Discontinued: JCRB; NIHS0339; true.

ST   Source(s): Cosmic-CLP; JCRB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 12

ST   D16S539: 9

ST   D18S51: 12

ST   D19S433: 14,15.2

ST   D21S11: 30,33.2

ST   D2S1338: 18,23

ST   D3S1358: 18

ST   D5S818: 9,13

ST   D7S820: 11,12

ST   D8S1179: 11

ST   FGA: 19

ST   Penta D: 9,13

ST   Penta E: 5,11

ST   TH01: 9

ST   TPOX: 8,11

ST   vWA: 18

DI   NCIt; C105555; High grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OVMANA

AC   CVCL_3111

DR   BTO; BTO:0003500

DR   EFO; EFO_0006726

DR   BioSample; SAMN03472488

DR   CCLE; OVMANA_OVARY

DR   CGH-DB; 337-2

DR   Cosmic; 1223317

DR   Cosmic; 1305330

DR   Cosmic; 1328066

DR   Cosmic; 1434894

DR   Cosmic; 1708384

DR   Cosmic; 2074247

DR   GEO; GSM459731

DR   GEO; GSM659397

DR   GEO; GSM887488

DR   GEO; GSM888570

DR   GEO; GSM1176281

DR   JCRB; JCRB1045

DR   JCRB; NIHS0298

DR   JCRB; NIHS0340

DR   PRIDE; PXD003105

RX   PubMed=9328139;

RX   PubMed=15677628;

RX   PubMed=17671176;

RX   PubMed=22460905;

RX   PubMed=22710073;

RX   PubMed=23839242;

RX   PubMed=24023729;

RX   PubMed=25485619;

RX   PubMed=25984343;

RX   PubMed=26972028;

RX   PubMed=27141528;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: 70 hours (PubMed=25984343).

CC   Omics: Deep RNAseq analysis.

CC   Omics: GPI-anchored proteins analysis by proteomics.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: JCRB; NIHS0298; true.

CC   Discontinued: JCRB; NIHS0340; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12,13

ST   D13S317: 8,9

ST   D16S539: 10

ST   D5S818: 13

ST   D7S820: 10,11

ST   TH01: 7,9

ST   TPOX: 8

ST   vWA: 15,16

DI   NCIt; C40078; Ovarian clear cell adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OVMIU

AC   CVCL_3112

DR   BioSample; SAMN03151882

DR   BioSample; SAMN03472489

DR   Cosmic; 1995608

DR   Cosmic-CLP; 1240200

DR   GDSC; 1240200

DR   GEO; GSM827252

DR   GEO; GSM1670324

DR   JCRB; JCRB1049

DR   JCRB; NIHS0302

DR   JCRB; NIHS0344

RX   PubMed=20143388;

RX   PubMed=27397505;

WW   http://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/summary.htm

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a OVSAYO derivative (PubMed=20143388).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Discontinued: JCRB; NIHS0302; true.

CC   Discontinued: JCRB; NIHS0344; true.

ST   Source(s): Cosmic-CLP; JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,11

ST   D16S539: 9,10

ST   D5S818: 11,12

ST   D7S820: 10,12

ST   TH01: 7

ST   TPOX: 9,11

ST   vWA: 17,18

DI   NCIt; C105555; High grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3115 ! OVSAYO

SX   Female

CA   Cancer cell line

//

ID   OVMIU-II

AC   CVCL_3113

DR   BioSample; SAMN03472490

DR   JCRB; JCRB1050

DR   JCRB; NIHS0303

DR   JCRB; NIHS0345

CC   Discontinued: JCRB; NIHS0303; true.

CC   Discontinued: JCRB; NIHS0345; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 14

ST   D16S539: 11

ST   D5S818: 13

ST   D7S820: 13,14

ST   TH01: 9

ST   TPOX: 9,11

ST   vWA: 14

DI   NCIt; C7700; Ovarian adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OVNIS

AC   CVCL_3409

DR   CLO; CLO_0008281

DR   CLDB; cl3782

DR   ECACC; 93122324

CC   Discontinued: ECACC; 93122324; probable.

OX   NCBI_TaxID=9940; ! Ovis aries

CA   Undefined cell line type

//

ID   OVSAHO

AC   CVCL_3114

DR   BTO; BTO:0003502

DR   EFO; EFO_0006727

DR   BioSample; SAMN03472860

DR   CCLE; OVSAHO_OVARY

DR   CGH-DB; 334-2

DR   GEO; GSM459648

DR   GEO; GSM659398

DR   GEO; GSM887489

DR   GEO; GSM888571

DR   JCRB; JCRB1046

DR   JCRB; NIHS0299

DR   JCRB; NIHS0341

DR   PRIDE; PXD003105

RX   PubMed=9328139;

RX   PubMed=15677628;

RX   PubMed=17671176;

RX   PubMed=22460905;

RX   PubMed=23839242;

RX   PubMed=25485619;

RX   PubMed=26972028;

RX   PubMed=27141528;

RX   PubMed=27561551;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: GPI-anchored proteins analysis by proteomics.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: JCRB; NIHS0299; true.

CC   Discontinued: JCRB; NIHS0341; true.

ST   Source(s): JCRB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 8

ST   D16S539: 9

ST   D18S51: 16,20

ST   D21S11: 31

ST   D3S1358: 15

ST   D5S818: 12,13

ST   D7S820: 8,10

ST   D8S1179: 14

ST   FGA: 24

ST   Penta D: 9

ST   Penta E: 15

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 14

DI   NCIt; C105555; High grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OVSAYO

AC   CVCL_3115

DR   BTO; BTO:0003501

DR   JCRB; JCRB1047

DR   JCRB; NIHS0300

DR   JCRB; NIHS0342

DR   PRIDE; PXD003105

RX   PubMed=9328139;

RX   PubMed=15677628;

RX   PubMed=24023729;

RX   PubMed=26972028;

RX   PubMed=27141528;

CC   Omics: GPI-anchored proteins analysis by proteomics.

CC   Discontinued: JCRB; NIHS0300; true.

CC   Discontinued: JCRB; NIHS0342; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,11

ST   D16S539: 9,10

ST   D5S818: 11,12

ST   D7S820: 10,12

ST   TH01: 7

ST   TPOX: 9,11

ST   vWA: 17,18

DI   NCIt; C105555; High grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OVT2

AC   CVCL_W292

RX   PubMed=12080474;

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OVTOKO

AC   CVCL_3117

DR   BTO; BTO:0003499

DR   EFO; EFO_0006728

DR   BioSample; SAMN03472861

DR   CCLE; OVTOKO_OVARY

DR   CGH-DB; 331-2

DR   Cosmic; 1223318

DR   Cosmic; 1328067

DR   Cosmic; 1434895

DR   Cosmic; 1708379

DR   Cosmic; 1889263

DR   Cosmic; 2074248

DR   Cosmic-CLP; 1298365

DR   GDSC; 1298365

DR   GEO; GSM459732

DR   GEO; GSM659399

DR   GEO; GSM827253

DR   GEO; GSM887490

DR   GEO; GSM888572

DR   GEO; GSM1176282

DR   GEO; GSM1670325

DR   JCRB; JCRB1048

DR   JCRB; NIHS0301

DR   JCRB; NIHS0343

RX   PubMed=9328139;

RX   PubMed=15677628;

RX   PubMed=17671176;

RX   PubMed=22460905;

RX   PubMed=23430509;

RX   PubMed=23839242;

RX   PubMed=24023729;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: JCRB; NIHS0301; true.

CC   Discontinued: JCRB; NIHS0343; true.

CC   Derived from metastatic site: Spleen.

ST   Source(s): Cosmic-CLP; JCRB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,12

ST   D16S539: 11,12

ST   D18S51: 19

ST   D21S11: 29,31

ST   D3S1358: 15

ST   D5S818: 11,12

ST   D7S820: 9,10

ST   D8S1179: 10,14

ST   FGA: 21,23

ST   Penta D: 9,10

ST   Penta E: 14

ST   TH01: 6,9.3

ST   TPOX: 8,12

ST   vWA: 14,17

DI   NCIt; C40078; Ovarian clear cell adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OVXF 1023

AC   CVCL_D166

SY   OVXF1023

DR   ChEMBL-Cells; CHEMBL3308696

DR   ChEMBL-Targets; CHEMBL615008

DI   NCIt; C7700; Ovarian adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OVXF 1353

AC   CVCL_D167

SY   OVXF1353

DR   ChEMBL-Cells; CHEMBL3307799

DR   ChEMBL-Targets; CHEMBL612271

DI   NCIt; C7700; Ovarian adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OVXF 1544

AC   CVCL_D168

DI   NCIt; C7700; Ovarian adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OVXF 1619L

AC   CVCL_D169

DI   NCIt; C7700; Ovarian adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OVXF 899L

AC   CVCL_D170

SY   OVXF 899

DI   NCIt; C7700; Ovarian adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OX-1

AC   CVCL_G677

SY   OX1

DR   ECACC; 84112004

CC   Monoclonal antibody target: UniProtKB; P04157; Rat Ptprc/Cd45.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-101

AC   CVCL_U017

SY   OX101

DR   ECACC; 03062503

CC   Monoclonal antibody target: UniProtKB; P97829; Rat Cd47.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-102

AC   CVCL_U018

SY   OX102

DR   ECACC; 03062504

CC   Monoclonal antibody target: UniProtKB; Q9ES58; Rat Cd200r1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-104

AC   CVCL_U019

SY   OX104

DR   ECACC; 03062505

CC   Monoclonal antibody target: UniProtKB; P41217; Human CD200.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-106

AC   CVCL_X517

SY   OX106

DR   ECACC; 13082220

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-108

AC   CVCL_X518

SY   OX108

DR   ECACC; 13082222

CC   Monoclonal antibody target: UniProtKB; Q8TD46; Human CD200R1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-109

AC   CVCL_U020

SY   OX109

DR   ECACC; 13082223

CC   Monoclonal antibody target: UniProtKB; Q8TD46; Human CD200R1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-110

AC   CVCL_X519

SY   OX110

DR   ECACC; 13082225

RX   PubMed=23691022;

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   OX-114

AC   CVCL_U021

SY   OX114

DR   ECACC; 13082227

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   OX-115

AC   CVCL_X520

SY   OX115

DR   ECACC; 13082229

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   OX-116

AC   CVCL_X521

SY   OX116

DR   ECACC; 13082231

RX   PubMed=15294972;

CC   Monoclonal antibody target: UniProtKB; Q9P1W8; Human SIRPG.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-117

AC   CVCL_X522

SY   OX117

DR   ECACC; 13082233

RX   PubMed=15294972;

CC   Monoclonal antibody target: UniProtKB; Q9P1W8; Human SIRPG.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-118

AC   CVCL_X523

SY   OX118

DR   ECACC; 13082235

RX   PubMed=15294972;

CC   Monoclonal antibody target: UniProtKB; Q9P1W8; Human SIRPG.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-119

AC   CVCL_X524

SY   OX119

DR   ECACC; 13082237

RX   PubMed=15294972;

CC   Monoclonal antibody target: UniProtKB; Q9P1W8; Human SIRPG.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-12

AC   CVCL_G678

SY   OX12

DR   ECACC; 88051301

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-129

AC   CVCL_X525

SY   OX129

DR   ECACC; 13082239

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-131

AC   CVCL_X526

SY   OX131

DR   ECACC; 13082241

RX   PubMed=23691022;

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   OX-132

AC   CVCL_U022

SY   OX132

DR   ECACC; 13082243

RX   PubMed=23691022;

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   OX-14

AC   CVCL_G679

SY   OX14

DR   ECACC; 87112401

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-17

AC   CVCL_J180

SY   MRC-OX17; OX17

DR   ECACC; 84112010

RX   PubMed=6178598;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-18

AC   CVCL_G680

SY   MRC-OX18; OX18

DR   ECACC; 84112011

RX   PubMed=6178598;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-19

AC   CVCL_G681

SY   OX19

DR   ECACC; 84112012

CC   Monoclonal antibody target: UniProtKB; P51882; Rat Cd5.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-2

AC   CVCL_G682

SY   OX2

DR   ECACC; 84112005

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-20

AC   CVCL_G683

SY   OX20

DR   ECACC; 88070801

CC   Discontinued: ECACC; 88070801; probable.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   OX-21

AC   CVCL_G684

SY   OX21

DR   ECACC; 91060417

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-22

AC   CVCL_G685

SY   OX22

DR   ECACC; 84112013

CC   Monoclonal antibody target: UniProtKB; P04157; Rat Ptprc/Cd45.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-23

AC   CVCL_U023

SY   MRC OX-23; MRC-OX23; OX23

DR   ECACC; 00010402

RX   PubMed=6199050;

CC   Monoclonal antibody target: UniProtKB; P08603; Human CFH.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   OX-24

AC   CVCL_U024

SY   MRC OX-24; MRC-OX24; OX24

DR   ECACC; 00010403

RX   PubMed=6199050;

CC   Monoclonal antibody target: UniProtKB; P08603; Human CFH.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   OX-26

AC   CVCL_J181

SY   OX26

DR   ECACC; 84112014

CC   Monoclonal antibody target: UniProtKB; Q99376; Rat Tfrc/Cd71.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   OX-27

AC   CVCL_J182

SY   OX27

DR   ECACC; 84112015

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-29

AC   CVCL_J183

SY   OX29

DR   ECACC; 88070802

CC   Monoclonal antibody target: UniProtKB; P04157; Rat Ptprc/Cd45.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   OX-3

AC   CVCL_J184

SY   MRC-OX3; OX3

DR   ECACC; 84112006

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-30

AC   CVCL_J185

SY   OX30

DR   ECACC; 86100901

CC   Monoclonal antibody target: UniProtKB; P04157; Rat Ptprc/Cd45.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   OX-32

AC   CVCL_G686

SY   OX32

DR   ECACC; 88051302

CC   Monoclonal antibody target: UniProtKB; P04157; Rat Ptprc/Cd45.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-33

AC   CVCL_J186

SY   OX33

DR   ECACC; 86100902

CC   Monoclonal antibody target: UniProtKB; P04157; Rat Ptprc/Cd45.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   OX-34

AC   CVCL_J187

SY   OX34

DR   ECACC; 86100903

CC   Monoclonal antibody target: UniProtKB; P08921; Rat Cd2.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   OX-35 clone 5

AC   CVCL_J188

DR   ECACC; 89041184

CC   Monoclonal antibody target: UniProtKB; P05540; Rat Cd4.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   OX-36 clone 3

AC   CVCL_J189

DR   ECACC; 91051422

CC   Monoclonal antibody target: UniProtKB; P05540; Rat Cd4.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   OX-38

AC   CVCL_J190

SY   OX38

DR   ECACC; 88051303

CC   Monoclonal antibody target: UniProtKB; P05540; Rat Cd4.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   OX-39

AC   CVCL_J191

SY   OX39

DR   ECACC; 86100905

RX   PubMed=2828930;

CC   Monoclonal antibody target: UniProtKB; P26897; Rat Il2ra/Cd25.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   OX-40

AC   CVCL_J192

SY   OX40

DR   ECACC; 86100906

RX   PubMed=2828930;

CC   Monoclonal antibody target: UniProtKB; P15725; Rat Tnfrsf4.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-41

AC   CVCL_J193

SY   OX41

DR   ECACC; 88051304

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   OX-42

AC   CVCL_J194

SY   OX42

DR   ECACC; 87081803

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   OX-43

AC   CVCL_J195

SY   OX43

DR   ECACC; 87081804

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   OX-44

AC   CVCL_J196

SY   OX44

DR   ECACC; 92102355

CC   Monoclonal antibody target: UniProtKB; P24485; Rat Cd53.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   OX-45

AC   CVCL_J197

SY   OX45

DR   ECACC; 86100910

RX   PubMed=2942461;

CC   Monoclonal antibody target: UniProtKB; P10252; Rat Cd48.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   OX-46

AC   CVCL_U025

SY   OX46

DR   ECACC; 13082205

RX   PubMed=2942461;

CC   Monoclonal antibody target: UniProtKB; P10252; Rat Cd48.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   OX-47

AC   CVCL_J198

SY   OX47

DR   ECACC; 90071611

RX   PubMed=2828930;

CC   Discontinued: ECACC; 90071611; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   OX-48

AC   CVCL_X512

SY   OX48

DR   ECACC; 13082207

RX   PubMed=2828930;

RX   PubMed=14734622;

CC   Monoclonal antibody target: UniProtKB; O35531; Rat Cd86.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   OX-49

AC   CVCL_J199

SY   OX49

DR   ECACC; 91062501

RX   PubMed=2828930;

CC   Monoclonal antibody target: UniProtKB; P26051; Rat Cd44.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   OX-50

AC   CVCL_J200

SY   OX50

DR   ECACC; 91062502

RX   PubMed=2828930;

CC   Monoclonal antibody target: UniProtKB; P26051; Rat Cd44.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   OX-52

AC   CVCL_J201

SY   OX52

DR   ECACC; 87081805

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   OX-53

AC   CVCL_J202

SY   OX53

DR   ECACC; 89081707

CC   Monoclonal antibody target: UniProtKB; P08921; Rat Cd2.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   OX-54

AC   CVCL_J203

SY   OX54

DR   ECACC; 88070803

CC   Monoclonal antibody target: UniProtKB; P08921; Rat Cd2.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   OX-55

AC   CVCL_J204

SY   OX55

DR   ECACC; 88070804

CC   Monoclonal antibody target: UniProtKB; P08921; Rat Cd2.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   OX-57

AC   CVCL_J205

SY   OX57

DR   ECACC; 91051424

CC   Monoclonal antibody target: UniProtKB; P13838; Rat Spn.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-58

AC   CVCL_J206

SY   OX58

DR   ECACC; 91051425

CC   Monoclonal antibody target: UniProtKB; P13838; Rat Spn.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-59

AC   CVCL_J207

SY   OX59

DR   ECACC; 92102356

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-6

AC   CVCL_J208

SY   MRC-OX6; OX6

DR   ECACC; 84112007

RX   PubMed=6178598;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-60

AC   CVCL_J209

SY   OX60

DR   ECACC; 92102357

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   OX-61

AC   CVCL_J210

SY   OX61

DR   ECACC; 91100409

CC   Monoclonal antibody target: UniProtKB; P14740; Rat Dpp4/Cd26.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   OX-62

AC   CVCL_J211

SY   OX62

DR   ECACC; 91061805

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   OX-68

AC   CVCL_J212

SY   OX68

DR   ECACC; 94011007

CC   Monoclonal antibody target: UniProtKB; P05540; Rat Cd4.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   OX-7

AC   CVCL_J213

SY   OX7

DR   ECACC; 84112008

CC   Monoclonal antibody target: UniProtKB; P01830; Rat Thy1/Cd90.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-74

AC   CVCL_J214

SY   OX74

DR   ECACC; 91051426

CC   Monoclonal antibody target: UniProtKB; P13838; Rat Spn.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-75

AC   CVCL_J215

SY   OX75

DR   ECACC; 91051427

CC   Monoclonal antibody target: UniProtKB; P13838; Rat Spn.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-76

AC   CVCL_U026

SY   OX76

DR   ECACC; 13082209

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-78

AC   CVCL_J216

SY   OX78

DR   ECACC; 92102358

CC   Monoclonal antibody target: UniProtKB; P18181; Mouse Cd48.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   OX-8

AC   CVCL_J217

SY   OX8

DR   ECACC; 84112009

CC   Monoclonal antibody target: UniProtKB; P07725; Rat Cd8a.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-80

AC   CVCL_U027

SY   OX80

DR   ECACC; 13082211

CC   Monoclonal antibody target: UniProtKB; Q61451; Mouse Cd53.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   OX-81

AC   CVCL_J218

SY   OX81

DR   ECACC; 95040518

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-82

AC   CVCL_X513

SY   OX82

DR   ECACC; 13082213

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-83

AC   CVCL_X514

SY   OX83

DR   ECACC; 13082214

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-85

AC   CVCL_J219

SY   OX85

DR   ECACC; 95111405

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-86

AC   CVCL_J220

SY   OX86

DR   ECACC; 96110601

CC   Monoclonal antibody target: UniProtKB; P47741; Mouse Tnfrsf4.

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-87

AC   CVCL_J221

SY   OX87

DR   ECACC; 95102516

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-89

AC   CVCL_U028

SY   OX89

DR   ECACC; 03062501

RX   PubMed=11359859;

CC   Monoclonal antibody target: UniProtKB; P43488; Mouse Tnfsf4/Cd252.

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-90

AC   CVCL_U029

SY   OX90

DR   ECACC; 03062502

CC   Monoclonal antibody target: UniProtKB; O54901; Mouse Cd200.

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-96

AC   CVCL_X515

SY   OX96

DR   ECACC; 13082216

CC   Monoclonal antibody target: UniProtKB; P35329; Mouse Cd22.

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-97

AC   CVCL_X516

SY   OX97

DR   ECACC; 13082218

CC   Monoclonal antibody target: UniProtKB; P35329; Mouse Cd22.

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OX-CO-1

AC   CVCL_B451

SY   OXCO-1; OXCO1

DR   GEO; GSM1448134

RX   PubMed=17312135;

RX   PubMed=20606684;

RX   PubMed=25926053;

CC   Microsatellite instability: Stable (MSS) (PubMed=25926053).

CC   Omics: Transcriptome analysis.

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OX-CO-2

AC   CVCL_2H53

SY   OXCO-2; OXCO2

DR   GEO; GSM1448146

RX   PubMed=20606684;

RX   PubMed=25926053;

CC   Microsatellite instability: Instable (MSI) (PubMed=25926053).

CC   Omics: Transcriptome analysis.

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OX-CO-3

AC   CVCL_B452

SY   OXCO-3; OXCO3

DR   GEO; GSM1448147

RX   PubMed=17312135;

RX   PubMed=20606684;

RX   PubMed=25926053;

CC   Microsatellite instability: Stable (MSS) (PubMed=25926053).

CC   Omics: Transcriptome analysis.

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OxF1

AC   CVCL_B021

SY   OXF1

DR   ISCR; 1652

RX   PubMed=20333479;

RX   PubMed=22528356;

CC   From: University of Oxford; Oxford; UK.

CC   Registration: UK Stem Cell Bank (UKSCB); R-11-001, Steering comm. appl. SCSC10-40.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   OxF2

AC   CVCL_L185

SY   OXF2

DR   ISCR; 2230

RX   PubMed=22528356;

WW   http://www.nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_lines/available_human_cell_lines/laboratory_grade/oxf2.aspx

CC   From: University of Oxford; Oxford; UK.

CC   Registration: UK Stem Cell Bank (UKSCB); R-11-002, Steering comm. appl. SCSC10-38.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   OxF3

AC   CVCL_L186

SY   OXF3

DR   ISCR; 2231

RX   PubMed=22528356;

CC   From: University of Oxford; Oxford; UK.

CC   Registration: UK Stem Cell Bank (UKSCB); R-11-003, Steering comm. appl. SCSC10-39.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   OxF4

AC   CVCL_L187

SY   OXF4

DR   ISCR; 2232

RX   PubMed=22528356;

CC   From: University of Oxford; Oxford; UK.

CC   Registration: UK Stem Cell Bank (UKSCB); R-11-004, Steering comm. appl. SCSC10-41.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   oxMMNK1-L

AC   CVCL_AE16

RX   PubMed=26100205;

CC   Selected for resistance to: ChEBI; CHEBI:16240; Hydrogen peroxide.

CC   Transfected with: HGNC; 11730; TERT.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_M266 ! MMNK-1

CA   Telomerase immortalized cell line

//

ID   OZ [Human cholangiocarcinoma]

AC   CVCL_3118

DR   BioSample; SAMN03472539

DR   Cosmic; 1122353

DR   Cosmic; 1373552

DR   JCRB; JCRB1032

DR   JCRB; NIHS0282

RX   CelloPub=CLPUB00275;

RX   PubMed=2889643;

CC   Discontinued: JCRB; NIHS0282; true.

CC   Derived from metastatic site: Ascites.

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 8,12

ST   D16S539: 10

ST   D5S818: 13,14

ST   D7S820: 10

ST   TH01: 6,9

ST   TPOX: 9,11

ST   vWA: 14,16

DI   NCIt; C35417; Intrahepatic cholangiocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OZ [Human ESC]

AC   CVCL_B022

SY   IMHe008-A

DR   hPSCreg; IMHe008-A

DR   ISCR; 1143

RX   DOI=10.5772/25010;

RX   PubMed=20349214;

CC   From: Istanbul Memorial Hospital; Istanbul; Turkey.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   OZ [Human diffuse large B-cell lymphoma]

AC   CVCL_M710

SY   Oz

DR   Cosmic; 929818

DR   Cosmic; 2297001

DR   GEO; GSM115816

DR   GEO; GSM201347

RX   PubMed=9600110;

RX   PubMed=16960149;

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OZ-1

AC   CVCL_B023

SY   IMHe009-A

DR   hPSCreg; IMHe009-A

DR   ISCR; 1144

RX   DOI=10.5772/25010;

RX   PubMed=20349214;

CC   From: Istanbul Memorial Hospital; Istanbul; Turkey.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   OZ-2

AC   CVCL_B024

SY   IMHe010-A

DR   hPSCreg; IMHe010-A

DR   ISCR; 1145

RX   DOI=10.5772/25010;

RX   PubMed=20349214;

CC   From: Istanbul Memorial Hospital; Istanbul; Turkey.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   OZ-3

AC   CVCL_B025

SY   IMHe014-A

DR   hPSCreg; IMHe014-A

DR   ISCR; 1146

RX   DOI=10.5772/25010;

RX   PubMed=20349214;

CC   From: Istanbul Memorial Hospital; Istanbul; Turkey.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   OZ-4

AC   CVCL_B026

SY   IMHe015-A

DR   hPSCreg; IMHe015-A

DR   ISCR; 1147

RX   DOI=10.5772/25010;

RX   PubMed=20349214;

CC   From: Istanbul Memorial Hospital; Istanbul; Turkey.

DI   NCIt; C2993; Down syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   OZ-5

AC   CVCL_B027

SY   IMHe016-A

DR   hPSCreg; IMHe016-A

DR   ISCR; 1148

RX   DOI=10.5772/25010;

RX   PubMed=20349214;

CC   From: Istanbul Memorial Hospital; Istanbul; Turkey.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   OZ-6

AC   CVCL_B028

SY   IMHe017-A

DR   hPSCreg; IMHe017-A

DR   ISCR; 1149

RX   DOI=10.5772/25010;

RX   PubMed=20349214;

CC   From: Istanbul Memorial Hospital; Istanbul; Turkey.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   OZ-7

AC   CVCL_B029

SY   IMHe018-A

DR   hPSCreg; IMHe018-A

DR   ISCR; 1150

RX   DOI=10.5772/25010;

RX   PubMed=20349214;

CC   From: Istanbul Memorial Hospital; Istanbul; Turkey.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   OZ-8

AC   CVCL_B030

SY   IMHe011-A

DR   hPSCreg; IMHe011-A

DR   ISCR; 1151

RX   DOI=10.5772/25010;

RX   PubMed=20349214;

CC   From: Istanbul Memorial Hospital; Istanbul; Turkey.

DI   NCIt; C34375; Thalassemia major

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   OzA

AC   CVCL_W200

SY   OZA

RX   PubMed=3164747;

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OZB

AC   CVCL_E799

SY   TER205; TER306

DR   dbMHC; 48994

DR   ECACC; 94022545

DR   IHW; IHW9216

DR   IMGT/HLA; 11224

WW   http://bioinformatics.hsanmartino.it/ecbr/cl216.html

CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   P-1

AC   CVCL_G239

SY   P1

DR   CLO; CLO_0008286

DR   ATCC; CRL-2588

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6971 ! FOX-NY

CA   Hybridoma

//

ID   P-16(2)

AC   CVCL_6G32

RX   PubMed=3879567;

RX   PubMed=7951345;

OX   NCBI_TaxID=9823; ! Sus scrofa

CA   Spontaneously immortalized cell line

//

ID   P-6

AC   CVCL_G242

DR   CLO; CLO_0008339

DR   ATCC; CRL-2589

RX   PubMed=1426051;

CC   Monoclonal antibody target: UniProtKB; P07384; Human CAPN1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   P-9

AC   CVCL_G243

DR   CLO; CLO_0008343

DR   ATCC; CRL-2590

CC   Monoclonal antibody target: UniProtKB; P07384; Human CAPN1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   p-hiPS01

AC   CVCL_C959

DR   ISCR; 1839

RX   PubMed=19481515;

CC   From: Harvard Medical School; Boston; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2435 ! Detroit 573

SX   Female

CA   Induced pluripotent stem cell

//

ID   p-hiPS02

AC   CVCL_C960

DR   ISCR; 1840

RX   PubMed=19481515;

CC   From: Harvard Medical School; Boston; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2435 ! Detroit 573

SX   Female

CA   Induced pluripotent stem cell

//

ID   P-SC(1)

AC   CVCL_6G33

SY   P-SC

RX   PubMed=3879567;

RX   PubMed=7951345;

OX   NCBI_TaxID=9823; ! Sus scrofa

CA   Spontaneously immortalized cell line

//

ID   P-STS

AC   CVCL_L298

DR   GEO; GSM966945

RX   PubMed=19528452;

RX   PubMed=22538498;

DI   NCIt; C6422; Midgut carcinoid tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_L296 ! H-STS

OI   CVCL_L297 ! L-STS

SX   Male

CA   Cancer cell line

//

ID   P-tyr-1

AC   CVCL_G188

DR   CLO; CLO_0008521

DR   ATCC; CRL-1955

DR   BCRC; 60342

DR   ECACC; 95092903

CC   Monoclonal antibody target: ChEBI; CHEBI:74956; O(4)-phosphotyrosine.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   P.H.

AC   CVCL_S460

DR   ATCC; CRL-6177

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6177; true.

OX   NCBI_TaxID=71117; ! Paradoxurus hermaphroditus

SX   Female

CA   Finite cell line

//

ID   P0318

AC   CVCL_W189

RX   PubMed=20418894;

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   P1

AC   CVCL_Z996

DR   CLO; CLO_0008285

DR   CLDB; cl3802

DR   ECACC; 90070556

CC   Group: Insect cell line.

CC   Discontinued: ECACC; 90070556; probable.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   P1-iPSC

AC   CVCL_DD57

SY   P01-iPSC

RX   PubMed=25843045;

RX   PubMed=27191603;

ST   Source(s): PubMed=27191603

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 11,12

ST   D16S539: 10,11

ST   D21S11: 28,32.2

ST   D5S818: 11,13

ST   D7S820: 9,11

ST   TH01: 8,9.3

ST   TPOX: 8

ST   vWA: 16,17

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_DD47 ! ND30171

SX   Male

CA   Induced pluripotent stem cell

//

ID   P1.17

AC   CVCL_3564

DR   CLO; CLO_0008288

DR   ATCC; TIB-10

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   P1.1A3

AC   CVCL_A042

SY   P1-1A3

DR   BioSample; SAMN03151919

RX   PubMed=7514905;

RX   PubMed=10508494;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a SK-HEP-1 derivative (PubMed=10508494, PubMed=20143388).

CC   Characteristics: Has lost chromosome Y.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C3099; Hepatocellular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0525 ! SK-HEP-1

SX   Male

CA   Cancer cell line

//

ID   P1.1C3

AC   CVCL_A043

RX   PubMed=7514905;

CC   Problematic cell line: Possibly contaminated. May originate from SK-HEP-1 as 4 other cell lines from the same paper (PubMed=7514905) have been shown to be contaminated.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_A037 ! PEC.1

CA   Finite cell line

//

ID   P1.2C8

AC   CVCL_A044

RX   PubMed=7514905;

CC   Problematic cell line: Possibly contaminated. May originate from SK-HEP-1 as 4 other cell lines from the same paper (PubMed=7514905) have been shown to be contaminated.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_A037 ! PEC.1

CA   Finite cell line

//

ID   P1.3F6

AC   CVCL_A045

RX   PubMed=7514905;

CC   Problematic cell line: Possibly contaminated. May originate from SK-HEP-1 as 4 other cell lines from the same paper (PubMed=7514905) have been shown to be contaminated.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_A037 ! PEC.1

CA   Finite cell line

//

ID   P1.4D6

AC   CVCL_A046

SY   P1-4D6

DR   BioSample; SAMN03151920

RX   PubMed=7514905;

RX   PubMed=10508494;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a SK-HEP-1 derivative (PubMed=10508494, PubMed=20143388).

CC   Characteristics: Has lost chromosome Y.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C3099; Hepatocellular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0525 ! SK-HEP-1

SX   Male

CA   Cancer cell line

//

ID   P1.HTR

AC   CVCL_4265

SY   P1.HTR1; P1.B5.4.8.12.16.2

DR   CLO; CLO_0008289

DR   CLDB; cl3803

DR   ECACC; 87121104

RX   PubMed=3929396;

RX   PubMed=18432777;

CC   Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).

CC   Transfected with: UniProtKB; Q9QNF7; HHV-1 TK.

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21632; Mouse mast cell neoplasm

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_F735 ! P815-X2

SX   Male

CA   Cancer cell line

//

ID   P1.HTR.TK-

AC   CVCL_4266

SY   P1.HTR.tk-; P1.HTR1.tk-; P1.B5.4.8.12.16.2.1

DR   CLO; CLO_0008290

DR   CLDB; cl3804

DR   ECACC; 87121103

RX   PubMed=3929396;

CC   Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).

CC   Transfected with: UniProtKB; Q9QNF7; HHV-1 TK.

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21632; Mouse mast cell neoplasm

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4265 ! P1.HTR

SX   Male

CA   Cancer cell line

//

ID   P11-90

AC   CVCL_9U43

RX   PubMed=7586804;

CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).

CC   Breed/subspecies: Kunming.

DI   NCIt; C24068; Mouse cervical carcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_9U22 ! L10-90

OI   CVCL_9U56 ! U14

SX   Female

CA   Cancer cell line

//

ID   P114

AC   CVCL_L410

DR   GEO; GSM724827

DR   GEO; GSM724828

DR   GEO; GSM724841

DR   GEO; GSM724842

DR   GEO; GSM1075090

DR   GEO; GSM1075094

DR   GEO; GSM1075099

DR   GEO; GSM1290248

DR   GEO; GSM1290249

DR   GEO; GSM1889007

DR   GEO; GSM1889008

RX   PubMed=9042250;

RX   PubMed=20453304;

DI   NCIt; C124249; Canine mammary carcinoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   P116

AC   CVCL_6429

DR   CLO; CLO_0008292

DR   ATCC; CRL-2676

DR   BioSample; SAMN03471760

DR   GDSC; 1330986

DR   GEO; GSM827152

DR   TOKU-E; 2820

RX   PubMed=9488454;

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8,12

ST   D16S539: 11

ST   D5S818: 9

ST   D7S820: 8,11.3

ST   TH01: 6,9.3

ST   TPOX: 8,10

ST   vWA: 18,19

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0367 ! Jurkat E6.1

SX   Male

CA   Cancer cell line

//

ID   P116.cl39

AC   CVCL_6430

SY   P116.c39

DR   CLO; CLO_0008293

DR   ATCC; CRL-2677

DR   BioSample; SAMN03471762

RX   PubMed=9488454;

CC   Transfected with: HGNC; 12858; ZAP70.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8,12

ST   D16S539: 11

ST   D5S818: 9

ST   D7S820: 8,11.3

ST   TH01: 6,9.3

ST   TPOX: 8,10

ST   vWA: 19

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6429 ! P116

SX   Male

CA   Cancer cell line

//

ID   P12

AC   CVCL_CW37

SY   P 12

DR   ATCC; HB-8551

DR   NCBI_Iran; H133

RX   Patent=US4762800;

RX   Patent=US5168043;

CC   Discontinued: ATCC; HB-8551; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   P12-Ichikawa

AC   CVCL_1630

SY   P12-ICHIKAWA; P12/ICHIKAWA; P12/Ichikawa; P12ichikawa; P12/ICH; P12/ICh; P12-ICH; P-12; P12

DR   BTO; BTO:0002839

DR   CLO; CLO_0008298

DR   CLDB; cl3807

DR   BioSample; SAMN03473354

DR   CCLE; P12ICHIKAWA_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   ChEMBL-Cells; CHEMBL3307676

DR   ChEMBL-Targets; CHEMBL614660

DR   Cosmic; 721706

DR   Cosmic; 909251

DR   Cosmic; 913422

DR   Cosmic; 933543

DR   Cosmic; 1118465

DR   Cosmic; 1151789

DR   Cosmic; 1224371

DR   Cosmic; 1281381

DR   Cosmic; 1330492

DR   Cosmic; 1375582

DR   Cosmic; 1524812

DR   Cosmic; 1641387

DR   Cosmic; 1664526

DR   Cosmic; 1760529

DR   Cosmic; 2165715

DR   Cosmic-CLP; 909251

DR   DSMZ; ACC-34

DR   GDSC; 909251

DR   GEO; GSM887491

DR   GEO; GSM888573

DR   GEO; GSM1670326

RX   PubMed=6582512;

RX   PubMed=9933131;

RX   PubMed=10071127;

RX   PubMed=22460905;

RX   PubMed=22675565;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: ~40-50 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; DSMZ

ST   Amelogenin: X

ST   CSF1PO: 11,13

ST   D13S317: 10,11

ST   D16S539: 9,10

ST   D5S818: 12,13

ST   D7S820: 11,12

ST   TH01: 6,9

ST   TPOX: 8,11

ST   vWA: 18

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   P153SV40T

AC   CVCL_4874

SY   P153SV40-T

RX   PubMed=21544329;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   P1798

AC   CVCL_B453

SY   P-1798

DR   BTO; BTO:0000796

RX   PubMed=6892700;

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   P19

AC   CVCL_2153

SY   P-19

DR   BTO; BTO:0000596

DR   CLO; CLO_0008301

DR   CLO; CLO_0008302

DR   CLDB; cl3813

DR   CLDB; cl4980

DR   ATCC; CRL-1825

DR   BCRC; 60052

DR   CCRID; 3111C0001CCC000020

DR   CCRID; 3131C0001000800027

DR   CLS; 400416/p533_P19

DR   ChEMBL-Cells; CHEMBL3307297

DR   ChEMBL-Targets; CHEMBL614064

DR   DSMZ; ACC-316

DR   ECACC; 95102107

DR   ICLC; ATL99013

DR   IZSLER; BS TCL 206

DR   KCB; KCB 200844YJ

DR   NCBI_Iran; C422

DR   RSCB; RSCB0346

DR   TOKU-E; 2822

DR   Wikidata; Q7117837

RX   PubMed=7056443;

RX   PubMed=8507558;

RX   PubMed=12757864;

WW   https://en.wikipedia.org/wiki/P19_cell

WW   http://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/p19/p19cells.html

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-229.html

CC   Doubling time: ~2-3 days (DSMZ).

CC   Caution: There seems to be 3 distinct cell lines which were assigned NCBI_Iran catalog number C422.

CC   Breed/subspecies: C3H/He.

DI   NCIt; C129859; Mouse teratocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Cancer cell line

//

ID   P19C6

AC   CVCL_L988

DR   RCB; RCB1790

RX   PubMed=11414696;

CC   Breed/subspecies: C3H/He.

DI   NCIt; C129859; Mouse teratocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2153 ! P19

SX   Male

CA   Cancer cell line

//

ID   P19CL6

AC   CVCL_L981

SY   P19Cl6; P19.CL6; CL6

DR   CLO; CLO_0050544

DR   CLO; CLO_0050545

DR   RCB; RCB1539

DR   RCB; RCB2318

DR   Wikidata; Q28473091

RX   PubMed=8790939;

RX   PubMed=12757864;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-475.html

CC   Breed/subspecies: C3H/He.

DI   NCIt; C129859; Mouse teratocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2153 ! P19

SX   Male

CA   Cancer cell line

//

ID   P1Bb1.1 (DBA/2)

AC   CVCL_7693

DR   CLO; CLO_0008306

DR   CLDB; cl3816

DR   ECACC; 87121102

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21632; Mouse mast cell neoplasm

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_F735 ! P815-X2

SX   Male

CA   Cancer cell line

//

ID   P2

AC   CVCL_Z997

DR   CLO; CLO_0008307

DR   CLDB; cl3817

DR   ECACC; 90070558

CC   Group: Insect cell line.

CC   Discontinued: ECACC; 90070558; probable.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   P2 50D8

AC   CVCL_L684

DR   ATCC; HB-9506

RX   Patent=US5126258;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   P2 57G4

AC   CVCL_L685

DR   ATCC; HB-9505

RX   Patent=US5126258;

CC   Discontinued: ATCC; HB-9505; true.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   P20.1

AC   CVCL_K262

DR   CLO; CLO_0050392

DR   RCB; RCB2815

RX   PubMed=18787202;

RX   PubMed=18847346;

WW   http://www.wako-chem.co.jp/english/labchem/product/life/TARGET_Tag/

CC   Monoclonal antibody target: UniProtKB; Q96RI0; Human F2RL3/PAR4 (binds to the hexapeptide GYPGQV used in the TARGET tag system).

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   P25.15

AC   CVCL_N084

DR   ATCC; HB-9140

RX   Patent=US4970299;

RX   Patent=US5177000;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   P25.48

AC   CVCL_G240

DR   CLO; CLO_0008312

DR   ATCC; HB-9119

RX   Patent=US4970299;

RX   Patent=US5177000;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   P25.91

AC   CVCL_N085

DR   ATCC; HB-9120

RX   Patent=US4970299;

RX   Patent=US5177000;

CC   Discontinued: ATCC; HB-9120; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   P2UR/K-562

AC   CVCL_L434

DR   CLO; CLO_0050120

DR   RCB; RCB1197

CC   Transfected with: HGNC; 8541; P2RY2.

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 9,10

ST   D13S317: 8

ST   D16S539: 11,12

ST   D5S818: 11,12

ST   D7S820: 9,11

ST   TH01: 9.3

ST   TPOX: 8,9

ST   vWA: 16

DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0004 ! K-562

SX   Female

CA   Cancer cell line

//

ID   P3 6D4

AC   CVCL_L683

SY   P3 6D4 (SCRF 43.1)

DR   CLO; CLO_0008314

DR   ATCC; HB-9168

RX   Patent=US5126258;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   P3 8D2

AC   CVCL_G687

SY   P3 8D2 (SCRF 43.1)

DR   CLO; CLO_0008316

DR   ATCC; HB-9169

RX   Patent=US5126258;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   P3.6.2.8.1

AC   CVCL_3565

DR   CLO; CLO_0008318

DR   ATCC; TIB-8

DR   JCRB; JCRB9109

RX   PubMed=4758896;

CC   Breed/subspecies: BALB/c.

DI   NCIt; C125417; Mouse plasma cell myeloma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_T278 ! P3K

SX   Female

CA   Cancer cell line

//

ID   P3/NS1/1-Ag4.1

AC   CVCL_2155

SY   P3/NSI/1-AG4-1; P3/NS1/1-Ag4-1; P3/NS1/1-AG4-1; P3/NS1/Ag4-1; P3 NS1 Ag4/1; P3 NS1 Ag4; P3.NS-1/1.Ag4.1; P3-NS1/1-Ag4-1; P3-NS1/1Ag 4.1; P3/NS-1; NS1/1-Ag4.1; NS1-1 Ag4.1; NS-1-Ag4-1; NS1-Ag4/1; NS1-Ag 4/1; P3X63NS1; NS-I/1; NS-1; NS1; GM03573

DR   BTO; BTO:0001907

DR   CLO; CLO_0008317

DR   CLO; CLO_0008319

DR   CLO; CLO_0008320

DR   CLO; CLO_0017234

DR   CLO; CLO_0050176

DR   CLDB; cl3823

DR   CLDB; cl3824

DR   CLDB; cl3825

DR   CLDB; cl3826

DR   CLDB; cl3827

DR   CLDB; cl3828

DR   ATCC; TIB-18

DR   BCRC; 60036

DR   CCRID; 3111C0001CCC000384

DR   CCRID; 3111C0002000000041

DR   CCRID; 3131C0001000800025

DR   CCRID; 3142C0001000000011

DR   CLS; 400108/p2759_NS-1_(P3-NS1-Ag4-1)

DR   Coriell; GM03573

DR   DSMZ; ACC-145

DR   ECACC; 85011427

DR   IZSLER; BS TCL 50

DR   JCRB; JCRB0009

DR   JCRB; JCRB9107

DR   KCLB; 40018

DR   KCLB; 60059

DR   NCBI_Iran; C522

DR   RCB; RCB0095

DR   TKG; TKG 0233

CC   Group: Hybridoma fusion partner cell line.

CC   Doubling time: ~24 hours (DSMZ).

CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.

CC   Caution: There seems to be two distinct cell lines which were assigned NCBI_Iran catalog number C522.

CC   Breed/subspecies: BALB/c.

DI   NCIt; C125417; Mouse plasma cell myeloma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3411 ! P3X63Ag8

SX   Female

CA   Cancer cell line

//

ID   P30/OHK

AC   CVCL_1631

SY   P30-OHK; P30 OHK; P30OHK; P30/Ohkubo; P30-OHKUBO; P30/0HK

DR   CLO; CLO_0051011

DR   BioSample; SAMN01821712

DR   BioSample; SAMN03471069

DR   ChEMBL-Cells; CHEMBL3308275

DR   ChEMBL-Targets; CHEMBL2366165

DR   Cosmic; 909252

DR   Cosmic; 919141

DR   Cosmic; 998703

DR   Cosmic; 1037718

DR   Cosmic-CLP; 909252

DR   DSMZ; ACC-727

DR   GDSC; 909252

DR   GEO; GSM827254

DR   GEO; GSM1670327

DR   JCRB; JCRB0094

DR   RCB; RCB1938

DR   TKG; TKG 0463

RX   PubMed=6983990;

RX   PubMed=27397505;

CC   Doubling time: ~30 hours (DSMZ).

CC   Microsatellite instability: Instable (MSI-high) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): Cosmic-CLP; DSMZ; JCRB; RCB; TKG

ST   Amelogenin: X

ST   CSF1PO: 9,11

ST   D13S317: 10

ST   D16S539: 9

ST   D5S818: 11,12

ST   D7S820: 10,11

ST   TH01: 9

ST   TPOX: 10,11

ST   vWA: 14,21

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   P31/FUJ

AC   CVCL_1632

SY   P31-FUJ; P31 FUJ; P31FUJ; P31/Fujioka

DR   BioSample; SAMN03471067

DR   CCLE; P31FUJ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   ChEMBL-Cells; CHEMBL3308276

DR   ChEMBL-Targets; CHEMBL2366370

DR   Cosmic; 717683

DR   Cosmic; 909253

DR   Cosmic; 996318

DR   Cosmic; 998749

DR   Cosmic; 1037670

DR   Cosmic; 2089656

DR   Cosmic; 2131555

DR   Cosmic-CLP; 909253

DR   GDSC; 909253

DR   GEO; GSM827226

DR   GEO; GSM887492

DR   GEO; GSM888574

DR   GEO; GSM1670328

DR   JCRB; JCRB0091

DR   PRIDE; PXD000185

RX   PubMed=6962783;

RX   PubMed=22460905;

RX   PubMed=23955599;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Instable (MSI-high) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'P31-FUF' in Cosmic 717683.

ST   Source(s): Cosmic-CLP; JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 13,14

ST   D13S317: 9,12,13

ST   D16S539: 9,10

ST   D5S818: 11

ST   D7S820: 10

ST   TH01: 9

ST   TPOX: 7,11

ST   vWA: 19,21

DI   NCIt; C3171; Acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   P32/ISH

AC   CVCL_3119

SY   P32/ish; P32-ISH; P32 ISH; P32/Ishishida; P32

DR   BioSample; SAMN03471070

DR   Cosmic; 1995609

DR   Cosmic; 2297027

DR   Cosmic-CLP; 1330987

DR   GDSC; 1330987

DR   GEO; GSM115814

DR   GEO; GSM827227

DR   GEO; GSM1670329

DR   JCRB; JCRB0095

RX   PubMed=6667834;

RX   PubMed=16960149;

RX   PubMed=27397505;

CC   Characteristics: EBV-negative.

CC   Doubling time: 40 hours (JCRB).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): Cosmic-CLP; JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 12

ST   D16S539: 9,12

ST   D5S818: 9,10

ST   D7S820: 10,11

ST   TH01: 6,9

ST   TPOX: 8,11

ST   vWA: 14,18

DI   NCIt; C2912; Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   P388

AC   CVCL_7222

SY   P-388

DR   BTO; BTO:0000748

DR   CLO; CLO_0008321

DR   CLO; CLO_0050216

DR   CLDB; cl3829

DR   BCRJ; 0198

DR   CCRID; 3111C0002000000073

DR   ChEMBL-Cells; CHEMBL3308401

DR   ChEMBL-Targets; CHEMBL389

DR   JCRB; JCRB0017

DR   RCB; RCB2776

DR   TKG; TKG 0326

RX   PubMed=10516761;

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Cancer cell line

//

ID   P388/A20

AC   CVCL_D642

RX   PubMed=2824504;

CC   Selected for resistance to: ChEBI; CHEBI:2687; Amsacrine.

CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_D641 ! P388/amsacrine

SX   Female

CA   Cancer cell line

//

ID   P388/amsacrine

AC   CVCL_D641

RX   PubMed=3037302;

CC   Selected for resistance to: ChEBI; CHEBI:2687; Amsacrine.

CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_7222 ! P388

SX   Female

CA   Cancer cell line

//

ID   P388/BR/A

AC   CVCL_4Y67

SY   BR/A

RX   PubMed=7917900;

CC   Selected for resistance to: ChEBI; CHEBI:88353; Bryostatin-1.

CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_7222 ! P388

SX   Female

CA   Cancer cell line

//

ID   P388/BR/B

AC   CVCL_4Y68

SY   BR/B

RX   PubMed=7917900;

CC   Selected for resistance to: ChEBI; CHEBI:88353; Bryostatin-1.

CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_7222 ! P388

SX   Female

CA   Cancer cell line

//

ID   P388/BR/C

AC   CVCL_4Y69

SY   BR/C

RX   PubMed=7917900;

CC   Selected for resistance to: ChEBI; CHEBI:88353; Bryostatin-1.

CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_7222 ! P388

SX   Female

CA   Cancer cell line

//

ID   P388/BR/D

AC   CVCL_4Y70

SY   BR/D

RX   PubMed=7917900;

CC   Selected for resistance to: ChEBI; CHEBI:88353; Bryostatin-1.

CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_7222 ! P388

SX   Female

CA   Cancer cell line

//

ID   P388/CPA

AC   CVCL_4Y58

DR   ChEMBL-Cells; CHEMBL3307336

DR   ChEMBL-Targets; CHEMBL614219

RX   PubMed=6354439;

CC   Selected for resistance to: ChEBI; CHEBI:4027; Cyclophosphamide (CP; Endoxan).

CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_7222 ! P388

SX   Female

CA   Cancer cell line

//

ID   P388/CPT45

AC   CVCL_D638

SY   P388CPT45; P388/CPT; CPT45

DR   ChEMBL-Cells; CHEMBL3307567

DR   ChEMBL-Targets; CHEMBL614223

RX   PubMed=2172765;

RX   PubMed=14679002;

CC   Selected for resistance to: ChEBI; CHEBI:27656; Camptothecin (CPT).

CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_D640 ! P388/S

SX   Female

CA   Cancer cell line

//

ID   P388/DDP

AC   CVCL_1B39

DR   ChEMBL-Cells; CHEMBL3307305

DR   ChEMBL-Targets; CHEMBL614138

RX   PubMed=1556003;

CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).

CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_7222 ! P388

SX   Female

CA   Cancer cell line

//

ID   P388/Dx

AC   CVCL_9123

SY   P388/DX; P388/dx

DR   CLO; CLO_0008324

DR   CLDB; cl3832

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_7222 ! P388

SX   Female

CA   Cancer cell line

//

ID   P388/NVB-0.63

AC   CVCL_4W03

SY   P388-N.63; N.63

RX   PubMed=11488526;

RX   PubMed=18071633;

CC   Selected for resistance to: ChEBI; CHEBI:480999; Vinorelbine (Navelbine; NVB).

CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_D640 ! P388/S

SX   Female

CA   Cancer cell line

//

ID   P388/NVB-2.5

AC   CVCL_4W04

SY   P388-N2.5; N2.5

RX   PubMed=11488526;

RX   PubMed=18071633;

CC   Selected for resistance to: ChEBI; CHEBI:480999; Vinorelbine (Navelbine; NVB).

CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_D640 ! P388/S

SX   Female

CA   Cancer cell line

//

ID   P388/PtR4

AC   CVCL_4V15

SY   P388PtR4

DR   ChEMBL-Cells; CHEMBL3307340

DR   ChEMBL-Targets; CHEMBL614225

RX   PubMed=3335002;

CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).

CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_7222 ! P388

SX   Female

CA   Cancer cell line

//

ID   P388/S

AC   CVCL_D640

SY   p388/s; P388S; P388 sensitive; P388 leukemia-sensitive

DR   ChEMBL-Cells; CHEMBL3307337

DR   ChEMBL-Targets; CHEMBL614220

RX   PubMed=3037302;

CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_7222 ! P388

SX   Female

CA   Cancer cell line

//

ID   P388/VCR-20

AC   CVCL_1B38

SY   P388/VCR20

DR   ChEMBL-Cells; CHEMBL3307484

DR   ChEMBL-Targets; CHEMBL614221

CC   Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).

CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_7222 ! P388

SX   Female

CA   Cancer cell line

//

ID   P388/VFL-10

AC   CVCL_4W05

RX   PubMed=11488526;

CC   Selected for resistance to: ChEBI; CHEBI:90241; Vinflunine (VFL; Javlor).

CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_D640 ! P388/S

SX   Female

CA   Cancer cell line

//

ID   P388/VFL-2.5

AC   CVCL_4W06

RX   PubMed=11488526;

CC   Selected for resistance to: ChEBI; CHEBI:90241; Vinflunine (VFL; Javlor).

CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_D640 ! P388/S

SX   Female

CA   Cancer cell line

//

ID   P388/WT20

AC   CVCL_D643

RX   PubMed=2824504;

CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_D640 ! P388/S

SX   Female

CA   Cancer cell line

//

ID   P388D1

AC   CVCL_0477

SY   P-388D1; P388-D1; P388.D1; P3 88 D1

DR   BTO; BTO:0000984

DR   CLO; CLO_0008315

DR   CLO; CLO_0008326

DR   CLO; CLO_0008327

DR   MCCL; MCC:0000375

DR   CLDB; cl3833

DR   CLDB; cl3834

DR   ATCC; CCL-46

DR   BCRC; 60222

DR   CLS; 400308/p665_P388-D1

DR   IFO; IFO50036

DR   IZSLER; BS TCL 51

DR   JCRB; JCRB0016

DR   KCB; KCB 200775YJ

DR   KCLB; 10046

RX   PubMed=3792703;

RX   PubMed=10516761;

WW   http://www.infarktforschung.de/macrophages_cell_lines.html

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-231.html

CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_7222 ! P388

SX   Female

CA   Cancer cell line

//

ID   P388D1 (IL-1)

AC   CVCL_0625

SY   P388D1(IL-1); P388 D1 IL-1

DR   CLO; CLO_0008325

DR   CLO; CLO_0008328

DR   CLDB; cl3835

DR   ATCC; TIB-63

DR   BCRC; 60341

DR   BCRJ; 0199

DR   CCRID; 3111C0001CCC000235

DR   CCRID; 3131C0001000800011

DR   DSMZ; ACC-288

CC   Doubling time: ~30-60 hours, depending on cell density (DSMZ).

CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0477 ! P388D1

SX   Female

CA   Cancer cell line

//

ID   P388D1 clone 3124

AC   CVCL_3410

SY   P388.D1 clone 3124; P388.D1 (clone 3124); P388.D1(cl3124)

DR   CLO; CLO_0008322

DR   CLO; CLO_0008323

DR   CLDB; cl3831

DR   CLDB; cl4921

DR   ECACC; 85011439

DR   ICLC; ATL97013

CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0477 ! P388D1

SX   Female

CA   Cancer cell line

//

ID   P39

AC   CVCL_0478

SY   P39/TSU; P39-TSU; P39 TSU; P39TSU; P39/Tsugane; P39/TSUGANE; TSUGANE

DR   MCCL; MCC:0000376

DR   BioSample; SAMN03151775

DR   BioSample; SAMN03471068

DR   Cosmic; 717681

DR   Cosmic; 998740

DR   Cosmic; 2089663

DR   JCRB; JCRB0092

RX   PubMed=6597119;

RX   PubMed=12592342;

RX   PubMed=20143388;

RX   PubMed=20421273;

RX   PubMed=23955599;

WW   http://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/summary.htm

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a HL-60 derivative (PubMed=12592342, PubMed=20143388, PubMed=20421273).

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 13,14

ST   D13S317: 8,11

ST   D16S539: 11

ST   D5S818: 11,12

ST   D7S820: 11,12

ST   TH01: 7,8

ST   TPOX: 8,11

ST   vWA: 15,16

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0002 ! HL-60

SX   Female

CA   Cancer cell line

//

ID   P3D

AC   CVCL_G241

DR   CLO; CLO_0008329

DR   ATCC; HB-11129

RX   Patent=WO1994010201A1;

CC   Monoclonal antibody target: UniProtKB; Q66T51; Brugia malayi beta-tubulin (also reacts with other nematods).

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   P3H3

AC   CVCL_B066

DR   CLO; CLO_0008330

DR   CLDB; cl3836

DR   Cosmic; 931108

RX   PubMed=9473234;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2676 ! P3HR-1

SX   Male

CA   Cancer cell line

//

ID   P3HR-1

AC   CVCL_2676

SY   P 3 HR 1; P3HR1; P3HRI; P3HR1-BL; P3J HR-1; P3J-HR-1; P3JHR-1; P3JHR1; P3J HR1-K; P3J.HR1K; HR-1; HR1K

DR   CLO; CLO_0008282

DR   CLO; CLO_0008331

DR   EFO; EFO_0002312

DR   CLDB; cl3837

DR   CLDB; cl5159

DR   CLDB; cl5242

DR   ATCC; HTB-62

DR   BCRJ; 0338

DR   CCLE; P3HR1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   CGH-DB; 9199-4

DR   ChEMBL-Cells; CHEMBL3307242

DR   ChEMBL-Targets; CHEMBL612705

DR   Cosmic; 724830

DR   Cosmic; 1517661

DR   ECACC; 86010701

DR   GDSC; 1330988

DR   GEO; GSM887493

DR   GEO; GSM888575

DR   IGRhCellID; P3HR1

DR   IZSLER; BS TCL 99

RX   PubMed=170370;

RX   PubMed=327080;

RX   PubMed=1915267;

RX   PubMed=2052620;

RX   PubMed=4115493;

RX   PubMed=4122458;

RX   PubMed=4321974;

RX   PubMed=4364259;

RX   PubMed=4912237;

RX   PubMed=4932228;

RX   PubMed=6265077;

RX   PubMed=6286763;

RX   PubMed=8344493;

RX   PubMed=12967475;

RX   PubMed=19358282;

RX   PubMed=22460905;

RX   PubMed=25355872;

RX   PubMed=28196595;

WW   http://www.rccc.cytspb.rssi.ru/RussianCellBank/CellLinePerson/clP3HR-1%28P3J-HR1K%29.htm

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: MYC genetic alteration cell panel (ATCC TCP-1035).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Omics: Virome analysis using RNAseq.

ST   Source(s): ATCC; ECACC

ST   Amelogenin: X,Y (ATCC)

ST   Amelogenin: X (ECACC)

ST   CSF1PO: 10,11

ST   D13S317: 12

ST   D16S539: 10,11

ST   D5S818: 12

ST   D7S820: 8,10

ST   TH01: 7,9

ST   TPOX: 6,8

ST   vWA: 15,19

DI   NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1317 ! Jiyoye

SX   Male

CA   Cancer cell line

//

ID   P3K

AC   CVCL_T278

RX   PubMed=5439579;

CC   Breed/subspecies: BALB/c.

DI   NCIt; C125417; Mouse plasma cell myeloma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_T277 ! MOPC-21

SX   Female

CA   Cancer cell line

//

ID   P3NP

AC   CVCL_D018

CC   Group: Hybridoma fusion partner cell line.

DI   NCIt; C125417; Mouse plasma cell myeloma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   P3NP/PFn

AC   CVCL_4549

SY   P3NP/PFN

DR   CLO; CLO_0008283

DR   CLO; CLO_0008332

DR   CLDB; cl5243

DR   ATCC; HB-91

DR   IZSLER; BS Hy 18

CC   Monoclonal antibody target: UniProtKB; P02751; Human FN.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_D018 ! P3NP

CA   Hybridoma

//

ID   P3X63Ag8

AC   CVCL_3411

SY   P3-X63-Ag8; P3/X63-Ag8; P3/X63/Ag8; P3-X63Ag8; P3X63 Ag8; X63-Ag8; x63-Ag8; X63; GM03571

DR   BTO; BTO:0001118

DR   CLO; CLO_0008334

DR   CLO; CLO_0017237

DR   CLDB; cl3840

DR   CLDB; cl3841

DR   CLDB; cl7165

DR   ATCC; TIB-9

DR   BCRC; 60340

DR   CCRID; 3131C0001000800009

DR   Coriell; GM03571

DR   ECACC; 85011401

DR   ICLC; ATL05001

DR   JCRB; JCRB9105

CC   Group: Hybridoma fusion partner cell line.

CC   Doubling time: 16-26 hours (ECACC).

CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.

CC   Breed/subspecies: BALB/c.

DI   NCIt; C125417; Mouse plasma cell myeloma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_T278 ! P3K

SX   Female

CA   Cancer cell line

//

ID   P3X63Ag8.653

AC   CVCL_4032

AS   CVCL_2243

SY   P3-X63-Ag8.653; P3-X63-Ag8-653; P3-x63-Ag8 653; P3-X63-Ag 8.653; P3-X63Ag8.653; P3-X63.Ag8.653; P3/X63/Ag8.653; P3X63 Ag8.653; P3X63 AG8-653; P3X63-Ag8.653; P3x63-Ag8.653; P3X63 AG 8.653; P3X63Ag8653; P3-X63-Ag8-6-5-3; P3X63Ag8-6-5-3; P3.times.63 Ag8.653; P3.653; X63-Ag8-653; X63-Ag8.653; X63.Ag8.653; X63Ag8-653; X63Ag8.653; X63AG8.653; GM03570; GM3570; NS653

DR   CLO; CLO_0008335

DR   CLO; CLO_0009643

DR   CLO; CLO_0017240

DR   CLO; CLO_0050177

DR   CLDB; cl3842

DR   CLDB; cl3843

DR   CLDB; cl3844

DR   CLDB; cl3845

DR   CLDB; cl3846

DR   ATCC; CRL-1580

DR   ATCC; CRL-8008

DR   CCRID; 3111C0002000000042

DR   CCRID; 3131C0001000800010

DR   CCRID; 3142C0001000000014

DR   CLS; 400118/p8830_P3X63Ag8653

DR   Coriell; GM03570

DR   DSMZ; ACC-43

DR   ECACC; 85011420

DR   JCRB; JCRB9030

DR   KCLB; 21580

DR   NCBI_Iran; C109

DR   RCB; RCB0146

DR   TOKU-E; 4144

RX   PubMed=113458;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-230.html

CC   Group: Hybridoma fusion partner cell line.

CC   Doubling time: ~30-60 hours (DSMZ).

CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.

CC   Misspelling: Occasionally 'P3-X63-Ag8-635'.

CC   Misspelling: Occasionally 'P3X63-A68.653'.

CC   Discontinued: ATCC; CRL-8008; probable.

CC   Discontinued: KCLB; 21580; probable.

CC   Breed/subspecies: BALB/c.

DI   NCIt; C125417; Mouse plasma cell myeloma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3411 ! P3X63Ag8

SX   Female

CA   Cancer cell line

//

ID   P3X63Ag8.653-Turbodoma

AC   CVCL_Z937

DR   ECACC; 03092502

CC   Group: Hybridoma fusion partner cell line.

CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.

CC   Breed/subspecies: BALB/c.

DI   NCIt; C125417; Mouse plasma cell myeloma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

SX   Female

CA   Cancer cell line

//

ID   P3X63Ag8U.1

AC   CVCL_3412

AS   CVCL_4268

SY   P3-X63-Ag8-U1; P3-X63-Ag8.U1; P3X63-Ag8-U1; P3X63Ag8-U1; P3X63Ag8.U1; P3.x63.Ag8.U1; P3U1; P3UI; P3U-1

DR   CLO; CLO_0008333

DR   CLO; CLO_0008336

DR   CLDB; cl3839

DR   CLDB; cl3847

DR   CLDB; cl3848

DR   CLDB; cl3849

DR   CLDB; cl3850

DR   ATCC; CRL-1597

DR   ECACC; 85011417

DR   ECACC; 94120802

DR   ICLC; ATL96012

DR   JCRB; JCRB0708

DR   JCRB; JCRB9085

DR   NCBI_Iran; C579

CC   Group: Hybridoma fusion partner cell line.

CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.

CC   Breed/subspecies: BALB/c.

DI   NCIt; C125417; Mouse plasma cell myeloma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3411 ! P3X63Ag8

SX   Female

CA   Cancer cell line

//

ID   P4

AC   CVCL_Z998

DR   CLO; CLO_0008337

DR   CLDB; cl3851

DR   ECACC; 90070557

CC   Group: Insect cell line.

CC   Discontinued: ECACC; 90070557; probable.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   P4 MAGI CCR5+

AC   CVCL_1H21

SY   P4.R5 MAGI; P4-R5 MAGI

DR   NIH-ARP; 3580-31

CC   Transfected with: HGNC; 1606; CCR5.

CC   Transfected with: HGNC; 1678; CD4.

CC   Transfected with: UniProtKB; P00722; E.coli lacZ.

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0030 ! HeLa

SX   Female

CA   Cancer cell line

//

ID   P404

AC   CVCL_L411

RX   PubMed=21801068;

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

CA   Cancer cell line

//

ID   P43D09

AC   CVCL_J590

DR   ATCC; HB-8594

RX   Patent=US5015571;

RX   Patent=US5733738;

CC   Discontinued: ATCC; HB-8594; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   P44E11

AC   CVCL_J542

DR   ATCC; HB-8593

RX   Patent=US5015571;

RX   Patent=US5733738;

CC   Discontinued: ATCC; HB-8593; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   P493-6

AC   CVCL_6783

SY   P-493-6; p493-6

DR   BTO; BTO:0003291

DR   PRIDE; PXD000589

RX   PubMed=10956386;

RX   PubMed=25894527;

CC   Transfected with: HGNC; 7553; MYC.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Cell surface proteome.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_W845 ! EREB2-5

CA   Transformed cell line

//

ID   P4E6

AC   CVCL_2677

DR   BTO; BTO:0003540

DR   ECACC; 10112301

RX   PubMed=11121225;

RX   PubMed=17163777;

WW   http://capcelllines.ca/details.asp?id=111

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6].

ST   Source(s): ECACC

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11

ST   D16S539: 11

ST   D5S818: 12

ST   D7S820: 7,8

ST   TH01: 7,9.3

ST   TPOX: 8

ST   vWA: 17,19

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   p53-def-MOSE

AC   CVCL_C563

DR   JCRB; JCRB0151.1

DR   JCRB; NIHS0215

RX   PubMed=9820870;

CC   Discontinued: JCRB; NIHS0215; true.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Spontaneously immortalized cell line

//

ID   p53-RE-luc/A549

AC   CVCL_5J44

SY   P53-RE-luc/A549

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Discontinued: PerkinElmer; Catalog number 119274.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0023 ! A-549

SX   Male

CA   Cancer cell line

//

ID   p53HCT116

AC   CVCL_S744

SY   P53HCT116; p53-/- HCT116; p53(-/-) HCT-116; HCT116-p53-/-; HCT116-p53

DR   Cosmic; 1132690

DR   SKY/M-FISH/CGH; 1688

DR   SKY/M-FISH/CGH; 2781

RX   PubMed=9822382;

RX   PubMed=19927377;

CC   Knockout cell: Method=Gamma radiation; HGNC; 11998; TP53.

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0291 ! HCT 116

SX   Male

CA   Cancer cell line

//

ID   P53LMACO1

AC   CVCL_U220

DR   JCRB; JCRB0150

DR   JCRB; NIHS0213

RX   PubMed=9299470;

CC   Discontinued: JCRB; NIHS0213; true.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   p53NiS1

AC   CVCL_8902

SY   P53N1S1

DR   CLO; CLO_0008338

DR   ATCC; CRL-2619

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   p53R

AC   CVCL_J916

DR   ATCC; CRL-2781

DR   ATCC; JHU-56

DR   BioSample; SAMN03471788

RX   PubMed=12082016;

CC   Problematic cell line: Misidentified. Originally thought to derive from Hs 766T but was later (erratum) shown to be derived from RKO (PubMed=12082016).

CC   Discontinued: ATCC; CRL-2781; true.

CC   Discontinued: ATCC; JHU-56; true.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 8,10

ST   D13S317: 8,11

ST   D16S539: 12,13

ST   D5S818: 11,13

ST   D7S820: 8,10

ST   TH01: 6,10

ST   TPOX: 11

ST   vWA: 16,22

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0504 ! RKO

CA   Cancer cell line

//

ID   P59M8

AC   CVCL_T837

SY   59M8; P59-M08

DR   RCB; HPS0061

DR   SKIP; SKIP000143

RX   Patent=US20130224156;

RX   PubMed=21347327;

DI   NCIt; C85045; Retinitis pigmentosa

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   P69SV40T

AC   CVCL_4875

SY   P69SV40-T; P69SV40 T; P69SV40; P69

DR   BTO; BTO:0005982

DR   Cosmic; 1172630

RX   PubMed=9018337;

RX   PubMed=12725112;

RX   PubMed=21544329;

WW   http://capcelllines.ca/details.asp?id=145

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   P6C

AC   CVCL_T056

RX   PubMed=23736004;

CC   Group: Cancer stem cell line.

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   P72-9

AC   CVCL_Y455

DR   ATCC; CRL-6525

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6525; true.

OX   NCBI_TaxID=34884; ! Callorhinus ursinus

SX   Male

CA   Finite cell line

//

ID   P815

AC   CVCL_2154

SY   P-815; P 815

DR   BTO; BTO:0000985

DR   CLO; CLO_0008340

DR   CLO; CLO_0008341

DR   CLO; CLO_0050217

DR   CLDB; cl3784

DR   CLDB; cl3785

DR   CLDB; cl5244

DR   ATCC; TIB-64

DR   BCRC; 60178

DR   BCRJ; 0200

DR   CCRID; 3111C0001CCC000114

DR   CCRID; 3131C0001000800012

DR   CCRID; 3142C0001000000084

DR   ChEMBL-Cells; CHEMBL3307568

DR   ChEMBL-Targets; CHEMBL614226

DR   CLS; 400242/p600_P-815

DR   DSMZ; ACC-1

DR   IZSLER; BS TCL 118

DR   JCRB; JCRB0078

DR   KCB; KCB 93032YJ

DR   NCBI_Iran; C550

DR   RCB; RCB1167

DR   TKG; TKG 0168

RX   PubMed=3792703;

RX   PubMed=18432777;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-232.html

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-233.html

CC   Doubling time: ~18-22 hours (DSMZ).

CC   Misspelling: Occasionally 'P825'.

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21632; Mouse mast cell neoplasm

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Cancer cell line

//

ID   P815 MB

AC   CVCL_4Z63

DR   ATCC; CRL-6448

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6448; true.

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21632; Mouse mast cell neoplasm

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2154 ! P815

SX   Male

CA   Cancer cell line

//

ID   P815-1-1

AC   CVCL_4269

DR   CLO; CLO_0008342

DR   CLDB; cl3852

DR   ECACC; 85011406

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21632; Mouse mast cell neoplasm

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2154 ! P815

SX   Male

CA   Cancer cell line

//

ID   P815-X2

AC   CVCL_F735

SY   P815.X2; P815X2; P815-(X2); P815 subline X2

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21632; Mouse mast cell neoplasm

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2154 ! P815

SX   Male

CA   Cancer cell line

//

ID   PA

AC   CVCL_E800

SY   PA-PP

DR   dbMHC; 48995

DR   ECACC; 94050333

DR   IHW; IHW9217

DR   IMGT/HLA; 11226

WW   http://bioinformatics.hsanmartino.it/ecbr/cl217.html

CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   PA #2

AC   CVCL_1E44

SY   PA 2

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=994214;

CC   Doubling time: 106 hours, at 5th passage (PubMed=994214).

CC   Derived from metastatic site: Colon.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PA 16/23

AC   CVCL_W771

RX   PubMed=1320446;

RX   PubMed=8198972;

DI   NCIt; C4650; Parotid gland pleomorphic adenoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PA 3

AC   CVCL_AX17

SY   PA3

DR   Cosmic; 2361387

RX   PubMed=8547074;

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Pa Coo

AC   CVCL_U790

DR   ATCC; CRL-1293

CC   Discontinued: ATCC; CRL-1293; true.

DI   NCIt; C26837; Osteogenesis imperfecta

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   Pa Kel-1

AC   CVCL_3324

DR   CLO; CLO_0008348

DR   ATCC; CRL-1341

DI   NCIt; C125696; Ehlers-Danlos syndrome, type I

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_3325 ! Pa Kel-2

SX   Female

CA   Finite cell line

//

ID   Pa Kel-2

AC   CVCL_3325

DR   CLO; CLO_0008349

DR   ATCC; CRL-1344

DI   NCIt; C125696; Ehlers-Danlos syndrome, type I

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_3324 ! Pa Kel-1

SX   Female

CA   Finite cell line

//

ID   Pa Mer

AC   CVCL_U684

DR   ATCC; CRL-1169

CC   Discontinued: ATCC; CRL-1169; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   PA-1

AC   CVCL_0479

SY   PA1; PA I; PAI

DR   BTO; BTO:0001591

DR   CLO; CLO_0008350

DR   EFO; EFO_0006465

DR   MCCL; MCC:0000377

DR   CLDB; cl3856

DR   CLDB; cl3857

DR   CLDB; cl3858

DR   CLDB; cl3859

DR   ATCC; CRL-1572

DR   BCRC; 60063

DR   BioSample; SAMN01821586

DR   BioSample; SAMN03473209

DR   BioSample; SAMN03472415

DR   CCRID; 3111C0001CCC000021

DR   CGH-DB; 9358-4

DR   ChEMBL-Cells; CHEMBL3308812

DR   ChEMBL-Targets; CHEMBL614949

DR   CLS; 300402/p655_PA-1

DR   Cosmic; 688112

DR   Cosmic; 801353

DR   Cosmic; 809111

DR   Cosmic; 844343

DR   Cosmic; 909255

DR   Cosmic; 931368

DR   Cosmic; 1305331

DR   Cosmic; 1995610

DR   Cosmic-CLP; 909255

DR   ECACC; 90013101

DR   GDSC; 909255

DR   GEO; GSM186444

DR   GEO; GSM186445

DR   GEO; GSM784566

DR   GEO; GSM1374804

DR   GEO; GSM1670330

DR   ICLC; HTL97002

DR   IZSLER; BS TCL 179

DR   JCRB; JCRB9061

DR   RCB; RCB1946

RX   PubMed=2653399;

RX   PubMed=6931103;

RX   PubMed=9290701;

RX   PubMed=11314036;

RX   PubMed=11330945;

RX   PubMed=10567668;

RX   PubMed=15677628;

RX   PubMed=22710073;

RX   PubMed=23415752;

RX   PubMed=25485619;

RX   PubMed=27397505;

CC   Part of: KuDOS 95 cell line panel.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: RCB; RCB1946; true.

CC   Derived from metastatic site: Ascites.

ST   Source(s): ATCC; CLS; COG; Cosmic-CLP; ECACC; JCRB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 9,12

ST   D13S317: 9,10 (ATCC; CLS; COG; Cosmic-CLP; ECACC; PubMed=25877200)

ST   D13S317: 9,10,13 (JCRB)

ST   D16S539: 9,12 (ATCC; COG; Cosmic-CLP; ECACC; JCRB; PubMed=25877200)

ST   D16S539: 9 (CLS)

ST   D18S51: 15,18

ST   D19S433: 13

ST   D21S11: 29,31.2

ST   D2S1338: 24

ST   D3S1358: 15

ST   D5S818: 11

ST   D7S820: 9

ST   D8S1179: 14,15

ST   FGA: 24

ST   Penta D: 9,12

ST   Penta E: 14,20

ST   TH01: 7,9

ST   TPOX: 11

ST   vWA: 15,17

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PA-1/6TG-r

AC   CVCL_3121

DR   JCRB; JCRB1052

DR   JCRB; NIHS0328

CC   Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).

CC   Discontinued: JCRB; NIHS0328; true.

CC   Derived from metastatic site: Ascites.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 9,12

ST   D13S317: 9,10

ST   D16S539: 9,12

ST   D5S818: 11

ST   D7S820: 9

ST   TH01: 7,9

ST   TPOX: 11

ST   vWA: 15,17

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0479 ! PA-1

SX   Female

CA   Cancer cell line

//

ID   PA-23

AC   CVCL_J296

SY   PA23

DR   BTO; BTO:0004529

RX   PubMed=19039943;

DI   NCIt; C60504; Rat rhabdomyosarcoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Cancer cell line

//

ID   PA-CLS-52

AC   CVCL_5852

SY   PA-CLS 52

DR   CLS; 300386/NA

CC   Discontinued: CLS; 300386; true.

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Pa-E-HNU6

AC   CVCL_Z571

SY   Pa-E-HNU 6

RX   CelloPub=CLPUB00177;

CC   Group: Insect cell line.

OX   NCBI_TaxID=254370; ! Ctenoplusia agnata

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   PA-GRS1

AC   CVCL_6711

SY   PAGRS1

RX   PubMed=1319328;

RX   PubMed=15541573;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Female

CA   Transformed cell line

//

ID   PA-III

AC   CVCL_6D67

SY   PAIII

RX   PubMed=1326342;

RX   PubMed=1661415;

CC   Breed/subspecies: Lobund-Wistar (L-W).

DI   NCIt; C64013; Adenocarcinoma of the rat prostate

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Cancer cell line

//

ID   PA018

AC   CVCL_1G11

DR   Cosmic; 1820268

RX   PubMed=22156295;

CC   Omics: Deep exome analysis.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PA028

AC   CVCL_1G12

DR   Cosmic; 1820260

RX   PubMed=22156295;

CC   Omics: Deep exome analysis.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PA055

AC   CVCL_1G13

DR   Cosmic; 1820261

RX   PubMed=22156295;

CC   Omics: Deep exome analysis.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PA086

AC   CVCL_1G14

DR   Cosmic; 1820265

RX   PubMed=22156295;

CC   Omics: Deep exome analysis.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PA090

AC   CVCL_1G15

DR   Cosmic; 1820269

RX   PubMed=22156295;

CC   Omics: Deep exome analysis.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PA1

AC   CVCL_T887

DR   SKIP; SKIP000521

RX   PubMed=23039195;

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T885 ! PA9

OI   CVCL_T886 ! PA22

SX   Female

CA   Induced pluripotent stem cell

//

ID   PA107

AC   CVCL_1G16

DR   Cosmic; 1820266

RX   PubMed=22156295;

CC   Omics: Deep exome analysis.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PA12

AC   CVCL_0E98

RX   PubMed=2985952;

CC   Group: Retrovirus packaging cell line.

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_9116 ! NIH 3T3-TK-

SX   Male

CA   Transformed cell line

//

ID   PA12-Rb

AC   CVCL_0E99

SY   PA12-RB

DR   ATCC; CRL-1916

CC   Group: Retrovirus packaging cell line.

CC   Transfected with: HGNC; 9884; RB.

CC   Discontinued: ATCC; CRL-1916; true.

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0E98 ! PA12

SX   Male

CA   Transformed cell line

//

ID   PA122

AC   CVCL_1G17

DR   Cosmic; 1820264

RX   PubMed=22156295;

CC   Omics: Deep exome analysis.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PA167

AC   CVCL_1G18

DR   Cosmic; 1820258

RX   PubMed=22156295;

CC   Omics: Deep exome analysis.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PA182

AC   CVCL_1G19

DR   Cosmic; 1820263

RX   PubMed=22156295;

CC   Omics: Deep exome analysis.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PA195

AC   CVCL_1G20

DR   Cosmic; 1820259

RX   PubMed=22156295;

CC   Omics: Deep exome analysis.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PA2.1

AC   CVCL_G245

DR   CLO; CLO_0008352

DR   ATCC; HB-117

RX   PubMed=95015;

CC   Monoclonal antibody target: UniProtKB; P10316; Human HLA-A Aw69.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   PA2.6

AC   CVCL_G244

SY   PA 2.6

DR   CLO; CLO_0008347

DR   ATCC; HB-118

RX   PubMed=95015;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   PA202

AC   CVCL_1G21

DR   Cosmic; 1820257

RX   PubMed=22156295;

CC   Omics: Deep exome analysis.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PA215

AC   CVCL_1G22

DR   Cosmic; 1820262

RX   PubMed=22156295;

CC   Omics: Deep exome analysis.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PA22

AC   CVCL_T886

DR   SKIP; SKIP000207

RX   PubMed=23039195;

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T887 ! PA1

OI   CVCL_T885 ! PA9

SX   Female

CA   Induced pluripotent stem cell

//

ID   PA254

AC   CVCL_1G23

DR   Cosmic; 1820270

RX   PubMed=22156295;

CC   Omics: Deep exome analysis.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PA285

AC   CVCL_1G24

DR   Cosmic; 1820267

RX   PubMed=22156295;

CC   Omics: Deep exome analysis.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PA317

AC   CVCL_3920

DR   CLO; CLO_0008353

DR   CLDB; cl3864

DR   CLDB; cl3865

DR   CLDB; cl7178

DR   ATCC; CRL-9078

DR   CCRID; 3111C0001CCC000260

DR   CCRID; 3131C0001000300007

DR   CCRID; 3142C0001000000097

DR   ECACC; 89032007

DR   ICLC; HTL06006

DR   KCB; KCB 2011112YJ

DR   TOKU-E; 2844

CC   Group: Retrovirus packaging cell line.

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_9116 ! NIH 3T3-TK-

SX   Male

CA   Transformed cell line

//

ID   PA317 containing JR-gal

AC   CVCL_6505

DR   CLO; CLO_0008354

DR   ATCC; CRL-9995

CC   Group: Retrovirus packaging cell line.

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3920 ! PA317

SX   Male

CA   Transformed cell line

//

ID   PA317 cyclin E-L

AC   CVCL_6506

DR   CLO; CLO_0008355

DR   ATCC; CRL-2187

CC   Group: Retrovirus packaging cell line.

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3920 ! PA317

SX   Male

CA   Transformed cell line

//

ID   PA317 cyclin E-S

AC   CVCL_6507

DR   CLO; CLO_0008356

DR   ATCC; CRL-2188

CC   Group: Retrovirus packaging cell line.

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3920 ! PA317

SX   Male

CA   Transformed cell line

//

ID   PA317 LXSN

AC   CVCL_6508

DR   CLO; CLO_0008357

DR   ATCC; CRL-2202

CC   Group: Retrovirus packaging cell line.

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3920 ! PA317

SX   Male

CA   Transformed cell line

//

ID   PA317 LXSN 16E6

AC   CVCL_6509

DR   CLO; CLO_0008358

DR   ATCC; CRL-2204

CC   Group: Retrovirus packaging cell line.

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6].

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3920 ! PA317

SX   Male

CA   Transformed cell line

//

ID   PA317 LXSN 16E6E7

AC   CVCL_6510

SY   PA317/LXSN-16E6E7

DR   CLO; CLO_0008359

DR   ATCC; CRL-2203

CC   Group: Retrovirus packaging cell line.

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3920 ! PA317

SX   Male

CA   Transformed cell line

//

ID   PA317 LXSN 16E7

AC   CVCL_6511

SY   PA317LXSN16E7

DR   CLO; CLO_0008360

DR   ATCC; CRL-2205

CC   Group: Retrovirus packaging cell line.

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E7].

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3920 ! PA317

SX   Male

CA   Transformed cell line

//

ID   PA317 LXSN 6E6

AC   CVCL_6512

DR   CLO; CLO_0008361

DR   ATCC; CRL-2206

CC   Group: Retrovirus packaging cell line.

CC   Transformant: NCBI_TaxID; 10600; Human papillomavirus type 6b (HPV6b) [E6].

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3920 ! PA317

SX   Male

CA   Transformed cell line

//

ID   PA317 LXSN 6E7

AC   CVCL_6513

SY   PA317LXSN6E7

DR   CLO; CLO_0008362

DR   ATCC; CRL-2207

CC   Group: Retrovirus packaging cell line.

CC   Transformant: NCBI_TaxID; 10600; Human papillomavirus type 6b (HPV6b) [E7].

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3920 ! PA317

SX   Male

CA   Transformed cell line

//

ID   PA333

AC   CVCL_1G25

DR   Cosmic; 1820271

RX   PubMed=22156295;

CC   Omics: Deep exome analysis.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PA682 BM1

AC   CVCL_IV25

SY   PA682BM

RX   PubMed=6316501;

RX   PubMed=9973220;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C539 ! PA682 PB

OI   CVCL_IV26 ! PA682 PE1

SX   Male

CA   Cancer cell line

//

ID   PA682 PB

AC   CVCL_C539

SY   PA682(PB); PA682PB; Pa682PB; PA682; PA 682; PA-682

DR   Cosmic; 850212

DR   Cosmic; 931131

DR   Cosmic; 1515190

RX   PubMed=2052620;

RX   PubMed=3927261;

RX   PubMed=6316501;

RX   PubMed=9473234;

RX   PubMed=9973220;

RX   PubMed=19358282;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IV25 ! PA682 BM1

OI   CVCL_IV26 ! PA682 PE1

SX   Male

CA   Cancer cell line

//

ID   PA682 PE1

AC   CVCL_IV26

SY   PA 682/PE-1; PA682PE

RX   PubMed=6316501;

RX   PubMed=9973220;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IV25 ! PA682 BM1

OI   CVCL_C539 ! PA682 PB

SX   Male

CA   Cancer cell line

//

ID   PA9

AC   CVCL_T885

DR   SKIP; SKIP000206

RX   PubMed=23039195;

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T887 ! PA1

OI   CVCL_T886 ! PA22

SX   Female

CA   Induced pluripotent stem cell

//

ID   PAb 100

AC   CVCL_2156

SY   PAB-100; Clone 7

DR   CLO; CLO_0008367

DR   CLO; CLO_0008371

DR   CLDB; cl3870

DR   ATCC; TIB-115

DR   DSMZ; ACC-188

RX   PubMed=6155477;

CC   Monoclonal antibody target: UniProtKB; P03070; SV40 large T antigen.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   PAb 101

AC   CVCL_4609

SY   Clone 412

DR   CLO; CLO_0008368

DR   ATCC; TIB-117

RX   PubMed=6155477;

CC   Monoclonal antibody target: UniProtKB; P03070; SV40 large T antigen.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   PAb 108

AC   CVCL_4610

DR   CLO; CLO_0008369

DR   ATCC; TIB-230

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Hybridoma

//

ID   PAb 122

AC   CVCL_2157

SY   PAB-122; PAb122; Clone 122

DR   CLO; CLO_0008370

DR   CLO; CLO_0008372

DR   CLDB; cl3871

DR   ATCC; TIB-116

DR   DSMZ; ACC-166

RX   PubMed=6155477;

CC   Monoclonal antibody target: UniProtKB; P04637; Human TP53 (also reacts with other species).

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   PAb 1400

AC   CVCL_4562

SY   PAb1400

DR   CLO; CLO_0050286

DR   RCB; RCB0026

CC   Monoclonal antibody target: UniProtKB; P03070; SV40 large T antigen.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   PAb 1620

AC   CVCL_2158

SY   PAB-1620; PAb1620

DR   CLO; CLO_0008373

DR   DSMZ; ACC-280

CC   Doubling time: ~24 hours (DSMZ).

CC   Monoclonal antibody target: UniProtKB; P04637; Human TP53 (also reacts with other species).

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   PAb 419

AC   CVCL_B954

SY   PAb419

DR   CLO; CLO_0050282

DR   RCB; RCB0195

CC   Monoclonal antibody target: UniProtKB; P03070; SV40 large T antigen.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Hybridoma

//

ID   PaBrH01

AC   CVCL_DR67

RX   PubMed=20011515;

CC   Group: Bat cell line.

CC   Transfected with: HGNC; 11730; TERT.

OX   NCBI_TaxID=9402; ! Pteropus alecto

CA   Telomerase immortalized cell line

//

ID   PaBrH02

AC   CVCL_DR68

RX   PubMed=20011515;

CC   Group: Bat cell line.

CC   Transfected with: HGNC; 11730; TERT.

OX   NCBI_TaxID=9402; ! Pteropus alecto

CA   Telomerase immortalized cell line

//

ID   PaBrH03

AC   CVCL_DR69

RX   PubMed=20011515;

CC   Group: Bat cell line.

CC   Transfected with: HGNC; 11730; TERT.

OX   NCBI_TaxID=9402; ! Pteropus alecto

CA   Telomerase immortalized cell line

//

ID   PaBrH04

AC   CVCL_DR70

RX   PubMed=20011515;

CC   Group: Bat cell line.

CC   Transfected with: HGNC; 11730; TERT.

OX   NCBI_TaxID=9402; ! Pteropus alecto

CA   Telomerase immortalized cell line

//

ID   PaBrH05

AC   CVCL_DR71

RX   PubMed=20011515;

CC   Group: Bat cell line.

CC   Transfected with: HGNC; 11730; TERT.

OX   NCBI_TaxID=9402; ! Pteropus alecto

CA   Telomerase immortalized cell line

//

ID   PaBrH06

AC   CVCL_DR72

RX   PubMed=20011515;

CC   Group: Bat cell line.

CC   Transfected with: HGNC; 11730; TERT.

OX   NCBI_TaxID=9402; ! Pteropus alecto

CA   Telomerase immortalized cell line

//

ID   PaBrH07

AC   CVCL_DR73

RX   PubMed=20011515;

CC   Group: Bat cell line.

CC   Transfected with: HGNC; 11730; TERT.

OX   NCBI_TaxID=9402; ! Pteropus alecto

CA   Telomerase immortalized cell line

//

ID   PaBrT01

AC   CVCL_DR74

RX   PubMed=20011515;

CC   Group: Bat cell line.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9402; ! Pteropus alecto

CA   Transformed cell line

//

ID   PaBrT02

AC   CVCL_DR75

RX   PubMed=20011515;

CC   Group: Bat cell line.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9402; ! Pteropus alecto

CA   Transformed cell line

//

ID   PaBrT03

AC   CVCL_DR76

RX   PubMed=20011515;

CC   Group: Bat cell line.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9402; ! Pteropus alecto

CA   Transformed cell line

//

ID   PAC1

AC   CVCL_U511

AS   CVCL_D258

SY   PAC-1; CS-54; CS54

DR   BTO; BTO:0003338

RX   PubMed=1333373;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-506.html

CC   Breed/subspecies: Sprague-Dawley.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Spontaneously immortalized cell line

//

ID   PAC2

AC   CVCL_5853

SY   PAC-2

DR   EFO; EFO_0001224

DR   ChEMBL-Cells; CHEMBL3307808

DR   ChEMBL-Targets; CHEMBL612709

DR   Lonza; 1136

RX   CelloPub=CLPUB00276;

RX   PubMed=18377224;

RX   PubMed=20147193;

CC   Group: Fish cell line.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=7955; ! Danio rerio

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   PaCa 5061

AC   CVCL_C886

SY   PaCa-5061

DR   Cosmic; 1352405

RX   PubMed=20553613;

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PaCa 5072

AC   CVCL_C887

SY   PaCa-5072

RX   PubMed=22490524;

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PaCa-44

AC   CVCL_7087

SY   PACA 44; PaCa44

DR   BTO; BTO:0004848

DR   Cosmic; 710863

DR   Cosmic; 933533

RX   PubMed=11787853;

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PaCaDD-119

AC   CVCL_1848

SY   PACADD-119

DR   Cosmic; 1559062

DR   DSMZ; ACC-709

RX   PubMed=21683373;

CC   Doubling time: ~3-4 days (DSMZ).

ST   Source(s): DSMZ

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 13

ST   D16S539: 9,12

ST   D5S818: 12,13

ST   D7S820: 10,12

ST   TH01: 7

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PaCaDD-135

AC   CVCL_1849

SY   PACADD-135

DR   Cosmic; 1559064

DR   DSMZ; ACC-710

RX   PubMed=21683373;

CC   Doubling time: ~72 hours (DSMZ).

ST   Source(s): DSMZ

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 11,13

ST   D16S539: 11,12

ST   D5S818: 11,12

ST   D7S820: 11,12

ST   TH01: 9,9.3

ST   TPOX: 8,11

ST   vWA: 14,19

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PaCaDD-137

AC   CVCL_1850

SY   PACADD-137

DR   Cosmic; 1559066

DR   DSMZ; ACC-711

RX   PubMed=21683373;

CC   Doubling time: ~2-3 days (DSMZ).

ST   Source(s): DSMZ

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11

ST   D16S539: 11,12

ST   D5S818: 9,12

ST   D7S820: 9,10

ST   TH01: 9,9.3

ST   TPOX: 8

ST   vWA: 18,19

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PaCaDD-141

AC   CVCL_M464

SY   PACADD-141

RX   CelloPub=CLPUB00002;

CC   Doubling time: 33.7 hours (CelloPub=CLPUB00002).

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PaCaDD-159

AC   CVCL_M465

SY   PACADD-159

DR   DSMZ; ACC-745

RX   CelloPub=CLPUB00002;

CC   Doubling time: 41.3 hours (CelloPub=CLPUB00002); ~1 week (DSMZ).

ST   Source(s): DSMZ

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 11,14

ST   D16S539: 12,13

ST   D5S818: 11

ST   D7S820: 9

ST   TH01: 7

ST   TPOX: 8

ST   vWA: 14,16

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PaCaDD-161

AC   CVCL_M466

SY   PACADD-161

DR   DSMZ; ACC-746

RX   CelloPub=CLPUB00002;

CC   Doubling time: 20.6 hours (CelloPub=CLPUB00002); ~48 hours (DSMZ).

CC   Derived from metastatic site: Liver.

ST   Source(s): DSMZ

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 8

ST   D16S539: 12

ST   D5S818: 12

ST   D7S820: 10,11

ST   TH01: 8,9.3

ST   TPOX: 8,12

ST   vWA: 16,19

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PaCaDD-165

AC   CVCL_M467

SY   PACADD-165

DR   DSMZ; ACC-750

RX   CelloPub=CLPUB00002;

CC   Doubling time: 26.2 hours (CelloPub=CLPUB00002); ~35-45 hours (DSMZ).

CC   Derived from metastatic site: Ascites.

ST   Source(s): DSMZ

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 11

ST   D16S539: 11

ST   D5S818: 10,12

ST   D7S820: 10

ST   TH01: 8,9.3

ST   TPOX: 8,11

ST   vWA: 16,17

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PaCaDD-183

AC   CVCL_M468

SY   PACADD-183

DR   DSMZ; ACC-751

RX   CelloPub=CLPUB00002;

CC   Doubling time: 43.3 hours (CelloPub=CLPUB00002); ~2-3 days (DSMZ).

CC   Derived from metastatic site: Ascites.

ST   Source(s): DSMZ

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 11,12

ST   D16S539: 11

ST   D5S818: 12,13

ST   D7S820: 12

ST   TH01: 9,9.3

ST   TPOX: 11

ST   vWA: 19

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PaCaDD-188

AC   CVCL_M469

SY   PACADD-188

DR   DSMZ; ACC-753

RX   CelloPub=CLPUB00002;

CC   Doubling time: 30.8 hours (CelloPub=CLPUB00002); ~2-4 days (DSMZ).

ST   Source(s): DSMZ

ST   Amelogenin: X

ST   CSF1PO: 12,14

ST   D13S317: 11,15

ST   D16S539: 11,12

ST   D5S818: 9,11

ST   D7S820: 8,10

ST   TH01: 7

ST   TPOX: 8,11

ST   vWA: 14,16

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PaCaDD-43

AC   CVCL_8781

SY   PACADD-43

DR   Cosmic; 1559058

RX   PubMed=21683373;

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PaCaDD-60

AC   CVCL_8782

SY   PACADD-60

DR   Cosmic; 1559060

RX   PubMed=21683373;

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PAE-iPS-1

AC   CVCL_E019

SY   Aries; PL-iPS-01

DR   SKIP; SKIP000352

WW   http://nrichd.ncchd.go.jp/reproduction/hipscell.htm

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D692 ! PAE551

SX   Male

CA   Induced pluripotent stem cell

//

ID   PAE-iPS-10

AC   CVCL_E020

SY   Capricornus; PL-iPS-10

DR   SKIP; SKIP000404

WW   http://nrichd.ncchd.go.jp/reproduction/hipscell.htm

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D692 ! PAE551

SX   Male

CA   Induced pluripotent stem cell

//

ID   PAE-iPS-11

AC   CVCL_E021

SY   Aquarius; PL-iPS-11

DR   SKIP; SKIP000355

RX   PubMed=23631808;

WW   http://nrichd.ncchd.go.jp/reproduction/hipscell.htm

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D692 ! PAE551

SX   Male

CA   Induced pluripotent stem cell

//

ID   PAE-iPS-12

AC   CVCL_E022

SY   Pisces; PL-iPS-12

DR   SKIP; SKIP000403

WW   http://nrichd.ncchd.go.jp/reproduction/hipscell.htm

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D692 ! PAE551

SX   Male

CA   Induced pluripotent stem cell

//

ID   PAE-iPS-2

AC   CVCL_E023

SY   Taurus; PL-iPS-02

DR   SKIP; SKIP000397

WW   http://nrichd.ncchd.go.jp/reproduction/hipscell.htm

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D692 ! PAE551

SX   Male

CA   Induced pluripotent stem cell

//

ID   PAE-iPS-3

AC   CVCL_E024

SY   Gemini; PL-iPS-03

DR   SKIP; SKIP000398

WW   http://nrichd.ncchd.go.jp/reproduction/hipscell.htm

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D692 ! PAE551

SX   Male

CA   Induced pluripotent stem cell

//

ID   PAE-iPS-4

AC   CVCL_E025

SY   Cancer; PL-iPS-04

DR   SKIP; SKIP000353

WW   http://nrichd.ncchd.go.jp/reproduction/hipscell.htm

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D692 ! PAE551

SX   Male

CA   Induced pluripotent stem cell

//

ID   PAE-iPS-5

AC   CVCL_E026

SY   Leo; PL-iPS-05

DR   SKIP; SKIP000354

RX   PubMed=23631808;

WW   http://nrichd.ncchd.go.jp/reproduction/hipscell.htm

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D692 ! PAE551

SX   Male

CA   Induced pluripotent stem cell

//

ID   PAE-iPS-6

AC   CVCL_E027

SY   Virgo; PL-iPS-06

DR   SKIP; SKIP000399

WW   http://nrichd.ncchd.go.jp/reproduction/hipscell.htm

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D692 ! PAE551

SX   Male

CA   Induced pluripotent stem cell

//

ID   PAE-iPS-7

AC   CVCL_E028

SY   Libra; PL-iPS-07

DR   SKIP; SKIP000400

WW   http://nrichd.ncchd.go.jp/reproduction/hipscell.htm

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D692 ! PAE551

SX   Male

CA   Induced pluripotent stem cell

//

ID   PAE-iPS-8

AC   CVCL_E029

SY   Scorpio; PL-iPS-08

DR   SKIP; SKIP000401

WW   http://nrichd.ncchd.go.jp/reproduction/hipscell.htm

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D692 ! PAE551

SX   Male

CA   Induced pluripotent stem cell

//

ID   PAE-iPS-9

AC   CVCL_E030

SY   Sagittarius; PL-iPS-09

DR   SKIP; SKIP000402

WW   http://nrichd.ncchd.go.jp/reproduction/hipscell.htm

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D692 ! PAE551

SX   Male

CA   Induced pluripotent stem cell

//

ID   PAE551

AC   CVCL_D692

SY   PL551Ar

DR   JCRB; JCRB1543

RX   PubMed=21637780;

RX   PubMed=23631808;

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 8,12

ST   D16S539: 10,13

ST   D5S818: 11,13

ST   D7S820: 8,11

ST   TH01: 6,10

ST   TPOX: 8

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8532 ! PL551SF

SX   Male

CA   Finite cell line

//

ID   PaFeT01

AC   CVCL_DR77

RX   PubMed=20011515;

CC   Group: Bat cell line.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9402; ! Pteropus alecto

OI   CVCL_DR78 ! PaFeT02

OI   CVCL_DR79 ! PaFeT03

OI   CVCL_DR80 ! PaFeT04

OI   CVCL_DR81 ! PaFeT05

OI   CVCL_DR82 ! PaFeT06

OI   CVCL_DR83 ! PaFeT07

OI   CVCL_DR84 ! PaFeT08

OI   CVCL_DR85 ! PaFeT09

OI   CVCL_DR86 ! PaFeT10

CA   Transformed cell line

//

ID   PaFeT02

AC   CVCL_DR78

RX   PubMed=20011515;

CC   Group: Bat cell line.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9402; ! Pteropus alecto

OI   CVCL_DR77 ! PaFeT01

OI   CVCL_DR79 ! PaFeT03

OI   CVCL_DR80 ! PaFeT04

OI   CVCL_DR81 ! PaFeT05

OI   CVCL_DR82 ! PaFeT06

OI   CVCL_DR83 ! PaFeT07

OI   CVCL_DR84 ! PaFeT08

OI   CVCL_DR85 ! PaFeT09

OI   CVCL_DR86 ! PaFeT10

CA   Transformed cell line

//

ID   PaFeT03

AC   CVCL_DR79

RX   PubMed=20011515;

CC   Group: Bat cell line.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9402; ! Pteropus alecto

OI   CVCL_DR77 ! PaFeT01

OI   CVCL_DR78 ! PaFeT02

OI   CVCL_DR80 ! PaFeT04

OI   CVCL_DR81 ! PaFeT05

OI   CVCL_DR82 ! PaFeT06

OI   CVCL_DR83 ! PaFeT07

OI   CVCL_DR84 ! PaFeT08

OI   CVCL_DR85 ! PaFeT09

OI   CVCL_DR86 ! PaFeT10

CA   Transformed cell line

//

ID   PaFeT04

AC   CVCL_DR80

RX   PubMed=20011515;

CC   Group: Bat cell line.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9402; ! Pteropus alecto

OI   CVCL_DR77 ! PaFeT01

OI   CVCL_DR78 ! PaFeT02

OI   CVCL_DR79 ! PaFeT03

OI   CVCL_DR81 ! PaFeT05

OI   CVCL_DR82 ! PaFeT06

OI   CVCL_DR83 ! PaFeT07

OI   CVCL_DR84 ! PaFeT08

OI   CVCL_DR85 ! PaFeT09

OI   CVCL_DR86 ! PaFeT10

CA   Transformed cell line

//

ID   PaFeT05

AC   CVCL_DR81

RX   PubMed=20011515;

CC   Group: Bat cell line.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9402; ! Pteropus alecto

OI   CVCL_DR77 ! PaFeT01

OI   CVCL_DR78 ! PaFeT02

OI   CVCL_DR79 ! PaFeT03

OI   CVCL_DR80 ! PaFeT04

OI   CVCL_DR82 ! PaFeT06

OI   CVCL_DR83 ! PaFeT07

OI   CVCL_DR84 ! PaFeT08

OI   CVCL_DR85 ! PaFeT09

OI   CVCL_DR86 ! PaFeT10

CA   Transformed cell line

//

ID   PaFeT06

AC   CVCL_DR82

RX   PubMed=20011515;

CC   Group: Bat cell line.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9402; ! Pteropus alecto

OI   CVCL_DR77 ! PaFeT01

OI   CVCL_DR78 ! PaFeT02

OI   CVCL_DR79 ! PaFeT03

OI   CVCL_DR80 ! PaFeT04

OI   CVCL_DR81 ! PaFeT05

OI   CVCL_DR83 ! PaFeT07

OI   CVCL_DR84 ! PaFeT08

OI   CVCL_DR85 ! PaFeT09

OI   CVCL_DR86 ! PaFeT10

CA   Transformed cell line

//

ID   PaFeT07

AC   CVCL_DR83

RX   PubMed=20011515;

CC   Group: Bat cell line.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9402; ! Pteropus alecto

OI   CVCL_DR77 ! PaFeT01

OI   CVCL_DR78 ! PaFeT02

OI   CVCL_DR79 ! PaFeT03

OI   CVCL_DR80 ! PaFeT04

OI   CVCL_DR81 ! PaFeT05

OI   CVCL_DR82 ! PaFeT06

OI   CVCL_DR84 ! PaFeT08

OI   CVCL_DR85 ! PaFeT09

OI   CVCL_DR86 ! PaFeT10

CA   Transformed cell line

//

ID   PaFeT08

AC   CVCL_DR84

RX   PubMed=20011515;

CC   Group: Bat cell line.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9402; ! Pteropus alecto

OI   CVCL_DR77 ! PaFeT01

OI   CVCL_DR78 ! PaFeT02

OI   CVCL_DR79 ! PaFeT03

OI   CVCL_DR80 ! PaFeT04

OI   CVCL_DR81 ! PaFeT05

OI   CVCL_DR82 ! PaFeT06

OI   CVCL_DR83 ! PaFeT07

OI   CVCL_DR85 ! PaFeT09

OI   CVCL_DR86 ! PaFeT10

CA   Transformed cell line

//

ID   PaFeT09

AC   CVCL_DR85

RX   PubMed=20011515;

CC   Group: Bat cell line.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9402; ! Pteropus alecto

OI   CVCL_DR77 ! PaFeT01

OI   CVCL_DR78 ! PaFeT02

OI   CVCL_DR79 ! PaFeT03

OI   CVCL_DR80 ! PaFeT04

OI   CVCL_DR81 ! PaFeT05

OI   CVCL_DR82 ! PaFeT06

OI   CVCL_DR83 ! PaFeT07

OI   CVCL_DR84 ! PaFeT08

OI   CVCL_DR86 ! PaFeT10

CA   Transformed cell line

//

ID   PaFeT10

AC   CVCL_DR86

RX   PubMed=20011515;

CC   Group: Bat cell line.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9402; ! Pteropus alecto

OI   CVCL_DR77 ! PaFeT01

OI   CVCL_DR78 ! PaFeT02

OI   CVCL_DR79 ! PaFeT03

OI   CVCL_DR80 ! PaFeT04

OI   CVCL_DR81 ! PaFeT05

OI   CVCL_DR82 ! PaFeT06

OI   CVCL_DR83 ! PaFeT07

OI   CVCL_DR84 ! PaFeT08

OI   CVCL_DR85 ! PaFeT09

CA   Transformed cell line

//

ID   PAGRS-21

AC   CVCL_6640

SY   PA-GRS21; Grs-21

RX   PubMed=2171916;

RX   PubMed=2845413;

RX   PubMed=15541573;

CC   Transfected with: HGNC; 5173; HRAS (with V-12).

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Female

CA   Transformed cell line

//

ID   PAGRS-28

AC   CVCL_6641

SY   PA-GRS28; Grs-28

RX   PubMed=2845413;

RX   PubMed=15541573;

CC   Transfected with: HGNC; 5173; HRAS (with V-12).

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Female

CA   Transformed cell line

//

ID   PAGS-6

AC   CVCL_W171

SY   PA-GS6

RX   PubMed=2171916;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Female

CA   Transformed cell line

//

ID   PAI

AC   CVCL_J288

DR   JCRB; JCRB0113

RX   CelloPub=CLPUB00097;

CC   Group: Hybridoma fusion partner cell line.

CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.

CC   Breed/subspecies: BALB/c.

DI   NCIt; C125417; Mouse plasma cell myeloma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3411 ! P3X63Ag8

SX   Female

CA   Cancer cell line

//

ID   PAI-0

AC   CVCL_Z070

SY   PAI-O

RX   CelloPub=CLPUB00097;

CC   Group: Hybridoma fusion partner cell line.

CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.

CC   Breed/subspecies: BALB/c.

DI   NCIt; C125417; Mouse plasma cell myeloma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_J288 ! PAI

SX   Female

CA   Cancer cell line

//

ID   Paju

AC   CVCL_U415

RX   PubMed=6436232;

RX   PubMed=15218547;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-241.html

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PaKiT01

AC   CVCL_DR87

RX   PubMed=20011515;

CC   Group: Bat cell line.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9402; ! Pteropus alecto

CA   Transformed cell line

//

ID   PaKiT02

AC   CVCL_DR88

RX   PubMed=20011515;

CC   Group: Bat cell line.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9402; ! Pteropus alecto

CA   Transformed cell line

//

ID   PaKiT03

AC   CVCL_DR89

DR   BioSample; SAMN04335741

DR   BioSample; SAMN04335743

DR   BioSample; SAMN04335748

DR   PRIDE; PXD001165

RX   PubMed=20011515;

RX   PubMed=25398248;

RX   PubMed=26535029;

CC   Group: Bat cell line.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: Genome sequenced.

CC   Omics: Proteome analysis by 2D-DE/MS.

OX   NCBI_TaxID=9402; ! Pteropus alecto

CA   Transformed cell line

//

ID   Pal Man

AC   CVCL_X709

DR   ATCC; CRL-1116

CC   Discontinued: ATCC; CRL-1116; probable.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   Pal-1

AC   CVCL_X749

RX   PubMed=12028021;

RX   PubMed=17488335;

RX   PubMed=18079737;

DI   NCIt; C45691; Pyothorax-associated lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PAL1.K

AC   CVCL_S318

DR   ATCC; CRL-6292

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6292; true.

OX   NCBI_TaxID=9689; ! Panthera leo

OI   CVCL_S319 ! PAL1.Ln

OI   CVCL_S320 ! PAL1.Ov

SX   Female

CA   Finite cell line

//

ID   PAL1.Ln

AC   CVCL_S319

DR   ATCC; CRL-6293

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6293; true.

OX   NCBI_TaxID=9689; ! Panthera leo

OI   CVCL_S318 ! PAL1.K

OI   CVCL_S320 ! PAL1.Ov

SX   Female

CA   Finite cell line

//

ID   PAL1.Ov

AC   CVCL_S320

DR   ATCC; CRL-6294

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6294; true.

OX   NCBI_TaxID=9689; ! Panthera leo

OI   CVCL_S318 ! PAL1.K

OI   CVCL_S319 ! PAL1.Ln

SX   Female

CA   Finite cell line

//

ID   Pala

AC   CVCL_9W19

RX   PubMed=1373173;

RX   PubMed=6160591;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   PALL-1

AC   CVCL_D694

RX   PubMed=8428799;

DI   NCIt; C114819; Adult B acute lymphoblastic leukemia with t(9;22)(q34;q11.2) BCR-ABL1

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PALL-2

AC   CVCL_3122

SY   PALL2

DR   JCRB; JCRB1345

DR   JCRB; NIHS0546

RX   PubMed=8428799;

CC   Discontinued: JCRB; NIHS0546; true.

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 8

ST   D16S539: 9,10

ST   D5S818: 11,12

ST   D7S820: 8,11

ST   TH01: 7,9

ST   TPOX: 8

ST   vWA: 18,19

DI   NCIt; C114819; Adult B acute lymphoblastic leukemia with t(9;22)(q34;q11.2) BCR-ABL1

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PaLuT01

AC   CVCL_DR90

RX   PubMed=20011515;

CC   Group: Bat cell line.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9402; ! Pteropus alecto

CA   Transformed cell line

//

ID   PaLuT02

AC   CVCL_DR91

RX   PubMed=20011515;

CC   Group: Bat cell line.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9402; ! Pteropus alecto

CA   Transformed cell line

//

ID   PaLuT03

AC   CVCL_DR92

RX   PubMed=20011515;

CC   Group: Bat cell line.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9402; ! Pteropus alecto

CA   Transformed cell line

//

ID   PaLuT04

AC   CVCL_DR93

RX   PubMed=20011515;

CC   Group: Bat cell line.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9402; ! Pteropus alecto

CA   Transformed cell line

//

ID   Pam 212

AC   CVCL_7694

SY   PAM 212; PAM212; Pam212; PAM 2-12

DR   BTO; BTO:0005067

DR   ChEMBL-Cells; CHEMBL3307343

DR   ChEMBL-Targets; CHEMBL614231

DR   TOKU-E; 4030

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-242.html

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Cancer cell line

//

ID   Pam LU-1

AC   CVCL_Z592

SY   PAM LU1; LU-1

RX   PubMed=9247255;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_7694 ! Pam 212

SX   Male

CA   Cancer cell line

//

ID   Pam LY-1

AC   CVCL_Z593

SY   PAM LY1

RX   PubMed=9247255;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_7694 ! Pam 212

SX   Male

CA   Cancer cell line

//

ID   Pam LY-2

AC   CVCL_Z594

SY   PAM LY2; PAM-LY2; LY-2

RX   PubMed=9247255;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_7694 ! Pam 212

SX   Male

CA   Cancer cell line

//

ID   PAMC82

AC   CVCL_H271

SY   PAMC-82

DR   Cosmic; 2484975

DR   GEO; GSM1374805

RX   PubMed=11351862;

CC   Omics: Transcriptome analysis.

DI   NCIt; C4911; Gastric carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PAN-03-JCK

AC   CVCL_B454

SY   PAN03JCK

DR   Cosmic; 707258

DR   Cosmic; 1066190

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PAN-07-JCK

AC   CVCL_B455

SY   PAN07JCK

DR   Cosmic; 1066191

RX   PubMed=19265263;

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PAN-08-JCK

AC   CVCL_B456

SY   PAN08JCK

DR   Cosmic; 1066192

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PAN-09-JCK

AC   CVCL_B457

SY   PAN09JCK

DR   Cosmic; 1066193

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Panc 01.28

AC   CVCL_7666

SY   Panc 1.28; Panc1.28

DR   ATCC; CRL-2548

DR   BioSample; SAMN03471609

RX   PubMed=9612602;

RX   PubMed=18000365;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Probably contaminated. Panc 01.28, Panc 04.21 and Panc 06.03 have been shown to be identical (on the basis of STR profile).

CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.

CC   Discontinued: ATCC; CRL-2548; true.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 8,11

ST   D16S539: 11,12

ST   D5S818: 11,12

ST   D7S820: 10,12

ST   TH01: 6,9.3

ST   TPOX: 9,11

ST   vWA: 16,17

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7664 ! Panc 04.21

OI   CVCL_7665 ! Panc 06.03

CA   Cancer cell line

//

ID   Panc 02.02

AC   CVCL_U875

SY   Panc 2.02

RX   PubMed=18000365;

CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Panc 02.03

AC   CVCL_1633

AS   CVCL_H597

SY   PANC-02-03; Panc_02_03; Panc02.03; Panc 2.03; Panc2.03; Panc2_03; PANC 203; Panc203; PANC203; PANC0203

DR   CLO; CLO_0008374

DR   EFO; EFO_0006466

DR   ATCC; CRL-2553

DR   BioSample; SAMN03473181

DR   CCLE; PANC0203_PANCREAS

DR   ChEMBL-Cells; CHEMBL3307761

DR   ChEMBL-Targets; CHEMBL612584

DR   Cosmic; 2009528

DR   Cosmic; 2434088

DR   Cosmic-CLP; 1298475

DR   GDSC; 1298475

DR   GEO; GSM206527

DR   GEO; GSM621891

DR   GEO; GSM887494

DR   GEO; GSM888576

DR   GEO; GSM1024405

DR   GEO; GSM1374810

DR   GEO; GSM1670331

DR   PRIDE; PXD003198

RX   PubMed=9612602;

RX   PubMed=18000365;

RX   PubMed=22460905;

RX   PubMed=25167228;

RX   PubMed=25485619;

RX   PubMed=27259358;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=Panc%2002.03

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 12

ST   D16S539: 11

ST   D18S51: 14

ST   D21S11: 28,31

ST   D3S1358: 14

ST   D5S818: 12,13

ST   D7S820: 9,10

ST   D8S1179: 11,12

ST   FGA: 20,21

ST   Penta D: 9

ST   Penta E: 5,7

ST   TH01: 6

ST   TPOX: 9,12

ST   vWA: 17

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Panc 02.05

AC   CVCL_E278

AS   CVCL_U876

SY   Panc 2.05; PANC 2.5; Panc2.5; Pa21C

DR   Cosmic; 1473043

DR   Cosmic; 1509862

RX   PubMed=18000365;

RX   PubMed=22753594;

CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Panc 02.08

AC   CVCL_E277

AS   CVCL_U877

SY   Panc 2.08; PANC 2.8; Panc2.8; Panc2_8; Pa104C

DR   Cosmic; 949523

DR   Cosmic; 1509880

RX   PubMed=18000365;

RX   PubMed=22753594;

CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Panc 02.13

AC   CVCL_1634

SY   Panc 2.13; Panc-02.13; Panc2.13; PANC0213; PL1; PL-1

DR   CLO; CLO_0008375

DR   ATCC; CRL-2554

DR   BioSample; SAMN03472905

DR   CCLE; PANC0213_PANCREAS

DR   GEO; GSM887495

DR   GEO; GSM888577

DR   GEO; GSM1024406

RX   PubMed=9612602;

RX   PubMed=14695172;

RX   PubMed=18000365;

RX   PubMed=22460905;

RX   PubMed=25167228;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,11

ST   D16S539: 9,12

ST   D18S51: 11

ST   D21S11: 29

ST   D3S1358: 16,18

ST   D5S818: 12

ST   D7S820: 7,11

ST   D8S1179: 12,13

ST   FGA: 21,23

ST   Penta D: 12

ST   Penta E: 8,13

ST   TH01: 6,9.3

ST   TPOX: 8

ST   vWA: 16,18

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Panc 02.43

AC   CVCL_E282

SY   PANC 2.43; Panc2.43; Pa113C

DR   Cosmic; 1473018

DR   Cosmic; 1509882

RX   PubMed=18000365;

RX   PubMed=22753594;

CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Panc 03.27

AC   CVCL_1635

AS   CVCL_H601

SY   Panc 3.27; Panc-03.27; PANC-03-27; Panc_03_27; Panc-3_27; PANC3.27; Panc3.27; Panc3_27; PANC 327; Panc327; Panc-327; PANC0327; PL11; PL-11

DR   CLO; CLO_0008376

DR   EFO; EFO_0006467

DR   ATCC; CRL-2549

DR   BioSample; SAMN03473169

DR   CCLE; PANC0327_PANCREAS

DR   ChEMBL-Cells; CHEMBL3308124

DR   ChEMBL-Targets; CHEMBL1075557

DR   Cosmic; 925346

DR   Cosmic; 949522

DR   Cosmic; 1198222

DR   Cosmic; 2434102

DR   Cosmic-CLP; 925346

DR   GDSC; 925346

DR   GEO; GSM206528

DR   GEO; GSM621904

DR   GEO; GSM784705

DR   GEO; GSM887496

DR   GEO; GSM888578

DR   GEO; GSM1024407

DR   GEO; GSM1374811

DR   GEO; GSM1670332

DR   PRIDE; PXD003198

RX   PubMed=9612602;

RX   PubMed=14695172;

RX   PubMed=18000365;

RX   PubMed=22460905;

RX   PubMed=25167228;

RX   PubMed=25485619;

RX   PubMed=25984343;

RX   PubMed=27259358;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=Panc%2003.27

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: RAS genetic alteration cell panel (ATCC TCP-1031).

CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.

CC   Doubling time: 51 hours (PubMed=25984343).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 11,12

ST   D16S539: 12

ST   D18S51: 18

ST   D21S11: 29,30

ST   D3S1358: 15,16

ST   D5S818: 12,13

ST   D7S820: 8,13

ST   D8S1179: 13,14

ST   FGA: 22,26

ST   Penta D: 10,15

ST   Penta E: 7,11

ST   TH01: 6

ST   TPOX: 8,9

ST   vWA: 16,17

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Panc 04.03

AC   CVCL_1636

SY   PANC-04-03; Panc_04_03; Panc04.03; Panc 4.03; PANC 4.03; Panc4.03; PANC0403; PANC403; Pa17C; Pa017C; PL5; PL-5; PL 5

DR   CLO; CLO_0008377

DR   EFO; EFO_0006468

DR   ATCC; CRL-2555

DR   BioSample; SAMN03473168

DR   CCLE; PANC0403_PANCREAS

DR   Cosmic; 1198213

DR   Cosmic; 1509872

DR   Cosmic; 2434101

DR   Cosmic-CLP; 1298476

DR   GDSC; 1298476

DR   GEO; GSM206529

DR   GEO; GSM621892

DR   GEO; GSM887497

DR   GEO; GSM888579

DR   GEO; GSM1024408

DR   GEO; GSM1374812

DR   GEO; GSM1670333

DR   PRIDE; PXD003198

RX   PubMed=9612602;

RX   PubMed=18000365;

RX   PubMed=22460905;

RX   PubMed=22753594;

RX   PubMed=25167228;

RX   PubMed=25485619;

RX   PubMed=27259358;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=Panc%2004.03

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11,12

ST   D16S539: 11,12

ST   D18S51: 16

ST   D21S11: 28

ST   D3S1358: 15,17

ST   D5S818: 11

ST   D7S820: 8,12

ST   D8S1179: 10,15

ST   FGA: 22,23

ST   Penta D: 10,13

ST   Penta E: 13,14

ST   TH01: 9.3

ST   TPOX: 10,11

ST   vWA: 14,16

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Panc 04.03 MAP2K4(-/-)

AC   CVCL_HE14

SY   MAP2K4 (-/-) Panc 04.03; MKK4-/- cells

RX   PubMed=16740690;

WW   https://www.horizondiscovery.com/human-map2k4-panc-04-03-cell-lines-hd-109-002

CC   Knockout cell: Method=Homologous recombination; HGNC; 6844; MAP2K4.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1636 ! Panc 04.03

SX   Male

CA   Cancer cell line

//

ID   Panc 04.14

AC   CVCL_U872

SY   Panc 4.14; PL3; PL-3

RX   PubMed=14695172;

RX   PubMed=18000365;

CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.

CC   Omics: Transcriptome analysis.

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Panc 04.21

AC   CVCL_7664

SY   Panc 4.21; Panc-04.21; Panc4.21

DR   ATCC; CRL-2556

RX   PubMed=9612602;

RX   PubMed=18000365;

CC   Problematic cell line: Probably contaminated. Panc 01.28, Panc 04.21 and Panc 06.03 have been shown to be identical (on the basis of STR profile).

CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.

CC   Discontinued: ATCC; CRL-2556; true.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 8,11

ST   D16S539: 11,12

ST   D5S818: 11,12

ST   D7S820: 10,12

ST   TH01: 6,9.3

ST   TPOX: 9,11

ST   vWA: 16,17

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7666 ! Panc 01.28

OI   CVCL_7665 ! Panc 06.03

CA   Cancer cell line

//

ID   Panc 05.04

AC   CVCL_1637

SY   Panc-05.04; Panc_05_04; Panc05.04; Panc 5.04; Panc5.04; PANC0504; Pa18C

DR   CLO; CLO_0008378

DR   EFO; EFO_0006469

DR   ATCC; CRL-2557

DR   BioSample; SAMN03473170

DR   CCLE; PANC0504_PANCREAS

DR   Cosmic; 1473038

DR   Cosmic; 1509860

DR   Cosmic; 2434083

DR   GEO; GSM206530

DR   GEO; GSM621931

DR   GEO; GSM887498

DR   GEO; GSM888580

DR   GEO; GSM1024409

DR   PRIDE; PXD003198

RX   PubMed=9612602;

RX   PubMed=22460905;

RX   PubMed=22753594;

RX   PubMed=25167228;

RX   PubMed=25485619;

RX   PubMed=27259358;

RX   PubMed=28196595;

WW   http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=Panc%2005.04

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12,13

ST   D13S317: 10,12

ST   D16S539: 9,11

ST   D18S51: 14

ST   D21S11: 28,33.2

ST   D3S1358: 14,16

ST   D5S818: 12,13

ST   D7S820: 9,12

ST   D8S1179: 11,13

ST   FGA: 19,23

ST   Penta D: 7,9

ST   Penta E: 5,18

ST   TH01: 6,9.3

ST   TPOX: 8,9

ST   vWA: 15,20

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Panc 06.03

AC   CVCL_7665

SY   Panc-06.03; Panc 6.03; PANC 6.03; Panc6.03; Pa19C; Pa019C

DR   ATCC; CRL-2550

DR   Cosmic; 1473096

DR   Cosmic; 1509873

RX   PubMed=9612602;

RX   PubMed=14695172;

RX   PubMed=18000365;

RX   PubMed=22753594;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Probably contaminated. Panc 01.28, Panc 04.21 and Panc 06.03 have been shown to be identical (on the basis of STR profile).

CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.

CC   Omics: Transcriptome analysis.

CC   Discontinued: ATCC; CRL-2550; true.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 8,11

ST   D16S539: 11,12

ST   D5S818: 11,12

ST   D7S820: 10,12

ST   TH01: 6,9.3

ST   TPOX: 9,11

ST   vWA: 16,17

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7666 ! Panc 01.28

OI   CVCL_7664 ! Panc 04.21

CA   Cancer cell line

//

ID   Panc 08.13

AC   CVCL_1638

AS   CVCL_H599

SY   Panc 8.13; Panc-08.13; PANC-08-13; Panc_08_13; Panc08.13; Panc8.13; Panc-8_13; Panc-813; PANC 813; Panc813; PANC813; PANC0813; Pa14C; PL9; PL-9

DR   CLO; CLO_0008379

DR   EFO; EFO_0006470

DR   ATCC; CRL-2551

DR   BioSample; SAMN03472947

DR   CCLE; PANC0813_PANCREAS

DR   ChEMBL-Cells; CHEMBL3308777

DR   ChEMBL-Targets; CHEMBL1075558

DR   Cosmic; 925347

DR   Cosmic; 949526

DR   Cosmic; 1198215

DR   Cosmic; 1198221

DR   Cosmic; 1473126

DR   Cosmic; 1509858

DR   Cosmic; 2434104

DR   Cosmic-CLP; 925347

DR   GDSC; 925347

DR   GEO; GSM206531

DR   GEO; GSM621905

DR   GEO; GSM784709

DR   GEO; GSM827278

DR   GEO; GSM887499

DR   GEO; GSM888581

DR   GEO; GSM1024410

DR   GEO; GSM1374813

DR   GEO; GSM1670334

DR   PRIDE; PXD003198

RX   PubMed=9612602;

RX   PubMed=14695172;

RX   PubMed=18000365;

RX   PubMed=22460905;

RX   PubMed=22753594;

RX   PubMed=25167228;

RX   PubMed=25485619;

RX   PubMed=25984343;

RX   PubMed=27259358;

RX   PubMed=27397505;

WW   http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=Panc%2008.13

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.

CC   Doubling time: 117 hours (PubMed=25984343).

CC   Microsatellite instability: Instable (MSI-low) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 13

ST   D16S539: 13

ST   D18S51: 19

ST   D21S11: 32.2

ST   D3S1358: 16

ST   D5S818: 13,14

ST   D7S820: 11

ST   D8S1179: 10,14

ST   FGA: 21,23

ST   Penta D: 10

ST   Penta E: 5,16,17

ST   TH01: 6,9.3

ST   TPOX: 8,12

ST   vWA: 18

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Panc 09.06

AC   CVCL_U873

SY   Panc 9.06; Panc9.06; Panc9_06; PL13; PL-13

DR   ATCC; CRL-2552

DR   BioSample; SAMN03471670

DR   Cosmic; 949520

DR   Cosmic; 1198217

RX   PubMed=9612602;

RX   PubMed=18000365;

CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.

CC   Discontinued: ATCC; CRL-2552; true.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 11,13

ST   D13S317: 8,12

ST   D16S539: 11,14

ST   D5S818: 9,11

ST   D7S820: 8,12

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 17,18

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Panc 09.06.94

AC   CVCL_E297

SY   PANC 9.6.94; Panc9.6.94; Pa221C

DR   Cosmic; 1473044

DR   Cosmic; 1509959

RX   PubMed=22753594;

CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_U873 ! Panc 09.06

SX   Female

CA   Cancer cell line

//

ID   Panc 10.05

AC   CVCL_1639

AS   CVCL_H600

SY   Panc-10.05; Panc10.05; PANC-10-05; PANC 1005; Panc1005; PANC1005; Pa16C; PL12; PL-12

DR   CLO; CLO_0008380

DR   ATCC; CRL-2547

DR   CCLE; PANC1005_PANCREAS

DR   ChEMBL-Cells; CHEMBL3307991

DR   ChEMBL-Targets; CHEMBL612583

DR   Cosmic; 925348

DR   Cosmic; 1198216

DR   Cosmic; 1473147

DR   Cosmic; 1509859

DR   Cosmic; 2046532

DR   Cosmic; 2434097

DR   Cosmic-CLP; 925348

DR   GDSC; 925348

DR   GEO; GSM206533

DR   GEO; GSM784707

DR   GEO; GSM887500

DR   GEO; GSM888582

DR   GEO; GSM1024412

DR   GEO; GSM1374809

DR   GEO; GSM1670335

DR   PRIDE; PXD003198

RX   PubMed=9612602;

RX   PubMed=18000365;

RX   PubMed=22460905;

RX   PubMed=22753594;

RX   PubMed=25167228;

RX   PubMed=25984343;

RX   PubMed=27259358;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=Panc%2010.05

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: RAS genetic alteration cell panel (ATCC TCP-1031).

CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.

CC   Doubling time: 30 hours (PubMed=25984343).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 12

ST   D16S539: 9,12

ST   D5S818: 13

ST   D7S820: 8,9

ST   TH01: 6,9.3

ST   TPOX: 11

ST   vWA: 16

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_3567 ! PL45

SX   Male

CA   Cancer cell line

//

ID   Panc 12.01

AC   CVCL_Y004

RX   PubMed=9612602;

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PANC 1002

AC   CVCL_E283

SY   Panc1002; Pa231C

RX   PubMed=22753594;

CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PANC 185

AC   CVCL_E284

SY   Panc185; Pa37C

RX   PubMed=22753594;

CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PANC 198

AC   CVCL_E285

SY   Panc198; Pa20C

DR   Cosmic; 1473061

DR   Cosmic; 1509861

RX   PubMed=22753594;

CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PANC 215

AC   CVCL_E286

SY   Panc215; Pa09C

DR   Cosmic; 1473090

DR   Cosmic; 1509855

RX   PubMed=22753594;

CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PANC 233

AC   CVCL_E300

SY   Panc233; Pa223C

DR   Cosmic; 1477298

DR   Cosmic; 1509961

CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PANC 247

AC   CVCL_E287

SY   Panc247; Pa34C

RX   PubMed=22753594;

CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PANC 253

AC   CVCL_E288

SY   Panc253; Pa39C

RX   PubMed=22753594;

CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PANC 3.014

AC   CVCL_E298

SY   Panc 3.014; 3.014; Pa28C

DR   Cosmic; 1473074

DR   Cosmic; 1509863

RX   PubMed=22753594;

CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PANC 430

AC   CVCL_H598

SY   Panc430; Panc-4_30

DR   ChEMBL-Cells; CHEMBL3307680

DR   ChEMBL-Targets; CHEMBL614673

DR   Cosmic; 1198223

CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PANC 480

AC   CVCL_E289

SY   Panc480; Pa102C

DR   Cosmic; 1509879

RX   PubMed=22753594;

CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PANC 486

AC   CVCL_E290

SY   Panc486; Pa222C

DR   Cosmic; 1473045

DR   Cosmic; 1509960

RX   PubMed=22753594;

CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PANC 502

AC   CVCL_E291

SY   Panc502; Pa227C

RX   PubMed=22753594;

CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PANC 503

AC   CVCL_E292

SY   Panc503; Pa228C

RX   PubMed=22753594;

CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PANC 504

AC   CVCL_E293

SY   Panc504; Pa229C

RX   PubMed=22753594;

CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PANC-1

AC   CVCL_0480

SY   Panc-1; PANC.1; Panc 1; PanC1; Panc1; PANC1

DR   BCGO; BCGO_0000122

DR   BTO; BTO:0000304

DR   CLO; CLO_0008381

DR   CLO; CLO_0050102

DR   EFO; EFO_0002713

DR   MCCL; MCC:0000378

DR   CLDB; cl3872

DR   CLDB; cl3873

DR   CLDB; cl3874

DR   ATCC; CRL-1469

DR   BCRC; 60284

DR   BCRJ; 0201

DR   BioSample; SAMN01821587

DR   BioSample; SAMN03472068

DR   CCLE; PANC1_PANCREAS

DR   CCRID; 3111C0001CCC000023

DR   CCRID; 3131C0001000700098

DR   CGH-DB; 180-1

DR   CGH-DB; 9267-4

DR   ChEMBL-Cells; CHEMBL3307545

DR   ChEMBL-Targets; CHEMBL614139

DR   CLS; 300228/p635_Panc-1

DR   Cosmic; 707250

DR   Cosmic; 710864

DR   Cosmic; 724643

DR   Cosmic; 730533

DR   Cosmic; 753625

DR   Cosmic; 808171

DR   Cosmic; 868242

DR   Cosmic; 873000

DR   Cosmic; 913307

DR   Cosmic; 918054

DR   Cosmic; 922248

DR   Cosmic; 923171

DR   Cosmic; 932521

DR   Cosmic; 947397

DR   Cosmic; 948377

DR   Cosmic; 949235

DR   Cosmic; 968106

DR   Cosmic; 1006367

DR   Cosmic; 1108335

DR   Cosmic; 1122348

DR   Cosmic; 1198204

DR   Cosmic; 1299304

DR   Cosmic; 1320459

DR   Cosmic; 1366282

DR   Cosmic; 1477432

DR   Cosmic; 1518236

DR   Cosmic; 1534320

DR   Cosmic; 1571781

DR   Cosmic; 1644316

DR   Cosmic; 1609544

DR   Cosmic; 1768264

DR   Cosmic; 2434107

DR   Cosmic; 2546060

DR   DSMZ; ACC-783

DR   ECACC; 87092802

DR   ENCODE; ENCBS397PLZ

DR   ENCODE; ENCBS399ENC

DR   ENCODE; ENCBS425ENC

DR   ENCODE; ENCBS465AAA

DR   ENCODE; ENCBS466AAA

DR   ENCODE; ENCBS467AAA

DR   ENCODE; ENCBS470AAA

DR   ENCODE; ENCBS492WPY

DR   ENCODE; ENCBS556WYR

DR   ENCODE; ENCBS761TKL

DR   ENCODE; ENCBS729QZR

DR   ENCODE; ENCBS945URM

DR   GEO; GSM206532

DR   GEO; GSM244423

DR   GEO; GSM472938

DR   GEO; GSM472939

DR   GEO; GSM621900

DR   GEO; GSM784698

DR   GEO; GSM887501

DR   GEO; GSM888583

DR   GEO; GSM923421

DR   GEO; GSM945246

DR   GEO; GSM945261

DR   GEO; GSM1024411

DR   GEO; GSM1374806

DR   GEO; GSM1374807

DR   GEO; GSM1374808

DR   GEO; GSM1588613

DR   IZSLER; BS TCL 49

DR   KCB; KCB 200809YJ

DR   KCLB; 21469

DR   NCBI_Iran; C556

DR   PRIDE; PXD002192

DR   PRIDE; PXD003198

DR   RCB; RCB2095

DR   SKY/M-FISH/CGH; 2001

DR   TKG; TKG 0606

DR   TOKU-E; 2865

RX   DOI=10.4172/jpb.1000057;

RX   PubMed=1140870;

RX   PubMed=6435863;

RX   PubMed=10027410;

RX   PubMed=11169957;

RX   PubMed=11169959;

RX   PubMed=11787853;

RX   PubMed=12692724;

RX   PubMed=12800145;

RX   PubMed=14695172;

RX   PubMed=15126341;

RX   PubMed=15688027;

RX   PubMed=18380791;

RX   PubMed=20418756;

RX   PubMed=22460905;

RX   PubMed=23325432;

RX   PubMed=25167228;

RX   PubMed=25485619;

RX   PubMed=27259358;

RX   PubMed=28196595;

WW   http://www.pawefish.path.cam.ac.uk/PancCellLineDescriptions/PANC-1.html

WW   http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=PANC-1

WW   http://genome.ucsc.edu/ENCODE/protocols/cell/human/PANC-1_Myers_protocol.pdf

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=65

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-179.html

WW   http://tcpaportal.org/mclp/

CC   Part of: AKT genetic alteration cell panel (ATCC TCP-1029).

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: ENCODE project common cell types; tier 3.

CC   Part of: KuDOS 95 cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Characteristics: Has lost chromosome Y.

CC   Doubling time: ~42 hours (DSMZ).

CC   Omics: Array-based CGH.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: H3K4me3 ChIP-seq epigenome analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: Proteome analysis by 2D-DE/MS.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; CLS; DSMZ; ECACC; KCLB; PubMed=25877200; RCB; TKG

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 11

ST   D16S539: 11

ST   D18S51: 12

ST   D21S11: 28

ST   D3S1358: 17

ST   D5S818: 11,13

ST   D7S820: 8,10

ST   D8S1179: 14,15

ST   FGA: 21

ST   Penta D: 14

ST   Penta E: 7,14

ST   TH01: 7,8

ST   TPOX: 8,11

ST   vWA: 15

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Panc-4

AC   CVCL_IU72

RX   PubMed=21475719;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C7977; Pancreatic acinar cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Panc02

AC   CVCL_D627

SY   Panc-02; Panc 02; Pan02; Panc02-H0

DR   BTO; BTO:0005175

RX   PubMed=6692374;

RX   PubMed=12754403;

RX   PubMed=20805420;

RX   PubMed=21720167;

RX   PubMed=22208613;

CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).

CC   Breed/subspecies: C57BL/6.

DI   NCIt; C34041; Mouse pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Cancer cell line

//

ID   Panc02-H7

AC   CVCL_D628

DR   BTO; BTO:0005175

RX   PubMed=12754403;

RX   PubMed=22208613;

CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).

CC   Breed/subspecies: C57BL/6.

DI   NCIt; C34041; Mouse pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_D627 ! Panc02

SX   Male

CA   Cancer cell line

//

ID   Panc03

AC   CVCL_1U10

SY   Panc-03; Panc 03

RX   PubMed=6692374;

CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).

CC   Breed/subspecies: C57BL/6.

DI   NCIt; C34041; Mouse pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Cancer cell line

//

ID   Panc1-bC2GnT-M

AC   CVCL_0Q69

DR   BTO; BTO:0005502

RX   PubMed=10455130;

RX   PubMed=22525330;

CC   Transfected with: HGNC; 7508; MUC1.

CC   Transfected with: UniProtKB; Q92180; Bovine GCNT1.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0Q68 ! Panc1-MUC1

SX   Male

CA   Cancer cell line

//

ID   Panc1-MUC1

AC   CVCL_0Q68

SY   Panc1/MUC1

CC   Transfected with: HGNC; 7508; MUC1.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0480 ! PANC-1

SX   Male

CA   Cancer cell line

//

ID   PANC3

AC   CVCL_3921

SY   PANC-3

DR   BTO; BTO:0000979

RX   PubMed=11332991;

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PancTu-I

AC   CVCL_4012

SY   PancTu-1; PancTu 1; Panc-TU-I; Panc-Tu1; Panc-TuI; Panc TUI; PancTuI; PancTUI; PaTu-I; PaTu I; PaTu1

DR   EFO; EFO_0002715

DR   Cosmic; 710865

DR   Cosmic; 736275

DR   Cosmic; 933530

DR   Cosmic; 1534321

DR   GEO; GSM244424

RX   PubMed=11169959;

RX   PubMed=11787853;

RX   PubMed=12692724;

RX   PubMed=12800145;

WW   http://www.pawefish.path.cam.ac.uk/PancCellLineDescriptions/PaTu%201.html

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_4013 ! PancTu-II

SX   Female

CA   Cancer cell line

//

ID   PancTu-II

AC   CVCL_4013

SY   PaTu II; PaTu-II; Pa Tu-II; Patu-2; PATU2; PancTuII; Panc-TU-II; Panc-Tu2

DR   Cosmic; 736276

DR   Cosmic; 808162

DR   Cosmic; 933531

RX   PubMed=11169959;

WW   http://www.pawefish.path.cam.ac.uk/PancCellLineDescriptions/PaTu%20II.html

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_4012 ! PancTu-I

SX   Female

CA   Cancer cell line

//

ID   PandPush

AC   CVCL_9W24

SY   PANDPUSH

DR   IMGT/HLA; 11279

RX   PubMed=10372548;

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   PanG 12.1

AC   CVCL_X926

SY   PanG 12-1

RX   PubMed=2247455;

CC   Transformant: NCBI_TaxID; 11909; Human T-lymphotropic virus 2 (HTLV-2).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   PAP 7

AC   CVCL_J770

SY   PAP7

DR   ECACC; 86080701

RX   PubMed=3545314;

CC   Monoclonal antibody target: UniProtKB; P05994; Papaya proteinase 4.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   PAP 8

AC   CVCL_J771

SY   PAP8

DR   ECACC; 86080702

RX   PubMed=3545314;

CC   Monoclonal antibody target: UniProtKB; P10056; Papaya proteinase 3 (omega).

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   PAP-HT25

AC   CVCL_4678

DR   BTO; BTO:0001527

RX   PubMed=3303963;

OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus

HI   CVCL_9702 ! GRB-PAP1

CA   Spontaneously immortalized cell line

//

ID   PAR

AC   CVCL_E801

DR   dbMHC; 48996

DR   ECACC; 94050315

DR   IHW; IHW9266

DR   IMGT/HLA; 11231

WW   http://bioinformatics.hsanmartino.it/ecbr/cl266.html

CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   Par Bel

AC   CVCL_U680

DR   ATCC; CRL-1191

RX   PubMed=3860870;

CC   Discontinued: ATCC; CRL-1191; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   Par-C10

AC   CVCL_8903

SY   PAR-C10; ParC10; Parotid C10; C10; Pa-3

RX   PubMed=9112124;

RX   PubMed=9542637;

RX   PubMed=9688590;

RX   PubMed=20121592;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: Sprague-Dawley.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Transformed cell line

//

ID   Par-C5

AC   CVCL_D695

SY   PAR-C5; ParC5; Parotid C5; C5; Pa-4

RX   PubMed=9112124;

RX   PubMed=9542637;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: Sprague-Dawley.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Transformed cell line

//

ID   PARK4-14

AC   CVCL_T869

DR   SKIP; SKIP000195

RX   PubMed=22848530;

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_F204 ! ND27760

SX   Female

CA   Induced pluripotent stem cell

//

ID   PARK4-4

AC   CVCL_T870

DR   SKIP; SKIP000194

RX   PubMed=22848530;

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_F204 ! ND27760

SX   Female

CA   Induced pluripotent stem cell

//

ID   Parks

AC   CVCL_DN32

SY   PARKS

RX   PubMed=27197945;

RX   PubMed=27257868;

CC   Part of: FACC canine tumor cell line panel.

CC   Omics: Transcriptome analysis.

DI   NCIt; C120298; Canine melanoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

CA   Cancer cell line

//

ID   PAS

AC   CVCL_R914

SY   Purplish Amberjack Skin

RX   DOI=10.1577/1548-8667(1993)005<0127:COTCCL>2.3.CO;2;

RX   DOI=10.3147/jsfp.28.27;

CC   Group: Fish cell line.

OX   NCBI_TaxID=41447; ! Seriola dumerili

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   Pat Bru

AC   CVCL_X708

SY   PatBru

DR   ATCC; CRL-1121

RX   PubMed=865488;

CC   Discontinued: ATCC; CRL-1121; probable.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   Pat5

AC   CVCL_0J19

SY   Pat 5

RX   PubMed=17828574;

WW   http://inventions.umich.edu/technologies/1862_pluripotent-mouse-embryonic-stem-cell-line-pat-5

CC   Breed/subspecies: 129X1/SvJ.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Embryonic stem cell

//

ID   Patas-BARF1

AC   CVCL_4T88

SY   P-BA

RX   PubMed=9223671;

RX   PubMed=19724690;

CC   Group: Non-human primate cell line.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV) [BARF1].

CC   Transformant: EBV BARF1.

OX   NCBI_TaxID=9538; ! Erythrocebus patas

CA   Transformed cell line

//

ID   PATH.1

AC   CVCL_9W29

SY   Peripheral Adrenergic TH-expressing 1

RX   Patent=US5591626;

RX   PubMed=7680068;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6 x DBA/2.

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_9W30 ! PATH.2

SX   Female

CA   Transformed cell line

//

ID   PATH.2

AC   CVCL_9W30

SY   Peripheral Adrenergic TH-expressing 2

RX   Patent=US5591626;

RX   PubMed=7680068;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6 x DBA/2.

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_9W29 ! PATH.1

SX   Female

CA   Transformed cell line

//

ID   Patrick

AC   CVCL_IU34

SY   NK-45

RX   PubMed=4320167;

RX   PubMed=5021706;

DI   NCIt; C2912; Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Patscl-52

AC   CVCL_8400

SY   PatScl 52; Patscl52

DI   NCIt; C3850; Pancreatic carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Patski

AC   CVCL_Y494

SY   PATSKI

DR   EFO; EFO_0005481

DR   ENCODE; ENCBS171ENC

DR   ENCODE; ENCBS172ENC

DR   ENCODE; ENCBS463JXY

DR   GEO; GSM1014171

RX   PubMed=9500539;

RX   PubMed=20363980;

WW   http://genome.ucsc.edu/ENCODE/protocols/cell/mouse/Patski_Stam_protocol.pdf

CC   Part of: ENCODE project mouse cell lines.

CC   Omics: Deep RNAseq analysis.

OX   NCBI_TaxID=186842; ! Mus musculus x Mus spretus

SX   Female

CA   Spontaneously immortalized cell line

//

ID   PaTu 8902

AC   CVCL_1845

SY   PA-TU-8902; PATU-8902; PaTu8902; PATU8902; 8902

DR   CLO; CLO_0008382

DR   EFO; EFO_0006729

DR   CLDB; cl3860

DR   BioSample; SAMN03473078

DR   CCLE; PATU8902_PANCREAS

DR   Cosmic; 873004

DR   Cosmic; 948381

DR   Cosmic; 2434100

DR   Cosmic-CLP; 1298526

DR   DSMZ; ACC-179

DR   GDSC; 1298526

DR   GEO; GSM206534

DR   GEO; GSM887502

DR   GEO; GSM888584

DR   GEO; GSM1670336

DR   NCBI_Iran; C557

RX   PubMed=8287116;

RX   PubMed=11787853;

RX   PubMed=15126341;

RX   PubMed=15688027;

RX   PubMed=22460905;

RX   PubMed=25167228;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: ~25-40 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Array-based CGH.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; DSMZ; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 11,12

ST   D16S539: 9,11

ST   D18S51: 15

ST   D21S11: 30

ST   D3S1358: 16,18

ST   D5S818: 11,12

ST   D7S820: 8,10

ST   D8S1179: 13

ST   FGA: 23

ST   Penta D: 11

ST   Penta E: 12,15

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 18

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PaTu 8988s

AC   CVCL_1846

SY   PA-TU-8988S; PaTu8988s; PaTu8988S; PATU8988S; PaTu 8988 S; PaTu-8988s; PATU-8988S; PATU-S

DR   BTO; BTO:0005879

DR   CLO; CLO_0008383

DR   EFO; EFO_0006730

DR   CLDB; cl3861

DR   CCLE; PATU8988S_PANCREAS

DR   Cosmic; 873007

DR   Cosmic; 2046530

DR   Cosmic; 2434103

DR   DSMZ; ACC-204

DR   GEO; GSM887503

DR   GEO; GSM888585

RX   PubMed=1348891;

RX   PubMed=15126341;

RX   PubMed=15688027;

RX   PubMed=22460905;

RX   PubMed=25167228;

RX   PubMed=25485619;

RX   PubMed=28196595;

WW   http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=PaTu_8988S

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: ~40-60 hours (DSMZ).

CC   Omics: Array-based CGH.

CC   Omics: Deep RNAseq analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): DSMZ; PubMed=11416159

ST   Amelogenin: X

ST   CSF1PO: 11,13

ST   D13S317: 12,13

ST   D16S539: 11,12

ST   D18S51: 12

ST   D21S11: 26

ST   D5S818: 11,13

ST   D7S820: 7,8

ST   D8S1179: 13,16

ST   FGA: 23

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 16

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1847 ! PaTu 8988t

SX   Female

CA   Cancer cell line

//

ID   PaTu 8988t

AC   CVCL_1847

SY   PA-TU-8988T; PaTu8988t; PaTu8988T; PATU8988T; PaTu 8988 T; PaTu-8988t; PATU-8988T; PATU-T; 8988T

DR   BTO; BTO:0005878

DR   CLO; CLO_0008384

DR   EFO; EFO_0005713

DR   CLDB; cl3862

DR   BioSample; SAMN03473157

DR   CCLE; PATU8988T_PANCREAS

DR   Cosmic; 873006

DR   Cosmic; 948382

DR   Cosmic; 1524020

DR   Cosmic; 1995611

DR   Cosmic; 2046531

DR   Cosmic; 2434111

DR   Cosmic-CLP; 1240201

DR   DSMZ; ACC-162

DR   ENCODE; ENCBS158AAA

DR   GDSC; 1240201

DR   GEO; GSM206535

DR   GEO; GSM385524

DR   GEO; GSM385535

DR   GEO; GSM816667

DR   GEO; GSM827178

DR   GEO; GSM887504

DR   GEO; GSM888586

DR   GEO; GSM16703371

DR   IGRhCellID; PA-TU-8988T%20GEO

RX   PubMed=1348891;

RX   PubMed=15126341;

RX   PubMed=15688027;

RX   PubMed=22460905;

RX   PubMed=25167228;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=PaTu_8988T

WW   http://genome.ucsc.edu/ENCODE/protocols/cell/human/8988T_Crawford_protocol.pdf

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: ENCODE project common cell types; tier 3.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: ~22-30 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Array-based CGH.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; DSMZ; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11,13

ST   D13S317: 12,13

ST   D16S539: 11,12

ST   D18S51: 12

ST   D21S11: 26

ST   D3S1358: 15,17

ST   D5S818: 11,13

ST   D7S820: 7,8

ST   D8S1179: 13,16

ST   FGA: 23

ST   Penta D: 8

ST   Penta E: 14

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 16

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1846 ! PaTu 8988s

SX   Female

CA   Cancer cell line

//

ID   PaTuO2

AC   CVCL_L218

SY   PaTuO-2

DR   BTO; BTO:0005398

CC   Miscellaneous: Only mentioned as a pancreatic adenocarcinoma cell line in PubMed=20709028.

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PAV-1

AC   CVCL_7995

DR   BTO; BTO:0003523

RX   PubMed=12007639;

RX   PubMed=17760834;

CC   Breed/subspecies: Wistar.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Spontaneously immortalized cell line

//

ID   PAZ6

AC   CVCL_GS29

SY   PAZ-6

DR   GEO; GSM1543670

DR   GEO; GSM1543671

RX   Patent=US6071747;

RX   PubMed=9133667;

RX   PubMed=18283285;

RX   PubMed=22649407;

RX   PubMed=25925588;

CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-1531.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Omics: Deep RNAseq analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   PB-1 [Human]

AC   CVCL_8443

SY   PB1

RX   PubMed=11021758;

RX   PubMed=11737246;

DI   NCIt; C9265; Mycosis fungoides and Sezary syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PB-1 [Mouse mast cell]

AC   CVCL_Y654

RX   PubMed=3493490;

RX   PubMed=6873525;

CC   Breed/subspecies: DBA/2.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Spontaneously immortalized cell line

//

ID   PB-1 [Mouse pre-B cell]

AC   CVCL_2159

DR   CLO; CLO_0008385

DR   CLDB; cl836

DR   DSMZ; ACC-241

RX   PubMed=10699580;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=PB-1

CC   Characteristics: IL7 dependent.

CC   Doubling time: ~50 hours (DSMZ).

CC   Breed/subspecies: C57BL/6 x CBA.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Factor-dependent cell line

//

ID   PB-3c

AC   CVCL_5346

SY   PB-3C; PB-3

DR   IFO; IFO50267

RX   PubMed=3079807;

RX   PubMed=3493490;

RX   PubMed=6873525;

CC   Characteristics: IL3 dependent.

CC   Breed/subspecies: DBA/2.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Factor-dependent cell line

//

ID   PB03

AC   CVCL_C345

SY   PB3; UPS-FRi004-A; UPSFRi001-A

DR   hPSCreg; UPSFRi001-A

RX   PubMed=22425713;

RX   PubMed=22514597;

RX   PubMed=26938212;

CC   From: Universite Paris-Sud 11; Paris; France.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PB04

AC   CVCL_C346

SY   PB4; UPS-FRi005-A; UPSFRi002-A

DR   hPSCreg; UPSFRi002-A

RX   PubMed=22425713;

RX   PubMed=22514597;

RX   PubMed=26938212;

CC   From: Universite Paris-Sud 11; Paris; France.

DI   NCIt; C34375; Thalassemia major

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PB05

AC   CVCL_C347

SY   PB5; UPS-FRi007-A; UPSFRi004-A

DR   hPSCreg; UPSFRi004-A

RX   PubMed=22425713;

RX   PubMed=26938212;

CC   From: Universite Paris-Sud 11; Paris; France.

DI   NCIt; C34375; Thalassemia major

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PB05-1

AC   CVCL_C348

SY   PB05.1; UPS-FRi006-A; UPSFRi003-A

DR   hPSCreg; UPSFRi003-A

RX   PubMed=22425713;

CC   From: Universite Paris-Sud 11; Paris; France.

DI   NCIt; C34375; Thalassemia major

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_C347 ! PB05

SX   Male

CA   Induced pluripotent stem cell

//

ID   PB06

AC   CVCL_C349

SY   UPS-FRi008-A; UPSFRi005-A

DR   hPSCreg; UPSFRi005-A

RX   PubMed=22425713;

CC   From: Universite Paris-Sud 11; Paris; France.

DI   NCIt; C2993; Down syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PB06-1

AC   CVCL_C350

SY   UPS-FRi008-A-1; UPSFRi005-A-1

DR   hPSCreg; UPSFRi005-A-1

CC   From: Universite Paris-Sud 11; Paris; France.

DI   NCIt; C2993; Down syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_C349 ! PB06

SX   Male

CA   Induced pluripotent stem cell

//

ID   PB07

AC   CVCL_C351

SY   PB7; UPS-FRi009-A; UPSFRi006-A

DR   hPSCreg; UPSFRi006-A

RX   PubMed=26938212;

CC   From: Universite Paris-Sud 11; Paris; France.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PB08

AC   CVCL_C352

SY   PB8; UPS-FRi010-A; UPSFRi007-A

DR   hPSCreg; UPSFRi007-A

RX   PubMed=22514597;

RX   PubMed=26938212;

CC   From: Universite Paris-Sud 11; Paris; France.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PB09

AC   CVCL_C353

SY   PB9; UPS-FRi011-A; UPSFRi008-A

DR   hPSCreg; UPSFRi008-A

RX   PubMed=22425713;

RX   PubMed=22514597;

RX   PubMed=26938212;

CC   From: Universite Paris-Sud 11; Paris; France.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PB1

AC   CVCL_T881

DR   SKIP; SKIP000202

RX   PubMed=23039195;

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T882 ! PB2

OI   CVCL_T883 ! PB18

OI   CVCL_T884 ! PB20

SX   Male

CA   Induced pluripotent stem cell

//

ID   PB10

AC   CVCL_C354

SY   UPS-FRi012-A; UPSFRi009-A

DR   hPSCreg; UPSFRi009-A

RX   PubMed=22425713;

RX   PubMed=22514597;

RX   PubMed=26938212;

CC   From: Universite Paris-Sud 11; Paris; France.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PB11

AC   CVCL_GR17

RX   PubMed=26938212;

CC   From: Universite Paris-Sud 11; Paris; France.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Induced pluripotent stem cell

//

ID   PB13

AC   CVCL_Y593

RX   PubMed=22514597;

RX   PubMed=26938212;

CC   From: Universite Paris-Sud 11; Paris; France.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Induced pluripotent stem cell

//

ID   PB150.18

AC   CVCL_2H73

SY   BALB/cByJ-PB150.18

WW   http://jaxmice.jax.org/strain/012488.html

CC   From: Predictive Biology, Inc.

CC   Breed/subspecies: BALB/cByJ.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   PB151.24

AC   CVCL_2H74

SY   C3H/HeJ-PB151.24

WW   http://jaxmice.jax.org/strain/012490.html

CC   From: Predictive Biology, Inc.

CC   Breed/subspecies: C3H/HeJ.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   PB17

AC   CVCL_GR18

RX   PubMed=26938212;

CC   From: Universite Paris-Sud 11; Paris; France.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Induced pluripotent stem cell

//

ID   PB18

AC   CVCL_T883

DR   SKIP; SKIP000204

RX   PubMed=23039195;

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T881 ! PB1

OI   CVCL_T882 ! PB2

OI   CVCL_T884 ! PB20

SX   Male

CA   Induced pluripotent stem cell

//

ID   PB2

AC   CVCL_T882

DR   SKIP; SKIP000203

RX   PubMed=23039195;

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T881 ! PB1

OI   CVCL_T883 ! PB18

OI   CVCL_T884 ! PB20

SX   Male

CA   Induced pluripotent stem cell

//

ID   PB20

AC   CVCL_T884

DR   SKIP; SKIP000205

RX   PubMed=23039195;

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T881 ! PB1

OI   CVCL_T882 ! PB2

OI   CVCL_T883 ! PB18

SX   Male

CA   Induced pluripotent stem cell

//

ID   PB30

AC   CVCL_GR19

RX   PubMed=26938212;

CC   From: Universite Paris-Sud 11; Paris; France.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Induced pluripotent stem cell

//

ID   PB32

AC   CVCL_GR24

RX   PubMed=27879209;

CC   From: Universite Paris-Sud 11; Paris; France.

DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PB32-1

AC   CVCL_GR25

RX   PubMed=27879209;

CC   From: Universite Paris-Sud 11; Paris; France.

DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_GR24 ! PB32

SX   Male

CA   Induced pluripotent stem cell

//

ID   PB32-4

AC   CVCL_GR26

RX   PubMed=27879209;

CC   From: Universite Paris-Sud 11; Paris; France.

DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_GR24 ! PB32

SX   Male

CA   Induced pluripotent stem cell

//

ID   PB32-5

AC   CVCL_GR27

RX   PubMed=27879209;

CC   From: Universite Paris-Sud 11; Paris; France.

DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_GR24 ! PB32

SX   Male

CA   Induced pluripotent stem cell

//

ID   PB33

AC   CVCL_GR20

RX   PubMed=26938212;

CC   From: Universite Paris-Sud 11; Paris; France.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Induced pluripotent stem cell

//

ID   PB35.17

AC   CVCL_2H75

SY   NZW/LacJ-PB35.17

WW   http://jaxmice.jax.org/strain/012489.html

CC   From: Predictive Biology, Inc.

CC   Breed/subspecies: NZW/LacJ.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   PB48

AC   CVCL_GQ02

RX   PubMed=27558615;

CC   From: Universite Paris-Sud 11; Paris; France.

DI   NCIt; C123329; Multiple endocrine neoplasia type 2

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PB60.6

AC   CVCL_2H76

SY   BTBR T+ Itpr3tf/J-PB60.6

WW   http://jaxmice.jax.org/strain/012486.html

CC   From: Predictive Biology, Inc.

CC   Breed/subspecies: BTBR T+ Itpr3tf/J.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   PB61.11

AC   CVCL_2H77

SY   MRL/MpJ-PB61.11

WW   http://jaxmice.jax.org/strain/012485.html

CC   From: Predictive Biology, Inc.

CC   Breed/subspecies: MRL/MpJ.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   PB84.3

AC   CVCL_2H78

SY   FVB/NJ-PB84.3

WW   http://jaxmice.jax.org/strain/012487.html

CC   From: Predictive Biology, Inc.

CC   Breed/subspecies: FVB/NJ.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   PBEI

AC   CVCL_8270

DR   BioSample; SAMN03151852

RX   PubMed=10508494;

RX   PubMed=12592342;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a NALM-6 derivative (PubMed=10508494, PubMed=12592342, PubMed=20143388).

DI   NCIt; C9143; Adult B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0092 ! NALM-6

SX   Male

CA   Cancer cell line

//

ID   PBL-Om

AC   CVCL_G007

RX   PubMed=6088403;

RX   PubMed=6189906;

CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_F912 ! ILT-Om

SX   Male

CA   Transformed cell line

//

ID   PBLE

AC   CVCL_R845

SY   Peripheral Blood Leukocyte Eel

RX   PubMed=17163780;

CC   Group: Fish cell line.

OX   NCBI_TaxID=7938; ! Anguilla rostrata

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   PBMC1-iPS4F1

AC   CVCL_9U44

RX   PubMed=26987924;

RX   PubMed=27346199;

ST   Source(s): PubMed=27346199

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11,12

ST   D16S539: 9,13

ST   D18S51: 10,16

ST   D19S433: 12,14

ST   D21S11: 30,34

ST   D2S1338: 17

ST   D3S1358: 16,17

ST   D5S818: 11,12

ST   D7S820: 9,10

ST   D8S1179: 13,16

ST   FGA: 18,22

ST   TH01: 7,9

ST   TPOX: 8,11

ST   vWA: 15,19

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PBMC1-iPS4F1 shDLL4

AC   CVCL_DQ81

RX   PubMed=27346199;

CC   Knockout cell: Method=shRNA knockdown; HGNC; 2910; DLL4.

ST   Source(s): PubMed=27346199

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11,12

ST   D16S539: 9,13

ST   D18S51: 10,16

ST   D19S433: 12,14

ST   D21S11: 30,34

ST   D2S1338: 17

ST   D3S1358: 16,17

ST   D5S818: 11,12

ST   D7S820: 9,10

ST   D8S1179: 13,16

ST   FGA: 18,22

ST   TH01: 7,9

ST   TPOX: 8,11

ST   vWA: 15,19

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9U44 ! PBMC1-iPS4F1

SX   Female

CA   Induced pluripotent stem cell

//

ID   PBMC1-iPS4F1 shSCR

AC   CVCL_DQ82

RX   PubMed=27346199;

ST   Source(s): PubMed=27346199

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11,12

ST   D16S539: 9,13

ST   D18S51: 10,16

ST   D19S433: 12,14

ST   D21S11: 30,34

ST   D2S1338: 17

ST   D3S1358: 16,17

ST   D5S818: 11,12

ST   D7S820: 9,10

ST   D8S1179: 13,16

ST   FGA: 18,22

ST   TH01: 7,9

ST   TPOX: 8,11

ST   vWA: 15,19

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9U44 ! PBMC1-iPS4F1

SX   Female

CA   Induced pluripotent stem cell

//

ID   PBS-1

AC   CVCL_1K16

RX   DOI=10.4172/2157-7560.1000345;

RX   PubMed=18524432;

RX   PubMed=25903999;

CC   Group: Bird cell line.

CC   Group: Vaccine production cell line.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=9031; ! Gallus gallus

HI   CVCL_Y589 ! CHCC-OU2

CA   Transformed cell line

//

ID   PBS-12SF

AC   CVCL_1K17

SY   PBS-12 SF; PBS12SF

DR   ATCC; PTA-8565

RX   DOI=10.4172/2157-7560.1000345;

RX   Patent=US8716016;

RX   PubMed=18524432;

RX   PubMed=21911025;

RX   PubMed=25903999;

CC   Group: Bird cell line.

CC   Group: Vaccine production cell line.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

CC   Discontinued: ATCC; PTA-8565; probable.

OX   NCBI_TaxID=9031; ! Gallus gallus

HI   CVCL_1K16 ! PBS-1

CA   Transformed cell line

//

ID   PC 61-5-3

AC   CVCL_4550

SY   PC 61 5.3; PC 61.5.3; PC615.3; PC 61

DR   CLO; CLO_0008390

DR   CLO; CLO_0008391

DR   CLDB; cl5246

DR   ATCC; TIB-222

DR   BCRC; 60492

DR   CCRID; 3131C0001000600052

DR   ECACC; 88041902

DR   IZSLER; BS Hy 23

CC   Monoclonal antibody target: UniProtKB; P01590; Mouse Il2ra/Cd25.

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   PC-0199-BR

AC   CVCL_Z242

RX   PubMed=11562717;

CC   Group: Insect cell line.

OX   NCBI_TaxID=869071; ! Psorophora confinnis

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   PC-1 [Hamster]

AC   CVCL_L900

SY   PC1

DR   BTO; BTO:0002747

RX   PubMed=2000935;

RX   PubMed=2539915;

RX   PubMed=8382114;

RX   PubMed=8863680;

OX   NCBI_TaxID=10036; ! Mesocricetus auratus

SX   Male

CA   Cancer cell line

//

ID   PC-1 [Human lung carcinoma]

AC   CVCL_S978

SY   PC1

DR   EFO; EFO_0002842

DR   Cosmic; 1089227

DR   Cosmic; 1571733

RX   PubMed=3731100;

CC   From: Immuno-Biological Laboratories (IBL); Tokyo; Japan.

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PC-1 [Human pancreatic carcinoma]

AC   CVCL_S969

DR   Cosmic; 965556

RX   PubMed=2118052;

RX   PubMed=14640107;

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PC-1 [Plagionotus]

AC   CVCL_Z274

SY   Plagionotus Christophi-1

RX   PubMed=18946707;

CC   Group: Insect cell line.

CC   Doubling time: 3.79 days (PubMed=18946707).

OX   NCBI_TaxID=157322; ! Plagionotus christophi

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   PC-1.0

AC   CVCL_L901

SY   PC1.0

DR   BTO; BTO:0002746

RX   PubMed=1530768;

RX   PubMed=8382114;

RX   PubMed=8863680;

OX   NCBI_TaxID=10036; ! Mesocricetus auratus

HI   CVCL_L900 ! PC-1 [Hamster]

SX   Male

CA   Cancer cell line

//

ID   PC-1.2

AC   CVCL_L902

SY   PC1.2

RX   PubMed=1530768;

RX   PubMed=8863680;

OX   NCBI_TaxID=10036; ! Mesocricetus auratus

HI   CVCL_L900 ! PC-1 [Hamster]

SX   Male

CA   Cancer cell line

//

ID   PC-10

AC   CVCL_7088

SY   PC10

DR   BTO; BTO:0004886

DR   EFO; EFO_0002843

DR   CGH-DB; 190-1

DR   CGH-DB; 9175-4

DR   ChEMBL-Cells; CHEMBL3307345

DR   ChEMBL-Targets; CHEMBL614234

DR   Cosmic; 713859

DR   Cosmic; 801575

DR   Cosmic; 844813

DR   Cosmic; 876168

DR   Cosmic; 917999

DR   Cosmic; 929155

DR   Cosmic; 1089228

DR   Cosmic; 1219087

DR   Cosmic; 1239915

DR   Cosmic; 1571736

DR   Cosmic; 2125280

RX   PubMed=3731100;

RX   PubMed=11005564;

RX   PubMed=14581340;

RX   PubMed=15185009;

RX   PubMed=15746151;

RX   PubMed=19472407;

RX   PubMed=23381221;

RX   PubMed=25120651;

CC   From: Immuno-Biological Laboratories (IBL); Tokyo; Japan.

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PC-12

AC   CVCL_S979

SY   PC12

RX   PubMed=3731100;

CC   From: Immuno-Biological Laboratories (IBL); Tokyo; Japan.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PC-12 Adh

AC   CVCL_F659

SY   PC-12 ADH; PC-12Adh; PC-12 Adherent

DR   ATCC; CRL-1721.1

DR   BCRJ; 0202

WW   http://www.atcc.org/support/faqs/2ef3f/PC12%20Cells%20%20ATCC%20CRL1721%20vs%20ATCC%20CRL17211-783.aspx

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0481 ! PC12

SX   Male

CA   Cancer cell line

//

ID   PC-12 HD-Q23 cell 14

AC   CVCL_AU97

DR   Ximbio; 152416

RX   PubMed=11532992;

CC   Transfected with: HGNC; 4851; HTT (1st exon with 23-Q run).

CC   Transfected with: UniProtKB; P42212; GFP.

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0481 ! PC12

SX   Male

CA   Cancer cell line

//

ID   PC-12 HD-Q23 cell 7

AC   CVCL_AU98

DR   Ximbio; 152416

RX   PubMed=11532992;

CC   Transfected with: HGNC; 4851; HTT (1st exon with 23-Q run).

CC   Transfected with: UniProtKB; P42212; GFP.

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0481 ! PC12

SX   Male

CA   Cancer cell line

//

ID   PC-12 HD-Q74 cell 10

AC   CVCL_AU99

DR   Ximbio; 152417

RX   PubMed=11532992;

CC   Transfected with: HGNC; 4851; HTT (1st exon with 74-Q run).

CC   Transfected with: UniProtKB; P42212; GFP.

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0481 ! PC12

SX   Male

CA   Cancer cell line

//

ID   PC-12 HD-Q74 cell 1b

AC   CVCL_AV00

DR   Ximbio; 152417

RX   PubMed=11532992;

CC   Transfected with: HGNC; 4851; HTT (1st exon with 74-Q run).

CC   Transfected with: UniProtKB; P42212; GFP.

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0481 ! PC12

SX   Male

CA   Cancer cell line

//

ID   PC-12TG

AC   CVCL_5574

SY   PC12TG

DR   IFO; IFO50496

RX   PubMed=7763725;

CC   Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0481 ! PC12

SX   Male

CA   Cancer cell line

//

ID   PC-13

AC   CVCL_B259

SY   PC13

DR   CGH-DB; 9184-4

DR   ChEMBL-Cells; CHEMBL3307865

DR   ChEMBL-Targets; CHEMBL614100

DR   Cosmic; 801576

DR   Cosmic; 809128

DR   Cosmic; 844835

DR   Cosmic; 876173

DR   Cosmic; 917996

DR   Cosmic; 946059

DR   Cosmic; 1239926

DR   Cosmic; 2125281

RX   PubMed=3731100;

RX   PubMed=4094096;

RX   PubMed=11005564;

RX   PubMed=15185009;

RX   PubMed=15746151;

RX   PubMed=19472407;

CC   From: Immuno-Biological Laboratories (IBL); Tokyo; Japan.

DI   NCIt; C4450; Large cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PC-14

AC   CVCL_1640

SY   PC14

DR   BTO; BTO:0002877

DR   CLO; CLO_0008394

DR   EFO; EFO_0002844

DR   CLDB; cl3880

DR   CCLE; PC14_LUNG

DR   CGH-DB; 205-1

DR   CGH-DB; 9169-4

DR   ChEMBL-Cells; CHEMBL3307306

DR   ChEMBL-Targets; CHEMBL614140

DR   Cosmic; 753608

DR   Cosmic; 801577

DR   Cosmic; 876138

DR   Cosmic; 897744

DR   Cosmic; 932924

DR   Cosmic; 946060

DR   Cosmic; 1239897

DR   Cosmic; 1571737

DR   Cosmic; 1656894

DR   Cosmic; 1995612

DR   Cosmic; 2125282

DR   Cosmic-CLP; 753608

DR   ECACC; 90071810

DR   GDSC; 753608

DR   GEO; GSM827410

DR   GEO; GSM887505

DR   GEO; GSM888587

DR   GEO; GSM1670338

DR   RCB; RCB0446

RX   PubMed=4094096;

RX   PubMed=11005564;

RX   PubMed=14581340;

RX   PubMed=15185009;

RX   PubMed=15746151;

RX   PubMed=19472407;

RX   PubMed=22313637;

RX   PubMed=22460905;

RX   PubMed=25120651;

RX   PubMed=27397505;

WW   http://www.brc.riken.jp/lab/cell/english/rcb0446_announce.shtml

CC   Problematic cell line: Contaminated. Shown to be a PC-9 derivative.

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   From: Immuno-Biological Laboratories (IBL); Tokyo; Japan.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: RCB; RCB0446; true.

ST   Source(s): Cosmic-CLP; ECACC; PubMed=11416159

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 8

ST   D16S539: 9

ST   D18S51: 15

ST   D21S11: 29,30

ST   D5S818: 11

ST   D7S820: 10,11 (Cosmic-CLP)

ST   D7S820: 10 (ECACC; PubMed=11416159)

ST   D8S1179: 11,15

ST   FGA: 23,25

ST   TH01: 7

ST   TPOX: 11

ST   vWA: 17

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B260 ! PC-9

SX   Male

CA   Cancer cell line

//

ID   PC-14-PM4

AC   CVCL_9W69

SY   PC-14 PM4

RX   PubMed=9563004;

CC   Problematic cell line: Contaminated. Parent cell line (PC-14) has been shown to be a PC-9 derivative.

CC   Caution: We are not certain that PC-14-PM4 and PC14PE6 are identical.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1640 ! PC-14

SX   Male

CA   Cancer cell line

//

ID   PC-2 [Human pancreatic carcinoma]

AC   CVCL_S970

SY   PC2

DR   Cosmic; 965557

RX   PubMed=2118052;

RX   PubMed=11169957;

RX   PubMed=14640107;

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PC-2 [Rat liver]

AC   CVCL_1G62

RX   PubMed=4277389;

CC   Breed/subspecies: Donryu.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_1G61 ! RLN-E7

SX   Male

CA   Transformed cell line

//

ID   PC-295

AC   CVCL_4876

RX   PubMed=8780407;

WW   http://capcelllines.ca/details.asp?id=136

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PC-3

AC   CVCL_0035

SY   PC3; PC.3

DR   BTO; BTO:0001061

DR   CLO; CLO_0008395

DR   CLO; CLO_0051535

DR   EFO; EFO_0002074

DR   MCCL; MCC:0000380

DR   CLDB; cl3881

DR   CLDB; cl3883

DR   ATCC; CRL-1435

DR   ATCC; CRL-7934

DR   BCRC; 60122

DR   BCRJ; 0269

DR   BioSample; SAMN01821588

DR   BioSample; SAMN01821653

DR   BioSample; SAMN01821713

DR   BioSample; SAMN03472063

DR   CCLE; PC3_PROSTATE

DR   CCRID; 3111C0001CCC000115

DR   CCRID; 3131C0001000700041

DR   CCRID; 3131C0001000700158

DR   CCRID; 3142C0001000000113

DR   ChEMBL-Cells; CHEMBL3307570

DR   ChEMBL-Targets; CHEMBL390

DR   CLS; 300312/p1699_PC-3

DR   Cosmic; 688118

DR   Cosmic; 704849

DR   Cosmic; 713868

DR   Cosmic; 719680

DR   Cosmic; 721366

DR   Cosmic; 721556

DR   Cosmic; 755297

DR   Cosmic; 759894

DR   Cosmic; 801350

DR   Cosmic; 809225

DR   Cosmic; 850414

DR   Cosmic; 869157

DR   Cosmic; 873002

DR   Cosmic; 875892

DR   Cosmic; 876396

DR   Cosmic; 897455

DR   Cosmic; 905934

DR   Cosmic; 911997

DR   Cosmic; 918502

DR   Cosmic; 920968

DR   Cosmic; 921048

DR   Cosmic; 922551

DR   Cosmic; 923957

DR   Cosmic; 943175

DR   Cosmic; 948379

DR   Cosmic; 949249

DR   Cosmic; 974299

DR   Cosmic; 1028650

DR   Cosmic; 1028702

DR   Cosmic; 1071477

DR   Cosmic; 1075273

DR   Cosmic; 1092627

DR   Cosmic; 1172628

DR   Cosmic; 1175888

DR   Cosmic; 1188436

DR   Cosmic; 1212489

DR   Cosmic; 1219448

DR   Cosmic; 1305380

DR   Cosmic; 1312367

DR   Cosmic; 1330910

DR   Cosmic; 1436048

DR   Cosmic; 1689714

DR   Cosmic; 1995613

DR   Cosmic; 1998469

DR   Cosmic; 2301588

DR   Cosmic; 2580130

DR   Cosmic; 2585153

DR   Cosmic; 2585230

DR   Cosmic-CLP; 905934

DR   DSMZ; ACC-465

DR   ECACC; 90112714

DR   ENCODE; ENCBS420VDY

DR   ENCODE; ENCBS451OVM

DR   ENCODE; ENCBS504WVV

DR   ENCODE; ENCBS596CTT

DR   ENCODE; ENCBS608AAA

DR   ENCODE; ENCBS609AAA

DR   GDSC; 905934

DR   GEO; GSM50225

DR   GEO; GSM50289

DR   GEO; GSM91930

DR   GEO; GSM142459

DR   GEO; GSM142460

DR   GEO; GSM482670

DR   GEO; GSM525804

DR   GEO; GSM595615

DR   GEO; GSM648823

DR   GEO; GSM750835

DR   GEO; GSM784792

DR   GEO; GSM799370

DR   GEO; GSM799433

DR   GEO; GSM847110

DR   GEO; GSM844675

DR   GEO; GSM844674

DR   GEO; GSM887506

DR   GEO; GSM888588

DR   GEO; GSM1153442

DR   GEO; GSM1181274

DR   GEO; GSM1181303

DR   GEO; GSM1374817

DR   GEO; GSM1374818

DR   GEO; GSM1670339

DR   ICLC; HTL97018

DR   IZSLER; BS TCL 175

DR   JCRB; JCRB9110

DR   KCB; KCB 200725YJ

DR   KCLB; 21435

DR   LINCS; 50454

DR   NCBI_Iran; C427

DR   PRIDE; PRD000228

DR   PRIDE; PRD000597

DR   PRIDE; PXD002107

DR   PRIDE; PXD003105

DR   RCB; RCB2145

DR   SKY/M-FISH/CGH; 2799

DR   TKG; TKG 0600

DR   TOKU-E; 2868

DR   Wikidata; Q7118483

RX   DOI=10.4172/2157-7145.S2-005;

RX   PubMed=447482;

RX   PubMed=2041050;

RX   PubMed=6244232;

RX   PubMed=8687134;

RX   PubMed=9018337;

RX   PubMed=10702678;

RX   PubMed=10754530;

RX   PubMed=10972993;

RX   PubMed=11135431;

RX   PubMed=11172901;

RX   PubMed=11414198;

RX   PubMed=12725112;

RX   PubMed=14518029;

RX   PubMed=15486987;

RX   PubMed=17088437;

RX   PubMed=17254797;

RX   PubMed=19372543;

RX   PubMed=22336246;

RX   PubMed=22460905;

RX   PubMed=23671654;

RX   PubMed=23856246;

RX   PubMed=23933261;

RX   PubMed=25485619;

RX   PubMed=26256267;

RX   PubMed=26972028;

RX   PubMed=27141528;

RX   PubMed=27397505;

RX   PubMed=27807467;

RX   PubMed=28196595;

WW   https://en.wikipedia.org/wiki/PC3

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=53

WW   http://www.proteinatlas.org/learn/cellines

WW   http://capcelllines.ca/details.asp?id=37

WW   http://www.addexbio.com/productdetail?pid=61

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-96.html

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: JFCR39 cancer cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Part of: NCI60 cancer cell line panel.

CC   Doubling time: 27.1 hours (DTP); 25 hours (ATCC); ~50 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (PubMed=23671654; Sanger).

CC   Omics: Array-based CGH.

CC   Omics: Deep antibody staining analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep glycome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: GPI-anchored proteins analysis by proteomics.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Caution: There seems to be two distinct cell lines which were assigned NCBI_Iran catalog number C427.

CC   Discontinued: ATCC; CRL-7934; true.

CC   Derived from metastatic site: Bone.

ST   Source(s): ATCC; CLS; Cosmic-CLP; DSMZ; ECACC; JCRB; KCLB; DOI=10.4172/2157-7145.S2-005; PubMed=11416159; PubMed=17254797; PubMed=19372543; PubMed=25877200; RCB; TKG

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11

ST   D16S539: 11

ST   D18S51: 14,15 (CLS; DOI=10.4172/2157-7145.S2-005; PubMed=11416159; PubMed=19372543; PubMed=25877200)

ST   D18S51: 13,14 (PubMed=17254797)

ST   D19S433: 14

ST   D21S11: 29,31.2 (CLS; DOI=10.4172/2157-7145.S2-005; PubMed=11416159; PubMed=19372543; PubMed=25877200)

ST   D21S11: 29,31 (PubMed=17254797)

ST   D2S1338: 18,20

ST   D3S1358: 16

ST   D5S818: 13

ST   D7S820: 8,11 (ATCC; CLS; Cosmic-CLP; DSMZ; ECACC; JCRB; KCLB; DOI=10.4172/2157-7145.S2-005; PubMed=19372543; PubMed=25877200; RCB)

ST   D7S820: 8 (PubMed=17254797; TKG)

ST   D8S1179: 13

ST   FGA: 24

ST   Penta D: 9

ST   Penta E: 10,17

ST   TH01: 6,7

ST   TPOX: 8,9

ST   vWA: 17

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PC-3 [Human lung carcinoma]

AC   CVCL_S982

SY   PC-3; PC3; JPC-3

DR   BioSample; SAMN03471064

DR   Cosmic; 801572

DR   Cosmic; 844833

DR   Cosmic; 876135

DR   Cosmic; 917973

DR   Cosmic; 929150

DR   Cosmic; 932923

DR   Cosmic; 946056

DR   Cosmic; 1154599

DR   Cosmic; 1239894

DR   Cosmic; 1571734

DR   Cosmic; 1995465

DR   Cosmic; 2125283

DR   Cosmic-CLP; 1240202

DR   GDSC; 1240202

DR   GEO; GSM827580

DR   GEO; GSM1670340

DR   JCRB; JCRB0077

RX   PubMed=9290701;

RX   PubMed=11005564;

RX   PubMed=19472407;

RX   PubMed=27397505;

CC   From: Immuno-Biological Laboratories (IBL); Tokyo; Japan.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): Cosmic-CLP; JCRB

ST   Amelogenin: X

ST   CSF1PO: 12,15

ST   D13S317: 11,12

ST   D16S539: 10

ST   D5S818: 12

ST   D7S820: 11,13

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 14

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PC-3 [Human pancreatic carcinoma]

AC   CVCL_X130

DR   Cosmic; 965558

RX   PubMed=14640107;

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PC-3 D12

AC   CVCL_4Y40

RX   PubMed=21982118;

CC   Selected for resistance to: ChEBI; CHEBI:4672; Docetaxel anhydrous (Taxotere).

CC   Derived from metastatic site: Bone.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0035 ! PC-3

SX   Male

CA   Cancer cell line

//

ID   PC-3 D8

AC   CVCL_4Y41

RX   PubMed=21982118;

CC   Selected for resistance to: ChEBI; CHEBI:4672; Docetaxel anhydrous (Taxotere).

CC   Derived from metastatic site: Bone.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0035 ! PC-3

SX   Male

CA   Cancer cell line

//

ID   PC-3 MC

AC   CVCL_6E88

RX   PubMed=1773917;

CC   Derived from metastatic site: Bone.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0035 ! PC-3

SX   Male

CA   Cancer cell line

//

ID   PC-3 MK

AC   CVCL_6E89

SY   PC-3 Metastasis in Knee bone

RX   PubMed=1773917;

CC   Derived from metastatic site: Bone.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0035 ! PC-3

SX   Male

CA   Cancer cell line

//

ID   PC-3 ML

AC   CVCL_6E90

SY   PC3-ML; PC-3 Metastasis in Lumbar vertebrae

RX   PubMed=1352184;

RX   PubMed=1773917;

CC   Derived from metastatic site: Bone.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0035 ! PC-3

SX   Male

CA   Cancer cell line

//

ID   PC-3 MR

AC   CVCL_6E91

SY   PC-3 Metastasis in Rib cartilage

RX   PubMed=1773917;

CC   Derived from metastatic site: Bone.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0035 ! PC-3

SX   Male

CA   Cancer cell line

//

ID   PC-3-1A

AC   CVCL_4877

RX   PubMed=7176035;

WW   http://capcelllines.ca/details.asp?id=75

CC   Derived from metastatic site: Bone.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0035 ! PC-3

SX   Male

CA   Cancer cell line

//

ID   PC-3-Luc

AC   CVCL_J265

DR   JCRB; JCRB1406

DR   JCRB; NIHS0656

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Discontinued: JCRB; NIHS0656; true.

CC   Derived from metastatic site: Bone.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11

ST   D16S539: 11

ST   D5S818: 13

ST   D7S820: 8,11

ST   TH01: 6,7

ST   TPOX: 8,9

ST   vWA: 17

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0035 ! PC-3

SX   Male

CA   Cancer cell line

//

ID   PC-3-luc2

AC   CVCL_5J26

CC   Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression).

CC   Discontinued: PerkinElmer; Catalog number 124089.

CC   Derived from metastatic site: Bone.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0035 ! PC-3

SX   Male

CA   Cancer cell line

//

ID   PC-3-luc2-GFP

AC   CVCL_5J29

CC   Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression).

CC   Transfected with: UniProtKB; P42212; GFP.

CC   Discontinued: PerkinElmer; Catalog number 133416.

CC   Derived from metastatic site: Bone.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0035 ! PC-3

SX   Male

CA   Cancer cell line

//

ID   PC-3-Red-FLuc

AC   CVCL_5J08

SY   PC3-Red-FLuc; PC3 Red-FLuc

WW   http://www.perkinelmer.com/Catalog/Product/ID/BW128444

CC   Transfected with: UniProtKB; Q1AG35; Italian firefly luciferase.

CC   Derived from metastatic site: Bone.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0035 ! PC-3

SX   Male

CA   Cancer cell line

//

ID   PC-3-Red-FLuc-GFP

AC   CVCL_5J09

SY   PC3-Red-FLuc-GFP; PC3 Red-FLuc-GFP

WW   http://www.perkinelmer.com/Catalog/Product/ID/BW133416

CC   Transfected with: UniProtKB; Q1AG35; Italian firefly luciferase.

CC   Transfected with: UniProtKB; P42212; GFP.

CC   Derived from metastatic site: Bone.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0035 ! PC-3

SX   Male

CA   Cancer cell line

//

ID   PC-3/nKR

AC   CVCL_M060

DR   KCLB; 60069

CC   Derived from metastatic site: Bone.

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11

ST   D3S1358: 16

ST   D5S818: 13

ST   D7S820: 8,11

ST   FGA: 24

ST   TH01: 6,7

ST   TPOX: 8,9

ST   vWA: 17

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0035 ! PC-3

SX   Male

CA   Cancer cell line

//

ID   PC-310

AC   CVCL_4878

RX   PubMed=8780407;

WW   http://capcelllines.ca/details.asp?id=128

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PC-324

AC   CVCL_4879

RX   PubMed=8780407;

WW   http://capcelllines.ca/details.asp?id=137

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PC-329

AC   CVCL_4880

RX   PubMed=8780407;

WW   http://capcelllines.ca/details.asp?id=138

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PC-339

AC   CVCL_4881

RX   PubMed=8780407;

WW   http://capcelllines.ca/details.asp?id=139

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PC-346

AC   CVCL_4882

SY   PC346

RX   PubMed=8780407;

WW   http://capcelllines.ca/details.asp?id=140

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PC-346C

AC   CVCL_4883

SY   PC346C

DR   BTO; BTO:0002831

DR   GEO; GSM539100

DR   GEO; GSM539101

DR   GEO; GSM539102

DR   GEO; GSM539103

DR   GEO; GSM539104

DR   GEO; GSM539105

DR   GEO; GSM539106

DR   GEO; GSM539107

DR   GEO; GSM539108

DR   GEO; GSM539109

DR   GEO; GSM539110

DR   GEO; GSM539111

DR   GEO; GSM1374819

RX   PubMed=14518029;

RX   PubMed=15900601;

RX   PubMed=20976069;

CC   Characteristics: Optimal proliferation of the cell line requires androgens and is inhibited by the antiandrogen hydroxyflutamide.

CC   Omics: Transcriptome analysis.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4882 ! PC-346

SX   Male

CA   Cancer cell line

//

ID   PC-374

AC   CVCL_4884

RX   PubMed=8780407;

WW   http://capcelllines.ca/details.asp?id=141

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PC-3H

AC   CVCL_B289

SY   PC3H

DR   BTO; BTO:0004853

CC   Derived from metastatic site: Bone.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0035 ! PC-3

SX   Male

CA   Cancer cell line

//

ID   PC-3M

AC   CVCL_9555

SY   PC3-M; PC-3/M; PC3M; Pc3M

DR   BTO; BTO:0005220

DR   Cosmic; 1945877

DR   KCLB; 80020

DR   TOKU-E; 3851

RX   PubMed=447482;

RX   PubMed=7471073;

CC   Derived from metastatic site: Bone.

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11

ST   D3S1358: 16

ST   D5S818: 13

ST   D7S820: 8,11

ST   FGA: 24

ST   TH01: 6,7

ST   TPOX: 8,9

ST   vWA: 17

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0035 ! PC-3

SX   Male

CA   Cancer cell line

//

ID   PC-3M-2B4

AC   CVCL_G256

SY   PC-3M 2B4; PC3M-2B4; 2B4-L

DR   CCRID; 3111C0001CCC000200

RX   PubMed=18060641;

CC   Derived from metastatic site: Bone.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9555 ! PC-3M

SX   Male

CA   Cancer cell line

//

ID   PC-3M-IE8

AC   CVCL_G257

SY   PC-3M IE8; PC3M-IE8; 1E8-H

DR   CCRID; 3111C0001CCC000199

RX   PubMed=18060641;

CC   Derived from metastatic site: Bone.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9555 ! PC-3M

SX   Male

CA   Cancer cell line

//

ID   PC-3M-LN1

AC   CVCL_L155

RX   PubMed=9816342;

CC   Derived from metastatic site: Bone.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9555 ! PC-3M

SX   Male

CA   Cancer cell line

//

ID   PC-3M-LN2

AC   CVCL_L156

RX   PubMed=9816342;

CC   Derived from metastatic site: Bone.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_L155 ! PC-3M-LN1

SX   Male

CA   Cancer cell line

//

ID   PC-3M-LN3

AC   CVCL_L157

RX   PubMed=9816342;

CC   Derived from metastatic site: Bone.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_L156 ! PC-3M-LN2

SX   Male

CA   Cancer cell line

//

ID   PC-3M-LN4

AC   CVCL_D578

SY   PC3M-LN4; PC3MLN4

DR   BTO; BTO:0005221

RX   PubMed=9816342;

CC   Derived from metastatic site: Bone.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_L157 ! PC-3M-LN3

SX   Male

CA   Cancer cell line

//

ID   PC-3M-luc-C6

AC   CVCL_D577

RX   PubMed=14713107;

RX   PubMed=14713108;

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Discontinued: PerkinElmer; Catalog number 119270.

CC   Derived from metastatic site: Bone.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9555 ! PC-3M

SX   Male

CA   Cancer cell line

//

ID   PC-3M-luc2

AC   CVCL_5J25

CC   Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression).

CC   Discontinued: PerkinElmer; Catalog number 128444.

CC   Derived from metastatic site: Bone.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9555 ! PC-3M

SX   Male

CA   Cancer cell line

//

ID   PC-3M-Red-FLuc

AC   CVCL_5J10

SY   PC3M-Red-FLuc; PC3M Red-FLuc

WW   http://www.perkinelmer.com/Catalog/Product/ID/BW124089

CC   Transfected with: UniProtKB; Q1AG35; Italian firefly luciferase.

CC   Derived from metastatic site: Bone.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9555 ! PC-3M

SX   Male

CA   Cancer cell line

//

ID   PC-3M-Pro1

AC   CVCL_L158

RX   PubMed=9816342;

CC   Derived from metastatic site: Bone.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9555 ! PC-3M

SX   Male

CA   Cancer cell line

//

ID   PC-3M-Pro2

AC   CVCL_L159

RX   PubMed=9816342;

CC   Derived from metastatic site: Bone.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_L158 ! PC-3M-Pro1

SX   Male

CA   Cancer cell line

//

ID   PC-3M-Pro3

AC   CVCL_L301

RX   PubMed=9816342;

CC   Derived from metastatic site: Bone.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_L159 ! PC-3M-Pro2

SX   Male

CA   Cancer cell line

//

ID   PC-3M-Pro4

AC   CVCL_D579

SY   PC-3M-Pro-4; PC3MPro4; PC3MPRO4

DR   BTO; BTO:0005222

RX   PubMed=9816342;

CC   Derived from metastatic site: Bone.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_L301 ! PC-3M-Pro3

SX   Male

CA   Cancer cell line

//

ID   PC-3/MA2

AC   CVCL_6E87

SY   PC-3 MA2

RX   PubMed=447482;

RX   PubMed=7459854;

RX   PubMed=10754530;

CC   Derived from metastatic site: Bone.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9555 ! PC-3M

SX   Male

CA   Cancer cell line

//

ID   PC-3N

AC   CVCL_4886

SY   PC3N

RX   PubMed=10487836;

WW   http://capcelllines.ca/details.asp?id=169

CC   Derived from metastatic site: Bone.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0035 ! PC-3

SX   Male

CA   Cancer cell line

//

ID   PC-3U

AC   CVCL_0482

DR   MCCL; MCC:0000381

CC   Derived from metastatic site: Bone.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0035 ! PC-3

SX   Male

CA   Cancer cell line

//

ID   PC-4

AC   CVCL_X128

DR   Cosmic; 965559

RX   PubMed=14640107;

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PC-44

AC   CVCL_B258

SY   PC44; PC 44

DR   Cosmic; 873001

DR   Cosmic; 948378

RX   PubMed=11169957;

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PC-5

AC   CVCL_M124

RX   PubMed=8200854;

CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).

CC   Derived from metastatic site: Bone.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0035 ! PC-3

SX   Male

CA   Cancer cell line

//

ID   PC-53

AC   CVCL_W802

SY   PC53

DR   Cosmic; 2491090

RX   PubMed=2314113;

RX   PubMed=9067587;

DI   NCIt; C9143; Adult B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_W803 ! PC-53A

SX   Female

CA   Cancer cell line

//

ID   PC-53A

AC   CVCL_W803

SY   PC53A

RX   PubMed=2314113;

DI   NCIt; C9143; Adult B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_W802 ! PC-53

SX   Female

CA   Cancer cell line

//

ID   PC-6

AC   CVCL_C002

SY   PC6

DR   EFO; EFO_0002845

DR   CGH-DB; 105-1

DR   CGH-DB; 9051-4

DR   ChEMBL-Cells; CHEMBL3307571

DR   ChEMBL-Targets; CHEMBL614235

DR   Cosmic; 1212199

DR   Cosmic; 1571745

RX   PubMed=2982333;

RX   PubMed=3731100;

RX   PubMed=12107105;

RX   PubMed=15185009;

CC   From: Immuno-Biological Laboratories (IBL); Tokyo; Japan.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PC-6/SN2-5

AC   CVCL_S850

RX   PubMed=9259410;

CC   Selected for resistance to: ChEBI; CHEBI:8988; SN-38 (7-ethyl-10-hydroxy-camptothecin).

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_C002 ! PC-6

CA   Cancer cell line

//

ID   PC-6/TAX1-1

AC   CVCL_S849

SY   PC-6/Tax1-1

CC   Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_C002 ! PC-6

CA   Cancer cell line

//

ID   PC-7

AC   CVCL_A786

SY   PC7

DR   BTO; BTO:0005440

DR   EFO; EFO_0002846

DR   Cosmic; 801573

DR   Cosmic; 844834

DR   Cosmic; 876136

DR   Cosmic; 918000

DR   Cosmic; 946057

DR   Cosmic; 1239895

DR   Cosmic; 2125284

RX   DOI=10.5795/jjscc.24.451;

RX   PubMed=3731100;

RX   PubMed=11005564;

RX   PubMed=19472407;

CC   From: Immuno-Biological Laboratories (IBL); Tokyo; Japan.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PC-7 [Human pancreatic carcinoma]

AC   CVCL_X129

DR   Cosmic; 965560

RX   PubMed=14640107;

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PC-7/CPT

AC   CVCL_A787

RX   PubMed=2168285;

CC   Selected for resistance to: ChEBI; CHEBI:80630; Irinotecan (Camptothecin-11; CPT-11).

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_A786 ! PC-7

SX   Male

CA   Cancer cell line

//

ID   PC-8

AC   CVCL_4Z01

DR   ChEMBL-Cells; CHEMBL3307866

DR   ChEMBL-Targets; CHEMBL614101

RX   PubMed=1367039;

RX   PubMed=3902783;

CC   From: Immuno-Biological Laboratories (IBL); Tokyo; Japan.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PC-82

AC   CVCL_4887

SY   PC 82

DR   Cosmic; 704851

RX   PubMed=7279800;

WW   http://capcelllines.ca/details.asp?id=135

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PC-9

AC   CVCL_B260

SY   PC9; PC-9/S1; PC-9S1

DR   BTO; BTO:0005518

DR   CLO; CLO_0050067

DR   EFO; EFO_0002847

DR   BCRJ; 0331

DR   BioSample; SAMN03470946

DR   ChEMBL-Cells; CHEMBL3307867

DR   ChEMBL-Targets; CHEMBL614102

DR   Cosmic; 713867

DR   Cosmic; 801574

DR   Cosmic; 876137

DR   Cosmic; 897746

DR   Cosmic; 911753

DR   Cosmic; 915329

DR   Cosmic; 917985

DR   Cosmic; 929156

DR   Cosmic; 946058

DR   Cosmic; 1001658

DR   Cosmic; 1002731

DR   Cosmic; 1047092

DR   Cosmic; 1128254

DR   Cosmic; 1146943

DR   Cosmic; 1239896

DR   Cosmic; 1336875

DR   Cosmic; 1571735

DR   Cosmic; 1656893

DR   Cosmic; 1731370

DR   Cosmic; 1745414

DR   Cosmic; 2015224

DR   Cosmic; 2125285

DR   ENCODE; ENCBS177ANS

DR   ENCODE; ENCBS480XRH

DR   ENCODE; ENCBS761VSF

DR   ENCODE; ENCBS987JQH

DR   GEO; GSM434290

DR   GEO; GSM481160

DR   GEO; GSM784274

DR   GEO; GSM794406

DR   GEO; GSM827407

DR   GEO; GSM1374821

DR   IGRhCellID; PC9GEO

DR   LINCS; 50038

DR   PRIDE; PXD002224

DR   RCB; RCB4455

RX   DOI=10.5795/jjscc.24.451;

RX   PubMed=4094096;

RX   PubMed=11005564;

RX   PubMed=11078804;

RX   PubMed=19472407;

RX   PubMed=22313637;

RX   PubMed=23733853;

RX   PubMed=26202522;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   From: Immuno-Biological Laboratories (IBL); Tokyo; Japan.

CC   Omics: Deep membrane proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 8

ST   D16S539: 9

ST   D18S51: 15

ST   D19S433: 13,15.2

ST   D21S11: 30

ST   D2S1338: 19,20

ST   D3S1358: 16

ST   D5S818: 11

ST   D7S820: 10,11

ST   D8S1179: 11,15

ST   FGA: 23

ST   Penta D: 13

ST   Penta E: 11

ST   TH01: 7

ST   TPOX: 11

ST   vWA: 17

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PC-9-GR-high

AC   CVCL_S706

DR   Cosmic; 1896429

RX   PubMed=23542356;

CC   Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B260 ! PC-9

SX   Male

CA   Cancer cell line

//

ID   PC-9-GR-step

AC   CVCL_S707

DR   Cosmic; 1896428

RX   PubMed=23542356;

CC   Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B260 ! PC-9

SX   Male

CA   Cancer cell line

//

ID   PC-9/BR

AC   CVCL_T015

SY   PC-9BR; PC-9/BRc1; PC-9BRc1

DR   Cosmic; 2015227

RX   PubMed=21734175;

RX   PubMed=23733853;

CC   Selected for resistance to: ChEBI; CHEBI:61390; Afatinib (BIBW-2992).

CC   Omics: Deep RNAseq analysis.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B260 ! PC-9

SX   Male

CA   Cancer cell line

//

ID   PC-9/DR1

AC   CVCL_DI33

SY   PC-9 DR1

DR   GEO; GSM481167

RX   PubMed=20118985;

CC   Selected for resistance to: ChEBI; CHEBI:132268; Dacomitinib (PF-00299804).

CC   Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_DH34 ! PC-9/GR4

SX   Male

CA   Cancer cell line

//

ID   PC-9/DR2

AC   CVCL_DI34

SY   PC-9 DR2

DR   GEO; GSM481168

RX   PubMed=20118985;

CC   Selected for resistance to: ChEBI; CHEBI:132268; Dacomitinib (PF-00299804).

CC   Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_DH34 ! PC-9/GR4

SX   Male

CA   Cancer cell line

//

ID   PC-9/DR3

AC   CVCL_DI35

SY   PC-9 DR3

DR   GEO; GSM481169

RX   PubMed=20118985;

CC   Selected for resistance to: ChEBI; CHEBI:132268; Dacomitinib (PF-00299804).

CC   Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_DH34 ! PC-9/GR4

SX   Male

CA   Cancer cell line

//

ID   PC-9/DR4

AC   CVCL_DI36

SY   PC-9 DR4

DR   GEO; GSM481170

RX   PubMed=20118985;

CC   Selected for resistance to: ChEBI; CHEBI:132268; Dacomitinib (PF-00299804).

CC   Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_DH34 ! PC-9/GR4

SX   Male

CA   Cancer cell line

//

ID   PC-9/DR5

AC   CVCL_DI37

SY   PC-9 DR5

DR   GEO; GSM481171

RX   PubMed=20118985;

CC   Selected for resistance to: ChEBI; CHEBI:132268; Dacomitinib (PF-00299804).

CC   Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_DH34 ! PC-9/GR4

SX   Male

CA   Cancer cell line

//

ID   PC-9/DR6

AC   CVCL_DI38

SY   PC-9 DR6

DR   GEO; GSM481172

RX   PubMed=20118985;

CC   Selected for resistance to: ChEBI; CHEBI:132268; Dacomitinib (PF-00299804).

CC   Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_DH34 ! PC-9/GR4

SX   Male

CA   Cancer cell line

//

ID   PC-9/ER/WR

AC   CVCL_DG28

RX   PubMed=26980747;

CC   Selected for resistance to: ChEBI; CHEBI:114785; Erlotinib.

CC   Selected for resistance to: ChEBI; CHEBI:61400; WZ4002.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B260 ! PC-9

SX   Male

CA   Cancer cell line

//

ID   PC-9/ER1

AC   CVCL_D778

SY   PC-9-ER1; PC9-ER1

DR   Cosmic; 1731371

RX   PubMed=22815900;

CC   Selected for resistance to: ChEBI; CHEBI:114785; Erlotinib.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B260 ! PC-9

SX   Male

CA   Cancer cell line

//

ID   PC-9/ER3

AC   CVCL_D726

SY   PC-9-ER3

DR   Cosmic; 1745415

RX   PubMed=22712764;

CC   Selected for resistance to: ChEBI; CHEBI:114785; Erlotinib.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B260 ! PC-9

SX   Male

CA   Cancer cell line

//

ID   PC-9/f14

AC   CVCL_U149

DR   Cosmic; 915331

RX   PubMed=11506965;

RX   PubMed=17982658;

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B260 ! PC-9

SX   Male

CA   Cancer cell line

//

ID   PC-9/f9

AC   CVCL_U150

DR   Cosmic; 915330

RX   PubMed=11078804;

RX   PubMed=11506965;

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B260 ! PC-9

SX   Male

CA   Cancer cell line

//

ID   PC-9/GR1

AC   CVCL_DI28

SY   PC-9 GR1

DR   GEO; GSM481161

RX   PubMed=20118985;

CC   Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B260 ! PC-9

SX   Male

CA   Cancer cell line

//

ID   PC-9/GR2

AC   CVCL_DI29

SY   PC-9 GR2

DR   GEO; GSM481162

RX   PubMed=20118985;

CC   Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B260 ! PC-9

SX   Male

CA   Cancer cell line

//

ID   PC-9/GR3

AC   CVCL_DI30

SY   PC-9 GR3

DR   GEO; GSM481163

RX   PubMed=20118985;

CC   Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B260 ! PC-9

SX   Male

CA   Cancer cell line

//

ID   PC-9/GR4

AC   CVCL_DH34

SY   PC-9 GR4; PC9GR4; GR4

DR   GEO; GSM925738

DR   GEO; GSM481164

RX   PubMed=20118985;

RX   PubMed=22961667;

CC   Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B260 ! PC-9

SX   Male

CA   Cancer cell line

//

ID   PC-9/GR5

AC   CVCL_DI31

SY   PC-9 GR5

DR   GEO; GSM481165

RX   PubMed=20118985;

CC   Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B260 ! PC-9

SX   Male

CA   Cancer cell line

//

ID   PC-9/GR6

AC   CVCL_DI32

SY   PC-9 GR6

DR   GEO; GSM481166

RX   PubMed=20118985;

CC   Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B260 ! PC-9

SX   Male

CA   Cancer cell line

//

ID   PC-9/GR/WR

AC   CVCL_DG27

RX   PubMed=26980747;

CC   Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).

CC   Selected for resistance to: ChEBI; CHEBI:61400; WZ4002.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B260 ! PC-9

SX   Male

CA   Cancer cell line

//

ID   PC-9/IR

AC   CVCL_DP47

SY   PC-9-IR; PC9-IR; PC9/IR; PC9IR; PC9/gef

DR   PRIDE; PXD002224

RX   PubMed=26202522;

CC   Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).

CC   Omics: Deep membrane proteome analysis.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B260 ! PC-9

SX   Male

CA   Cancer cell line

//

ID   PC-9/R

AC   CVCL_S750

SY   PC-9R; PC-9/ER; PC-9ER

DR   Cosmic; 1890454

DR   Cosmic; 2015225

RX   PubMed=21734175;

RX   PubMed=22773810;

RX   PubMed=23733853;

CC   Selected for resistance to: ChEBI; CHEBI:114785; Erlotinib.

CC   Omics: Deep RNAseq analysis.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B260 ! PC-9

SX   Male

CA   Cancer cell line

//

ID   PC-9/S2

AC   CVCL_T016

SY   PC-9S2

DR   Cosmic; 2015226

RX   PubMed=23733853;

CC   Omics: Deep RNAseq analysis.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B260 ! PC-9

SX   Male

CA   Cancer cell line

//

ID   PC-9/WR

AC   CVCL_DG29

RX   PubMed=26980747;

CC   Selected for resistance to: ChEBI; CHEBI:61400; WZ4002.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B260 ! PC-9

SX   Male

CA   Cancer cell line

//

ID   PC-9/WZR09

AC   CVCL_DG30

SY   WZR09; WZR9

DR   GEO; GSM925739

RX   PubMed=22961667;

CC   Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).

CC   Selected for resistance to: ChEBI; CHEBI:61400; WZ4002.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_DH34 ! PC-9/GR4

SX   Male

CA   Cancer cell line

//

ID   PC-9/WZR10

AC   CVCL_DG31

SY   WZR10

DR   GEO; GSM925740

RX   PubMed=22961667;

CC   Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).

CC   Selected for resistance to: ChEBI; CHEBI:61400; WZ4002.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_DH34 ! PC-9/GR4

SX   Male

CA   Cancer cell line

//

ID   PC-9/WZR11

AC   CVCL_DG32

SY   WZR11

DR   GEO; GSM925741

RX   PubMed=22961667;

CC   Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).

CC   Selected for resistance to: ChEBI; CHEBI:61400; WZ4002.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_DH34 ! PC-9/GR4

SX   Male

CA   Cancer cell line

//

ID   PC-9/WZR12

AC   CVCL_DG33

SY   WZR12

DR   GEO; GSM925742

RX   PubMed=22961667;

CC   Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).

CC   Selected for resistance to: ChEBI; CHEBI:61400; WZ4002.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_DH34 ! PC-9/GR4

SX   Male

CA   Cancer cell line

//

ID   PC-9/ZD

AC   CVCL_V337

SY   PC9 ZD

DR   GEO; GSM1374824

DR   Cosmic; 911754

RX   PubMed=15761868;

CC   Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).

CC   Omics: Transcriptome analysis.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B260 ! PC-9

SX   Male

CA   Cancer cell line

//

ID   PC-93

AC   CVCL_4888

DR   BioSample; SAMN03151752

RX   PubMed=6602397;

RX   PubMed=12725112;

RX   PubMed=14518029;

RX   PubMed=20143388;

WW   http://capcelllines.ca/details.asp?id=142

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=14518029, PubMed=20143388).

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0030 ! HeLa

SX   Female

CA   Cancer cell line

//

ID   PC-EN

AC   CVCL_X063

DR   Cosmic; 965561

RX   PubMed=11869555;

RX   PubMed=14640107;

DI   NCIt; C45843; Pancreatic carcinoma with mixed differentiation

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PC-J

AC   CVCL_X641

DR   BTO; BTO:0004191

RX   PubMed=18649734;

CC   Derived from metastatic site: Bone.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0035 ! PC-3

SX   Male

CA   Cancer cell line

//

ID   PC-MDS

AC   CVCL_1Q81

DR   BioSample; SAMN03151810

RX   PubMed=17350682;

RX   PubMed=17917092;

RX   PubMed=19344951;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a K-562 derivative (PubMed=19344951).

DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0004 ! K-562

SX   Female

CA   Cancer cell line

//

ID   PC/AA

AC   CVCL_B261

RX   DOI=10.1007/978-1-4612-0411-4_28;

RX   PubMed=2369746;

RX   PubMed=6746117;

DI   NCIt; C5673; Colorectal adenoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PC/AA/C1

AC   CVCL_IQ04

SY   AA/C1

RX   DOI=10.1007/978-1-4612-0411-4_28;

RX   PubMed=2369746;

RX   PubMed=16465285;

DI   NCIt; C5673; Colorectal adenoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B261 ! PC/AA

SX   Male

CA   Cancer cell line

//

ID   PC/AA/C1/SB

AC   CVCL_IQ05

SY   AA/C1/SB

RX   DOI=10.1007/978-1-4612-0411-4_28;

RX   PubMed=2369746;

CC   Selected for resistance to: ChEBI; CHEBI:64103; Sodium butyrate.

DI   NCIt; C5673; Colorectal adenoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_IQ04 ! PC/AA/C1

SX   Male

CA   Cancer cell line

//

ID   PC/AA/C1/SB10

AC   CVCL_IQ06

SY   PC/AA/C1/SB/10; AA/C1/SB10

RX   DOI=10.1007/978-1-4612-0411-4_28;

RX   PubMed=2369746;

RX   PubMed=16465285;

CC   Selected for resistance to: ChEBI; CHEBI:64103; Sodium butyrate.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

DI   NCIt; C5673; Colorectal adenoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_IQ05 ! PC/AA/C1/SB

SX   Male

CA   Cancer cell line

//

ID   PC/BH

AC   CVCL_IQ07

RX   PubMed=6746117;

DI   NCIt; C5673; Colorectal adenoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PC/BH/C1

AC   CVCL_IQ08

RX   PubMed=16465285;

DI   NCIt; C5673; Colorectal adenoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_IQ07 ! PC/BH

SX   Female

CA   Cancer cell line

//

ID   PC/FF

AC   CVCL_IQ09

RX   PubMed=6746117;

DI   NCIt; C5673; Colorectal adenoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PC/JW

AC   CVCL_B262

SY   PCJW

DR   Cosmic; 948837

DR   Cosmic; 1043823

DR   Cosmic; 1312308

DR   GEO; GSM1374825

RX   PubMed=6746117;

RX   PubMed=20606684;

CC   Omics: Transcriptome analysis.

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PC/JW/FI

AC   CVCL_IQ10

SY   PC/JW/Feeder Independent

RX   PubMed=16465285;

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B262 ! PC/JW

SX   Male

CA   Cancer cell line

//

ID   PC1

AC   CVCL_6B05

SY   Proximal Caput 1

RX   PubMed=12399533;

RX   PubMed=17233813;

WW   https://www.abmgood.com/Immortalized-Mouse-Proximal-Caput-Epididymal-Epithelial-Cell-Line-(PC1)--T0598.html

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Conditionally immortalized cell line

//

ID   PC12

AC   CVCL_0481

SY   PC-12; PC 12

DR   BTO; BTO:0001009

DR   CLO; CLO_0008392

DR   CLO; CLO_0050821

DR   EFO; EFO_0001225

DR   MCCL; MCC:0000379

DR   CLDB; cl3876

DR   CLDB; cl3877

DR   CLDB; cl3878

DR   CLDB; cl4922

DR   CLDB; cl5245

DR   ATCC; CRL-1721

DR   BCRC; 60048

DR   BCRJ; 0203

DR   CCRID; 3111C0001CCC000024

DR   CCRID; 3131C0001001000003

DR   CCRID; 3142C0001000000006

DR   CCRID; 3153C0001000000030

DR   ChEMBL-Cells; CHEMBL3307976

DR   ChEMBL-Targets; CHEMBL612556

DR   CLS; 500311/p701_PC-12

DR   DSMZ; ACC-159

DR   ECACC; 88022401

DR   ICLC; ATL98004

DR   IFO; IFO50278

DR   IZSLER; BS TCL 91

DR   JCRB; JCRB0733

DR   KCB; KCB 93033YJ

DR   KCB; KCB 200735YJ

DR   KCB; KCB 200736YJ

DR   KCLB; 21721

DR   MeSH; D016716

DR   NCBI_Iran; C153

DR   RCB; RCB0009

DR   TOKU-E; 2867

DR   TOKU-E; 3554

DR   Wikidata; Q7118481

RX   PubMed=682602;

RX   PubMed=1065897;

RX   PubMed=2493070;

RX   PubMed=15541571;

RX   PubMed=16223334;

RX   PubMed=18005394;

RX   PubMed=22538498;

WW   https://en.wikipedia.org/wiki/PC12_cell

WW   http://www.atcc.org/support/faqs/2ef3f/PC12%20Cells%20%20ATCC%20CRL1721%20vs%20ATCC%20CRL17211-783.aspx

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=PC12

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-11.html

WW   http://php.med.unsw.edu.au/cellbiology/index.php?title=Cells_-_PC12

CC   Characteristics: Responds reversibly to NGF by induction of a neuronal phenotype.

CC   Doubling time: ~50-60 hours (DSMZ); 92 hours (ECACC).

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Cancer cell line

//

ID   PC12 HTT-SW2-Q145 clone 14

AC   CVCL_DN60

SY   CHDI-90000424; CH00288

DR   Coriell; CH00288

CC   Transfected with: HGNC; 4851; HTT (with 145-Q run).

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0481 ! PC12

SX   Male

CA   Cancer cell line

//

ID   PC12 HTT-SW2-Q145-TagRFP clone 5

AC   CVCL_DN61

SY   CHDI-90000425; CH00289

DR   Coriell; CH00289

CC   Transfected with: HGNC; 4851; HTT (with 145-Q run).

CC   Transfected with: UniProtKB; Q9U6Y8; RFP.

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0481 ! PC12

SX   Male

CA   Cancer cell line

//

ID   PC12 HTT-SW2-Q23 clone 28

AC   CVCL_DN62

SY   CHDI-90000415; CH00284

DR   Coriell; CH00284

CC   Transfected with: HGNC; 4851; HTT (with 23-Q run).

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0481 ! PC12

SX   Male

CA   Cancer cell line

//

ID   PC12 HTT-SW2-Q23-TagRFP clone 34

AC   CVCL_DN63

SY   CHDI-90000417; CH00285

DR   Coriell; CH00285

CC   Transfected with: HGNC; 4851; HTT (with 23-Q run).

CC   Transfected with: UniProtKB; Q9U6Y8; RFP.

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0481 ! PC12

SX   Male

CA   Cancer cell line

//

ID   PC12 HTT-SW2-Q73 clone 29

AC   CVCL_DN64

SY   CHDI-90000419; CH00286

DR   Coriell; CH00286

CC   Transfected with: HGNC; 4851; HTT (with 73-Q run).

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0481 ! PC12

SX   Male

CA   Cancer cell line

//

ID   PC12 HTT-SW2-Q73-TagRFP clone 17

AC   CVCL_DN65

SY   CHDI-90000422; CH00287

DR   Coriell; CH00287

CC   Transfected with: HGNC; 4851; HTT (with 73-Q run).

CC   Transfected with: UniProtKB; Q9U6Y8; RFP.

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0481 ! PC12

SX   Male

CA   Cancer cell line

//

ID   PC12 Tet-Off

AC   CVCL_V361

WW   http://www.clontech.com/US/Products/Inducible_Systems/Tetracycline-Inducible_Expression/Tet-Off_Cell_Lines

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0481 ! PC12

SX   Male

CA   Cancer cell line

//

ID   PC12 Tet-On

AC   CVCL_V333

WW   http://www.clontech.com/US/Products/Inducible_Systems/Tetracycline-Inducible_Expression/Tet-On_Cell_Lines

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0481 ! PC12

SX   Male

CA   Cancer cell line

//

ID   PC12-615

AC   CVCL_C130

SY   PC12(615); PC-12 615; PC12 (615); 615

RX   PubMed=1384575;

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0481 ! PC12

SX   Male

CA   Cancer cell line

//

ID   PC12-AC

AC   CVCL_J442

DR   BTO; BTO:0003060

RX   PubMed=15456758;

WW   http://137.122.232.177/Protocols/PC12CultureDifferentiation.pdf

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0481 ! PC12

SX   Male

CA   Cancer cell line

//

ID   PC12-F7

AC   CVCL_T752

DR   CLO; CLO_0050822

DR   RCB; RCB2800

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0481 ! PC12

SX   Male

CA   Cancer cell line

//

ID   PC12-G11

AC   CVCL_T753

DR   CLO; CLO_0050823

DR   RCB; RCB2801

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0481 ! PC12

SX   Male

CA   Cancer cell line

//

ID   PC12.P3

AC   CVCL_5573

SY   PC-12.P3

DR   JCRB; JCRB0130

DR   JCRB; JCRB0130.1

DR   JCRB; NIHS0197

DR   JCRB; NIHS0373

CC   Discontinued: JCRB; NIHS0197; true.

CC   Discontinued: JCRB; NIHS0373; true.

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0481 ! PC12

SX   Male

CA   Cancer cell line

//

ID   PC12D

AC   CVCL_4681

SY   PC-12D

DR   BTO; BTO:0001676

RX   PubMed=2493070;

RX   PubMed=3033256;

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0481 ! PC12

SX   Male

CA   Cancer cell line

//

ID   PC12HS

AC   CVCL_J438

SY   PC12 clone HS

DR   JCRB; JCRB0266

DR   JCRB; NIHS0375

RX   PubMed=1493541;

CC   Discontinued: JCRB; NIHS0375; true.

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0481 ! PC12

SX   Male

CA   Cancer cell line

//

ID   PC12HS.P3

AC   CVCL_J439

SY   PC12 clone HS.P3

DR   JCRB; JCRB0263.1

DR   JCRB; NIHS0374

CC   Discontinued: JCRB; NIHS0374; true.

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_J438 ! PC12HS

SX   Male

CA   Cancer cell line

//

ID   PC12IS

AC   CVCL_J440

SY   PC12 clone IS

DR   JCRB; JCRB0268

DR   JCRB; NIHS0377

RX   PubMed=1493541;

CC   Discontinued: JCRB; NIHS0377; true.

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0481 ! PC12

SX   Male

CA   Cancer cell line

//

ID   PC12K

AC   CVCL_4925

SY   PC-12K

DR   BTO; BTO:0005061

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0481 ! PC12

SX   Male

CA   Cancer cell line

//

ID   PC12MS

AC   CVCL_J441

SY   PC12 clone MS

DR   JCRB; JCRB0267

DR   JCRB; NIHS0376

RX   PubMed=1493541;

CC   Discontinued: JCRB; NIHS0376; true.

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0481 ! PC12

SX   Male

CA   Cancer cell line

//

ID   PC12nnr14

AC   CVCL_C126

SY   PC12 not nerve growth factor responsive clone 14

RX   PubMed=3005338;

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0481 ! PC12

SX   Male

CA   Cancer cell line

//

ID   PC12nnr3

AC   CVCL_C127

SY   PC12 not nerve growth factor responsive clone 3

RX   PubMed=3005338;

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0481 ! PC12

SX   Male

CA   Cancer cell line

//

ID   PC12nnr5

AC   CVCL_C128

SY   PC12 not nerve growth factor responsive clone 5

RX   PubMed=3005338;

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0481 ! PC12

SX   Male

CA   Cancer cell line

//

ID   PC12nnr6

AC   CVCL_C129

SY   PC12 not nerve growth factor responsive clone 6

RX   PubMed=3005338;

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0481 ! PC12

SX   Male

CA   Cancer cell line

//

ID   PC14Br

AC   CVCL_9W71

RX   PubMed=10987313;

CC   Problematic cell line: Contaminated. Parent cell line (PC-14) has been shown to be a PC-9 derivative.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1640 ! PC-14

SX   Male

CA   Cancer cell line

//

ID   PC14HM

AC   CVCL_J032

RX   PubMed=22922681;

CC   Problematic cell line: Contaminated. Parent cell line (PC-14) has been shown to be a PC-9 derivative.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1640 ! PC-14

SX   Male

CA   Cancer cell line

//

ID   PC14PE6

AC   CVCL_9W70

SY   PC14-PE6; PC14/PE6

RX   PubMed=10741721;

RX   PubMed=10987313;

RX   PubMed=19771249;

CC   Problematic cell line: Contaminated. Parent cell line (PC-14) has been shown to be a PC-9 derivative.

CC   Caution: We are not certain that PC-14-PM4 and PC14PE6 are identical.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1640 ! PC-14

SX   Male

CA   Cancer cell line

//

ID   PC14PE6/AS2

AC   CVCL_9W72

RX   PubMed=16518408;

CC   Problematic cell line: Contaminated. Grand-parent cell line (PC-14) has been shown to be a PC-9 derivative.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9W70 ! PC14PE6

SX   Male

CA   Cancer cell line

//

ID   PC1CpTr

AC   CVCL_1G93

WW   http://mail.nbfgr.res.in/nrfc/celldetail.php?id=35

CC   Group: Fish cell line.

CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC035.

OX   NCBI_TaxID=586851; ! Pomacentrus caeruleus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   PC1F1Ex

AC   CVCL_1G94

WW   http://mail.nbfgr.res.in/nrfc/celldetail.php?id=36

CC   Group: Fish cell line.

CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC036.

OX   NCBI_TaxID=586851; ! Pomacentrus caeruleus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   PC1L1Tr

AC   CVCL_1G95

WW   http://mail.nbfgr.res.in/nrfc/celldetail.php?id=37

CC   Group: Fish cell line.

CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC037.

OX   NCBI_TaxID=586851; ! Pomacentrus caeruleus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   PC2

AC   CVCL_0483

AS   CVCL_7089

SY   PC12/PC2

DR   MCCL; MCC:0000382

RX   PubMed=8396168;

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0481 ! PC12

SX   Male

CA   Cancer cell line

//

ID   PC21A1

AC   CVCL_1Q49

RX   PubMed=6641706;

RX   PubMed=6686281;

CC   Group: Human/rodent somatic cell hybrid.

OX   NCBI_TaxID=9606; ! Homo sapiens

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_C522 ! 2102EP

HI   CVCL_1Q47 ! PCC4AO

CA   Hybrid cell line

//

ID   PC23

AC   CVCL_W864

RX   PubMed=3499854;

DI   NCIt; C7729; Squamous cell carcinoma of the penis

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PC3-MM2

AC   CVCL_4885

SY   PC3MM2; PC-3MM2; PC-3 MM2; PC-3M-MM2

DR   BTO; BTO:0005071

DR   KCLB; 80021

CC   Derived from metastatic site: Bone.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9555 ! PC-3M

SX   Male

CA   Cancer cell line

//

ID   PC3.1

AC   CVCL_U140

DR   CLO; CLO_0050388

DR   RCB; RCB2306

RX   PubMed=1409580;

CC   Monoclonal antibody target: UniProtKB; Q64361; Rat Lxn.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   PC346DCC

AC   CVCL_IP21

DR   GEO; GSM539100

DR   GEO; GSM539101

DR   GEO; GSM539102

DR   GEO; GSM539103

RX   PubMed=15900601;

RX   PubMed=20976069;

CC   Characteristics: Proliferation of this cell line is androgen independent.

CC   Omics: Transcriptome analysis.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4883 ! PC-346C

SX   Male

CA   Cancer cell line

//

ID   PC346Flu1

AC   CVCL_IP22

SY   PC346FLU1

DR   GEO; GSM539104

DR   GEO; GSM539105

DR   GEO; GSM539106

DR   GEO; GSM539107

DR   GEO; GSM1374820

RX   PubMed=15900601;

RX   PubMed=20976069;

CC   Characteristics: Proliferation of this cell line is androgen independent.

CC   Omics: Transcriptome analysis.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4883 ! PC-346C

SX   Male

CA   Cancer cell line

//

ID   PC346Flu2

AC   CVCL_IP23

DR   GEO; GSM539108

DR   GEO; GSM539109

DR   GEO; GSM539110

DR   GEO; GSM539111

RX   PubMed=15900601;

RX   PubMed=20976069;

CC   Characteristics: Proliferation of this cell line is androgen independent.

CC   Characteristics: Has a AR p.Thr878Ala mutation in the single copy of the AR gene of this cell line.

CC   Omics: Transcriptome analysis.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4883 ! PC-346C

SX   Male

CA   Cancer cell line

//

ID   PC3B1

AC   CVCL_D689

SY   PC3-B1

DR   BTO; BTO:0005121

RX   PubMed=19491258;

CC   Derived from metastatic site: Bone.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0035 ! PC-3

SX   Male

CA   Cancer cell line

//

ID   PC4

AC   CVCL_7090

RX   PubMed=8396168;

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0481 ! PC12

SX   Male

CA   Cancer cell line

//

ID   PC6

AC   CVCL_7091

SY   PC-6; PC 6

DR   BTO; BTO:0002752

RX   PubMed=8396168;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-94.html

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0481 ! PC12

SX   Male

CA   Cancer cell line

//

ID   PC6-1

AC   CVCL_7092

DR   BTO; BTO:0002753

RX   PubMed=8396168;

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_7091 ! PC6

SX   Male

CA   Cancer cell line

//

ID   PC6-10

AC   CVCL_7093

DR   BTO; BTO:0002762

RX   PubMed=8396168;

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_7091 ! PC6

SX   Male

CA   Cancer cell line

//

ID   PC6-11

AC   CVCL_7094

DR   BTO; BTO:0002763

RX   PubMed=8396168;

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_7091 ! PC6

SX   Male

CA   Cancer cell line

//

ID   PC6-12

AC   CVCL_7095

RX   PubMed=8396168;

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_7091 ! PC6

SX   Male

CA   Cancer cell line

//

ID   PC6-13

AC   CVCL_7096

DR   BTO; BTO:0002764

RX   PubMed=8396168;

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_7091 ! PC6

SX   Male

CA   Cancer cell line

//

ID   PC6-14

AC   CVCL_7097

DR   BTO; BTO:0002765

RX   PubMed=8396168;

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_7091 ! PC6

SX   Male

CA   Cancer cell line

//

ID   PC6-15

AC   CVCL_7098

DR   BTO; BTO:0002766

RX   PubMed=8396168;

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_7091 ! PC6

SX   Male

CA   Cancer cell line

//

ID   PC6-16

AC   CVCL_7099

DR   BTO; BTO:0002755

RX   PubMed=8396168;

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_7091 ! PC6

SX   Male

CA   Cancer cell line

//

ID   PC6-2

AC   CVCL_7100

DR   BTO; BTO:0002754

RX   PubMed=8396168;

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_7091 ! PC6

SX   Male

CA   Cancer cell line

//

ID   PC6-3

AC   CVCL_7101

DR   BTO; BTO:0002751

RX   PubMed=8396168;

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_7091 ! PC6

SX   Male

CA   Cancer cell line

//

ID   PC6-4

AC   CVCL_7102

DR   BTO; BTO:0002756

RX   PubMed=8396168;

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_7091 ! PC6

SX   Male

CA   Cancer cell line

//

ID   PC6-5

AC   CVCL_7103

DR   BTO; BTO:0002757

RX   PubMed=8396168;

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_7091 ! PC6

SX   Male

CA   Cancer cell line

//

ID   PC6-6

AC   CVCL_7104

DR   BTO; BTO:0002758

RX   PubMed=8396168;

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_7091 ! PC6

SX   Male

CA   Cancer cell line

//

ID   PC6-7

AC   CVCL_7105

DR   BTO; BTO:0002759

RX   PubMed=8396168;

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_7091 ! PC6

SX   Male

CA   Cancer cell line

//

ID   PC6-8

AC   CVCL_7106

DR   BTO; BTO:0002760

RX   PubMed=8396168;

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_7091 ! PC6

SX   Male

CA   Cancer cell line

//

ID   PC6-9

AC   CVCL_7107

DR   BTO; BTO:0002761

RX   PubMed=8396168;

DI   NCIt; C121568; Rat adrenal gland pheochromocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_7091 ! PC6

SX   Male

CA   Cancer cell line

//

ID   PC880

AC   CVCL_U147

RX   PubMed=12694655;

DI   NCIt; C40022; Primary peritoneal carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PC9-DPE2

AC   CVCL_S977

RX   PubMed=9052401;

CC   Transfected with: HGNC; 3148; TYMP.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B260 ! PC-9

CA   Cancer cell line

//

ID   PCA 31.1

AC   CVCL_G246

DR   CLO; CLO_0008397

DR   ATCC; HB-12314

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   PCA 33.28

AC   CVCL_G247

DR   CLO; CLO_0008398

DR   ATCC; HB-12315

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   PCBC16iPS

AC   CVCL_0H60

DR   SKIP; SKIP000584

RX   PubMed=23326500;

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Induced pluripotent stem cell

//

ID   PCC1

AC   CVCL_5T86

RX   PubMed=61803;

RX   PubMed=4599372;

CC   Breed/subspecies: 129/Sv.

DI   NCIt; C129859; Mouse teratocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_5572 ! OTT6050

SX   Male

CA   Cancer cell line

//

ID   PCC2

AC   CVCL_5T87

RX   PubMed=4599372;

CC   Breed/subspecies: 129/Sv.

DI   NCIt; C129859; Mouse teratocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_5572 ! OTT6050

SX   Male

CA   Cancer cell line

//

ID   PCC3

AC   CVCL_5T85

RX   PubMed=61803;

RX   PubMed=4599372;

RX   PubMed=6479493;

CC   Breed/subspecies: 129/Sv.

DI   NCIt; C129859; Mouse teratocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_5572 ! OTT6050

SX   Male

CA   Cancer cell line

//

ID   PCC3/A/1

AC   CVCL_E064

SY   PCC3-A/1

DR   CLO; CLO_0050538

DR   RCB; RCB1791

RX   PubMed=61803;

RX   PubMed=78963;

RX   PubMed=650144;

RX   PubMed=886245;

RX   PubMed=1893874;

CC   Breed/subspecies: 129/Sv.

DI   NCIt; C129859; Mouse teratocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_5T85 ! PCC3

SX   Male

CA   Cancer cell line

//

ID   PCC4

AC   CVCL_5854

DR   JCRB; JCRB0205

RX   PubMed=61803;

RX   PubMed=4599372;

CC   Discontinued: JCRB; JCRB0205; true.

CC   Breed/subspecies: 129/Sv.

DI   NCIt; C129859; Mouse teratocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_5572 ! OTT6050

SX   Male

CA   Cancer cell line

//

ID   PCC4 [Mouse lung papillary tumor]

AC   CVCL_5U82

SY   Peter's Clara Cell 4

RX   PubMed=2548715;

RX   PubMed=9149863;

RX   PubMed=9347924;

CC   Breed/subspecies: BALB/cJ.

DI   NCIt; C21763; Papillary adenoma of the mouse pulmonary system

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   PCC4 AG

AC   CVCL_5855

SY   PCC4 AG-r

DR   JCRB; JCRB0206

CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.

CC   Breed/subspecies: 129/Sv.

DI   NCIt; C129859; Mouse teratocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_5854 ! PCC4

SX   Male

CA   Cancer cell line

//

ID   PCC4 AG Cap

AC   CVCL_5856

SY   PCC4 AG-r Cap-r

DR   JCRB; JCRB0216

CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.

CC   Selected for resistance to: ChEBI; CHEBI:17698; Chloramphenicol.

CC   Breed/subspecies: 129/Sv.

DI   NCIt; C129859; Mouse teratocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_5855 ! PCC4 AG

SX   Male

CA   Cancer cell line

//

ID   PCC4 Type I

AC   CVCL_U221

SY   PCC4 TypeI

DR   JCRB; JCRB0204

CC   Discontinued: JCRB; JCRB0204; true.

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_C566 ! L6TG Cap

HI   CVCL_5854 ! PCC4

CA   Hybrid cell line

//

ID   PCC4 Type III

AC   CVCL_U222

SY   PCC4 TypeIII

DR   JCRB; JCRB0203

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_C566 ! L6TG Cap

HI   CVCL_5854 ! PCC4

CA   Hybrid cell line

//

ID   PCC4-azal

AC   CVCL_5857

SY   PCC4-Azal; PCC-4-azal; PCC4Azal; PCC4 aza1; PCC4.aza 1

DR   CLO; CLO_0008400

DR   CLDB; cl3887

DR   CLS; 400313/p562_PCC4-aza1

CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.

CC   Breed/subspecies: 129/Sv.

DI   NCIt; C129859; Mouse teratocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_5854 ! PCC4

SX   Male

CA   Cancer cell line

//

ID   PCC4-Azal-ECA2

AC   CVCL_G076

SY   PCC4-Aza1-ECA2; ECA2

RX   PubMed=2479740;

CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.

CC   Breed/subspecies: 129/Sv.

DI   NCIt; C129859; Mouse teratocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_5857 ! PCC4-azal

SX   Male

CA   Cancer cell line

//

ID   PCC4-AzaR

AC   CVCL_5912

SY   PCC4/AzaR; PCC-4 AzaR; PCC4.azaR; PCC4 azaR; PCC4 AzaR; PCC4-azaR 1; PCC4/AzaR1; PCC4/AzaRl; PCC4 azaR1

RX   PubMed=4599372;

CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.

CC   Breed/subspecies: 129/Sv.

DI   NCIt; C129859; Mouse teratocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_5854 ! PCC4

SX   Male

CA   Cancer cell line

//

ID   PCC4-F

AC   CVCL_5911

SY   PCC4/F; PCC4F

RX   PubMed=558822;

CC   Breed/subspecies: 129/Sv.

DI   NCIt; C129859; Mouse teratocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_5854 ! PCC4

SX   Male

CA   Cancer cell line

//

ID   PCC4AO

AC   CVCL_1Q47

SY   PCC4 8azaR OuR

RX   PubMed=6686281;

RX   PubMed=6951167;

CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.

CC   Selected for resistance to: ChEBI; CHEBI:472805; Ouabain.

CC   Breed/subspecies: 129/Sv.

DI   NCIt; C129859; Mouse teratocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_5854 ! PCC4

SX   Male

CA   Cancer cell line

//

ID   PCC7-Mz1

AC   CVCL_J426

SY   PCC7-MZ1; Mz1

CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.

CC   Breed/subspecies: 129 x C57BL/6.

DI   NCIt; C129859; Mouse teratocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_J430 ! PCC7-S-AzaRt clone 1009

SX   Male

CA   Cancer cell line

//

ID   PCC7-S

AC   CVCL_J429

RX   PubMed=78963;

CC   Breed/subspecies: 129 x C57BL/6.

DI   NCIt; C129859; Mouse teratocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Cancer cell line

//

ID   PCC7-S-AzaRt clone 1009

AC   CVCL_J430

SY   Clone 1009

RX   PubMed=78963;

CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.

CC   Breed/subspecies: 129 x C57BL/6.

DI   NCIt; C129859; Mouse teratocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_J429 ! PCC7-S

SX   Male

CA   Cancer cell line

//

ID   PCCL3

AC   CVCL_6712

SY   PC Cl 3; PCCl3; PCCL-3; PCCL 3

DR   BTO; BTO:0003800

DR   BCRJ; 0204

RX   PubMed=3670314;

CC   Discontinued: BCRJ; 0204; probable.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Spontaneously immortalized cell line

//

ID   PCE

AC   CVCL_1G96

SY   Puntius Chelynoides Eye

RX   PubMed=22465535;

CC   Group: Fish cell line.

OX   NCBI_TaxID=547593; ! Puntius chelynoides

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   PCF

AC   CVCL_W975

SY   Puntius Chelynoides Fin

RX   PubMed=24852132;

WW   http://mail.nbfgr.res.in/nrfc/celldetail.php?id=1

CC   Group: Fish cell line.

CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC001.

OX   NCBI_TaxID=547593; ! Puntius chelynoides

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   PCG.G6

AC   CVCL_1Q50

RX   PubMed=6641706;

CC   Group: Human/rodent somatic cell hybrid.

OX   NCBI_TaxID=9606; ! Homo sapiens

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_1Q46 ! G3.32.2

HI   CVCL_1Q47 ! PCC4AO

CA   Hybrid cell line

//

ID   PCH41-43

AC   CVCL_K257

DR   CLO; CLO_0050299

DR   RCB; RCB0673

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   PCH41-44

AC   CVCL_K258

DR   CLO; CLO_0050353

DR   RCB; RCB0674

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   PCH42-58

AC   CVCL_K259

DR   CLO; CLO_0050354

DR   RCB; RCB0676

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   PCH42-63

AC   CVCL_K260

DR   CLO; CLO_0050302

DR   RCB; RCB0669

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   PCH54-37

AC   CVCL_K261

DR   CLO; CLO_0050300

DR   RCB; RCB0678

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   PCI-01

AC   CVCL_C167

SY   PCI-1

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=2766286;

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PCI-02

AC   CVCL_C168

SY   PCI-2

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=2766286;

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PCI-03

AC   CVCL_C169

SY   PCI-3

DR   BioSample; SAMN03151894

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=2766286;

RX   PubMed=21868764;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a PC-3 derivative (PubMed=21868764). Originally thought to originate from a oropharyngeal squamous cell carcinoma.

CC   Derived from metastatic site: Bone.

ST   Source(s): PubMed=21868764

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11

ST   D16S539: 11

ST   D5S818: 13

ST   D7S820: 8,11

ST   TH01: 7

ST   TPOX: 8,9

ST   vWA: 17

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0035 ! PC-3

SX   Male

CA   Cancer cell line

//

ID   PCI-04A

AC   CVCL_C170

SY   PCI-4A; PCI-4T

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=2766286;

RX   PubMed=14996750;

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C171 ! PCI-04B

SX   Male

CA   Cancer cell line

//

ID   PCI-04B

AC   CVCL_C171

SY   PCI-4B; PCI-4M

DR   Cosmic-CLP; 1298531

DR   GDSC; 1298531

DR   GEO; GSM827146

DR   GEO; GSM1670344

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=2766286;

RX   PubMed=14996750;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): Cosmic-CLP

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 10,11

ST   D16S539: 12,13

ST   D5S818: 12

ST   D7S820: 12,13

ST   TH01: 6,7

ST   TPOX: 9

ST   vWA: 16,18

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C170 ! PCI-04A

SX   Male

CA   Cancer cell line

//

ID   PCI-05

AC   CVCL_C172

SY   PCI-5

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=2766286;

DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PCI-06A

AC   CVCL_C173

SY   PCI-6A; PCI-6T

DR   Cosmic-CLP; 1240206

DR   GDSC; 1240206

DR   GEO; GSM1670345

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=2766286;

RX   PubMed=14996750;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): Cosmic-CLP

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 10,13,14

ST   D16S539: 11,14

ST   D5S818: 11

ST   D7S820: 7,10

ST   TH01: 7,9.3

ST   TPOX: 8,11

ST   vWA: 16,17

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C174 ! PCI-06B

SX   Male

CA   Cancer cell line

//

ID   PCI-06B

AC   CVCL_C174

SY   PCI-6B; PCI-6M

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=2766286;

RX   PubMed=14996750;

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C173 ! PCI-06A

SX   Male

CA   Cancer cell line

//

ID   PCI-07

AC   CVCL_C175

SY   PCI-7

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=2766286;

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PCI-08

AC   CVCL_C176

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=2766286;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C4943; Pyriform fossa squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PCI-09A

AC   CVCL_C177

SY   PCI-9A; PCI9

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=2766286;

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C178 ! PCI-09B

SX   Male

CA   Cancer cell line

//

ID   PCI-09B

AC   CVCL_C178

SY   PCI-9B

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=2766286;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C177 ! PCI-09A

SX   Male

CA   Cancer cell line

//

ID   PCI-10 [Human HNSCC]

AC   CVCL_C179

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=2766286;

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PCI-10 [Human pancreatic carcinoma]

AC   CVCL_5193

RX   PubMed=7804431;

RX   PubMed=8797870;

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PCI-11

AC   CVCL_C180

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=2766286;

DI   NCIt; C4943; Pyriform fossa squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PCI-12

AC   CVCL_C181

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=2766286;

DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PCI-13

AC   CVCL_C182

SY   PCI13

DR   Cosmic; 2131852

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=2766286;

RX   PubMed=21868764;

RX   PubMed=28196595;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-522.html

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

ST   Source(s): PubMed=21868764

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 10,11

ST   D16S539: 12,13

ST   D5S818: 12

ST   D7S820: 12,13

ST   TH01: 6,7

ST   TPOX: 8,9

ST   vWA: 16,18

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PCI-14

AC   CVCL_C183

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=2766286;

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PCI-15A

AC   CVCL_C184

SY   PCI15A; PCI-15; PCI-15T

DR   Cosmic; 2131853

DR   Cosmic-CLP; 1240204

DR   GDSC; 1240204

DR   GEO; GSM1670341

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=2766286;

RX   PubMed=8084624;

RX   PubMed=14996750;

RX   PubMed=21868764;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

ST   Source(s): Cosmic-CLP; PubMed=21868764

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 11

ST   D16S539: 11

ST   D5S818: 11

ST   D7S820: 11

ST   TH01: 6

ST   TPOX: 8

ST   vWA: 18

DI   NCIt; C4943; Pyriform fossa squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C756 ! PCI-15B

SX   Male

CA   Cancer cell line

//

ID   PCI-15B

AC   CVCL_C756

SY   PCI-15b; PCI15B; PCI-15; PCI-15M; 15b

DR   Cosmic; 2131854

RX   PubMed=2766286;

RX   PubMed=8084624;

RX   PubMed=14996750;

RX   PubMed=21868764;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): PubMed=21868764

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 11

ST   D16S539: 11

ST   D5S818: 11

ST   D7S820: 11

ST   TH01: 6

ST   TPOX: 8

ST   vWA: 18

DI   NCIt; C4943; Pyriform fossa squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C184 ! PCI-15A

SX   Male

CA   Cancer cell line

//

ID   PCI-16

AC   CVCL_C185

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=2766286;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PCI-17

AC   CVCL_C186

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=2766286;

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PCI-18

AC   CVCL_C187

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=2766286;

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PCI-19

AC   CVCL_5194

DR   Cosmic; 1066195

RX   PubMed=7804431;

RX   PubMed=8797870;

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PCI-22A

AC   CVCL_1T56

DR   BioSample; SAMN03152034

RX   PubMed=21868764;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Probably contaminated. Supposed to be isogenic with PCI-22B (CVCL_1T57) but does not have the same STR profile and are therefore not originating from the same individual (PubMed=21868764).

ST   Source(s): PubMed=21868764

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 8,12

ST   D16S539: 9,11

ST   D5S818: 12

ST   D7S820: 8,9

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 18

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PCI-22B

AC   CVCL_1T57

DR   BioSample; SAMN03152035

RX   PubMed=21868764;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Probably contaminated. Supposed to be isogenic with PCI-22A (CVCL_1T56) but does not have the same STR profile and are therefore not originating from the same individual (PubMed=21868764).

ST   Source(s): PubMed=21868764

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 12

ST   D16S539: 9

ST   D5S818: 10,12

ST   D7S820: 10,11

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 17

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PCI-24 [Human OCSCC]

AC   CVCL_AT94

SY   PCI24

RX   PubMed=21868764;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

ST   Source(s): PubMed=21868764

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 11

ST   D16S539: 9,12

ST   D5S818: 11,12

ST   D7S820: 8,11

ST   TH01: 9,9.3

ST   TPOX: 8

ST   vWA: 15,18

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PCI-24 [Human pancreatic adenocarcinoma]

AC   CVCL_5195

DR   Cosmic; 1066196

DR   Cosmic; 1644308

RX   PubMed=7804431;

RX   PubMed=8797870;

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PCI-30

AC   CVCL_C757

DR   Cosmic-CLP; 1298529

DR   GDSC; 1298529

DR   GEO; GSM1670342

RX   PubMed=8084624;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): Cosmic-CLP

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 13

ST   D16S539: 12,13

ST   D5S818: 11,12

ST   D7S820: 10,12

ST   TH01: 6

ST   TPOX: 10,11

ST   vWA: 14,17

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PCI-35

AC   CVCL_5191

SY   PCI35

DR   BTO; BTO:0003286

DR   Cosmic; 707259

DR   Cosmic; 1066197

DR   Cosmic; 1644309

RX   PubMed=7804431;

RX   PubMed=8797870;

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PCI-37A

AC   CVCL_C758

SY   PCI-37a; UPCI-37A; PCI-37T

RX   PubMed=14996750;

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C759 ! PCI-37B

SX   Male

CA   Cancer cell line

//

ID   PCI-37B

AC   CVCL_C759

SY   UPCI-37B; PCI-37M

RX   PubMed=14996750;

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C758 ! PCI-37A

SX   Male

CA   Cancer cell line

//

ID   PCI-38

AC   CVCL_M471

DR   Cosmic-CLP; 1240205

DR   GDSC; 1240205

DR   GEO; GSM1670343

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): Cosmic-CLP

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 12

ST   D16S539: 13

ST   D5S818: 11

ST   D7S820: 9,10

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 17,18

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PCI-43

AC   CVCL_5139

SY   PCI43

DR   BTO; BTO:0003285

DR   Cosmic; 1066198

DR   Cosmic; 1644310

RX   PubMed=7804431;

RX   PubMed=8797870;

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PCI-50

AC   CVCL_M470

RX   PubMed=7873144;

RX   PubMed=8001029;

RX   PubMed=8443824;

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PCI-55

AC   CVCL_5196

DR   Cosmic; 707260

DR   Cosmic; 1066199

DR   Cosmic; 1644311

RX   PubMed=7804431;

RX   PubMed=8797870;

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PCI-6

AC   CVCL_5197

DR   Cosmic; 1066194

DR   Cosmic; 1644307

RX   PubMed=7804431;

RX   PubMed=8797870;

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PCI-64

AC   CVCL_5198

DR   Cosmic; 1066200

DR   Cosmic; 1644312

RX   PubMed=7804431;

RX   PubMed=8797870;

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PCI-66

AC   CVCL_5199

DR   Cosmic; 707261

DR   Cosmic; 1066201

RX   PubMed=8797870;

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PCI-68

AC   CVCL_5200

RX   PubMed=11173548;

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PCI-72

AC   CVCL_5201

RX   PubMed=11173548;

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PCI-79

AC   CVCL_5422

RX   PubMed=11173548;

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PCL12

AC   CVCL_2H32

SY   PCL-12

DR   DSMZ; ACC-794

RX   PubMed=26110819;

RX   PubMed=26222697;

CC   Doubling time: ~40-50 hours (DSMZ).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

ST   Source(s): DSMZ

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 8,13

ST   D16S539: 11,12

ST   D5S818: 11,13

ST   D7S820: 10

ST   TH01: 9.3

ST   TPOX: 8,11

ST   vWA: 14,18

DI   NCIt; C3163; Chronic lymphocytic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   PCL1643

AC   CVCL_F002

DR   Cosmic; 922666

RX   PubMed=8665486;

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PCL1691

AC   CVCL_F003

DR   Cosmic; 922667

RX   PubMed=8665486;

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PCL1771

AC   CVCL_F004

DR   Cosmic; 922668

RX   PubMed=8665486;

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PCL3014

AC   CVCL_F005

DR   Cosmic; 922669

RX   PubMed=8665486;

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PCL3091

AC   CVCL_F006

DR   Cosmic; 922670

RX   PubMed=8665486;

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PCL4199

AC   CVCL_M496

RX   PubMed=8665486;

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PCM6

AC   CVCL_4666

DR   CLO; CLO_0051009

DR   BioSample; SAMN03472144

DR   CCLE; PCM6_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   GEO; GSM887507

DR   GEO; GSM888589

DR   RCB; RCB1460

RX   PubMed=8112425;

RX   PubMed=10936422;

RX   PubMed=22460905;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Characteristics: IL6 dependent.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11,12

ST   D16S539: 9

ST   D5S818: 10

ST   D7S820: 11,12

ST   TH01: 7,9

ST   TPOX: 10,11

ST   vWA: 16,18

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PD PaCa

AC   CVCL_8401

SY   PDPaCa; Poorly Differentiated Pancreatic adenoCarcinoma; PD

RX   PubMed=3971476;

RX   PubMed=6435863;

RX   PubMed=6805945;

RX   PubMed=8863680;

OX   NCBI_TaxID=10036; ! Mesocricetus auratus

CA   Cancer cell line

//

ID   PD(H39)

AC   CVCL_Y454

DR   ATCC; CRL-6491

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6491; true.

OX   NCBI_TaxID=9823; ! Sus scrofa

SX   Sex undetermined

CA   Undefined cell line type

//

ID   PD-1.3

AC   CVCL_DF55

SY   PD1.3

RX   Patent=US8741295;

RX   PubMed=20587542;

CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4122.

CC   Monoclonal antibody target: UniProtKB; Q15116; Human PDCD1/PD1/CD279.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   PD-iPS1 [Human iPSC China]

AC   CVCL_L664

DR   ISCR; 1988

RX   PubMed=22673189;

CC   From: Guangzhou Medical College; China.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_L665 ! PD-iPS2

SX   Male

CA   Induced pluripotent stem cell

//

ID   PD-iPS1 [Human iPSC USA]

AC   CVCL_C952

SY   PD-IPS1

DR   ISCR; 5

RX   Patent=US20110151447;

RX   PubMed=18691744;

CC   From: Children's Hospital Boston; Boston; USA.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_L781 ! AG20446

SX   Male

CA   Induced pluripotent stem cell

//

ID   PD-iPS11

AC   CVCL_C953

SY   PD-IPS11

DR   ISCR; 2057

CC   From: Children's Hospital Boston; Boston; USA.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_L781 ! AG20446

SX   Male

CA   Induced pluripotent stem cell

//

ID   PD-iPS2

AC   CVCL_L665

DR   ISCR; 1989

RX   PubMed=22673189;

CC   From: Guangzhou Medical College; China.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_L664 ! PD-iPS1 [Human iPSC China]

SX   Male

CA   Induced pluripotent stem cell

//

ID   PD-iPS5

AC   CVCL_C954

SY   PD-IPS5

DR   ISCR; 4

RX   Patent=US20110151447;

RX   PubMed=18691744;

CC   From: Children's Hospital Boston; Boston; USA.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_L781 ! AG20446

SX   Male

CA   Induced pluripotent stem cell

//

ID   PD-L1.1

AC   CVCL_DF56

SY   PDL1.1

RX   Patent=US8741295;

RX   PubMed=20587542;

CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4080.

CC   Monoclonal antibody target: UniProtKB; Q9NZQ7; Human CD274.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   PD-L1.2

AC   CVCL_DF57

SY   PDL1.2

RX   Patent=US8741295;

RX   PubMed=20587542;

CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4081.

CC   Monoclonal antibody target: UniProtKB; Q9NZQ7; Human CD274.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   PD-Mel

AC   CVCL_M743

CC   From: Guadagni F.; Istituto Regina Elena; Roma; Italy.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PD20 RV:D2

AC   CVCL_AK49

SY   PD.20hygro:RV

RX   PubMed=12361951;

WW   http://www.ohsu.edu/research/fanconi-anemia/celllines.cfm

CC   Transfected with: HGNC; 3585; FANCD2.

CC   Transfected with: UniProtKB; P00557; E.coli hygromycin-B 4-O-kinase (hph).

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

DI   NCIt; C125706; Fanconi anemia, complementation group D2

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_G042 ! GM16633

SX   Male

CA   Transformed cell line

//

ID   PD352.F

AC   CVCL_AK48

SY   PD352-F; PD.352.F; PD352

RX   PubMed=12361951;

DI   NCIt; C125708; Fanconi anemia, complementation group G

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   PD5

AC   CVCL_4270

SY   PD 5

DR   CLO; CLO_0008402

DR   CLO; CLO_0008403

DR   CLDB; cl3889

DR   CLDB; cl3890

DR   ECACC; 93120830

DR   IZSLER; BS CL 99

OX   NCBI_TaxID=9823; ! Sus scrofa

CA   Spontaneously immortalized cell line

//

ID   PDA3F-1

AC   CVCL_0G96

DR   SKIP; SKIP000542

RX   PubMed=19269371;

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_N797 ! AG20443

SX   Male

CA   Induced pluripotent stem cell

//

ID   PDA3F-5

AC   CVCL_0G97

DR   SKIP; SKIP000589

RX   PubMed=19269371;

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_N797 ! AG20443

SX   Male

CA   Induced pluripotent stem cell

//

ID   PDB3F-1

AC   CVCL_0G98

DR   SKIP; SKIP000590

RX   PubMed=19269371;

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_X806 ! AG20442

SX   Male

CA   Induced pluripotent stem cell

//

ID   PDB3F-5

AC   CVCL_0G99

DR   SKIP; SKIP000591

RX   PubMed=19269371;

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_X806 ! AG20442

SX   Male

CA   Induced pluripotent stem cell

//

ID   PDB3F-8

AC   CVCL_0H00

DR   SKIP; SKIP000592

RX   PubMed=19269371;

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_X806 ! AG20442

SX   Male

CA   Induced pluripotent stem cell

//

ID   PDB3F-9

AC   CVCL_0H01

DR   SKIP; SKIP000593

RX   PubMed=19269371;

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_X806 ! AG20442

SX   Male

CA   Induced pluripotent stem cell

//

ID   PDB3F-d12

AC   CVCL_0H02

DR   SKIP; SKIP000594

RX   PubMed=19269371;

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_X806 ! AG20442

SX   Male

CA   Induced pluripotent stem cell

//

ID   PDB4F-1

AC   CVCL_0H03

DR   SKIP; SKIP000595

RX   PubMed=19269371;

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_X806 ! AG20442

SX   Male

CA   Induced pluripotent stem cell

//

ID   PDB4F-2

AC   CVCL_0H04

DR   SKIP; SKIP000596

RX   PubMed=19269371;

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_X806 ! AG20442

SX   Male

CA   Induced pluripotent stem cell

//

ID   PDB4F-3

AC   CVCL_0H05

DR   SKIP; SKIP000597

RX   PubMed=19269371;

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_X806 ! AG20442

SX   Male

CA   Induced pluripotent stem cell

//

ID   PDB4F-4

AC   CVCL_0H06

DR   SKIP; SKIP000598

RX   PubMed=19269371;

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_X806 ! AG20442

SX   Male

CA   Induced pluripotent stem cell

//

ID   PDB4F-5

AC   CVCL_0H07

DR   SKIP; SKIP000599

RX   PubMed=19269371;

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_X806 ! AG20442

SX   Male

CA   Induced pluripotent stem cell

//

ID   PDC3F-1

AC   CVCL_0H08

DR   SKIP; SKIP000600

RX   PubMed=19269371;

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_L781 ! AG20446

SX   Male

CA   Induced pluripotent stem cell

//

ID   PDD3F-1

AC   CVCL_0H09

DR   SKIP; SKIP000601

RX   PubMed=19269371;

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_X807 ! AG20445

SX   Male

CA   Induced pluripotent stem cell

//

ID   PDD3F-4

AC   CVCL_0H10

DR   SKIP; SKIP000602

RX   PubMed=19269371;

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_X807 ! AG20445

SX   Male

CA   Induced pluripotent stem cell

//

ID   PDD3F-7

AC   CVCL_0H11

DR   SKIP; SKIP000603

RX   PubMed=19269371;

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_X807 ! AG20445

SX   Male

CA   Induced pluripotent stem cell

//

ID   PDD4F-1

AC   CVCL_0H12

DR   SKIP; SKIP000604

RX   PubMed=19269371;

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_X807 ! AG20445

SX   Male

CA   Induced pluripotent stem cell

//

ID   PDD4F-4

AC   CVCL_0H13

DR   SKIP; SKIP000605

RX   PubMed=19269371;

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_X807 ! AG20445

SX   Male

CA   Induced pluripotent stem cell

//

ID   PDD4F-5

AC   CVCL_0H14

DR   SKIP; SKIP000606

RX   PubMed=19269371;

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_X807 ! AG20445

SX   Male

CA   Induced pluripotent stem cell

//

ID   PDD4F-8

AC   CVCL_0H15

DR   SKIP; SKIP000607

RX   PubMed=19269371;

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_X807 ! AG20445

SX   Male

CA   Induced pluripotent stem cell

//

ID   PDD4F-9

AC   CVCL_0H16

DR   SKIP; SKIP000608

RX   PubMed=19269371;

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_X807 ! AG20445

SX   Male

CA   Induced pluripotent stem cell

//

ID   PDE3F-3

AC   CVCL_0H17

DR   SKIP; SKIP000609

RX   PubMed=19269371;

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_N795 ! AG08395

SX   Female

CA   Induced pluripotent stem cell

//

ID   PDE3F-4

AC   CVCL_0H18

DR   SKIP; SKIP000610

RX   PubMed=19269371;

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_N795 ! AG08395

SX   Female

CA   Induced pluripotent stem cell

//

ID   PDF

AC   CVCL_1G97

SY   Puntius Denisonii Fin

RX   PubMed=21136193;

WW   http://mail.nbfgr.res.in/nrfc/celldetail.php?id=9

CC   Group: Fish cell line.

CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC009.

OX   NCBI_TaxID=1606683; ! Sahyadria denisonii

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   PDFS

AC   CVCL_M435

RX   PubMed=10720059;

RX   PubMed=15541569;

DI   NCIt; C3329; Pituitary gland adenoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PDH

AC   CVCL_1G98

SY   Puntius Denisonii Heart

RX   PubMed=21136193;

CC   Group: Fish cell line.

OX   NCBI_TaxID=1606683; ! Sahyadria denisonii

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   PDL-1

AC   CVCL_G248

DR   CLO; CLO_0008407

DR   ATCC; CRL-1882

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6971 ! FOX-NY

CA   Hybridoma

//

ID   PDL-L2

AC   CVCL_6B13

SY   PDL-L 2

RX   PubMed=12356921;

RX   PubMed=17233813;

RX   PubMed=24949082;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Omics: Transcriptome analysis.

CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   PDSS-26

AC   CVCL_B458

DR   Cosmic; 1212218

RX   PubMed=14553945;

DI   NCIt; C3400; Synovial sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PDV

AC   CVCL_5858

DR   CLS; 400314/p792_PDV

RX   PubMed=102384;

RX   PubMed=1855225;

RX   PubMed=1934268;

RX   PubMed=2185890;

RX   PubMed=2414007;

RX   PubMed=6190961;

CC   Breed/subspecies: C57BL/10 LP.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   PDVC 57B

AC   CVCL_4271

SY   PDVC57b; PDVC57; PDV.C57; PDV C57

DR   ECACC; 01022129

DR   Ximbio; 151630

RX   PubMed=1855225;

RX   PubMed=1934268;

RX   PubMed=2185890;

RX   PubMed=2414007;

CC   Breed/subspecies: C57BL/10 LP.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_5858 ! PDV

CA   Cancer cell line

//

ID   PE

AC   CVCL_1D86

DR   ChEMBL-Cells; CHEMBL3308676

DR   ChEMBL-Targets; CHEMBL614846

RX   PubMed=2871947;

WW   http://www.ott.nih.gov/erma/mouse-keratinocyte-tumor-cell-line-pe

WW   http://www.ctsaip.org/details.cfm?id=24518054

CC   Breed/subspecies: SENCAR.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   Pe Hay

AC   CVCL_U670

SY   PeHay; XP13BE

DR   ATCC; CRL-1258

RX   PubMed=225015;

CC   Discontinued: ATCC; CRL-1258; true.

DI   NCIt; C3452; Xeroderma pigmentosum

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   PE-1

AC   CVCL_6G49

SY   Porcine Endometrial cells-1

RX   PubMed=1280756;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

OX   NCBI_TaxID=9823; ! Sus scrofa

SX   Female

CA   Transformed cell line

//

ID   Pe-LCL

AC   CVCL_6D81

RX   PubMed=8127151;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   PE/CA-PJ15

AC   CVCL_2678

SY   PE-CA-PJ15; PE/CA PJ15; PE/CA-PJ-15; PE_CA-PJ15; PE CA PJ15; PECAPJ15

DR   EFO; EFO_0006733

DR   BioSample; SAMN03473150

DR   CCLE; PECAPJ15_UPPER_AERODIGESTIVE_TRACT

DR   Cosmic; 1339923

DR   Cosmic; 1995614

DR   Cosmic-CLP; 1240207

DR   ECACC; 96121230

DR   GDSC; 1240207

DR   GEO; GSM827436

DR   GEO; GSM887508

DR   GEO; GSM888590

DR   GEO; GSM1374826

DR   GEO; GSM1374827

DR   GEO; GSM1670346

DR   LINCS; 50039

RX   PubMed=9876219;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: KuDOS 95 cell line panel.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 8,10

ST   D16S539: 9,13

ST   D18S51: 17

ST   D21S11: 29

ST   D3S1358: 17

ST   D5S818: 11,13

ST   D7S820: 8,12

ST   D8S1179: 13,14

ST   FGA: 22

ST   Penta D: 13

ST   Penta E: 10

ST   TH01: 6,9.3

ST   TPOX: 8,11

ST   vWA: 17,19

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PE/CA-PJ34 (clone C12)

AC   CVCL_2679

SY   PE/CA-PJ34; PE/CA-PJ-34; PE CA PJ34; PJ34; Plaepi 34

DR   CLO; CLO_0008408

DR   CCLE; PECAPJ34CLONEC12_UPPER_AERODIGESTIVE_TRACT

DR   Cosmic; 1339919

DR   ECACC; 97062513

DR   GEO; GSM887509

DR   GEO; GSM888591

DR   GEO; GSM1374828

DR   GEO; GSM1374829

RX   PubMed=9876219;

RX   PubMed=21868764;

RX   PubMed=22460905;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: KuDOS 95 cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ECACC; PubMed=21868764

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 12

ST   D16S539: 9,13

ST   D5S818: 10,12

ST   D7S820: 9,10

ST   TH01: 6

ST   TPOX: 8

ST   vWA: 18

DI   NCIt; C54244; Basaloid squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PE/CA-PJ41 (clone D2)

AC   CVCL_2680

SY   PE/CA-PJ-41; PE CA PJ41; Plaepi 41

DR   CLO; CLO_0008409

DR   CCLE; PECAPJ41CLONED2_UPPER_AERODIGESTIVE_TRACT

DR   Cosmic; 1339922

DR   ECACC; 98020207

DR   GEO; GSM887510

DR   GEO; GSM888592

DR   GEO; GSM1374830

DR   GEO; GSM1374831

RX   PubMed=9876219;

RX   PubMed=22460905;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: KuDOS 95 cell line panel.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'PECAPJ34CLONED2' in GEO GSM1374830.

ST   Source(s): ECACC

ST   Amelogenin: X

ST   CSF1PO: 11,13

ST   D13S317: 11,12

ST   D16S539: 11,13

ST   D5S818: 12

ST   D7S820: 9,11

ST   TH01: 7

ST   TPOX: 8

ST   vWA: 15,19

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PE/CA-PJ49

AC   CVCL_2681

SY   PE CA PJ49; PECAPJ49

DR   CCLE; PECAPJ49_UPPER_AERODIGESTIVE_TRACT

DR   Cosmic; 1339918

DR   ECACC; 00060606

DR   GEO; GSM887511

DR   GEO; GSM888593

DR   GEO; GSM1374832

DR   GEO; GSM1374833

RX   PubMed=22460905;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: KuDOS 95 cell line panel.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ECACC

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8,11

ST   D16S539: 11

ST   D5S818: 8,12

ST   D7S820: 8,9

ST   TH01: 6,10

ST   TPOX: 8

ST   vWA: 16,19

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PE030810

AC   CVCL_W916

DR   Cosmic; 2054115

RX   PubMed=23833040;

DI   NCIt; C4035; Thyroid gland papillary carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PE117

AC   CVCL_E802

DR   dbMHC; 48997

DR   ECACC; 88052028

DR   IHW; IHW9028

DR   IMGT/HLA; 11643

WW   http://bioinformatics.hsanmartino.it/ecbr/cl28.html

CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   PE121410

AC   CVCL_W917

DR   Cosmic; 2054097

RX   PubMed=23833040;

DI   NCIt; C4035; Thyroid gland papillary carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PEA-10

AC   CVCL_2684

SY   PEA 10; Primary Embryonic Fibroblasts-10

DR   CLO; CLO_0008412

DR   CLDB; cl5105

DR   ATCC; CRL-2215

DR   ECACC; 97040310

RX   PubMed=8006085;

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Spontaneously immortalized cell line

//

ID   PEA-13

AC   CVCL_2685

SY   PEA 13; Primary Embryonic Fibroblasts-13

DR   BTO; BTO:0002832

DR   CLO; CLO_0008413

DR   ATCC; CRL-2216

DR   ECACC; 97040311

RX   PubMed=8006085;

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Spontaneously immortalized cell line

//

ID   PEA1

AC   CVCL_2682

DR   Cosmic; 1305317

DR   ECACC; 10032306

DR   GEO; GSM459742

DR   GEO; GSM459851

DR   Ximbio; 151678

RX   PubMed=3167863;

RX   PubMed=20581869;

RX   PubMed=23415752;

RX   PubMed=25230021;

CC   Part of: OCCP ovarian cancer cell line panel.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ECACC; PubMed=25230021

ST   Amelogenin: X

ST   CSF1PO: 14

ST   D13S317: 8

ST   D16S539: 12,13

ST   D18S51: 14,17

ST   D19S433: 12,13

ST   D21S11: 30

ST   D2S1338: 19,25

ST   D3S1358: 16,17

ST   D5S818: 11

ST   D7S820: 10

ST   D8S1179: 14

ST   FGA: 22,25

ST   Penta D: 13,15

ST   Penta E: 7,13

ST   TH01: 9

ST   TPOX: 8,12

ST   vWA: 18

DI   NCIt; C5228; Ovarian cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2683 ! PEA2

SX   Female

CA   Cancer cell line

//

ID   PEA2

AC   CVCL_2683

DR   ECACC; 10032307

DR   GEO; GSM459852

DR   GEO; GSM659401

DR   Ximbio; 151679

RX   PubMed=3167863;

RX   PubMed=20581869;

RX   PubMed=23415752;

RX   PubMed=25230021;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: OCCP ovarian cancer cell line panel.

CC   Doubling time: ~66 hours (ECACC).

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Derived from metastatic site: Ascites.

ST   Source(s): ECACC; PubMed=25230021

ST   Amelogenin: X

ST   CSF1PO: 11,14

ST   D13S317: 8

ST   D16S539: 12,13

ST   D18S51: 17

ST   D19S433: 12,13

ST   D21S11: 30

ST   D2S1338: 19

ST   D3S1358: 16

ST   D5S818: 11,13

ST   D7S820: 10,12

ST   D8S1179: 14

ST   FGA: 25

ST   Penta D: 13,15

ST   Penta E: 7,13

ST   TH01: 9

ST   TPOX: 8 (ECACC)

ST   TPOX: 8,12 (PubMed=25230021)

ST   vWA: 17,18

DI   NCIt; C5228; Ovarian cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2682 ! PEA1

SX   Female

CA   Cancer cell line

//

ID   pEAK Rapid

AC   CVCL_3772

SY   pEAK-Rapid; Peak Rapid; PEAKrapid; PeakRapid; HEK-293 PEAKrapid; PEAK 293; PEAK

DR   BTO; BTO:0003615

DR   CLO; CLO_0008414

DR   ATCC; CRL-2828

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 12,14

ST   D16S539: 9

ST   D5S818: 8,9

ST   D7S820: 11,12

ST   TH01: 7,9.3

ST   TPOX: 11

ST   vWA: 16,19

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   PEAZ-1

AC   CVCL_8437

DR   BioSample; SAMN03151782

RX   PubMed=11433418;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a HT-1080 derivative (PubMed=20143388). Originally thought to originate from a prostate carcinoma.

CC   Characteristics: Heterozygous for the IDH1 p.Arg132Cys mutation.

DI   NCIt; C3043; Fibrosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0317 ! HT-1080

SX   Male

CA   Cancer cell line

//

ID   PEC.1

AC   CVCL_A037

RX   PubMed=7514905;

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   PECA

AC   CVCL_5859

DR   CLS; 400189/p569_PECA

CC   Breed/subspecies: NMRI.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   PECA-4197

AC   CVCL_5860

SY   PECA 4197; PECA4197

RX   PubMed=1961926;

RX   PubMed=7908310;

RX   PubMed=11966317;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PECA-4451

AC   CVCL_5861

SY   PECA 4451; PECA4451

RX   PubMed=1961926;

RX   PubMed=7908310;

RX   PubMed=11966317;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PeCa-UkHb-01

AC   CVCL_2H31

RX   PubMed=26193922;

CC   Doubling time: 34.7 +- 3.8 hours (PubMed=26193922).

ST   Source(s): PubMed=26193922

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 12

ST   D16S539: 11

ST   D18S51: 13

ST   D21S11: 27,29,30

ST   D3S1358: 14

ST   D5S818: 13

ST   D7S820: 8

ST   D8S1179: 13,14

ST   FGA: 22,23

ST   Penta D: 10,13

ST   Penta E: 10,15

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 16,17

DI   NCIt; C4549; Conjunctival squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Peccary.K

AC   CVCL_6431

SY   Peccary K

DR   CLO; CLO_0008415

DR   ATCC; CRL-6488

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

OX   NCBI_TaxID=9829; ! Pecari tajacu

SX   Female

CA   Finite cell line

//

ID   PEE

AC   CVCL_IJ29

SY   Porcine Endometrial Endothelial

RX   PubMed=23220338;

CC   Doubling time: 40 hours (at 5th passage), 41.1 hours (at 15th passage), 36.6 hours (at 30th passage), 37 hours (at 50th passage) (PubMed=23220338).

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: Jiangquhai.

OX   NCBI_TaxID=9823; ! Sus scrofa

SX   Female

CA   Transformed cell line

//

ID   Peer

AC   CVCL_1913

SY   PEER

DR   BTO; BTO:0001959

DR   CLO; CLO_0008416

DR   CLO; CLO_0050081

DR   CLDB; cl4115

DR   BioSample; SAMN01821654

DR   BioSample; SAMN03472523

DR   BioSample; SAMN03473496

DR   CCLE; PEER_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   Cosmic; 721704

DR   Cosmic; 801731

DR   Cosmic; 933548

DR   Cosmic; 998727

DR   Cosmic; 1037685

DR   Cosmic; 1115597

DR   Cosmic; 1118460

DR   Cosmic; 1130238

DR   Cosmic; 1281382

DR   Cosmic; 1330494

DR   Cosmic; 1375591

DR   Cosmic; 1524813

DR   Cosmic; 1641383

DR   Cosmic; 1760530

DR   Cosmic; 2165707

DR   Cosmic; 2361369

DR   DSMZ; ACC-6

DR   GEO; GSM887512

DR   GEO; GSM888594

DR   JCRB; JCRB0830

DR   NCBI_Iran; C511

DR   RCB; RCB1879

DR   TKG; TKG 0377

DR   Wikidata; Q2067085

RX   PubMed=1373528;

RX   PubMed=6582512;

RX   PubMed=8547074;

RX   PubMed=9290701;

RX   PubMed=9933131;

RX   PubMed=10071127;

RX   PubMed=22460905;

RX   PubMed=22675565;

WW   https://de.wikipedia.org/wiki/Peer_(Zelllinie)

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: ~50-60 hours (DSMZ).

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): DSMZ; JCRB; RCB; TKG

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11,14 (DSMZ; RCB; TKG)

ST   D13S317: 14 (JCRB)

ST   D16S539: 8,13

ST   D5S818: 12

ST   D7S820: 10,12

ST   TH01: 7,8

ST   TPOX: 11

ST   vWA: 17,18

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PEL-5

AC   CVCL_9583

DR   EFO; EFO_0002075

DR   BioSamples; SAMEA365903

DR   BioSamples; SAMEA365997

DR   GEO; GSM38806

DR   GEO; GSM38807

RX   PubMed=15613351;

CC   Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).

CC   Omics: Transcriptome analysis.

DI   NCIt; C6915; Primary effusion lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PEL16

AC   CVCL_1Q41

SY   PEL 16; GM11938

DR   CLO; CLO_0020217

DR   Coriell; GM11938

RX   PubMed=2722195;

CC   Group: Human/rodent somatic cell hybrid.

OX   NCBI_TaxID=9606; ! Homo sapiens

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybrid cell line

//

ID   PEL40

AC   CVCL_1Q42

SY   PEL 40

RX   PubMed=2722195;

CC   Group: Human/rodent somatic cell hybrid.

OX   NCBI_TaxID=9606; ! Homo sapiens

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybrid cell line

//

ID   Pen-3

AC   CVCL_IQ93

RX   Patent=US7915004;

CC   Registration: International Depositary Authority, Advanced Biotechnology Center (ABC), Interlab Cell Line Collection (ICLC), Italy; PD 04004.

CC   Monoclonal antibody target: UniProtKB; P26022; Human PTX3.

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   PENN001i-87-2

AC   CVCL_EK01

SY   iPS-87-098-SeV2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN001i-87-2.cmsx

WW   http://shared.eagle-i.net/i/00000155-9d79-71a4-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN002i-442-1

AC   CVCL_EK02

SY   iPS-442-SeV1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN002i-442-1.cmsx

WW   http://shared.eagle-i.net/i/00000155-a741-c91d-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN003i-661-4

AC   CVCL_EK03

SY   661-SeV4

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN003i-661-4.cmsx

WW   http://shared.eagle-i.net/i/00000155-bc0a-8c72-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN004i-277-1

AC   CVCL_EK04

SY   iPS-277-SeV1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN004i-277-1.cmsx

WW   http://shared.eagle-i.net/i/00000155-9d18-60de-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN005i-35-3

AC   CVCL_EK05

SY   iPS-35-1360-010-SeV3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN005i-35-3.cmsx

WW   http://shared.eagle-i.net/i/00000155-a31b-0319-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN006i-149-1

AC   CVCL_EK06

SY   iPS-149-SeV1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN006i-149-1.cmsx

WW   http://shared.eagle-i.net/i/00000155-9d5f-b796-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN007i-765-3

AC   CVCL_EK07

SY   765-SeV3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN007i-765-3.cmsx

WW   http://shared.eagle-i.net/i/00000155-bbef-a9d4-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN008i-77-5

AC   CVCL_EK08

SY   iPS-77-1638-SeV5

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN008i-77-5.cmsx

WW   http://shared.eagle-i.net/i/00000155-9d56-483b-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN009i-57-52

AC   CVCL_EK09

SY   iPS-57-1673-SeV52

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN009i-57-52.cmsx

WW   http://shared.eagle-i.net/i/00000155-a760-3b17-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN010i-486-2

AC   CVCL_EK10

SY   iPS-486-1610-080-SeV2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN010i-486-2.cmsx

WW   http://shared.eagle-i.net/i/00000155-a74e-813b-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN011i-719-2

AC   CVCL_EK11

SY   iPS-719-SeV2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN011i-719-2.cmsx

WW   http://shared.eagle-i.net/i/00000155-bbf3-e328-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN012i-93-2

AC   CVCL_EK12

SY   iPS-93-1385-SeV2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN012i-93-2.cmsx

WW   http://shared.eagle-i.net/i/00000155-bc60-4042-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN013i-72-1

AC   CVCL_EK13

SY   iPS-72-1677-SeV1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN013i-72-1.cmsx

WW   http://shared.eagle-i.net/i/00000155-a764-699e-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN014i-37-3

AC   CVCL_EK14

SY   iPS-37-1189-SeV3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN014i-37-3.cmsx

WW   http://shared.eagle-i.net/i/00000155-a74b-c87f-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN015i-668-5

AC   CVCL_EK15

SY   iPS-668-SeV5

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN015i-668-5.cmsx

WW   http://shared.eagle-i.net/i/00000155-a216-ea8e-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN016i-821-1

AC   CVCL_EK16

SY   iPS-821-SeV1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN016i-821-1.cmsx

WW   http://shared.eagle-i.net/i/00000155-a2c4-4b05-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EK61 ! PENN061i-821-2

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN017i-638-2

AC   CVCL_EK17

SY   iPS-638-SeV2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN017i-638-2.cmsx

WW   http://shared.eagle-i.net/i/00000155-9d6d-0cde-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN018i-487-4

AC   CVCL_EK18

SY   iPS-487-1410-005-SeV4

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN018i-487-4.cmsx

WW   http://shared.eagle-i.net/i/00000155-a753-2e45-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN019i-136-2

AC   CVCL_EK19

SY   iPS-136-SeV2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN019i-136-2.cmsx

WW   http://shared.eagle-i.net/i/00000155-a2f2-3149-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN020i-588-6

AC   CVCL_EK20

SY   iPS-588-SeV6

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN020i-588-6.cmsx

WW   http://shared.eagle-i.net/i/00000155-a2c1-20c2-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EK91 ! PENN091i-588-2

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN021i-749-4

AC   CVCL_EK21

SY   749-SeV4

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN021i-749-4.cmsx

WW   http://shared.eagle-i.net/i/00000155-9d6f-d6d0-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN022i-89-1

AC   CVCL_EK22

SY   iPS-89-1342-SeV1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN022i-89-1.cmsx

WW   http://shared.eagle-i.net/i/00000155-bc5e-53c9-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN023i-82-1

AC   CVCL_EK23

SY   iPS-82-1572-SeV1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN023i-82-1.cmsx

WW   http://shared.eagle-i.net/i/00000155-bb91-3d49-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN024i-370-3

AC   CVCL_EK24

SY   iPS-370-SeV3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN024i-370-3 .cmsx

WW   http://shared.eagle-i.net/i/00000155-bbf9-b44f-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN025i-71-58

AC   CVCL_EK25

SY   iPS-71-044-SeV58

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN025i-71-58.cmsx

WW   http://shared.eagle-i.net/i/00000155-bc63-50da-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN026i-124-1

AC   CVCL_EK26

SY   iPS-124-1125-SeV1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN026i-124-1.cmsx

WW   http://shared.eagle-i.net/i/00000155-9d2f-1371-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN027i-40-2

AC   CVCL_EK27

SY   iPS-40-139-SeV2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN027i-40-2.cmsx

WW   http://shared.eagle-i.net/i/00000155-9d53-4d2d-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN028i-637-2

AC   CVCL_EK28

SY   iPS-637-SeV2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN028i-637-2.cmsx

WW   http://shared.eagle-i.net/i/00000155-9d6b-2e6e-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN029i-752-3

AC   CVCL_EK29

SY   iPS-752-SeV3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN029i-752-3.cmsx

WW   http://shared.eagle-i.net/i/00000155-a219-0c57-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN030i-384-4

AC   CVCL_EK30

SY   iPS-384-SeV4

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN030i-384-4.cmsx

WW   http://shared.eagle-i.net/i/00000155-bbf7-a8e0-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN031i-56-1

AC   CVCL_EK31

SY   iPS-56-061-SeV1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN031i-56-1.cmsx

WW   http://shared.eagle-i.net/i/00000155-a75c-acf2-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN032i-15-5

AC   CVCL_EK32

SY   iPS-15-1203-024-SeV5

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN032i-15-5.cmsx

WW   http://shared.eagle-i.net/i/00000155-a312-33fd-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN033i-182-2

AC   CVCL_EK33

SY   iPS-182-SeV2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN033i-182-2.cmsx

WW   http://shared.eagle-i.net/i/00000155-9cd0-2196-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN034i-322-1

AC   CVCL_EK34

SY   iPS-322-1725-058-SeV1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN034i-322-1.cmsx

WW   http://shared.eagle-i.net/i/00000155-a318-9d80-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN035i-746-3

AC   CVCL_EK35

SY   iPS-746-SeV3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN035i-746-3.cmsx

WW   http://shared.eagle-i.net/i/00000155-a23b-30cf-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN036i-286-3

AC   CVCL_EK36

SY   iPS-286-SeV3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN036i-286-3.cmsx

WW   http://shared.eagle-i.net/i/00000155-bbfd-af0f-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN037i-90-3

AC   CVCL_EK37

SY   iPS-90-1481-SeV3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN037i-90-3.cmsx

WW   http://shared.eagle-i.net/i/00000155-bb98-092c-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN038i-366-6

AC   CVCL_EK38

SY   iPS-366-SeV6

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN038i-366-6.cmsx

WW   http://shared.eagle-i.net/i/00000155-a302-6c95-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN039i-63-1

AC   CVCL_EK39

SY   iPS-63-1622-SeV1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN039i-63-1.cmsx

WW   http://shared.eagle-i.net/i/00000155-bba0-dc7d-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN040i-134-2

AC   CVCL_EK40

SY   iPS-134-SeV2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN040i-134-2.cmsx

WW   http://shared.eagle-i.net/i/00000155-a328-59d3-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN041i-177-46

AC   CVCL_EK41

SY   iPS-177-SeV46

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN041i-177-46.cmsx

WW   http://shared.eagle-i.net/i/00000155-a214-0c19-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN042i-258-12

AC   CVCL_EK42

SY   iPS-258-SeV12

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN042i-258-12.cmsx

WW   http://shared.eagle-i.net/i/00000155-a2f5-d063-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN043i-633-3

AC   CVCL_EK43

SY   iPS-633-1310-003-SeV3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN043i-633-3.cmsx

WW   http://shared.eagle-i.net/i/00000155-a322-1bdc-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN044i-51-1

AC   CVCL_EK44

SY   iPS-51-031-SeV1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN044i-51-1.cmsx

WW   http://shared.eagle-i.net/i/00000155-a755-7702-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN045i-25-12

AC   CVCL_EK45

SY   iPS-25-1371-101-SeV12

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN045i-25-12.cmsx

WW   http://shared.eagle-i.net/i/00000155-9d77-379d-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN046i-271-1

AC   CVCL_EK46

SY   iPS-271-SeV1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN046i-271-1.cmsx

WW   http://shared.eagle-i.net/i/00000155-a2fe-dbf0-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN047i-254-60

AC   CVCL_EK47

SY   iPS-254-SeV60

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN047i-254-60.cmsx

WW   http://shared.eagle-i.net/i/00000155-a32f-c9ad-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN048i-41-6

AC   CVCL_EK48

SY   iPS-41-1282-SeV6

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN048i-41-6.cmsx

WW   http://shared.eagle-i.net/i/00000155-bc57-fffc-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN049i-334-8

AC   CVCL_EK49

SY   iPS-334-SeV8

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN049i-334-8.cmsx

WW   http://shared.eagle-i.net/i/00000155-a740-07ef-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN050i-245-10

AC   CVCL_EK50

SY   iPS-245-clone10

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN050i-245-10.cmsx

WW   http://shared.eagle-i.net/i/00000155-a32e-2509-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN051i-108-1

AC   CVCL_EK51

SY   iPS-108-1665-SeV1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN051i-108-1.cmsx

WW   http://shared.eagle-i.net/i/00000155-bbb0-ff4b-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN052i-444-2

AC   CVCL_EK52

SY   iPS-444-SeV2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN052i-444-2.cmsx

WW   http://shared.eagle-i.net/i/00000155-a2b0-9262-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EL20 ! PENN120i-444-1

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN053i-292-3

AC   CVCL_EK53

SY   iPS-292-SeV3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN053i-292-3.cmsx

WW   http://shared.eagle-i.net/i/00000155-9d68-8557-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN054i-225-33

AC   CVCL_EK54

SY   iPS-225-SeV33

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN054i-225-33.cmsx

WW   http://shared.eagle-i.net/i/00000155-bc00-24fe-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN055i-106-2

AC   CVCL_EK55

SY   iPS-106-1231-SeV2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN055i-106-2.cmsx

WW   http://shared.eagle-i.net/i/00000155-bbe8-43fe-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN056i-1-1

AC   CVCL_EK56

SY   iPS-1-030-SeV1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN056i-1-1.cmsx

WW   http://shared.eagle-i.net/i/00000155-9307-ce41-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN057i-427-3

AC   CVCL_EK57

SY   iPS-427-SeV3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN057i-427-3.cmsx

WW   http://shared.eagle-i.net/i/00000155-a2a1-e9b5-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EK66 ! PENN066i-427-6

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN058i-285-3

AC   CVCL_EK58

SY   iPS-285-SeV3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN058i-285-3.cmsx

WW   http://shared.eagle-i.net/i/00000155-a300-8734-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN059i-555-1

AC   CVCL_EK59

SY   iPS-555-SeV1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN059i-555-1.cmsx

WW   http://shared.eagle-i.net/i/00000155-a2b8-36dd-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EK84 ! PENN084i-555-2

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN060i-23-1

AC   CVCL_EK60

SY   iPS-23-1346-028-SeV1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN060i-23-1.cmsx

WW   http://shared.eagle-i.net/i/00000155-bba6-b11f-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN061i-821-2

AC   CVCL_EK61

SY   iPS-821-SeV2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN061i-821-2.cmsx

WW   http://shared.eagle-i.net/i/00000155-a2c5-9b91-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EK16 ! PENN016i-821-1

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN062i-278-2

AC   CVCL_EK62

SY   iPS-278-SeV2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN062i-278-2.cmsx

WW   http://shared.eagle-i.net/i/00000155-a2dc-b9f1-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EK86 ! PENN086i-278-1

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN063i-114-1

AC   CVCL_EK63

SY   iPS-114-1160-SeV1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN063i-114-1.cmsx

WW   http://shared.eagle-i.net/i/00000155-bc10-4955-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN064i-22-2

AC   CVCL_EK64

SY   iPS-22-1158-SeV2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN064i-22-2.cmsx

WW   http://shared.eagle-i.net/i/00000155-bba8-9356-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN065i-553-2

AC   CVCL_EK65

SY   iPS-553-1631-SeV2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN065i-553-2.cmsx

WW   http://shared.eagle-i.net/i/00000155-a759-fc57-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN066i-427-6

AC   CVCL_EK66

SY   iPS-427-SeV6

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN066i-427-6.cmsx

WW   http://shared.eagle-i.net/i/00000155-a2a0-79bc-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EK57 ! PENN057i-427-3

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN067i-312-1

AC   CVCL_EK67

SY   iPS-312-clone1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN067i-312-1.cmsx

WW   http://shared.eagle-i.net/i/00000155-a73d-be06-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN068i-697-3

AC   CVCL_EK68

SY   697-SeV3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN068i-697-3.cmsx

WW   http://shared.eagle-i.net/i/00000155-a310-7a3a-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN069i-60-1

AC   CVCL_EK69

SY   iPS-60-099-SeV1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN069i-60-1.cmsx

WW   http://shared.eagle-i.net/i/00000155-a762-5056-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN070i-408-1

AC   CVCL_EK70

SY   iPS-408-SeV1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN070i-408-1.cmsx

WW   http://shared.eagle-i.net/i/00000155-a30a-24a3-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN071i-216-13

AC   CVCL_EK71

SY   iPS-216-SeV13

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN071i-216-13.cmsx

WW   http://shared.eagle-i.net/i/00000155-a229-f6e8-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN072i-187-3

AC   CVCL_EK72

SY   iPS-187-1563-146-SeV3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN072i-187-3.cmsx

WW   http://shared.eagle-i.net/i/00000155-9d4e-1c30-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN073i-133-8

AC   CVCL_EK73

SY   iPS-133-SeV8

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN073i-133-8.cmsx

WW   http://shared.eagle-i.net/i/00000155-9cbe-fe5d-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN074i-415-3

AC   CVCL_EK74

SY   iPS-415-SeV3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN074i-415-3.cmsx

WW   http://shared.eagle-i.net/i/00000155-a289-8a62-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EL27 ! PENN127i-415-1

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN075i-309-1

AC   CVCL_EK75

SY   iPS-309-SeV1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN075i-309-1.cmsx

WW   http://shared.eagle-i.net/i/00000155-9d85-2de9-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN076i-361-2

AC   CVCL_EK76

SY   iPS-361-SeV2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN076i-361-2.cmsx

WW   http://shared.eagle-i.net/i/00000155-9d23-49b7-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN077i-521-1

AC   CVCL_EK77

SY   iPS-521-SeV1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN077i-521-1.cmsx

WW   http://shared.eagle-i.net/i/00000155-a30b-d2a7-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN078i-SV10

AC   CVCL_EK78

SY   iPS-SV10

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN078i-SV10.cmsx

WW   http://shared.eagle-i.net/i/00000155-a2ea-8f18-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN079i-33-1

AC   CVCL_EK79

SY   iPS-33-016-SeV1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN079i-33-1.cmsx

WW   http://shared.eagle-i.net/i/00000155-a247-6ed9-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN080i-603-1

AC   CVCL_EK80

SY   iPS-603-SeV1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN080i-603-1.cmsx

WW   http://shared.eagle-i.net/i/00000155-bc06-8a68-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN081i-352-4

AC   CVCL_EK81

SY   iPS-352-SeV4

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN081i-352-4.cmsx

WW   http://shared.eagle-i.net/i/00000155-a238-7c8f-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN082i-562-6

AC   CVCL_EK82

SY   iPS-562-SeV6

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN082i-562-6.cmsx

WW   http://shared.eagle-i.net/i/00000155-9d27-b3f0-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN083i-679-4

AC   CVCL_EK83

SY   679-SeV4

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN083i-679-4.cmsx

WW   http://shared.eagle-i.net/i/00000155-a30e-efce-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN084i-555-2

AC   CVCL_EK84

SY   iPS-555-SeV2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN084i-555-2.cmsx

WW   http://shared.eagle-i.net/i/00000155-a2b6-dd85-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EK59 ! PENN059i-555-1

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN085i-76-5

AC   CVCL_EK85

SY   iPS-76-1544-SeV5

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN085i-76-5.cmsx

WW   http://shared.eagle-i.net/i/00000155-bb8a-f66d-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN086i-278-1

AC   CVCL_EK86

SY   iPS-278-SeV1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN086i-278-1.cmsx

WW   http://shared.eagle-i.net/i/00000155-a2df-4dc5-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EK62 ! PENN062i-278-2

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN087i-38-1

AC   CVCL_EK87

SY   iPS-38-1298-SeV1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN087i-38-1.cmsx

WW   http://shared.eagle-i.net/i/00000155-a31d-22aa-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN088i-854-7

AC   CVCL_EK88

SY   iPS-854-SeV7

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN088i-854-7.cmsx

WW   http://shared.eagle-i.net/i/00000155-bc0d-794c-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN089i-758-4

AC   CVCL_EK89

SY   758-SeV4

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN089i-758-4.cmsx

WW   http://shared.eagle-i.net/i/00000155-bbf2-1d7a-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN090i-111-4

AC   CVCL_EK90

SY   iPS-111-1008-SeV4

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN090i-111-4.cmsx

WW   http://shared.eagle-i.net/i/00000155-bbae-f314-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN091i-588-2

AC   CVCL_EK91

SY   iPS-588 SeV2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN091i-588-2.cmsx

WW   http://shared.eagle-i.net/i/00000155-a2bf-8ff9-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EK20 ! PENN020i-588-6

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN092i-560-3

AC   CVCL_EK92

SY   560-SeV3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN092i-560-3.cmsx

WW   http://shared.eagle-i.net/i/00000155-bbf5-de5c-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN093i-16-7

AC   CVCL_EK93

SY   iPS-16-1174-SeV7

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN093i-16-7.cmsx

WW   http://shared.eagle-i.net/i/00000155-a313-e8dc-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN094i-161-1

AC   CVCL_EK94

SY   iPS-161-SeV1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN094i-161-1.cmsx

WW   http://shared.eagle-i.net/i/00000155-a32b-78fb-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN095i-123-7

AC   CVCL_EK95

SY   iPS-123-1031-SeV7

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN095i-123-7.cmsx

WW   http://shared.eagle-i.net/i/00000155-9d72-3e43-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN096i-44-4

AC   CVCL_EK96

SY   iPS-44-1336-SeV4

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN096i-44-4.cmsx

WW   http://shared.eagle-i.net/i/00000155-bba3-8f32-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN097i-17-1

AC   CVCL_EK97

SY   iPS-17-1446-SeV1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN097i-17-1.cmsx

WW   http://shared.eagle-i.net/i/00000155-9d48-a659-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN098i-50-18

AC   CVCL_EK98

SY   iPS-50-1394-SeV18

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN098i-50-18.cmsx

WW   http://shared.eagle-i.net/i/00000155-a31e-d9d6-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN099i-218-1

AC   CVCL_EK99

SY   iPS-218-SeV1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN099i-218-1.cmsx

WW   http://shared.eagle-i.net/i/00000155-9d63-52b1-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN100i-623-3

AC   CVCL_EL00

SY   iPS-623-085-SeV3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN100i-623-3.cmsx

WW   http://shared.eagle-i.net/i/00000155-a227-95eb-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN101i-263-39

AC   CVCL_EL01

SY   iPS-263-SeV39

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN101i-263-39.cmsx

WW   http://shared.eagle-i.net/i/00000155-9d15-5ad4-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN102i-96-1

AC   CVCL_EL02

SY   iPS-96-11592-SeV1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN102i-96-1.cmsx

WW   http://shared.eagle-i.net/i/00000155-bb9a-229f-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN103i-330-4

AC   CVCL_EL03

SY   iPS-330-SeV4

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN103i-330-4.cmsx

WW   http://shared.eagle-i.net/i/00000155-9d1d-22a8-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN104i-321-6

AC   CVCL_EL04

SY   iPS-321-SeV6

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN104i-321-6.cmsx

WW   http://shared.eagle-i.net/i/00000155-bc04-7bce-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN105i-342-5

AC   CVCL_EL05

SY   iPS-342-SeV5

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN105i-342-5.cmsx

WW   http://shared.eagle-i.net/i/00000155-9d20-dd59-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN106i-75-39

AC   CVCL_EL06

SY   iPS-75-1681-SeV39

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN106i-75-39.cmsx

WW   http://shared.eagle-i.net/i/00000155-bb88-6777-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN107i-145-1

AC   CVCL_EL07

SY   iPS-145-SeV1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN107i-145-1.cmsx

WW   http://shared.eagle-i.net/i/00000155-a329-d9e3-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN108i-781-3

AC   CVCL_EL08

SY   781-SeV3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN108i-781-3.cmsx

WW   http://shared.eagle-i.net/i/00000155-bbeb-677b-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN109i-802-2

AC   CVCL_EL09

SY   iPS-802-SeV2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN109i-802-2.cmsx

WW   http://shared.eagle-i.net/i/00000155-bbe9-b3fe-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN110i-389-6

AC   CVCL_EL10

SY   iPS-389-SeV6

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN110i-389-6.cmsx

WW   http://shared.eagle-i.net/i/00000155-9d25-e7f9-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN111i-222-5

AC   CVCL_EL11

SY   iPS-222-SeV5

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN111i-222-5.cmsx

WW   http://shared.eagle-i.net/i/00000155-9d11-da19-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN112i-304-6

AC   CVCL_EL12

SY   iPS-304-SeV6

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN112i-304-6.cmsx

WW   http://shared.eagle-i.net/i/00000155-9d1a-4c05-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN113i-126-66

AC   CVCL_EL13

SY   iPS-126-1650-SeV66

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN113i-126-66.cmsx

WW   http://shared.eagle-i.net/i/00000155-bbad-0326-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN114i-127-2

AC   CVCL_EL14

SY   iPS-127-1188-SeV2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN114i-127-2.cmsx

WW   http://shared.eagle-i.net/i/00000155-bbab-024e-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN115i-316-1

AC   CVCL_EL15

SY   iPS-316-SeV1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN115i-316-1.cmsx

WW   http://shared.eagle-i.net/i/00000155-bbfb-b0f1-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN116i-125-16

AC   CVCL_EL16

SY   iPS-125-1006-SeV16

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN116i-125-16.cmsx

WW   http://shared.eagle-i.net/i/00000155-9d74-472d-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN117i-88-32

AC   CVCL_EL17

SY   iPS-88-1451-SeV32

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN117i-88-32.cmsx

WW   http://shared.eagle-i.net/i/00000155-bb9f-1014-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN118i-113-2

AC   CVCL_EL18

SY   iPS-113-1138-SeV2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN118i-113-2.cmsx

WW   http://shared.eagle-i.net/i/00000155-a745-1a38-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN119i-197-25

AC   CVCL_EL19

SY   iPS-197-SeV25

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN119i-197-25.cmsx

WW   http://shared.eagle-i.net/i/00000155-9d61-a888-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN120i-444-1

AC   CVCL_EL20

SY   iPS-444 SeV1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN120i-444-1.cmsx

WW   http://shared.eagle-i.net/i/00000155-a2b3-3ff2-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EK52 ! PENN052i-444-2

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN121i-69-1

AC   CVCL_EL21

SY   iPS-69-1313-008-SeV1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN121i-69-1.cmsx

WW   http://shared.eagle-i.net/i/00000155-a23d-16cd-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN122i-627-5

AC   CVCL_EL22

SY   iPS-627-SeV5

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN122i-627-5.cmsx

WW   http://shared.eagle-i.net/i/00000155-9d2a-6a0c-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN123i-SV20

AC   CVCL_EL23

SY   iPS-SV20

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN123i-SV20.cmsx

WW   http://shared.eagle-i.net/i/00000155-a2ec-b128-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN124i-28-3

AC   CVCL_EL24

SY   iPS-28-1619-SeV3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN124i-28-3.cmsx

WW   http://shared.eagle-i.net/i/00000155-a749-ee2e-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN125i-233-4

AC   CVCL_EL25

SY   iPS-233-SeV4

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN125i-233-4.cmsx

WW   http://shared.eagle-i.net/i/00000155-a2f4-3bde-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN126i-120-1

AC   CVCL_EL26

SY   iPS-120-1042-SeV1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN126i-120-1.cmsx

WW   http://shared.eagle-i.net/i/00000155-a748-0543-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN127i-415-1

AC   CVCL_EL27

SY   iPS-415 SeV1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN127i-415-1.cmsx

WW   http://shared.eagle-i.net/i/00000155-a298-e32b-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EK74 ! PENN074i-415-3

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN128i-8-4

AC   CVCL_EL28

SY   iPS-8-1433-023-SeV4

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN128i-8-4.cmsx

WW   http://shared.eagle-i.net/i/00000155-9d5b-2833-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN129i-20-14

AC   CVCL_EL29

SY   iPS-20-138-SeV14

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN129i-20-14.cmsx

WW   http://shared.eagle-i.net/i/00000155-bc66-3825-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN130i-78-3

AC   CVCL_EL30

SY   iPS-78-045-SeV3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN130i-78-3.cmsx

WW   http://shared.eagle-i.net/i/00000155-a324-7f5f-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN131i-86-3

AC   CVCL_EL31

SY   iPS-86-1380-SeV3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN131i-86-3.cmsx

WW   http://shared.eagle-i.net/i/00000155-bb93-c521-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN132i-131-5

AC   CVCL_EL32

SY   iPS-131-SeV5

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN132i-131-5.cmsx

WW   http://shared.eagle-i.net/i/00000155-a326-6ddf-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN133i-252-23

AC   CVCL_EL33

SY   iPS-252-SeV23

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN133i-252-23.cmsx

WW   http://shared.eagle-i.net/i/00000155-9d82-f650-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN134i-61-26

AC   CVCL_EL34

SY   iPS-61-1559-060-SeV26

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN134i-61-26.cmsx

WW   http://shared.eagle-i.net/i/00000155-bc59-ec0a-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN135i-30-8

AC   CVCL_EL35

SY   iPS-30-135-SeV8

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN135i-30-8.cmsx

WW   http://shared.eagle-i.net/i/00000155-bc55-36cc-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN136i-262-1

AC   CVCL_EL36

SY   iPS-262-SeV1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN136i-262-1.cmsx

WW   http://shared.eagle-i.net/i/00000155-a2f9-2b62-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN137i-18-11

AC   CVCL_EL37

SY   iPS-18-1418-025-SeV11

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN137i-18-11.cmsx

WW   http://shared.eagle-i.net/i/00000155-9d4a-8ba9-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN138i-24-4

AC   CVCL_EL38

SY   iPS-24-1311-SeV4

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN138i-24-4.cmsx

WW   http://shared.eagle-i.net/i/00000155-bc4a-af33-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN139i-M5-4

AC   CVCL_EL39

SY   iPS-M5-SeV4

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN139i-M5-4.cmsx

WW   http://shared.eagle-i.net/i/00000155-c60e-2ec3-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

DI   NCIt; C123416; Familial hypercholesterolemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EL67 ! PENN167i-M5-3

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN140i-M12-7

AC   CVCL_EL40

SY   M12-7

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN140i-M12-7.cmsx

WW   http://shared.eagle-i.net/i/00000155-a20f-c291-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EL58 ! PENN158i-M12-4

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN141i-M6-2

AC   CVCL_EL41

SY   iPS-M6-PB-SeV2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN141i-M6-2.cmsx

WW   http://shared.eagle-i.net/i/00000155-a276-fa9f-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EL60 ! PENN160i-M6-6

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN142i-M3-19

AC   CVCL_EL42

SY   iPS-M3-SeV19

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN142i-M3-19.cmsx

WW   http://shared.eagle-i.net/i/00000155-c175-2d55-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EL55 ! PENN155i-M3-21

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN143i-M10-11

AC   CVCL_EL43

SY   iPS-M10-SeV11

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN143i-M10-11.cmsx

WW   http://shared.eagle-i.net/i/00000155-c693-1b40-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

DI   NCIt; C85182; Tangier disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EL61 ! PENN161i-M10-5

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN144i-M7-16

AC   CVCL_EL44

SY   iPS-M7-SeV16

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN144i-M7-16.cmsx

WW   http://shared.eagle-i.net/i/00000155-9394-68d8-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

DI   NCIt; C84525; Abetalipoproteinemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EL50 ! PENN150i-M7-9

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN145i-M16-2

AC   CVCL_EL45

SY   M16-SeV2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN145i-M16-2.cmsx

WW   http://shared.eagle-i.net/i/00000155-bce1-251b-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

DI   NCIt; C123416; Familial hypercholesterolemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EL68 ! PENN168i-M16-1

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN146i-M11-5

AC   CVCL_EL46

SY   iPS-M11-SeV5

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN146i-M11-5.cmsx

WW   http://shared.eagle-i.net/i/00000155-a2d3-3c97-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EL64 ! PENN164i-M11-1

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN147i-M9-7

AC   CVCL_EL47

SY   M9-7

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN147i-M9-7.cmsx

WW   http://shared.eagle-i.net/i/00000155-c664-49d7-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

DI   NCIt; C123416; Familial hypercholesterolemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EL71 ! PENN171i-M9-9

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN148i-M8-3

AC   CVCL_EL48

SY   iPS-M8-PB-SeV3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN148i-M8-3.cmsx

WW   http://shared.eagle-i.net/i/00000155-a27e-6019-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EL56 ! PENN156i-M8-2

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN149i-M1-6

AC   CVCL_EL49

SY   iPS-M1-SeV6

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN149i-M1-6.cmsx

WW   http://shared.eagle-i.net/i/00000155-9d7f-1268-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EL51 ! PENN151i-M1-5

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN150i-M7-9

AC   CVCL_EL50

SY   iPS-M7-PB-SeV9

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN150i-M7-9.cmsx

WW   http://shared.eagle-i.net/i/00000155-93bb-9149-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

DI   NCIt; C84525; Abetalipoproteinemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EL44 ! PENN144i-M7-16

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN151i-M1-5

AC   CVCL_EL51

SY   iPS-M1-SeV5

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN151i-M1-5.cmsx

WW   http://shared.eagle-i.net/i/00000155-9d7c-06a2-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EL49 ! PENN149i-M1-6

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN152i-M18-1

AC   CVCL_EL52

SY   M18-SeV1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN152i-M18-1.cmsx

WW   http://shared.eagle-i.net/i/00000155-a21b-17a8-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EL54 ! PENN154i-M18-2

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN153i-M4-10

AC   CVCL_EL53

SY   iPS-M4-SeV10

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN153i-M4-10.cmsx

WW   http://shared.eagle-i.net/i/00000155-a250-d02f-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EL63 ! PENN163i-M4-4

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN154i-M18-2

AC   CVCL_EL54

SY   M18-SeV2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN154i-M18-2.cmsx

WW   http://shared.eagle-i.net/i/00000155-a21c-772c-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EL52 ! PENN152i-M18-1

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN155i-M3-21

AC   CVCL_EL55

SY   iPS-M3-SeV21

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN155i-M3-21.cmsx

WW   http://shared.eagle-i.net/i/00000155-c18a-ed0e-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EL42 ! PENN142i-M3-19

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN156i-M8-2

AC   CVCL_EL56

SY   iPS-M8-SeV2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN156i-M8-2.cmsx

WW   http://shared.eagle-i.net/i/00000155-a27f-ddd7-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EL48 ! PENN148i-M8-3

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN157i-M2-6

AC   CVCL_EL57

SY   iPS-M2-SeV6

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN157i-M2-6.cmsx

WW   http://shared.eagle-i.net/i/00000155-c167-fe5f-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

DI   NCIt; C85182; Tangier disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EL65 ! PENN165i-M2-21

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN158i-M12-4

AC   CVCL_EL58

SY   M12-4

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN158i-M12-4.cmsx

WW   http://shared.eagle-i.net/i/00000155-a20e-4065-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EL40 ! PENN140i-M12-7

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN159i-M14-4

AC   CVCL_EL59

SY   M14-4

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN159i-M14-4.cmsx

WW   http://shared.eagle-i.net/i/00000155-c681-22f5-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

DI   NCIt; C128806; Hyperalphalipoproteinemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EL62 ! PENN162i-M14-11

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN160i-M6-6

AC   CVCL_EL60

SY   iPS-M6-SeV6

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN160i-M6-6.cmsx

WW   http://shared.eagle-i.net/i/00000155-a278-e550-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EL41 ! PENN141i-M6-2

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN161i-M10-5

AC   CVCL_EL61

SY   iPS-M10-PB-SeV5

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN161i-M10-5.cmsx

WW   http://shared.eagle-i.net/i/00000155-c68f-e43c-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

DI   NCIt; C85182; Tangier disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EL43 ! PENN143i-M10-11

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN162i-M14-11

AC   CVCL_EL62

SY   M14-11

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN162i-M14-11.cmsx

WW   http://shared.eagle-i.net/i/00000155-c67e-796a-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

DI   NCIt; C128806; Hyperalphalipoproteinemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EL59 ! PENN159i-M14-4

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN163i-M4-4

AC   CVCL_EL63

SY   iPs-M4-SeV4

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN163i-M4-4.cmsx

WW   http://shared.eagle-i.net/i/00000155-a273-92a3-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EL53 ! PENN153i-M4-10

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN164i-M11-1

AC   CVCL_EL64

SY   iPS-M11-PB-SeV1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN164i-M11-1.cmsx

WW   http://shared.eagle-i.net/i/00000155-a2cb-5b29-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EL46 ! PENN146i-M11-5

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN165i-M2-21

AC   CVCL_EL65

SY   iPS-M2-SeV21

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN165i-M2-21.cmsx

WW   http://shared.eagle-i.net/i/00000155-c163-5212-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

DI   NCIt; C85182; Tangier disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EL57 ! PENN157i-M2-6

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN166i-M15-4

AC   CVCL_EL66

SY   M15-4

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN166i-M15-4.cmsx

WW   http://shared.eagle-i.net/i/00000155-a24c-3793-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EL72 ! PENN172i-M15-10

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN167i-M5-3

AC   CVCL_EL67

SY   iPS-M5-PB-SeV3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN167i-M5-3.cmsx

WW   http://shared.eagle-i.net/i/00000155-c5da-e6ae-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

DI   NCIt; C123416; Familial hypercholesterolemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EL39 ! PENN139i-M5-4

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN168i-M16-1

AC   CVCL_EL68

SY   M16-SeV1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN168i-M16-1.cmsx

WW   http://shared.eagle-i.net/i/00000155-bcdf-1728-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

DI   NCIt; C123416; Familial hypercholesterolemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EL45 ! PENN145i-M16-2

SX   Female

CA   Induced pluripotent stem cell

//

ID   PENN169i-M17-3

AC   CVCL_EL69

SY   iPS-M17-SeV3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN169i-M17-3.cmsx

WW   http://shared.eagle-i.net/i/00000155-bce7-41ae-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

DI   NCIt; C85182; Tangier disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EL70 ! PENN170i-M17-4

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN170i-M17-4

AC   CVCL_EL70

SY   iPS-M17-SeV4

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN170i-M17-4.cmsx

WW   http://shared.eagle-i.net/i/00000155-bcea-4ea5-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

DI   NCIt; C85182; Tangier disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EL69 ! PENN169i-M17-3

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN171i-M9-9

AC   CVCL_EL71

SY   M9-9

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN171i-M9-9.cmsx

WW   http://shared.eagle-i.net/i/00000155-c66e-740d-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

DI   NCIt; C123416; Familial hypercholesterolemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EL47 ! PENN147i-M9-7

SX   Male

CA   Induced pluripotent stem cell

//

ID   PENN172i-M15-10

AC   CVCL_EL72

SY   M15-10

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN172i-M15-10.cmsx

WW   http://shared.eagle-i.net/i/00000155-a24a-8995-dc2e-0c4980000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Rader D.; University of Pennsylvania; Philadelphia; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EL66 ! PENN166i-M15-4

SX   Female

CA   Induced pluripotent stem cell

//

ID   PEO1

AC   CVCL_2686

SY   PE01; PEO-1

DR   BTO; BTO:0005796

DR   EFO; EFO_0005445

DR   BioSample; SAMN03473296

DR   Cosmic; 991317

DR   Cosmic; 1102826

DR   Cosmic; 1305316

DR   Cosmic; 1524353

DR   Cosmic; 1709263

DR   Cosmic-CLP; 1480372

DR   ECACC; 10032308

DR   GDSC; 1480372

DR   GEO; GSM185145

DR   GEO; GSM185146

DR   GEO; GSM459703

DR   GEO; GSM459853

DR   GEO; GSM723253

DR   GEO; GSM851938

DR   GEO; GSM1670347

DR   Ximbio; 151672

RX   PubMed=3167863;

RX   PubMed=8824553;

RX   PubMed=9041185;

RX   PubMed=20581869;

RX   PubMed=22328975;

RX   PubMed=22710073;

RX   PubMed=23415752;

RX   PubMed=25230021;

RX   PubMed=25485619;

RX   PubMed=27235858;

RX   PubMed=27397505;

RX   PubMed=27561551;

CC   Part of: OCCP ovarian cancer cell line panel.

CC   Doubling time: ~37 hours (ECACC).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Ascites.

ST   Source(s): Cosmic-CLP; ECACC; PubMed=25230021; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 10

ST   D16S539: 9

ST   D18S51: 16,17

ST   D19S433: 13,15

ST   D21S11: 32.2

ST   D2S1338: 20,21

ST   D3S1358: 16

ST   D5S818: 11,12

ST   D7S820: 10

ST   D8S1179: 13,14 (PubMed=25230021)

ST   D8S1179: 13 (PubMed=25877200)

ST   FGA: 20

ST   Penta D: 14

ST   Penta E: 11,12

ST   TH01: 9.3

ST   TPOX: 9,11

ST   vWA: 15,16

DI   NCIt; C36100; BRCA1 syndrome

DI   NCIt; C5228; Ovarian cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2690 ! PEO4

OI   CVCL_2691 ! PEO6

SX   Female

CA   Cancer cell line

//

ID   PEO1-CDDP

AC   CVCL_Y032

SY   PEO1CDDP; PEO1 cDDPr

DR   Ximbio; 151784

RX   PubMed=8824553;

CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C36100; BRCA1 syndrome

DI   NCIt; C5228; Ovarian cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2686 ! PEO1

SX   Female

CA   Cancer cell line

//

ID   PEO14

AC   CVCL_2687

SY   PE014; PEO-14

DR   EFO; EFO_0005446

DR   Cosmic; 1305318

DR   ECACC; 10032311

DR   GEO; GSM313700

DR   GEO; GSM459856

DR   GEO; GSM659402

DR   Ximbio; 151675

RX   PubMed=3167863;

RX   PubMed=8824553;

RX   PubMed=20581869;

RX   PubMed=23415752;

RX   PubMed=25230021;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: OCCP ovarian cancer cell line panel.

CC   Doubling time: ~108 hours (ECACC).

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Derived from metastatic site: Ascites.

ST   Source(s): ECACC; PubMed=25230021

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11,12

ST   D16S539: 11

ST   D18S51: 15

ST   D19S433: 14,15

ST   D21S11: 27,30

ST   D2S1338: 19

ST   D3S1358: 16,18

ST   D5S818: 11,12 (ECACC)

ST   D5S818: 12 (PubMed=25230021)

ST   D7S820: 9,10

ST   D8S1179: 13,14

ST   FGA: 20

ST   Penta D: 9,13

ST   Penta E: 10

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 15,16

DI   NCIt; C5228; Ovarian cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2689 ! PEO23

OI   CVCL_2734 ! TO14

SX   Female

CA   Cancer cell line

//

ID   PEO16

AC   CVCL_2688

SY   PE016

DR   ECACC; 10032312

DR   Ximbio; 151676

RX   PubMed=3167863;

RX   PubMed=25230021;

CC   Part of: OCCP ovarian cancer cell line panel.

CC   Doubling time: ~120 hours (ECACC).

ST   Source(s): ECACC; PubMed=25230021

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 13

ST   D16S539: 12

ST   D18S51: 12,19

ST   D19S433: 13,14.2

ST   D21S11: 30

ST   D2S1338: 20,23

ST   D3S1358: 16

ST   D5S818: 11

ST   D7S820: 8

ST   D8S1179: 14,15

ST   FGA: 19,22

ST   Penta D: 13

ST   Penta E: 7

ST   TH01: 7

ST   TPOX: 8,11

ST   vWA: 15

DI   NCIt; C5228; Ovarian cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PEO23

AC   CVCL_2689

SY   PE023

DR   EFO; EFO_0005447

DR   ECACC; 10032313

DR   GEO; GSM459857

DR   Ximbio; 151677

RX   PubMed=3167863;

RX   PubMed=20581869;

RX   PubMed=23415752;

RX   PubMed=25230021;

CC   Part of: OCCP ovarian cancer cell line panel.

CC   Doubling time: ~120 hours (ECACC).

CC   Derived from metastatic site: Ascites.

ST   Source(s): ECACC; PubMed=25230021

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11,12

ST   D16S539: 11

ST   D18S51: 15

ST   D19S433: 14,15

ST   D21S11: 27,30

ST   D2S1338: 24

ST   D3S1358: 16

ST   D5S818: 11,12 (ECACC)

ST   D5S818: 12 (PubMed=25230021)

ST   D7S820: 9,10

ST   D8S1179: 13,14

ST   FGA: 20

ST   Penta D: 9,13

ST   Penta E: 10

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 15,16

DI   NCIt; C5228; Ovarian cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2687 ! PEO14

OI   CVCL_2734 ! TO14

SX   Female

CA   Cancer cell line

//

ID   PEO4

AC   CVCL_2690

SY   PE04; PEO-4

DR   BTO; BTO:0005797

DR   EFO; EFO_0005448

DR   Cosmic; 1709261

DR   ECACC; 10032309

DR   GEO; GSM185147

DR   GEO; GSM185148

DR   GEO; GSM459657

DR   GEO; GSM459854

DR   GEO; GSM851939

DR   Ximbio; 151673

RX   PubMed=3167863;

RX   PubMed=8824553;

RX   PubMed=9041185;

RX   PubMed=20581869;

RX   PubMed=22328975;

RX   PubMed=22710073;

RX   PubMed=23415752;

RX   PubMed=25230021;

RX   PubMed=27235858;

RX   PubMed=27561551;

CC   Part of: OCCP ovarian cancer cell line panel.

CC   Doubling time: ~36 hours (ECACC).

CC   Omics: Deep proteome analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Ascites.

ST   Source(s): ECACC; PubMed=25230021

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 10

ST   D16S539: 9

ST   D18S51: 16,17

ST   D19S433: 13,15

ST   D21S11: 30,32.2

ST   D2S1338: 20,21

ST   D3S1358: 16

ST   D5S818: 11,12

ST   D7S820: 10

ST   D8S1179: 13,14

ST   FGA: 20

ST   Penta D: 9,14

ST   Penta E: 11,12

ST   TH01: 9.3

ST   TPOX: 9,11

ST   vWA: 15,16

DI   NCIt; C36100; BRCA1 syndrome

DI   NCIt; C5228; Ovarian cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2686 ! PEO1

OI   CVCL_2691 ! PEO6

SX   Female

CA   Cancer cell line

//

ID   PEO6

AC   CVCL_2691

SY   PE06; PEO-6

DR   BTO; BTO:0005798

DR   EFO; EFO_0005449

DR   ECACC; 10032310

DR   GEO; GSM459855

DR   GEO; GSM659400

DR   Ximbio; 151674

RX   PubMed=3167863;

RX   PubMed=20581869;

RX   PubMed=22710073;

RX   PubMed=23415752;

CC   Doubling time: ~77 hours (ECACC).

CC   Derived from metastatic site: Ascites.

ST   Source(s): ECACC

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 10

ST   D16S539: 9

ST   D5S818: 11,12

ST   D7S820: 10

ST   TH01: 9.3

ST   TPOX: 9,11

ST   vWA: 15,16

DI   NCIt; C36100; BRCA1 syndrome

DI   NCIt; C5228; Ovarian cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2686 ! PEO1

OI   CVCL_2690 ! PEO4

SX   Female

CA   Cancer cell line

//

ID   Per Sel

AC   CVCL_3327

DR   CLO; CLO_0008419

DR   ATCC; CRL-1107

DI   NCIt; C26837; Osteogenesis imperfecta

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   PER-106

AC   CVCL_8904

SY   PER 106

RX   DOI=10.1007/0-306-46872-7_2;

RX   PubMed=1581878;

CC   Doubling time: 10.5 days for non-adherent, >30 days for adherent (PubMed=1581878).

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_8905 ! PER-107

OI   CVCL_8906 ! PER-108

SX   Male

CA   Cancer cell line

//

ID   PER-107

AC   CVCL_8905

SY   PER 107

RX   DOI=10.1007/0-306-46872-7_2;

RX   PubMed=1581878;

CC   Doubling time: 5.75 days (PubMed=1581878).

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_8904 ! PER-106

OI   CVCL_8906 ! PER-108

SX   Male

CA   Cancer cell line

//

ID   PER-108

AC   CVCL_8906

SY   PER 108

RX   DOI=10.1007/0-306-46872-7_2;

RX   PubMed=1581878;

CC   Doubling time: 3.25 days (PubMed=1581878).

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_8904 ! PER-106

OI   CVCL_8905 ! PER-107

SX   Male

CA   Cancer cell line

//

ID   PER-117

AC   CVCL_W979

SY   PER 117

RX   PubMed=3472019;

RX   PubMed=12883040;

RX   PubMed=17117183;

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PER-145

AC   CVCL_W976

RX   PubMed=2720661;

RX   PubMed=3472651;

RX   PubMed=7540895;

RX   PubMed=12883040;

RX   PubMed=17117183;

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_W977 ! PER-163

OI   CVCL_W978 ! PER-164

SX   Male

CA   Cancer cell line

//

ID   PER-163

AC   CVCL_W977

RX   PubMed=2720661;

RX   PubMed=3472651;

RX   PubMed=7540895;

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_W976 ! PER-145

OI   CVCL_W978 ! PER-164

SX   Male

CA   Cancer cell line

//

ID   PER-164

AC   CVCL_W978

RX   PubMed=2720661;

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_W976 ! PER-145

OI   CVCL_W977 ! PER-163

SX   Male

CA   Cancer cell line

//

ID   PER-255

AC   CVCL_W980

SY   PER 255

RX   PubMed=2546623;

RX   PubMed=12883040;

RX   PubMed=17117183;

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PER-278

AC   CVCL_W981

RX   PubMed=2340491;

RX   PubMed=12883040;

RX   PubMed=17117183;

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PER-365

AC   CVCL_A474

DR   Cosmic; 1130241

RX   PubMed=7536459;

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A475 ! PER-377

SX   Male

CA   Cancer cell line

//

ID   PER-371

AC   CVCL_W982

RX   PubMed=12883040;

RX   PubMed=17117183;

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PER-377

AC   CVCL_A475

SY   PER377

DR   Cosmic; 1130242

RX   PubMed=7536459;

RX   PubMed=12883040;

RX   PubMed=17117183;

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A474 ! PER-365

SX   Male

CA   Cancer cell line

//

ID   PER-423

AC   CVCL_K242

SY   PER 423

RX   PubMed=8429680;

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PER-427

AC   CVCL_W983

RX   PubMed=12883040;

RX   PubMed=17117183;

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PER-485

AC   CVCL_W984

RX   PubMed=12883040;

RX   PubMed=17117183;

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PER-487

AC   CVCL_W985

RX   PubMed=12883040;

RX   PubMed=17117183;

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PER-490

AC   CVCL_W986

RX   PubMed=12883040;

RX   PubMed=17117183;

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PER-495

AC   CVCL_W987

RX   PubMed=12883040;

RX   PubMed=17117183;

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PER-537

AC   CVCL_W988

RX   PubMed=12883040;

RX   PubMed=17117183;

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PER-550

AC   CVCL_W989

RX   PubMed=12883040;

RX   PubMed=17117183;

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PER-604

AC   CVCL_W990

RX   PubMed=17117183;

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PER-606

AC   CVCL_W991

RX   PubMed=17117183;

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PER-607

AC   CVCL_W992

RX   PubMed=17117183;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   PER-608

AC   CVCL_W993

RX   PubMed=17117183;

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PER-VAS

AC   CVCL_DI60

RX   PubMed=26345430;

CC   Doubling time: 16.5 hours (PubMed=26345430).

CC   Breed/subspecies: Labrador Retriever.

DI   NCIt; C128121; Canine lymphoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   PER.C6

AC   CVCL_G704

SY   PER C6; PER cell clone 6

RX   PubMed=9741429;

RX   PubMed=11257414;

RX   PubMed=25903999;

WW   http://web.archive.org/web/20140721200546/http://www.crucell.com/page/downloads/Factsheet_PER.C6_Technology.pdf

WW   http://web.archive.org/web/20121219090924/http://www.dsm.com/en_US/downloads/dpp/PER.C6_Brochure.pdf

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-452.html

CC   Group: Vaccine production cell line.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5 [E1A/E1B].

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1K15 ! 911

CA   Transformed cell line

//

ID   Peri.4U

AC   CVCL_1E62

WW   http://axiogenesis.com/products/neuronal-cells/peri-4u-hipsc-peripheral-neurons.html

WW   http://axiogenesis.com/images/pdf/flyers/140919_Flyer_Peri4U_v1.pdf

CC   From: Axiogenesis AG; Germany.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Induced pluripotent stem cell

//

ID   PERK-KO-DR

AC   CVCL_B067

DR   ATCC; CRL-2976

CC   Knockout cell: Method=KO mouse; MGI; MGI:1341830; Eif2ak3.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   pES[12]

AC   CVCL_C101

SY   pES(12); pES12; PES12; ESe027-A

DR   hPSCreg; ESe027-A

DR   ISCR; 2274

WW   http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Documento_Deposito_Lineas_pES12.pdf

CC   From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   PET

AC   CVCL_N816

DR   Cosmic; 1656048

RX   PubMed=15274292;

RX   PubMed=22426987;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PETCH

AC   CVCL_E803

DR   dbMHC; 48998

DR   ECACC; 94092801

DR   IHW; IHW9205

DR   IMGT/HLA; 11246

WW   http://bioinformatics.hsanmartino.it/ecbr/cl205.html

CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   PF

AC   CVCL_R981

SY   Poecilia Fry

RX   CelloPub=CLPUB00098;

CC   Group: Fish cell line.

CC   Doubling time: ~1.5 days (CelloPub=CLPUB00098).

OX   NCBI_TaxID=48698; ! Poecilia formosa

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   PF-382

AC   CVCL_1641

SY   PF382

DR   CLO; CLO_0008421

DR   CLDB; cl3895

DR   CLDB; cl4993

DR   BioSample; SAMN03473327

DR   CCLE; PF382_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   ChEMBL-Cells; CHEMBL3308246

DR   ChEMBL-Targets; CHEMBL2366235

DR   Cosmic; 909260

DR   Cosmic; 913414

DR   Cosmic; 1012113

DR   Cosmic; 1115593

DR   Cosmic; 1151790

DR   Cosmic; 1224370

DR   Cosmic; 1524814

DR   Cosmic; 1641384

DR   Cosmic; 2165708

DR   Cosmic-CLP; 909260

DR   DSMZ; ACC-38

DR   GDSC; 909260

DR   GEO; GSM887513

DR   GEO; GSM888595

DR   GEO; GSM1670348

DR   ICLC; HTL00006

RX   PubMed=2410652;

RX   PubMed=3499548;

RX   PubMed=15843827;

RX   PubMed=16408098;

RX   PubMed=22460905;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: ~70 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; DSMZ

ST   Amelogenin: X

ST   CSF1PO: 10,13

ST   D13S317: 11,12

ST   D16S539: 9,12

ST   D5S818: 11,12

ST   D7S820: 9,10

ST   TH01: 6,9.3

ST   TPOX: 11

ST   vWA: 16,17

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PF-R

AC   CVCL_0I61

SY   PF

DR   CCLV; CCLV-RIE 0200

RX   PubMed=19941903;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9103; ! Meleagris gallopavo

CA   Finite cell line

//

ID   PF04015

AC   CVCL_E804

DR   dbMHC; 48999

DR   ECACC; 95052212

DR   IHW; IHW9088

DR   IMGT/HLA; 11645

DR   PRIDE; PXD001205

RX   PubMed=25502872;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl88.html

CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: HLA class II peptidome analysis by proteomics.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   PF1038

AC   CVCL_M196

RX   PubMed=23516439;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PF97387

AC   CVCL_E805

DR   CLDB; cl7226

DR   dbMHC; 49000

DR   ECACC; 95042722

DR   ICLC; HTL14004

DR   IHW; IHW9027

DR   IMGT/HLA; 11644

WW   http://bioinformatics.hsanmartino.it/ecbr/cl27.html

CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   PFC

AC   CVCL_6F45

RX   PubMed=26341227;

CC   Transfected with: UniProtKB; F1S027; Pig TERT.

CC   Breed/subspecies: Jangquhaid.

OX   NCBI_TaxID=9823; ! Sus scrofa

CA   Telomerase immortalized cell line

//

ID   PFC6

AC   CVCL_S883

RX   PubMed=6184607;

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Spontaneously immortalized cell line

//

ID   Pfeiffer

AC   CVCL_3326

SY   PFEIFFER

DR   CLO; CLO_0008423

DR   EFO; EFO_0006472

DR   ATCC; CRL-2632

DR   BioSample; SAMN03471758

DR   CCLE; PFEIFFER_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   Cosmic; 1670184

DR   Cosmic; 1714155

DR   Cosmic; 1945187

DR   Cosmic; 2276336

DR   Cosmic; 2437318

DR   GEO; GSM380141

DR   GEO; GSM552461

DR   GEO; GSM887514

DR   GEO; GSM888596

DR   IGRhCellID; Pfeiffer

RX   PubMed=10485273;

RX   PubMed=19278952;

RX   PubMed=19358282;

RX   PubMed=22460905;

RX   PubMed=23292937;

RX   PubMed=25355872;

RX   PubMed=25485619;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Array-based CGH.

CC   Omics: CNV analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: miRNA expression profiling.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Omics: Virome analysis using RNAseq.

CC   Misspelling: 'Pfieffer' in Cosmic 1945187 and PubMed=23292937.

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 11,12

ST   D16S539: 12

ST   D5S818: 10,13

ST   D7S820: 8,12

ST   TH01: 9,9.3

ST   TPOX: 9

ST   vWA: 17,18

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PFF

AC   CVCL_R806

SY   Puntius Fasciatus Fin

RX   PubMed=23933168;

CC   Group: Fish cell line.

OX   NCBI_TaxID=1503185; ! Haludaria fasciata

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   PFHR-9

AC   CVCL_3566

SY   PFHR 9; PFHR9; PF HR-9

DR   CLO; CLO_0008424

DR   ATCC; CRL-2423

RX   PubMed=558822;

RX   PubMed=1917782;

CC   Breed/subspecies: 129/Sv.

DI   NCIt; C129859; Mouse teratocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_5911 ! PCC4-F

SX   Male

CA   Cancer cell line

//

ID   PFI-285

AC   CVCL_A664

DR   Cosmic; 1086320

RX   PubMed=2307225;

DI   NCIt; C3466; T-cell non-Hodgkin lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PFIZi001-A

AC   CVCL_9S31

SY   EM1-3F

DR   hPSCreg; PFIZi001-A

CC   From: Pfizer, Inc.

DI   NCIt; C34593; Erythromelalgia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PFIZi002-A

AC   CVCL_9S32

SY   EM1-7M

DR   hPSCreg; PFIZi002-A

CC   From: Pfizer, Inc.

DI   NCIt; C34593; Erythromelalgia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PFIZi003-A

AC   CVCL_9S33

SY   EM2-7M

DR   hPSCreg; PFIZi003-A

CC   From: Pfizer, Inc.

DI   NCIt; C34593; Erythromelalgia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PFIZi004-A

AC   CVCL_9S34

SY   EM2-7F

DR   hPSCreg; PFIZi004-A

CC   From: Pfizer, Inc.

DI   NCIt; C34593; Erythromelalgia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PFIZi013-A

AC   CVCL_IJ00

SY   RCFB59 C9; RCi215

DR   BioSamples; SAMEA4343623

DR   EBiSC; PFIZi013-A

DR   ECACC; 66540322

DR   hPSCreg; PFIZi013-A

CC   From: Pfizer, Inc.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PFIZi014-A

AC   CVCL_IJ01

SY   OD002-s7

DR   BioSamples; SAMEA4454946

DR   hPSCreg; PFIZi014-A

CC   From: Pfizer, Inc.

DI   NCIt; C116573; Dravet syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PFIZi015-A

AC   CVCL_IJ02

SY   OD003-s5

DR   BioSamples; SAMEA4454948

DR   hPSCreg; PFIZi015-A

CC   From: Pfizer, Inc.

DI   NCIt; C116573; Dravet syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PFIZi016-A

AC   CVCL_IJ03

SY   OD005-s9

DR   BioSamples; SAMEA4454950

DR   hPSCreg; PFIZi016-A

CC   From: Pfizer, Inc.

DI   NCIt; C116573; Dravet syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PFSK-1

AC   CVCL_1642

SY   PFSK

DR   CLO; CLO_0008425

DR   EFO; EFO_0005234

DR   ATCC; CRL-2060

DR   BioSample; SAMN03471425

DR   ChEMBL-Cells; CHEMBL3308802

DR   ChEMBL-Targets; CHEMBL1075560

DR   Cosmic; 683667

DR   Cosmic; 923655

DR   Cosmic; 973260

DR   Cosmic; 1728490

DR   Cosmic; 1995615

DR   Cosmic-CLP; 683667

DR   ENCODE; ENCBS054ENC

DR   GDSC; 683667

DR   GEO; GSM923430

DR   GEO; GSM1670349

DR   IZSLER; BS TCL 202

RX   DOI=10.1016/B978-0-12-333530-2.50005-8;

RX   PubMed=1316433;

RX   PubMed=23325432;

RX   PubMed=27397505;

WW   http://genome.ucsc.edu/ENCODE/protocols/cell/human/PFSK-1_protocol.pdf

CC   Part of: ENCODE project common cell types; tier 3.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): ATCC; Cosmic-CLP

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 12,14

ST   D16S539: 13

ST   D5S818: 11,12

ST   D7S820: 10

ST   TH01: 9,9.3

ST   TPOX: 8,9

ST   vWA: 17,18

DI   NCIt; C3716; Primitive neuroectodermal tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PFV

AC   CVCL_DR64

SY   Pig Flip-in Visualize

RX   PubMed=20336379;

CC   Characteristics: Transfected with a construct that contains a Sleeping Beauty (SB) DNA transposon, a puromycin resistance gene, an EGFP reporter gene and an Flp recombinase site for locus-directed gene insertion.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Breed/subspecies: Gottingen minipig.

OX   NCBI_TaxID=9823; ! Sus scrofa

SX   Male

CA   Spontaneously immortalized cell line

//

ID   PG [Esox lucius]

AC   CVCL_4272

DR   CLO; CLO_0008426

DR   ECACC; 95070629

RX   DOI=10.1007/BF02618036;

CC   Group: Fish cell line.

OX   NCBI_TaxID=8010; ! Esox lucius

SX   Female

CA   Spontaneously immortalized cell line

//

ID   PG [Human lung carcinoma]

AC   CVCL_4389

DR   BTO; BTO:0002412

RX   PubMed=10374431;

DI   NCIt; C4452; Lung giant cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PG-4 (S+L-)

AC   CVCL_3413

SY   PG-4(S+L-); PG-4 S+L-; PG-4

DR   CLO; CLO_0008429

DR   CLO; CLO_0008430

DR   CLDB; cl3898

DR   CLDB; cl3899

DR   ATCC; CRL-2032

DR   BCRC; 60470

DR   CCRID; 3111C0002000000080

DR   ECACC; 94102703

DR   ICLC; ATL97002

DR   JCRB; JCRB9125

CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).

OX   NCBI_TaxID=9685; ! Felis catus

HI   CVCL_GR56 ! G355

CA   Transformed cell line

//

ID   PG-49

AC   CVCL_D539

DR   ChEMBL-Cells; CHEMBL3308677

DR   ChEMBL-Targets; CHEMBL614847

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PG-BE1

AC   CVCL_4390

SY   PGBE1

DR   BTO; BTO:0002413

DR   CCRID; 3111C0001CCC000201

RX   PubMed=7656376;

DI   NCIt; C4452; Lung giant cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4389 ! PG [Human lung carcinoma]

CA   Cancer cell line

//

ID   PG-CL3

AC   CVCL_4391

SY   PGCL3

DR   BTO; BTO:0002414

RX   PubMed=7656376;

DI   NCIt; C4452; Lung giant cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4389 ! PG [Human lung carcinoma]

CA   Cancer cell line

//

ID   PG-LH7

AC   CVCL_4392

SY   PGLH7

DR   BTO; BTO:0002415

DR   CCRID; 3111C0001CCC000202

RX   PubMed=7656376;

DI   NCIt; C4452; Lung giant cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4389 ! PG [Human lung carcinoma]

CA   Cancer cell line

//

ID   PG/B95-8

AC   CVCL_Y555

SY   PG-EBV

DR   DSMZ; ACC-776

RX   PubMed=2836321;

RX   PubMed=23297799;

CC   Doubling time: ~35 hours (DSMZ).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

ST   Source(s): DSMZ

ST   Amelogenin: X,Y

ST   CSF1PO: 13

ST   D13S317: 8,12

ST   D16S539: 9,12

ST   D5S818: 11,12

ST   D7S820: 10,11

ST   TH01: 6,9.3

ST   TPOX: 8,11

ST   vWA: 17

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y545 ! PGA-1

SX   Male

CA   Transformed cell line

//

ID   PG1-iPS-1

AC   CVCL_L666

SY   PG1-IPS-1

DR   ISCR; 1990

RX   PubMed=21185252;

CC   From: A*STAR Institute of Medical Biology; Singapore; Singapore.

DI   NCIt; C34951; Progeria

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_H766 ! AG11498

SX   Male

CA   Induced pluripotent stem cell

//

ID   PG1-iPS-2

AC   CVCL_L667

SY   PG1-IPS-2

DR   ISCR; 1991

RX   PubMed=21185252;

CC   From: A*STAR Institute of Medical Biology; Singapore; Singapore.

DI   NCIt; C34951; Progeria

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_H766 ! AG11498

SX   Male

CA   Induced pluripotent stem cell

//

ID   PG100

AC   CVCL_Z278

SY   PG-100

RX   DOI=10.3748/wjg.v22.i43.9506;

RX   PubMed=20658094;

CC   Omics: Array-based CGH.

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PG13

AC   CVCL_4273

DR   CLO; CLO_0008427

DR   CLDB; cl3900

DR   ATCC; CRL-10686

DR   ECACC; 95110215

DR   TOKU-E; 2880

RX   PubMed=1850008;

CC   Group: Retrovirus packaging cell line.

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_9116 ! NIH 3T3-TK-

SX   Male

CA   Transformed cell line

//

ID   PG13/LN c8

AC   CVCL_8933

DR   CLO; CLO_0008428

DR   ATCC; CRL-10685

RX   PubMed=1850008;

CC   Group: Retrovirus packaging cell line.

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4273 ! PG13

SX   Male

CA   Transformed cell line

//

ID   PG19

AC   CVCL_S409

SY   C57Bl melanoma clone PG 19; PG 19

RX   PubMed=893544;

CC   Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).

CC   Breed/subspecies: C57BL/6J.

DI   NCIt; C21790; Mouse melanoma

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_0192 ! C57/B1

SX   Female

CA   Cancer cell line

//

ID   PG19T3

AC   CVCL_S407

RX   PubMed=510081;

CC   Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).

CC   Breed/subspecies: C57BL/6J.

DI   NCIt; C21790; Mouse melanoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_S409 ! PG19

SX   Female

CA   Cancer cell line

//

ID   PG19T3:MTXR10-4M

AC   CVCL_4Y71

SY   PG19T3:MTXR.10-4 M

RX   PubMed=510081;

CC   Selected for resistance to: ChEBI; CHEBI:44185; Methotrexate (MTX).

CC   Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).

CC   Breed/subspecies: C57BL/6J.

DI   NCIt; C21790; Mouse melanoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_S407 ! PG19T3

SX   Female

CA   Cancer cell line

//

ID   PG2-iPS-1

AC   CVCL_L668

SY   PG2-IPS-1

DR   ISCR; 1992

RX   PubMed=21185252;

CC   From: A*STAR Institute of Medical Biology; Singapore; Singapore.

DI   NCIt; C34951; Progeria

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_H765 ! AG06297

SX   Male

CA   Induced pluripotent stem cell

//

ID   PG2-iPS-2

AC   CVCL_L669

SY   PG2-IPS-2

DR   ISCR; 1993

RX   PubMed=21185252;

CC   From: A*STAR Institute of Medical Biology; Singapore; Singapore.

DI   NCIt; C34951; Progeria

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_H765 ! AG06297

SX   Male

CA   Induced pluripotent stem cell

//

ID   PG64SV.2

AC   CVCL_DQ62

RX   PubMed=27345795;

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   PGA-1

AC   CVCL_Y545

SY   PGA1; PG A1; CLL-PGA

DR   DSMZ; ACC-766

DR   NCBI_Iran; C583

RX   PubMed=2836321;

RX   PubMed=23297799;

CC   Doubling time: ~50 hours (DSMZ).

ST   Source(s): DSMZ

ST   Amelogenin: X,Y

ST   CSF1PO: 13

ST   D13S317: 8,12

ST   D16S539: 12

ST   D5S818: 11,12

ST   D7S820: 10,11

ST   TH01: 6,9.3

ST   TPOX: 8,11

ST   vWA: 17

DI   NCIt; C3163; Chronic lymphocytic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y555 ! PG/B95-8

SX   Male

CA   Cancer cell line

//

ID   PGC-2

AC   CVCL_6713

RX   PubMed=8916040;

RX   PubMed=15541573;

OX   NCBI_TaxID=9823; ! Sus scrofa

SX   Female

CA   Spontaneously immortalized cell line

//

ID   PGF

AC   CVCL_E806

SY   GM03107

DR   CLO; CLO_0013567

DR   Coriell; GM03107

DR   dbMHC; 49001

DR   ECACC; 94050342

DR   IHW; IHW9318

DR   IMGT/HLA; 11248

RX   PubMed=16702430;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl318.html

CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   PGK12.1

AC   CVCL_AS07

SY   Pgk12.1; PGK 12.1

DR   BioSample; SAMN00672592

DR   GEO; GSM761213

DR   GEO; GSM1081335

RX   PubMed=8156596;

RX   PubMed=8538762;

RX   PubMed=12874099;

RX   PubMed=16244654;

CC   Omics: Deep RNAseq analysis.

CC   Breed/subspecies: PGK x 129/Ola/Hsd.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Embryonic stem cell

//

ID   PGLC-33h

AC   CVCL_HA64

SY   PGLC-33H

RX   PubMed=788925;

RX   PubMed=824057;

RX   PubMed=5641111;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C34726; Infectious mononucleosis

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   PGME1

AC   CVCL_0F77

SY   PGME 1

RX   PubMed=2612208;

CC   Group: Human/rodent somatic cell hybrid.

OX   NCBI_TaxID=9606; ! Homo sapiens

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0F71 ! MB63

CA   Hybrid cell line

//

ID   pgsA-745

AC   CVCL_4589

SY   S745; 745; Mutant 745

DR   CLO; CLO_0008434

DR   ATCC; CRL-2242

DR   CCLV; CCLV-RIE 0316

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0214 ! CHO-K1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   pgsB-618

AC   CVCL_4590

SY   618; Mutant 618

DR   CLO; CLO_0008435

DR   ATCC; CRL-2241

RX   PubMed=2957376;

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0214 ! CHO-K1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   pgsB-650

AC   CVCL_4591

SY   650; Mutant 650

DR   CLO; CLO_0008436

DR   ATCC; CRL-2243

RX   PubMed=2957376;

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0214 ! CHO-K1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   pgsC-605

AC   CVCL_4592

SY   605; Mutant 605

DR   CLO; CLO_0008437

DR   ATCC; CRL-2245

RX   PubMed=3782085;

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0214 ! CHO-K1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   pgsD-677

AC   CVCL_4593

DR   CLO; CLO_0008438

DR   ATCC; CRL-2244

RX   PubMed=1532254;

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0214 ! CHO-K1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   pgsE-606

AC   CVCL_4594

DR   CLO; CLO_0008439

DR   ATCC; CRL-2246

DR   BCRC; 60542

DR   CCLV; CCLV-RIE 0317

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0214 ! CHO-K1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   PGV

AC   CVCL_W866

SY   Porcine Granulosa cell-Virus transformed

RX   PubMed=15832078;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9823; ! Sus scrofa

SX   Female

CA   Transformed cell line

//

ID   PH [Human]

AC   CVCL_L107

DR   ATCC; CRL-9851

DR   BioSample; SAMN03471075

RX   Patent=US5447861;

CC   Problematic cell line: Contaminated. Shown to be a U-937 derivative.

CC   Discontinued: ATCC; CRL-9851; true.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 10,12

ST   D16S539: 12

ST   D5S818: 10,12

ST   D7S820: 9,11

ST   TH01: 6,9.3

ST   TPOX: 8,11

ST   vWA: 15

DI   NCIt; C8263; Adult acute monocytic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0007 ! U-937

SX   Male

CA   Cancer cell line

//

ID   PH [Pilchard]

AC   CVCL_R915

SY   Pilchard Heart

RX   PubMed=15801155;

CC   Group: Fish cell line.

OX   NCBI_TaxID=59687; ! Sardinops neopilchardus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   Ph 310

AC   CVCL_T588

SY   Ph-310; SPPC-PH310

RX   PubMed=183370;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9054; ! Phasianus colchicus

CA   Spontaneously immortalized cell line

//

ID   PH-2

AC   CVCL_EJ71

SY   PH2

RX   Patent=US5830638;

CC   Group: Non-human primate cell line.

CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2165.

OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus

HI   CVCL_EJ70 ! Vero M

SX   Female

CA   Spontaneously immortalized cell line

//

ID   PH1-Fib-hiPSC4F

AC   CVCL_DQ60

RX   PubMed=27345794;

DI   NCIt; C123212; Primary hyperoxaluria type I

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_DQ61 ! PH1-PBMCs-hiPSC4F1

SX   Male

CA   Induced pluripotent stem cell

//

ID   PH1-PBMCs-hiPSC4F1

AC   CVCL_DQ61

RX   PubMed=27345794;

DI   NCIt; C123212; Primary hyperoxaluria type I

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_DQ60 ! PH1-Fib-hiPSC4F

SX   Male

CA   Induced pluripotent stem cell

//

ID   PH5

AC   CVCL_5862

SY   PH-5; Porcine Hyalocyte-derived cell line 5

DR   BTO; BTO:0004273

RX   PubMed=17707370;

CC   Doubling time: 56.9 +- 22.6 hours (PubMed=17707370).

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9823; ! Sus scrofa

CA   Transformed cell line

//

ID   PH61-N

AC   CVCL_D282

SY   PH61N

DR   BioSample; SAMN03151845

DR   BioSample; SAMN03472485

DR   CGH-DB; 181-1

DR   JCRB; JCRB1038

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a MIA PaCa-2 derivative (PubMed=20143388).

CC   Discontinued: JCRB; JCRB1038; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 12,13

ST   D16S539: 10,13

ST   D5S818: 12,13

ST   D7S820: 12,13

ST   TH01: 10

ST   TPOX: 9

ST   vWA: 15

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0428 ! MIA PaCa-2

SX   Male

CA   Cancer cell line

//

ID   PHA00356IN

AC   CVCL_E187

WW   http://www.biologia.uniba.it/primates/cell_lines.html

CC   Group: Non-human primate cell line.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9555; ! Papio anubis

SX   Sex undetermined

CA   Transformed cell line

//

ID   PHA00357IN

AC   CVCL_E188

WW   http://www.biologia.uniba.it/primates/cell_lines.html

CC   Group: Non-human primate cell line.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9555; ! Papio anubis

SX   Sex undetermined

CA   Transformed cell line

//

ID   PHA00358IN

AC   CVCL_E189

WW   http://www.biologia.uniba.it/primates/cell_lines.html

CC   Group: Non-human primate cell line.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9555; ! Papio anubis

SX   Sex undetermined

CA   Transformed cell line

//

ID   PHEC1

AC   CVCL_6G48

SY   Permanent Human Endothelial Cells 1

RX   PubMed=8835314;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pMK16].

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   Phi-1

AC   CVCL_4274

SY   Phi 1

DR   CLO; CLO_0008440

DR   CLDB; cl3903

DR   ECACC; 85061101

RX   PubMed=6149229;

CC   Breed/subspecies: AxC.

DI   NCIt; C60416; Rat hepatocellular carcinoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_5125 ! Fu5-5

SX   Male

CA   Cancer cell line

//

ID   PhIP12-1

AC   CVCL_AS17

DR   TKG; TKG 0718

RX   PubMed=11289141;

CC   Transformant: ChEBI; CHEBI:76290; 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).

CC   Breed/subspecies: Fischer 344 x Sprague-Dawley.

DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Female

CA   Cancer cell line

//

ID   PhIP7-4

AC   CVCL_AS18

DR   TKG; TKG 0717

RX   PubMed=11289141;

CC   Transformant: ChEBI; CHEBI:76290; 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).

CC   Breed/subspecies: Fischer 344 x Sprague-Dawley.

DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Female

CA   Cancer cell line

//

ID   PHK16-0b

AC   CVCL_3123

DR   BioSample; SAMN03470808

DR   JCRB; JCRB0141

DR   JCRB; NIHS0203

CC   Discontinued: JCRB; NIHS0203; true.

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 12,13

ST   D13S317: 11

ST   D16S539: 11,12

ST   D5S818: 9,11

ST   D7S820: 9,11

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 16

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   PHL

AC   CVCL_5863

SY   Pacific Herring Larva

DR   CLO; CLO_0008441

DR   ATCC; CRL-2750

RX   PubMed=10813363;

RX   PubMed=19002917;

CC   Group: Fish cell line.

OX   NCBI_TaxID=30724; ! Clupea pallasii

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   PHM1-31

AC   CVCL_R869

SY   Pregnant Human Myometrial 1-31

RX   PubMed=16371591;

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   PHM1-41

AC   CVCL_8566

SY   Pregnant Human Myometrial 1-41

DR   ATCC; CRL-3046

RX   PubMed=8828850;

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 14

ST   D16S539: 10,12

ST   D5S818: 11,13

ST   D7S820: 8,10

ST   TH01: 7

ST   TPOX: 8,11

ST   vWA: 16,17

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   PHMLEB

AC   CVCL_DG84

DR   GEO; GSM232917

DR   GEO; GSM232918

RX   PubMed=11156605;

CC   Transfected with: HGNC; 11730; TERT.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   PHMLER

AC   CVCL_DG85

DR   GEO; GSM232914

DR   GEO; GSM232915

DR   GEO; GSM232916

RX   PubMed=11156605;

CC   Transfected with: HGNC; 11730; TERT.

CC   Transfected with: HGNC; 5173; HRAS (with V-12).

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_DG84 ! PHMLEB

SX   Female

CA   Transformed cell line

//

ID   Phoenix-Ampho

AC   CVCL_H716

SY   Phoenix-AMPHO; Phoenix-ampho; Phoenix Ampho; Phoenix ampho; AmphoPhoenix; Phoenix-A; Phoenix A; PhoenixA; AmphoPack 293

DR   ATCC; CRL-3213

DR   ATCC; SD-3443

WW   http://web.stanford.edu/group/nolan/_OldWebsite/retroviral_systems/phx.html

CC   Group: Retrovirus packaging cell line.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA].

CC   Discontinued: ATCC; SD-3443; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0063 ! HEK293T

SX   Female

CA   Transformed cell line

//

ID   Phoenix-Eco

AC   CVCL_H717

SY   Phoenix-ECO; Phoenix Eco; PhoenixEco; Phoenix-E; Phoenix E

DR   ATCC; CRL-3214

DR   ATCC; SD-3444

WW   http://web.stanford.edu/group/nolan/_OldWebsite/retroviral_systems/phx.html

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-534.html

CC   Group: Retrovirus packaging cell line.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA].

CC   Discontinued: ATCC; SD-3444; true.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11,12,13

ST   D16S539: 9,13

ST   D5S818: 8,9

ST   D7S820: 11

ST   TH01: 7,9.3

ST   TPOX: 11

ST   vWA: 16,19

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0063 ! HEK293T

SX   Female

CA   Transformed cell line

//

ID   Phoenix-gp

AC   CVCL_H718

SY   Phoenix-GP; Phoenix GP; PhoenixGP

DR   ATCC; CRL-3215

WW   http://web.stanford.edu/group/nolan/_OldWebsite/tutorials/retpkg_7_phx_sys.html

CC   Group: Retrovirus packaging cell line.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA].

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 12,14

ST   D16S539: 9,13

ST   D5S818: 8,9

ST   D7S820: 11

ST   TH01: 7,9.3

ST   TPOX: 11

ST   vWA: 16,19

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0063 ! HEK293T

SX   Female

CA   Transformed cell line

//

ID   PI 153/3

AC   CVCL_G250

SY   PI153/3; GM04278

DR   CLO; CLO_0008442

DR   CLO; CLO_0019597

DR   ATCC; TIB-198

DR   Coriell; GM04278

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3411 ! P3X63Ag8

CA   Hybridoma

//

ID   Pi Kar

AC   CVCL_0F70

DR   ATCC; CRL-1102

CC   Discontinued: ATCC; CRL-1102; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   PI-11

AC   CVCL_G249

DR   CLO; CLO_0008445

DR   ATCC; CRL-2591

RX   PubMed=1426051;

CC   Monoclonal antibody target: UniProtKB; P20810; Human CAST.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   PI1

AC   CVCL_V129

DR   CLO; CLO_0008444

DR   CLDB; cl3904

DR   IHW; IHW8021

CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.

CC   Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).

CC   Breed/subspecies: C3H/An.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4536 ! L-M(TK-)

SX   Male

CA   Spontaneously immortalized cell line

//

ID   PICM-19

AC   CVCL_V146

SY   ARS-PICM-19; Pig Inner Cell Mass-19

RX   PubMed=7534591;

RX   PubMed=8354665;

RX   PubMed=8635514;

RX   PubMed=12097833;

RX   PubMed=20333478;

RX   PubMed=23148238;

CC   Characteristics: Requires feeder cells.

OX   NCBI_TaxID=9823; ! Sus scrofa

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   PICM-19B

AC   CVCL_5T67

RX   PubMed=20669140;

RX   PubMed=23148238;

CC   Characteristics: Requires feeder cells.

OX   NCBI_TaxID=9823; ! Sus scrofa

HI   CVCL_V146 ! PICM-19

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   PICM-19FF

AC   CVCL_5T69

SY   PICM-19 Feeder Free

RX   PubMed=23148238;

RX   PubMed=23397443;

CC   Characteristics: Does not require feeder cells.

OX   NCBI_TaxID=9823; ! Sus scrofa

HI   CVCL_V146 ! PICM-19

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   PICM-19H

AC   CVCL_5T68

RX   PubMed=20669140;

RX   PubMed=23148238;

CC   Characteristics: Requires feeder cells.

OX   NCBI_TaxID=9823; ! Sus scrofa

HI   CVCL_V146 ! PICM-19

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   PID0102

AC   CVCL_T906

DR   SKIP; SKIP000146

DI   NCIt; C3962; Adenosine deaminase deficiency

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   PID0401

AC   CVCL_T907

DR   SKIP; SKIP000145

DI   NCIt; C26788; Chronic granulomatous disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T908 ! PID0402

CA   Induced pluripotent stem cell

//

ID   PID0402

AC   CVCL_T908

DR   SKIP; SKIP000144

DI   NCIt; C26788; Chronic granulomatous disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T907 ! PID0401

CA   Induced pluripotent stem cell

//

ID   PIE

AC   CVCL_HC68

SY   Porcine Intestinal Epithelial cell line

DR   GEO; GSE77095

RX   PubMed=18082146;

CC   Omics: Transcriptome analysis.

CC   Breed/subspecies: LWD (Landrace x Large White x Duroc).

OX   NCBI_TaxID=9823; ! Sus scrofa

CA   Spontaneously immortalized cell line

//

ID   PIG1

AC   CVCL_S410

SY   PIGI

DR   ATCC; CRL-2208

DR   BioSample; SAMN03472565

RX   PubMed=9028834;

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].

CC   Discontinued: ATCC; CRL-2208; true.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 8,11

ST   D16S539: 8,11

ST   D5S818: 12,13

ST   D7S820: 8,10

ST   TH01: 6,7

ST   TPOX: 8

ST   vWA: 17

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   PIL

AC   CVCL_E807

DR   IHW; IHW0204

WW   http://bioinformatics.hsanmartino.it/ecbr/cl367.html

CC   Part of: 9th International Histocompatibility Workshop (9IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   PIL-6

AC   CVCL_5347

RX   PubMed=2785799;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=PIL-6

CC   Breed/subspecies: BALB/c.

DI   NCIt; C21631; Mouse plasmacytoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4001 ! MOPC-104E

CA   Cancer cell line

//

ID   PIN,LJ

AC   CVCL_E808

SY   PIN, LJ

DR   dbMHC; 49002

DR   ECACC; 94082208

DR   IHW; IHW9109

DR   IMGT/HLA; 11654

RX   PubMed=8307784;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl109.html

CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   PIR-P3

AC   CVCL_DD11

SY   CHO PIR-P3

DR   ATCC; CRL-11378

RX   Patent=US5272070;

CC   Selected for resistance to: ChEBI; CHEBI:9367; Swainsonine (Sw).

CC   Discontinued: ATCC; CRL-11378; probable.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_DD10 ! SwR-100

SX   Female

CA   Spontaneously immortalized cell line

//

ID   PIR-P8

AC   CVCL_IQ79

SY   CHO PIR-P8

RX   Patent=US5272070;

CC   Selected for resistance to: ChEBI; CHEBI:9367; Swainsonine (Sw).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_DD10 ! SwR-100

SX   Female

CA   Spontaneously immortalized cell line

//

ID   Pit1/0

AC   CVCL_U367

RX   PubMed=20829390;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: CD-1.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   Pit1/Prl

AC   CVCL_U368

RX   PubMed=20829390;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: CD-1.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   Pit1/Triple

AC   CVCL_U369

RX   PubMed=20829390;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: CD-1.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   PITOUT

AC   CVCL_E809

DR   dbMHC; 49003

DR   ECACC; 94070711

DR   IHW; IHW9051

DR   IMGT/HLA; 11255

DR   PRIDE; PXD001205

RX   PubMed=8307784;

RX   PubMed=25502872;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl51.html

CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: HLA class II peptidome analysis by proteomics.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   PJ-2

AC   CVCL_D338

SY   PJ2

RX   PubMed=15372243;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PJS1JTO

AC   CVCL_3124

SY   PJ1

DR   JCRB; JCRB0320

DR   JCRB; KURB2083

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 9,11

ST   D16S539: 9,11

ST   D5S818: 11,13

ST   D7S820: 8,11

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 17,18

DI   NCIt; C3324; Peutz-Jeghers syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   PJS1JTO(SVT)

AC   CVCL_4W90

DR   JCRB; KURB2084

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

DI   NCIt; C3324; Peutz-Jeghers syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3124 ! PJS1JTO

SX   Female

CA   Transformed cell line

//

ID   PJS5JTO

AC   CVCL_3125

SY   PJ5

DR   JCRB; JCRB0321

DR   JCRB; KURB2086

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 9,10

ST   D16S539: 9

ST   D5S818: 11,12

ST   D7S820: 10

ST   TH01: 7

ST   TPOX: 8,9

ST   vWA: 14,17

DI   NCIt; C3324; Peutz-Jeghers syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   PK

AC   CVCL_AZ81

SY   Pig Kidney; Porcine Kidney

RX   PubMed=13744439;

CC   Breed/subspecies: Hampshire.

OX   NCBI_TaxID=9823; ! Sus scrofa

SX   Male

CA   Spontaneously immortalized cell line

//

ID   PK-1

AC   CVCL_4717

SY   PK1

DR   BTO; BTO:0004854

DR   CLO; CLO_0050105

DR   BioSample; SAMN03472897

DR   CCLE; PK1_PANCREAS

DR   Cosmic; 707253

DR   Cosmic; 1066176

DR   Cosmic; 1644297

DR   Cosmic; 2046536

DR   GEO; GSM887515

DR   GEO; GSM888597

DR   GEO; GSM1588614

DR   RCB; RCB1972

DR   TKG; TKG 0239

RX   PubMed=6205469;

RX   PubMed=8872523;

RX   PubMed=22460905;

RX   PubMed=22490663;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=25877200; RCB; TKG

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 9,10

ST   D16S539: 12

ST   D18S51: 13

ST   D21S11: 31

ST   D3S1358: 15

ST   D5S818: 11,12

ST   D7S820: 11

ST   D8S1179: 10,15

ST   FGA: 22,24

ST   Penta D: 9

ST   Penta E: 9,20

ST   TH01: 9,10 (PubMed=25877200; RCB)

ST   TH01: 9 (TKG)

ST   TPOX: 9,11

ST   vWA: 15,19

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PK-12

AC   CVCL_D711

DR   Cosmic; 1066179

DR   Cosmic; 1644300

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PK-13

AC   CVCL_6433

SY   PK13; Porcine Kidney-13

DR   CLO; CLO_0008450

DR   ATCC; CRL-6489

RX   PubMed=19508353;

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Breed/subspecies: Hampshire.

OX   NCBI_TaxID=9823; ! Sus scrofa

HI   CVCL_S287 ! PK-2a

SX   Male

CA   Spontaneously immortalized cell line

//

ID   PK-14

AC   CVCL_D712

DR   Cosmic; 1066180

DR   Cosmic; 1644301

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PK-15

AC   CVCL_2160

SY   PK(15); PK (15); PK 15; PK15; Porcine Kidney-15

DR   BTO; BTO:0001865

DR   CLO; CLO_0008447

DR   CLO; CLO_0008448

DR   CLO; CLO_0050908

DR   CLDB; cl3906

DR   CLDB; cl3907

DR   CLDB; cl3908

DR   ATCC; CCL-33

DR   ATCC; CRL-6593

DR   BCRC; 60057

DR   BCRJ; 0355

DR   CCLV; CCLV-RIE 0005

DR   CCRID; 3111C0001CCC000385

DR   CCRID; 3142C0001000000060

DR   CLS; 607426/p798_PK-15

DR   DSMZ; ACC-640

DR   IZSLER; BS CL 72

DR   JCRB; JCRB9040

DR   KCB; KCB 201002YJ

DR   KCLB; 10033

DR   RCB; RCB0534

RX   PubMed=3009166;

RX   PubMed=4132403;

RX   PubMed=5962858;

RX   PubMed=19508353;

RX   PubMed=19941903;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=PK15

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Doubling time: ~25 hours (DSMZ).

CC   Discontinued: ATCC; CRL-6593; true.

CC   Breed/subspecies: Hampshire.

OX   NCBI_TaxID=9823; ! Sus scrofa

HI   CVCL_S287 ! PK-2a

SX   Male

CA   Spontaneously immortalized cell line

//

ID   PK-16

AC   CVCL_D713

DR   Cosmic; 1066181

DR   Cosmic; 1644302

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PK-2

AC   CVCL_5348

RX   PubMed=2679911;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=PK-2

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   PK-2a

AC   CVCL_S287

SY   PK 2 a; PK2a; PK2A

CC   Breed/subspecies: Hampshire.

OX   NCBI_TaxID=9823; ! Sus scrofa

HI   CVCL_AZ81 ! PK

SX   Male

CA   Spontaneously immortalized cell line

//

ID   PK-2a/CL 13

AC   CVCL_6434

DR   CLO; CLO_0008452

DR   ATCC; CRL-6492

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6492; true.

CC   Breed/subspecies: Hampshire.

OX   NCBI_TaxID=9823; ! Sus scrofa

HI   CVCL_S287 ! PK-2a

CA   Spontaneously immortalized cell line

//

ID   PK-36

AC   CVCL_D719

DR   Cosmic; 1066182

DR   Cosmic; 1644303

RX   PubMed=7622937;

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PK-45H

AC   CVCL_6748

SY   PK-45 H

DR   CLO; CLO_0050106

DR   EFO; EFO_0006734

DR   BioSample; SAMN03472048

DR   BioSample; SAMN03472949

DR   CCLE; PK45H_PANCREAS

DR   Cosmic; 1066184

DR   GEO; GSM887516

DR   GEO; GSM888598

DR   GEO; GSM1588610

DR   RCB; RCB1973

DR   TKG; TKG 0491

RX   PubMed=22460905;

RX   PubMed=25485619;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Omics: Deep RNAseq analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=25877200; RCB; TKG

ST   Amelogenin: X

ST   CSF1PO: 9,10

ST   D13S317: 9

ST   D16S539: 11,12

ST   D18S51: 17

ST   D21S11: 31.2,32.2

ST   D3S1358: 15

ST   D5S818: 10,12

ST   D7S820: 11

ST   D8S1179: 10

ST   FGA: 23,24

ST   Penta D: 12,13

ST   Penta E: 5,15

ST   TH01: 6,9

ST   TPOX: 11

ST   vWA: 18 (PubMed=25877200)

ST   vWA: 16,18 (RCB; TKG)

DI   NCIt; C3850; Pancreatic carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_6749 ! PK-45P

CA   Cancer cell line

//

ID   PK-45P

AC   CVCL_6749

SY   PK-45 P

DR   CLO; CLO_0050107

DR   EFO; EFO_0006735

DR   BioSample; SAMN03472015

DR   BioSample; SAMN03472900

DR   Cosmic; 1066183

DR   Cosmic; 1644304

DR   RCB; RCB2141

DR   TKG; TKG 0493

RX   PubMed=25485619;

CC   Omics: Deep RNAseq analysis.

CC   Omics: SNP array analysis.

ST   Source(s): PubMed=25877200; RCB; TKG

ST   Amelogenin: X

ST   CSF1PO: 9,10

ST   D13S317: 9,11

ST   D16S539: 11,12

ST   D18S51: 17

ST   D21S11: 31.2,32.2

ST   D3S1358: 15

ST   D5S818: 10,12

ST   D7S820: 11

ST   D8S1179: 10,13

ST   FGA: 23,24

ST   Penta D: 12,13

ST   Penta E: 5,15

ST   TH01: 9

ST   TPOX: 8,11 (PubMed=25877200; RCB)

ST   TPOX: 11 (TKG)

ST   vWA: 18 (PubMed=25877200; TKG)

ST   vWA: 16,18 (RCB)

DI   NCIt; C3850; Pancreatic carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_6748 ! PK-45H

CA   Cancer cell line

//

ID   PK-47

AC   CVCL_D720

DR   Cosmic; 1066185

DR   Cosmic; 1644305

RX   PubMed=7622937;

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PK-59

AC   CVCL_4897

SY   PK59

DR   BTO; BTO:0005487

DR   CLO; CLO_0050100

DR   EFO; EFO_0006736

DR   BioSample; SAMN03472950

DR   CCLE; PK59_PANCREAS

DR   Cosmic; 707257

DR   Cosmic; 1066186

DR   Cosmic; 1299305

DR   Cosmic; 1644306

DR   GEO; GSM887517

DR   GEO; GSM888599

DR   GEO; GSM1588611

DR   RCB; RCB1901

DR   TKG; TKG 0492

RX   PubMed=7622937;

RX   PubMed=22460905;

RX   PubMed=22490663;

RX   PubMed=25485619;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Omics: Deep RNAseq analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Liver.

ST   Source(s): PubMed=25877200; RCB; TKG

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 10,12

ST   D16S539: 11,12

ST   D18S51: 13

ST   D21S11: 30,31

ST   D3S1358: 18

ST   D5S818: 11

ST   D7S820: 8

ST   D8S1179: 11

ST   FGA: 19

ST   Penta D: 8,11

ST   Penta E: 16,22

ST   TH01: 8,9

ST   TPOX: 8,11

ST   vWA: 18

DI   NCIt; C3850; Pancreatic carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PK-8

AC   CVCL_4718

SY   PK8

DR   BTO; BTO:0004855

DR   CLO; CLO_0050112

DR   EFO; EFO_0006737

DR   BioSample; SAMN03472951

DR   Cosmic; 707254

DR   Cosmic; 1066177

DR   Cosmic; 1644298

DR   RCB; RCB2700

DR   TKG; TKG 0383

RX   PubMed=25485619;

CC   Omics: Deep RNAseq analysis.

CC   Omics: SNP array analysis.

ST   Source(s): PubMed=25877200; RCB; TKG

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 11

ST   D16S539: 9,10

ST   D18S51: 13

ST   D21S11: 31

ST   D3S1358: 16

ST   D5S818: 13

ST   D7S820: 9,12

ST   D8S1179: 13,15

ST   FGA: 23

ST   Penta D: 9

ST   Penta E: 13,15

ST   TH01: 7

ST   TPOX: 8,11

ST   vWA: 16

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PK-82

AC   CVCL_8402

DR   CLO; CLO_0008453

DR   CLDB; cl3909

WW   http://www.rccc.cytspb.rssi.ru/ecellbank/animal/apk-82.htm

OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus

CA   Spontaneously immortalized cell line

//

ID   PK-87-19

AC   CVCL_V285

SY   PK87-19; GM10612

DR   CLO; CLO_0024540

DR   Coriell; GM10612

RX   PubMed=2276735;

RX   PubMed=2307476;

CC   Group: Human/rodent somatic cell hybrid.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_V283 ! GM07890

HI   CVCL_4595 ! UV135

CA   Hybrid cell line

//

ID   PK-87-9

AC   CVCL_V286

SY   PK87-9; GM10611

DR   CLO; CLO_0024543

DR   Coriell; GM10611

RX   PubMed=2276735;

RX   PubMed=2307476;

RX   PubMed=8314568;

RX   PubMed=8661047;

CC   Group: Human/rodent somatic cell hybrid.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_V283 ! GM07890

HI   CVCL_4595 ! UV135

CA   Hybrid cell line

//

ID   PK-89-12

AC   CVCL_V284

SY   PK89-12; GM10868

DR   CLO; CLO_0024131

DR   Coriell; GM10868

RX   PubMed=2276735;

RX   PubMed=8314568;

CC   Group: Human/rodent somatic cell hybrid.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_V283 ! GM07890

HI   CVCL_4595 ! UV135

CA   Hybrid cell line

//

ID   PK-89-6A

AC   CVCL_V287

SY   PK89-6A; GM11580

DR   CLO; CLO_0021219

DR   Coriell; GM11580

CC   Group: Human/rodent somatic cell hybrid.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_V283 ! GM07890

HI   CVCL_4595 ! UV135

CA   Hybrid cell line

//

ID   PK-9

AC   CVCL_D721

SY   PK9

DR   BTO; BTO:0005486

DR   Cosmic; 707255

DR   Cosmic; 1066178

DR   Cosmic; 1644299

DR   GEO; GSM1588618

DR   TKG; TKG 0240

RX   PubMed=7622937;

RX   PubMed=8872523;

RX   PubMed=22490663;

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 9,10

ST   D16S539: 12

ST   D5S818: 11,12

ST   D7S820: 11

ST   TH01: 9

ST   TPOX: 9,11

ST   vWA: 15,19

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PK-SV40

AC   CVCL_9W55

RX   PubMed=6314331;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   PK(D1)

AC   CVCL_6432

DR   CLO; CLO_0008449

DR   ATCC; CRL-6490

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6490; true.

OX   NCBI_TaxID=9823; ! Sus scrofa

CA   Finite cell line

//

ID   PK136

AC   CVCL_7695

SY   PK-136

DR   CLO; CLO_0008451

DR   ATCC; HB-191

DR   CCRID; 3131C0001000600046

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   PK15cl28/BS

AC   CVCL_W715

SY   PK15-28; PK15 clone 28

DR   IZSLER; BS CL 179

CC   Breed/subspecies: Hampshire.

OX   NCBI_TaxID=9823; ! Sus scrofa

HI   CVCL_2160 ! PK-15

SX   Male

CA   Spontaneously immortalized cell line

//

ID   PKE20

AC   CVCL_IW61

RX   PubMed=2845797;

CC   Selected for resistance to: PubChem; 1795; Ethylisopropylamiloride (EIPA).

CC   Breed/subspecies: Hampshire.

OX   NCBI_TaxID=9823; ! Sus scrofa

HI   CVCL_IP75 ! LLC-PK1/Cl4

SX   Male

CA   Spontaneously immortalized cell line

//

ID   PKE5

AC   CVCL_IW62

SY   PKE 5

RX   PubMed=2833317;

RX   PubMed=3022596;

CC   Characteristics: Devoid of sodium-proton antiporter activity.

CC   Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).

CC   Breed/subspecies: Hampshire.

OX   NCBI_TaxID=9823; ! Sus scrofa

HI   CVCL_IP75 ! LLC-PK1/Cl4

SX   Male

CA   Transformed cell line

//

ID   PKF

AC   CVCL_2692

SY   Pig Kidney Fibroblastic

DR   IFO; IFO50422

OX   NCBI_TaxID=9823; ! Sus scrofa

CA   Spontaneously immortalized cell line

//

ID   PKR

AC   CVCL_2693

SY   Pig Kidney Rough

DR   IFO; IFO50423

OX   NCBI_TaxID=9823; ! Sus scrofa

CA   Spontaneously immortalized cell line

//

ID   PKS

AC   CVCL_2694

SY   Pig Kidney Smooth

DR   IFO; IFO50421

OX   NCBI_TaxID=9823; ! Sus scrofa

CA   Spontaneously immortalized cell line

//

ID   PKSV-PCT

AC   CVCL_0484

DR   MCCL; MCC:0000383

RX   PubMed=7474657;

RX   PubMed=8100235;

RX   PubMed=17219250;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   PKSV-PR

AC   CVCL_W355

RX   PubMed=8100235;

RX   PubMed=17219250;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   PKU-1

AC   CVCL_C065

SY   PKU1; BJMUe001-A

DR   hPSCreg; BJMUe001-A

DR   ISCR; 1590

RX   PubMed=16143641;

CC   From: Peking University Third Hospital; Beijing; China.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   PKU-2

AC   CVCL_C066

SY   PKU2; BJMUe002-A

DR   hPSCreg; BJMUe002-A

DR   ISCR; 1591

RX   PubMed=16143641;

CC   From: Peking University Third Hospital; Beijing; China.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   PL

AC   CVCL_R916

SY   Pilchard Liver

RX   PubMed=15801155;

CC   Group: Fish cell line.

OX   NCBI_TaxID=59687; ! Sardinops neopilchardus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   PL-14

AC   CVCL_L412

RX   PubMed=640319;

CC   Doubling time: 72 hours (PubMed=640319).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PL-20

AC   CVCL_0C86

RX   PubMed=20453304;

DI   NCIt; C124249; Canine mammary carcinoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   PL-21

AC   CVCL_2161

SY   PL21

DR   BTO; BTO:0005928

DR   EFO; EFO_0006473

DR   BioSample; SAMN01821655

DR   BioSample; SAMN01821714

DR   BioSample; SAMN03473265

DR   CCLE; PL21_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   Cosmic; 787419

DR   Cosmic; 975297

DR   Cosmic; 999725

DR   Cosmic; 1524840

DR   Cosmic; 2131556

DR   Cosmic; 2306237

DR   Cosmic-CLP; 1330991

DR   DSMZ; ACC-536

DR   GDSC; 1330991

DR   GEO; GSM236801

DR   GEO; GSM236837

DR   GEO; GSM887518

DR   GEO; GSM888600

DR   GEO; GSM1374834

DR   GEO; GSM1670351

DR   JCRB; JCRB1319

RX   PubMed=6362749;

RX   PubMed=6576961;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: ~40-50 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; DSMZ; JCRB; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 8,11

ST   D16S539: 11,13

ST   D18S51: 12,13

ST   D21S11: 29,30

ST   D3S1358: 15

ST   D5S818: 10

ST   D7S820: 12,13

ST   D8S1179: 10

ST   FGA: 21,24

ST   Penta D: 11,13

ST   Penta E: 5,17

ST   TH01: 9

ST   TPOX: 9,11

ST   vWA: 14,18

DI   NCIt; C3171; Acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PL-29018

AC   CVCL_M704

SY   PL29018

DR   Cosmic; 2297024

DR   GEO; GSM115812

RX   PubMed=16960149;

DI   NCIt; C2912; Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Pl 1Ut

AC   CVCL_3771

SY   Pl 1Ut (NBL-9); Pl 1 Ut (NBL-9); NBL-9; Pl.1 Ut; Pl 1 UT; Pl 1 Ut

DR   CLO; CLO_0008287

DR   CLO; CLO_0008443

DR   CLDB; cl3910

DR   ATCC; CCL-74

DR   ATCC; CRL-6596

DR   ECACC; 90111909

WW   http://fluoview.magnet.fsu.edu/gallery/cells/pl1ut/pl1utcells.html

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Misspelling: Occasionally 'P1 1Ut'.

CC   Discontinued: ATCC; CRL-6596; true.

OX   NCBI_TaxID=9654; ! Procyon lotor

SX   Female

CA   Finite cell line

//

ID   PL14

AC   CVCL_X982

DR   Cosmic; 949525

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PL18

AC   CVCL_X507

SY   PL-18

DR   Cosmic-CLP; 1240208

DR   GDSC; 1240208

DR   GEO; GSM1670350

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): Cosmic-CLP

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 8,11

ST   D16S539: 9,13

ST   D5S818: 10,12

ST   D7S820: 10,11

ST   TH01: 7,9.3

ST   TPOX: 8,11

ST   vWA: 16

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PL377

AC   CVCL_S875

RX   PubMed=12904596;

DI   NCIt; C6586; Extrarenal rhabdoid tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PL4

AC   CVCL_S976

SY   PL-4

DR   Cosmic; 1198212

DR   Cosmic-CLP; 1298533

DR   GDSC; 1298533

DR   GEO; GSM621906

DR   GEO; GSM1670352

DR   LINCS; 50040

RX   PubMed=14695172;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP

ST   Amelogenin: X

ST   CSF1PO: 11,13

ST   D13S317: 12

ST   D16S539: 12

ST   D5S818: 10,11

ST   D7S820: 12

ST   TH01: 7,9

ST   TPOX: 8

ST   vWA: 15,19

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PL45

AC   CVCL_3567

SY   PL-45; PL 45

DR   CLO; CLO_0008454

DR   ATCC; CRL-2558

DR   BioSample; SAMN03473284

DR   CCLE; PL45_PANCREAS

DR   Cosmic; 725721

DR   Cosmic; 932513

DR   Cosmic; 949236

DR   Cosmic; 949524

DR   Cosmic; 1006372

DR   Cosmic; 2046533

DR   Cosmic; 2434098

DR   GEO; GSM206536

DR   GEO; GSM621890

DR   GEO; GSM887519

DR   GEO; GSM888601

DR   GEO; GSM1024413

DR   PRIDE; PXD003198

RX   PubMed=22460905;

RX   PubMed=25167228;

RX   PubMed=25485619;

RX   PubMed=27259358;

RX   PubMed=28196595;

WW   http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=PL45

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 12

ST   D16S539: 9,12

ST   D18S51: 15

ST   D21S11: 30

ST   D3S1358: 14

ST   D5S818: 13

ST   D7S820: 8,9

ST   D8S1179: 13,14

ST   FGA: 20

ST   Penta D: 12

ST   Penta E: 11,13

ST   TH01: 6,9.3

ST   TPOX: 11

ST   vWA: 16

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1639 ! Panc 10.05

SX   Male

CA   Cancer cell line

//

ID   PL502

AC   CVCL_3126

DR   JCRB; JCRB1125

DR   JCRB; NIHS0421

CC   Discontinued: JCRB; NIHS0421; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 8,10,12

ST   D16S539: 9,10

ST   D5S818: 9,11,13

ST   D7S820: 9,10,11

ST   TH01: 7,8

ST   TPOX: 8,11

ST   vWA: 16,18,19

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Adult stem cell

//

ID   PL504

AC   CVCL_8305

DR   BioSample; SAMN03472382

DR   JCRB; JCRB1126

DR   JCRB; NIHS0423

CC   Discontinued: JCRB; NIHS0423; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,9

ST   D16S539: 9,10

ST   D5S818: 11

ST   D7S820: 8,11

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 17

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Adult stem cell

//

ID   PL505

AC   CVCL_3127

DR   BioSample; SAMN03472461

DR   JCRB; JCRB1128

DR   JCRB; NIHS0424

CC   Discontinued: JCRB; NIHS0424; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11,12

ST   D16S539: 9

ST   D5S818: 12

ST   D7S820: 8,10

ST   TH01: 6,8

ST   TPOX: 8

ST   vWA: 16,17

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Adult stem cell

//

ID   PL507

AC   CVCL_3128

DR   BioSample; SAMN03472462

DR   JCRB; JCRB1130

DR   JCRB; NIHS0426

CC   Discontinued: JCRB; NIHS0426; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11

ST   D16S539: 9

ST   D5S818: 9,11

ST   D7S820: 8,12

ST   TH01: 7,9

ST   TPOX: 8

ST   vWA: 14,19

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Adult stem cell

//

ID   PL508

AC   CVCL_3129

DR   BioSample; SAMN03472429

DR   JCRB; JCRB1194

DR   JCRB; NIHS0429

CC   Discontinued: JCRB; NIHS0429; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12,13

ST   D13S317: 9,12

ST   D16S539: 11,13

ST   D5S818: 12,13

ST   D7S820: 10,11

ST   TH01: 7,9

ST   TPOX: 11

ST   vWA: 14,17

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Adult stem cell

//

ID   PL509

AC   CVCL_8310

DR   BioSample; SAMN03472432

DR   JCRB; JCRB1197

DR   JCRB; NIHS0430

CC   Discontinued: JCRB; NIHS0430; true.

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 9,11

ST   D16S539: 11,12

ST   D5S818: 9,10

ST   D7S820: 11,12

ST   TH01: 6

ST   TPOX: 8

ST   vWA: 14,17

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Adult stem cell

//

ID   PL512

AC   CVCL_3130

DR   BioSample; SAMN03472449

DR   JCRB; JCRB1229

DR   JCRB; NIHS0565

CC   Problematic cell line: Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).

CC   Discontinued: JCRB; NIHS0565; true.

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 9,10

ST   D16S539: 10,11

ST   D5S818: 10,11

ST   D7S820: 8,12

ST   TH01: 6

ST   TPOX: 8,9

ST   vWA: 16

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Adult stem cell

//

ID   PL514

AC   CVCL_3131

DR   BioSample; SAMN03472390

DR   JCRB; JCRB1300

DR   JCRB; NIHS0566

CC   Discontinued: JCRB; NIHS0566; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 9

ST   D13S317: 11,12

ST   D16S539: 11,12

ST   D5S818: 11,13

ST   D7S820: 9,11

ST   TH01: 6,9

ST   TPOX: 8,11

ST   vWA: 16

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Adult stem cell

//

ID   PL516

AC   CVCL_3132

DR   BioSample; SAMN03472392

DR   JCRB; JCRB1302

DR   JCRB; NIHS0569

CC   Discontinued: JCRB; NIHS0569; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 12

ST   D16S539: 9,11

ST   D5S818: 9,13

ST   D7S820: 12,13

ST   TH01: 6,9

ST   TPOX: 11

ST   vWA: 16,18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Adult stem cell

//

ID   PL517

AC   CVCL_8314

DR   BioSample; SAMN03472395

DR   JCRB; JCRB1306

DR   JCRB; NIHS0570

CC   Problematic cell line: Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).

CC   Discontinued: JCRB; NIHS0570; true.

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 8,12

ST   D16S539: 10,11

ST   D5S818: 11,12

ST   D7S820: 10,11

ST   TH01: 7,9

ST   TPOX: 8

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Adult stem cell

//

ID   PL518

AC   CVCL_3133

DR   BioSample; SAMN03472396

DR   JCRB; JCRB1307

DR   JCRB; NIHS0571

CC   Discontinued: JCRB; NIHS0571; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 8,10

ST   D16S539: 9

ST   D5S818: 12,13

ST   D7S820: 11,12

ST   TH01: 6

ST   TPOX: 9

ST   vWA: 14,18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Adult stem cell

//

ID   PL519

AC   CVCL_8436

DR   JCRB; JCRB1360

DR   JCRB; NIHS0575

CC   Discontinued: JCRB; NIHS0575; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 10

ST   D16S539: 10

ST   D5S818: 9,12

ST   D7S820: 12,13

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 14,16

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Adult stem cell

//

ID   PL520

AC   CVCL_8322

DR   JCRB; JCRB1364

DR   JCRB; NIHS0576

CC   Discontinued: JCRB; NIHS0576; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 9,11

ST   D16S539: 11

ST   D5S818: 11,13

ST   D7S820: 10,13

ST   TH01: 6,8

ST   TPOX: 11

ST   vWA: 14,18

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Adult stem cell

//

ID   PL521

AC   CVCL_8530

DR   JCRB; JCRB1423

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 11,12

ST   D16S539: 9

ST   D5S818: 11,13

ST   D7S820: 10,13

ST   TH01: 6

ST   TPOX: 11

ST   vWA: 14

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Adult stem cell

//

ID   PL523

AC   CVCL_8531

DR   JCRB; JCRB1420

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 10,11

ST   D16S539: 9,12

ST   D5S818: 10,12

ST   D7S820: 11,13

ST   TH01: 7,9

ST   TPOX: 8,11

ST   vWA: 16,17

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Adult stem cell

//

ID   PL532

AC   CVCL_3134

DR   BioSample; SAMN03472444

DR   JCRB; JCRB1219

DR   JCRB; NIHS0516

CC   Discontinued: JCRB; NIHS0516; true.

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 11,12

ST   D16S539: 9,12

ST   D5S818: 11

ST   D7S820: 8,10

ST   TH01: 9

ST   TPOX: 8,11

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Adult stem cell

//

ID   PL551SF

AC   CVCL_8532

DR   JCRB; JCRB1412

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Adult stem cell

//

ID   PLA-801

AC   CVCL_7108

SY   PLA801

DI   NCIt; C4452; Lung giant cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PLA-801C

AC   CVCL_7109

SY   PLA801C; PLA801-95C; 95C

DR   BTO; BTO:0002183

RX   PubMed=2550196;

RX   PubMed=12748951;

CC   Omics: Deep proteome analysis.

DI   NCIt; C4452; Lung giant cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_7108 ! PLA-801

CA   Cancer cell line

//

ID   PLA-801D

AC   CVCL_7110

SY   PLA801D; PLA801-95D; 95D; 95-D; 801-D

DR   BTO; BTO:0002182

DR   CCRID; 3131C0001000700061

DR   Cosmic; 911995

DR   KCB; KCB 200690YJ

RX   PubMed=1839254;

RX   PubMed=2550196;

RX   PubMed=12748951;

CC   Omics: Deep proteome analysis.

DI   NCIt; C4452; Lung giant cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_7108 ! PLA-801

CA   Cancer cell line

//

ID   PLA-802

AC   CVCL_AX34

SY   PLA 802; PLA802

DR   Cosmic; 2296988

RX   CelloPub=CLPUB00322;

RX   PubMed=27008654;

CC   Doubling time: 42 hours (CelloPub=CLPUB00322).

DI   NCIt; C3749; Alveolar rhabdomyosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Plat-A

AC   CVCL_B489

SY   Platinum-A

WW   http://www.cellbiolabs.com/platinum-retroviral-packaging-cell-lines

CC   Group: Retrovirus packaging cell line.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA].

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0063 ! HEK293T

SX   Female

CA   Transformed cell line

//

ID   Plat-E

AC   CVCL_B488

SY   Platinum-E

RX   PubMed=10871756;

WW   http://www.cellbiolabs.com/platinum-retroviral-packaging-cell-lines

CC   Group: Retrovirus packaging cell line.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA].

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0063 ! HEK293T

SX   Female

CA   Transformed cell line

//

ID   Plat-GP

AC   CVCL_B490

SY   Platinum-GP; PlatGP; PLAT-gp

WW   http://www.cellbiolabs.com/platinum-retroviral-packaging-cell-lines

CC   Group: Retrovirus packaging cell line.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA].

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0063 ! HEK293T

SX   Female

CA   Transformed cell line

//

ID   PLB-985

AC   CVCL_2162

SY   PLB 985; PLB985

DR   BTO; BTO:0002908

DR   CLO; CLO_0008457

DR   EFO; EFO_0002313

DR   CLDB; cl3912

DR   BioSample; SAMN03151776

DR   Cosmic; 787475

DR   Cosmic; 1089520

DR   DSMZ; ACC-139

DR   IGRhCellID; PLB985

RX   PubMed=3475136;

RX   PubMed=12592342;

RX   PubMed=20143388;

RX   PubMed=25984343;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-65.html

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a HL-60 derivative (PubMed=12592342, PubMed=20143388).

CC   Doubling time: 35 hours (PubMed=25984343); ~24 hours (DSMZ).

CC   Omics: shRNA library screening.

ST   Source(s): DSMZ

ST   Amelogenin: X

ST   CSF1PO: 13,14

ST   D13S317: 8,11

ST   D16S539: 11

ST   D5S818: 12

ST   D7S820: 11,12

ST   TH01: 7,8

ST   TPOX: 8,11

ST   vWA: 16

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0002 ! HL-60

SX   Female

CA   Cancer cell line

//

ID   PLC/AN/2

AC   CVCL_5A03

RX   PubMed=1694812;

DI   NCIt; C3099; Hepatocellular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PLC/PRF/5

AC   CVCL_0485

AS   CVCL_6714

SY   Alexander cells; PLC-PRF-5; PLC/PRF5; PLCPRF5; PLC8024; PLC-8024; PLC

DR   BTO; BTO:0003492

DR   BTO; BTO:0004274

DR   CLO; CLO_0008458

DR   CLO; CLO_0008459

DR   EFO; EFO_0006291

DR   MCCL; MCC:0000384

DR   CLDB; cl3914

DR   CLDB; cl3915

DR   CLDB; cl3916

DR   CLDB; cl5248

DR   ATCC; CRL-8024

DR   BCRC; 60223

DR   BCRJ; 0274

DR   BioSample; SAMN03471130

DR   BioSample; SAMN03473236

DR   CCLE; PLCPRF5_LIVER

DR   CCLE; ALEXANDERCELLS_LIVER

DR   CCRID; 3111C0002000000071

DR   CCRID; 3131C0001000700119

DR   CGH-DB; 9070-4

DR   ChEMBL-Cells; CHEMBL3308140

DR   ChEMBL-Targets; CHEMBL1075561

DR   CLS; 300315/p526_PLC-PRF-5

DR   Cosmic; 721061

DR   Cosmic; 808505

DR   Cosmic; 871514

DR   Cosmic; 873402

DR   Cosmic; 925349

DR   Cosmic; 945155

DR   Cosmic; 948065

DR   Cosmic; 1019318

DR   Cosmic; 1351513

DR   Cosmic; 1518224

DR   Cosmic; 2023861

DR   Cosmic; 2162538

DR   Cosmic; 2321033

DR   ECACC; 85061113

DR   GDSC; 925349

DR   GEO; GSM207051

DR   GEO; GSM565881

DR   GEO; GSM827153

DR   GEO; GSM886865

DR   GEO; GSM887520

DR   GEO; GSM887930

DR   GEO; GSM888602

DR   GEO; GSM936773

DR   IFO; IFO50069

DR   IZSLER; BS TCL 122

DR   JCRB; JCRB0406

DR   KCB; KCB 200785YJ

DR   KCLB; 28024

DR   NCBI_Iran; C145

DR   TKG; TKG 0376

DR   TOKU-E; 2898

RX   PubMed=63998;

RX   PubMed=184551;

RX   PubMed=187208;

RX   PubMed=1661347;

RX   PubMed=2992761;

RX   PubMed=2992762;

RX   PubMed=2439335;

RX   PubMed=6268737;

RX   PubMed=6555060;

RX   PubMed=6225510;

RX   PubMed=8050184;

RX   PubMed=9290701;

RX   PubMed=12029633;

RX   PubMed=15767549;

RX   PubMed=20069059;

RX   PubMed=22460905;

RX   PubMed=23505090;

RX   PubMed=23887712;

RX   PubMed=25485619;

RX   PubMed=25574106;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: JFCR45 cancer cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Characteristics: Contains at least 7 copies of integrated HBV genomes.

CC   Characteristics: Secretes hepatitis virus B surface antigen (HBsAg).

CC   Characteristics: Has lost chromosome Y.

CC   Doubling time: 35-40 hours (PubMed=63998).

CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).

CC   Omics: Deep RNAseq analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: Secretome proteome analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Caution: Often called PLC8024 in Chinese literature probably because of a concatenation between PLC/PRF/5 and ATCC-8024.

CC   Misspelling: 'PCL/PRF/5' in Cosmic 873402.

ST   Source(s): ATCC; CLS; ECACC; JCRB; KCLB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 11,12

ST   D16S539: 13

ST   D18S51: 17

ST   D21S11: 30,33.2

ST   D3S1358: 15

ST   D5S818: 12

ST   D7S820: 9,11 (ATCC; ECACC; JCRB; KCLB; PubMed=25877200)

ST   D7S820: 9 (CLS)

ST   D8S1179: 13,16

ST   FGA: 25 (CLS)

ST   FGA: 19.2,25 (KCLB; PubMed=25877200)

ST   Penta D: 6,10

ST   Penta E: 10,16

ST   TH01: 8 (ATCC)

ST   TH01: 7,8 (CLS; ECACC; JCRB; KCLB; PubMed=25877200)

ST   TPOX: 8

ST   vWA: 15,16

DI   NCIt; C3099; Hepatocellular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PLH

AC   CVCL_E810

DR   dbMHC; 49004

DR   ECACC; 88052047

DR   IHW; IHW9047

DR   IMGT/HLA; 11258

DR   PRIDE; PXD001205

RX   PubMed=8307784;

RX   PubMed=25502872;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl47.html

CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: HLA class II peptidome analysis by proteomics.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   PLHC-1

AC   CVCL_3466

SY   Poeciliopsis Lucida Hepatocellular Carcinoma-1; PLHC-1/wt; PLHC1

DR   BTO; BTO:0002331

DR   CLO; CLO_0008460

DR   ATCC; CRL-2406

RX   PubMed=9734273;

RX   PubMed=22281180;

CC   Group: Fish cell line.

OX   NCBI_TaxID=56613; ! Poeciliopsis lucida

SX   Female

CA   Cancer cell line

//

ID   PLHC-1/dox

AC   CVCL_S585

DR   BTO; BTO:0005429

RX   PubMed=18950875;

CC   Group: Fish cell line.

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

OX   NCBI_TaxID=56613; ! Poeciliopsis lucida

HI   CVCL_3466 ! PLHC-1

SX   Female

CA   Cancer cell line

//

ID   PLJ-4.7

AC   CVCL_0486

SY   PLJ-47; CFPAC-PLJ-4.7; PLJ-CFTR-4.7

DR   MCCL; MCC:0000385

CC   Transfected with: HGNC; 1884; CFTR.

CC   Derived from metastatic site: Liver.

DI   NCIt; C2975; Cystic fibrosis

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1119 ! CFPAC-1

SX   Male

CA   Cancer cell line

//

ID   PLS-1

AC   CVCL_4U94

SY   PLS1

RX   PubMed=20419128;

DI   NCIt; C8795; Recurrent undifferentiated pleomorphic sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PLS10

AC   CVCL_Z945

SY   PLS-10

RX   PubMed=9045956;

CC   Breed/subspecies: Fischer 344.

DI   NCIt; C64013; Adenocarcinoma of the rat prostate

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Cancer cell line

//

ID   PLS20

AC   CVCL_Z946

SY   PLS-20

RX   PubMed=9045956;

CC   Breed/subspecies: Fischer 344.

DI   NCIt; C64013; Adenocarcinoma of the rat prostate

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Cancer cell line

//

ID   PLS30

AC   CVCL_Z947

SY   PLS-30

RX   PubMed=9045956;

CC   Breed/subspecies: Fischer 344.

DI   NCIt; C64013; Adenocarcinoma of the rat prostate

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Cancer cell line

//

ID   PLT-2

AC   CVCL_L208

RX   PubMed=14712486;

DI   NCIt; C4664; T-cell large granular lymphocyte leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2127 ! MOTN-1

SX   Female

CA   Cancer cell line

//

ID   PLum-AD

AC   CVCL_AV66

SY   Prostate Luminal-Androgen Dependent

RX   PubMed=27036046;

CC   Breed/subspecies: Rosa26-Cre(ER)Pten(fl/fl)P53(fl/fl).

DI   NCIt; C21732; Carcinoma of the mouse prostate gland

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Cancer cell line

//

ID   PLum-AI

AC   CVCL_AV67

SY   Prostate Luminal-Androgen Independent

RX   PubMed=27036046;

CC   Breed/subspecies: Rosa26-Cre(ER)Pten(fl/fl)P53(fl/fl).

DI   NCIt; C21732; Carcinoma of the mouse prostate gland

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Cancer cell line

//

ID   PLum-C

AC   CVCL_AV68

SY   Prostate Luminal-Clone

RX   PubMed=22022528;

CC   Breed/subspecies: Rosa26-Cre(ER)Pten(fl/fl)P53(fl/fl).

DI   NCIt; C21732; Carcinoma of the mouse prostate gland

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Cancer cell line

//

ID   PluriStem 129S6

AC   CVCL_C319

SY   PluriStem 129/S6; 129S6

DR   BTO; BTO:0004750

DR   Millipore; SCR012

CC   Breed/subspecies: 129S6/SvEv.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   PluriStem BALB/C

AC   CVCL_E924

DR   Millipore; SCC052

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   PluriStem C3H/HeN

AC   CVCL_E925

DR   Millipore; SCC055

CC   Breed/subspecies: C3H/HeN.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   PluriStem C57BL/6N

AC   CVCL_E926

DR   Millipore; SCC050

CC   Breed/subspecies: C57BL/6N.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   PluriStem DBA/2N

AC   CVCL_E927

DR   Millipore; SCC054

CC   Breed/subspecies: DBA/2N.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   PluriStem FVB/N

AC   CVCL_E928

DR   Millipore; SCC053

CC   Breed/subspecies: FVB/N.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   PluriStem NOD

AC   CVCL_GS43

DR   Millipore; SCC051

CC   Discontinued: Millipore; SCC051; true.

CC   Breed/subspecies: NOD.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Embryonic stem cell

//

ID   PlyI

AC   CVCL_H636

RX   PubMed=2917127;

RX   PubMed=15356658;

DI   NCIt; C3720; Anaplastic large cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PM-WK

AC   CVCL_A665

SY   PMWK

DR   ATCC; CRL-2624

DR   Cosmic; 1054843

DR   Cosmic; 1507621

DR   Cosmic; 2233665

RX   PubMed=1867326;

RX   PubMed=7680081;

RX   PubMed=17308088;

CC   Discontinued: ATCC; CRL-2624; true.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 9

ST   D13S317: 8

ST   D16S539: 11

ST   D5S818: 12

ST   D7S820: 9,12

ST   TH01: 7

ST   TPOX: 7

ST   vWA: 17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PM0001

AC   CVCL_8Y28

DR   ECACC; 01020501

CC   Part of: ECACC chromosomal abnormality collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   PM1

AC   CVCL_9472

DR   NIH-ARP; 3038-439

RX   PubMed=7745720;

DI   NCIt; C9265; Mycosis fungoides and Sezary syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0337 ! HuT 78

SX   Male

CA   Cancer cell line

//

ID   PMC2

AC   CVCL_3773

SY   PMC-2

DR   CLO; CLO_0008469

DR   ATCC; CRL-9852

DR   BioSample; SAMN03471077

RX   Patent=US5447861;

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 12,14

ST   D16S539: 12,13

ST   D5S818: 11,12

ST   D7S820: 10,11

ST   TH01: 6,7

ST   TPOX: 8

ST   vWA: 18,19

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   PMC42

AC   CVCL_5215

SY   PMC42ET; PMC42-ET

DR   GEO; GSM217595

RX   PubMed=2228321;

RX   PubMed=6381852;

RX   PubMed=6572752;

RX   PubMed=6606728;

RX   PubMed=11044355;

RX   PubMed=11161701;

WW   http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/pmc42.htm

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PMC42-LA

AC   CVCL_5216

SY   PMC42LA

RX   PubMed=12649344;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5215 ! PMC42

SX   Female

CA   Cancer cell line

//

ID   PMD1-15

AC   CVCL_Y529

DR   SKIP; SKIP000516

RX   PubMed=24936452;

DI   NCIt; C75487; Pelizaeus-Merzbacher disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y531 ! PMD1-7

OI   CVCL_Y530 ! PMD1-27

SX   Male

CA   Induced pluripotent stem cell

//

ID   PMD1-27

AC   CVCL_Y530

DR   SKIP; SKIP000517

RX   PubMed=24936452;

DI   NCIt; C75487; Pelizaeus-Merzbacher disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y531 ! PMD1-7

OI   CVCL_Y529 ! PMD1-15

SX   Male

CA   Induced pluripotent stem cell

//

ID   PMD1-7

AC   CVCL_Y531

DR   SKIP; SKIP000515

RX   PubMed=24936452;

DI   NCIt; C75487; Pelizaeus-Merzbacher disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y529 ! PMD1-15

OI   CVCL_Y530 ! PMD1-27

SX   Male

CA   Induced pluripotent stem cell

//

ID   PMD2-10

AC   CVCL_Y532

DR   SKIP; SKIP000519

RX   PubMed=24936452;

DI   NCIt; C75487; Pelizaeus-Merzbacher disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y534 ! PMD2-6

OI   CVCL_Y533 ! PMD2-22

SX   Male

CA   Induced pluripotent stem cell

//

ID   PMD2-22

AC   CVCL_Y533

DR   SKIP; SKIP000520

RX   PubMed=24936452;

DI   NCIt; C75487; Pelizaeus-Merzbacher disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y534 ! PMD2-6

OI   CVCL_Y532 ! PMD2-10

SX   Male

CA   Induced pluripotent stem cell

//

ID   PMD2-6

AC   CVCL_Y534

DR   SKIP; SKIP000518

RX   PubMed=24936452;

DI   NCIt; C75487; Pelizaeus-Merzbacher disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y532 ! PMD2-10

OI   CVCL_Y533 ! PMD2-22

SX   Male

CA   Induced pluripotent stem cell

//

ID   PMD4-11

AC   CVCL_T965

SY   PMD 4-11

DR   RCB; HPS0090

DI   NCIt; C75487; Pelizaeus-Merzbacher disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y935 ! PMD4-14

OI   CVCL_Y936 ! PMD4-16

SX   Male

CA   Induced pluripotent stem cell

//

ID   PMD4-14

AC   CVCL_Y935

SY   PMD 4-14

DR   RCB; HPS0091

DI   NCIt; C75487; Pelizaeus-Merzbacher disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T965 ! PMD4-11

OI   CVCL_Y936 ! PMD4-16

SX   Male

CA   Induced pluripotent stem cell

//

ID   PMD4-16

AC   CVCL_Y936

SY   PMD 4-16

DR   RCB; HPS0092

DI   NCIt; C75487; Pelizaeus-Merzbacher disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T965 ! PMD4-11

OI   CVCL_Y935 ! PMD4-14

SX   Male

CA   Induced pluripotent stem cell

//

ID   PMDC05

AC   CVCL_5G47

RX   PubMed=19443030;

RX   PubMed=25075025;

WW   http://www.clg.niigata-u.ac.jp/~matak/eng/resmat12.pdf

DI   NCIt; C7203; Blastic plasmacytoid dendritic cell neoplasm

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PME1

AC   CVCL_IU82

DR   Cosmic; 2559135

RX   PubMed=25653542;

CC   Doubling time: ~22 hours (PubMed=25653542).

DI   NCIt; C9351; Pleural mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   PMF No.1

AC   CVCL_0H64

RX   PubMed=24859480;

DI   NCIt; C2862; Primary myelofibrosis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0H65 ! PMF No.2

OI   CVCL_0H66 ! PMF No.4

OI   CVCL_0H67 ! PMF No.5

OI   CVCL_0H68 ! PMF No.7

OI   CVCL_0H69 ! PMF No.11

SX   Female

CA   Induced pluripotent stem cell

//

ID   PMF No.11

AC   CVCL_0H69

RX   PubMed=24859480;

DI   NCIt; C2862; Primary myelofibrosis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0H64 ! PMF No.1

OI   CVCL_0H65 ! PMF No.2

OI   CVCL_0H66 ! PMF No.4

OI   CVCL_0H67 ! PMF No.5

OI   CVCL_0H68 ! PMF No.7

SX   Female

CA   Induced pluripotent stem cell

//

ID   PMF No.2

AC   CVCL_0H65

DR   SKIP; SKIP000563

RX   PubMed=24859480;

DI   NCIt; C2862; Primary myelofibrosis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0H64 ! PMF No.1

OI   CVCL_0H66 ! PMF No.4

OI   CVCL_0H67 ! PMF No.5

OI   CVCL_0H68 ! PMF No.7

OI   CVCL_0H69 ! PMF No.11

SX   Female

CA   Induced pluripotent stem cell

//

ID   PMF No.4

AC   CVCL_0H66

RX   PubMed=24859480;

DI   NCIt; C2862; Primary myelofibrosis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0H64 ! PMF No.1

OI   CVCL_0H65 ! PMF No.2

OI   CVCL_0H67 ! PMF No.5

OI   CVCL_0H68 ! PMF No.7

OI   CVCL_0H69 ! PMF No.11

SX   Female

CA   Induced pluripotent stem cell

//

ID   PMF No.5

AC   CVCL_0H67

RX   PubMed=24859480;

DI   NCIt; C2862; Primary myelofibrosis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0H64 ! PMF No.1

OI   CVCL_0H65 ! PMF No.2

OI   CVCL_0H66 ! PMF No.4

OI   CVCL_0H68 ! PMF No.7

OI   CVCL_0H69 ! PMF No.11

SX   Female

CA   Induced pluripotent stem cell

//

ID   PMF No.7

AC   CVCL_0H68

DR   SKIP; SKIP000564

RX   PubMed=24859480;

DI   NCIt; C2862; Primary myelofibrosis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0H64 ! PMF No.1

OI   CVCL_0H65 ! PMF No.2

OI   CVCL_0H66 ! PMF No.4

OI   CVCL_0H67 ! PMF No.5

OI   CVCL_0H69 ! PMF No.11

SX   Female

CA   Induced pluripotent stem cell

//

ID   PMF-ko14

AC   CVCL_8747

AS   CVCL_H196

DR   CLO; CLO_0050629

DR   BioSample; SAMN03472136

DR   BioSample; SAMN03472887

DR   Cosmic; 1187313

DR   RCB; RCB1426

RX   PubMed=10853016;

CC   Misspelling: 'RMF-ko14' in Cosmic 1187313.

ST   Source(s): PubMed=25877200; RCB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 13,14,15

ST   D16S539: 11,12

ST   D18S51: 14

ST   D19S433: 11,14

ST   D21S11: 27,34.2

ST   D2S1338: 22,23

ST   D3S1358: 14,15

ST   D5S818: 11,16 (PubMed=25877200)

ST   D5S818: 11 (RCB)

ST   D7S820: 8,8.3 (PubMed=25877200)

ST   D7S820: 8 (RCB)

ST   D8S1179: 13

ST   FGA: 20,22

ST   Penta D: 12

ST   Penta E: 14,18,19

ST   TH01: 9.3,11 (PubMed=25877200)

ST   TH01: 9.3 (RCB)

ST   TPOX: 11,12

ST   vWA: 17 (PubMed=25877200)

ST   vWA: 17,18 (RCB)

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PMG075

AC   CVCL_E811

DR   dbMHC; 49005

DR   ECACC; 88052077

DR   IHW; IHW9078

DR   IMGT/HLA; 11646

WW   http://bioinformatics.hsanmartino.it/ecbr/cl78.html

CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   PMH161

AC   CVCL_E812

DR   dbMHC; 49006

DR   ECACC; 94062301

DR   IHW; IHW9351

DR   IMGT/HLA; 11261

WW   http://bioinformatics.hsanmartino.it/ecbr/cl351.html

CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   PMJ2-PC

AC   CVCL_5864

DR   CLO; CLO_0008470

DR   ATCC; CRL-2457

RX   PubMed=7683328;

CC   Transformant: Recombinant retrovirus J2.

CC   Breed/subspecies: C57BL/6J.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Transformed cell line

//

ID   PMJ2-R

AC   CVCL_5865

DR   CLO; CLO_0008471

DR   ATCC; CRL-2458

RX   PubMed=7683328;

WW   http://www.infarktforschung.de/macrophages_cell_lines.html

CC   Transformant: Recombinant retrovirus J2.

CC   Breed/subspecies: C57BL/6J.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Transformed cell line

//

ID   PMK

AC   CVCL_4275

SY   Primary Macaque Kidney

DR   CLO; CLO_0008472

DR   ECACC; 98020308

CC   Group: Non-human primate cell line.

CC   Discontinued: ECACC; 98020308; probable.

OX   NCBI_TaxID=9544; ! Macaca mulatta

CA   Finite cell line

//

ID   PMO

AC   CVCL_V647

SY   Penaeus Monodon Oka

DR   CCRID; 3142C0001000000547

RX   DOI=10.1016/0044-8486(95)01048-3;

RX   Patent=US6143547;

RX   PubMed=15994770;

CC   Group: Fish cell line.

CC   Problematic cell line: Misidentified. Originally deposited as a shrimp (Penaeus mondodon) cell line, is in fact a Anguilla japonica cell line (PubMed=15994770).

CC   Registration: International Depositary Authority, China Center for Type Culture Collection (CCTCC); C200004.

OX   NCBI_TaxID=7937; ! Anguilla japonica

CA   Spontaneously immortalized cell line

//

ID   PNEC25

AC   CVCL_B068

RX   PubMed=15060276;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   PNEC28

AC   CVCL_B069

RX   PubMed=15060276;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   PNEC30

AC   CVCL_B070

DR   ATCC; CRL-2930

RX   PubMed=15060276;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   PNEC30-3

AC   CVCL_B071

RX   PubMed=15060276;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_B070 ! PNEC30

SX   Male

CA   Transformed cell line

//

ID   PNET

AC   CVCL_4431

SY   Primary Neural Ectodermal Tumor cell

CC   Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-1960 but was never distributed.

DI   NCIt; C3716; Primitive neuroectodermal tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PNET-2

AC   CVCL_4432

SY   PNET2

DR   BTO; BTO:0004011

DI   NCIt; C7542; Askin tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PNG-1

AC   CVCL_4J78

SY   Papua New Guinea-1; Hagahai cell line

DR   ATCC; CRL-10528

RX   CelloPub=CLPUB00264;

RX   Patent=US5397696;

WW   http://www.wipo.int/wipo_magazine/en/2006/05/article_0008.html

WW   http://www.culturalsurvival.org/publications/cultural-survival-quarterly/papua-new-guinea/national-institutes-health-and-papua-new-g

WW   http://www.nytimes.com/1995/11/27/business/patents-recent-patent-papua-new-guinea-tribe-s-cell-line-prompts-outrage-charges.html

CC   Characteristics: HTLV-1 producing cell line.

CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).

CC   Anecdotal: The patent concerning this cell line caused a highly-mediatic controversy. The cell line is derived from a member of the Hagahai people from New Guinea and it was deemed outrageous that a patent be deposited on biological material originating from an indigenous population without an explicit consent.

CC   Discontinued: ATCC; CRL-10528; probable.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   PNKT-3

AC   CVCL_T685

RX   PubMed=221384;

RX   PubMed=1087310;

CC   Group: Amphibian cell line.

OX   NCBI_TaxID=8404; ! Lithobates pipiens

OI   CVCL_T686 ! PRKT

CA   Cancer cell line

//

ID   PNKT-4

AC   CVCL_T687

SY   PNKT4

RX   PubMed=221384;

RX   PubMed=1087310;

CC   Group: Amphibian cell line.

CC   Caution: Could be identical to PNKT-4B (CVCL_T688).

OX   NCBI_TaxID=8404; ! Lithobates pipiens

OI   CVCL_T688 ! PNKT-4B

CA   Cancer cell line

//

ID   PNKT-4B

AC   CVCL_T688

SY   PNKT4B

RX   PubMed=221384;

RX   PubMed=2328547;

CC   Group: Amphibian cell line.

CC   Caution: Could be identical to PNKT-4 (CVCL_T687).

OX   NCBI_TaxID=8404; ! Lithobates pipiens

OI   CVCL_T687 ! PNKT-4

CA   Cancer cell line

//

ID   PNM-Mel

AC   CVCL_M744

CC   From: Guadagni F.; Istituto Regina Elena; Roma; Italy.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PNMR 120E

AC   CVCL_U057

SY   120E

DR   ECACC; 01080926

RX   PubMed=11461669;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   PNMR 160D

AC   CVCL_U058

SY   160D

DR   ECACC; 01080923

RX   PubMed=11461669;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   PNMR OE

AC   CVCL_U059

SY   OE

DR   ECACC; 01080925

RX   PubMed=11461669;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   Pno

AC   CVCL_1K10

RX   PubMed=10910922;

RX   PubMed=11564178;

RX   PubMed=14962098;

DI   NCIt; C9265; Mycosis fungoides and Sezary syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PNP-Mel

AC   CVCL_G320

SY   PNP Mel

DR   Cosmic; 1295330

CC   From: Guadagni F.; Istituto Regina Elena; Roma; Italy.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PNT1

AC   CVCL_4804

RX   PubMed=1714974;

RX   PubMed=8977636;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pMK16].

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   PNT1A

AC   CVCL_2163

SY   PNT1a; PNT-1A; PNT1-a; PNT1/A

DR   BTO; BTO:0003068

DR   CLO; CLO_0008475

DR   CLDB; cl3926

DR   ECACC; 07052901

DR   ECACC; 95012614

DR   GEO; GSM1374835

RX   PubMed=7558421;

RX   PubMed=11694337;

RX   PubMed=21556542;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pMK16].

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=11416159

ST   Amelogenin: X,Y

ST   D18S51: 16

ST   D21S11: 27,28

ST   D8S1179: 10,12

ST   FGA: 24

ST   TH01: 6

ST   vWA: 17,19

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4804 ! PNT1

SX   Male

CA   Transformed cell line

//

ID   PNT1B

AC   CVCL_W767

SY   PNT1b; PNT-1B

RX   PubMed=7558421;

RX   PubMed=11135431;

RX   PubMed=21556542;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pMK16].

ST   Source(s): PubMed=11416159

ST   Amelogenin: X,Y

ST   D18S51: 16

ST   D21S11: 27,28

ST   D8S1179: 10,12

ST   FGA: 24

ST   TH01: 6

ST   vWA: 17,19

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4804 ! PNT1

SX   Male

CA   Transformed cell line

//

ID   PNT2

AC   CVCL_2164

SY   PNT 2; PNT-2

DR   BTO; BTO:0002399

DR   CLO; CLO_0008476

DR   CLDB; cl3927

DR   ECACC; 07042701

DR   ECACC; 95012613

RX   PubMed=11135431;

RX   PubMed=21556542;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

ST   Source(s): ECACC; PubMed=11416159

ST   Amelogenin: X,Y

ST   CSF1PO: 11,13

ST   D13S317: 8,13

ST   D16S539: 9

ST   D18S51: 16,17

ST   D21S11: 29,33.2

ST   D5S818: 12,13

ST   D7S820: 11

ST   D8S1179: 13,14

ST   FGA: 22,24

ST   TH01: 6,9.3

ST   TPOX: 8,9

ST   vWA: 17

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   PNT2-C2

AC   CVCL_4889

SY   PNT2C2

DR   BTO; BTO:0003539

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2164 ! PNT2

SX   Male

CA   Transformed cell line

//

ID   PNT2-LSD

AC   CVCL_W768

SY   PNT2-Less Serum Dependent

RX   PubMed=21556542;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2164 ! PNT2

SX   Male

CA   Transformed cell line

//

ID   PNUH-12

AC   CVCL_S889

RX   CelloPub=CLPUB00003;

RX   PubMed=17923759;

CC   Doubling time: 48 hours (CelloPub=CLPUB00003).

DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PNV35B

AC   CVCL_U068

DR   ECACC; 01080924

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Hybridoma

//

ID   PO

AC   CVCL_N593

DR   CCLV; CCLV-RIE 0017

RX   PubMed=19941903;

OX   NCBI_TaxID=9940; ! Ovis aries

CA   Spontaneously immortalized cell line

//

ID   Po Co

AC   CVCL_U690

SY   XP11BE

DR   ATCC; CRL-1199

CC   Discontinued: ATCC; CRL-1199; probable.

DI   NCIt; C3966; Xeroderma pigmentosum, complementation group B

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_L460 ! GM02252

SX   Female

CA   Finite cell line

//

ID   PO-2

AC   CVCL_9498

DR   CLO; CLO_0008477

DR   CLDB; cl3928

OX   NCBI_TaxID=9940; ! Ovis aries

CA   Undefined cell line type

//

ID   PO714

AC   CVCL_9279

DR   CCLV; CCLV-RIE 0714

RX   PubMed=15381362;

OX   NCBI_TaxID=9940; ! Ovis aries

HI   CVCL_N593 ! PO

CA   Spontaneously immortalized cell line

//

ID   POBC

AC   CVCL_6E00

SY   Paralichthys Olivaceus Brain Cell line

RX   PubMed=25974130;

CC   Group: Fish cell line.

OX   NCBI_TaxID=8255; ! Paralichthys olivaceus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   POC

AC   CVCL_0B89

RX   PubMed=3034934;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   POE

AC   CVCL_EJ01

DR   Cosmic; 2250466

RX   PubMed=25223734;

CC   From: Delattre O.; Institut Curie; Paris; France.

DI   NCIt; C4817; Ewing sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   POE9n

AC   CVCL_L237

RX   PubMed=10648628;

RX   PubMed=22546478;

WW   http://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf

DI   NCIt; C129863; Oral dysplasia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   POE9n/TERT

AC   CVCL_L238

SY   POE9n Tert; POE9n TERT

DR   GEO; GSM1431129

RX   PubMed=10648628;

RX   PubMed=25169794;

WW   http://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf

CC   Transfected with: HGNC; 11730; TERT.

CC   Omics: CNV analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C129863; Oral dysplasia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_L237 ! POE9n

SX   Male

CA   Telomerase immortalized cell line

//

ID   POG-1382.2

AC   CVCL_9513

RX   DOI=10.1007/0-306-46872-7_2;

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   POG-1643

AC   CVCL_9514

RX   DOI=10.1007/0-306-46872-7_2;

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   POG-1691

AC   CVCL_9515

RX   DOI=10.1007/0-306-46872-7_2;

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   POG-1771

AC   CVCL_9516

RX   DOI=10.1007/0-306-46872-7_2;

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   POGRS-1

AC   CVCL_7111

AS   CVCL_6710

SY   PO-GRS1; P0-GRS1; POGRS1

DR   BTO; BTO:0002287

RX   PubMed=2170421;

RX   PubMed=2171916;

RX   PubMed=8961254;

RX   PubMed=15541573;

CC   Transfected with: HGNC; 5173; HRAS (with V-12).

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Female

CA   Transformed cell line

//

ID   POGS-5

AC   CVCL_7112

SY   PO-GS5; POGS5

DR   BTO; BTO:0002286

RX   PubMed=2171916;

RX   PubMed=8961254;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Female

CA   Transformed cell line

//

ID   POLH KO

AC   CVCL_J376

DR   JCRB; JCRB1477

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 13

ST   D13S317: 9,13

ST   D16S539: 9,11

ST   D5S818: 11,13

ST   D7S820: 8,12

ST   TH01: 8,9

ST   TPOX: 8,10

ST   vWA: 15,17

DI   NCIt; C8644; B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_M247 ! POLH KO MSH-

OI   CVCL_4W71 ! POLK F171A MSH-

OI   CVCL_4W72 ! POLK KO hetero MSH-

OI   CVCL_4W73 ! POLK KO homo MSH-

OI   CVCL_M248 ! POLZ KO

OI   CVCL_M249 ! POLZ KO MSH

OI   CVCL_M250 ! POLZ L2618M

SX   Male

CA   Cancer cell line

//

ID   POLH KO MSH-

AC   CVCL_M247

DR   JCRB; JCRB1482

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 14

ST   D13S317: 9,13

ST   D16S539: 9,11

ST   D5S818: 11,13

ST   D7S820: 8,12

ST   TH01: 8,9

ST   TPOX: 8,10

ST   vWA: 15,16

DI   NCIt; C8644; B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_J376 ! POLH KO

OI   CVCL_4W71 ! POLK F171A MSH-

OI   CVCL_4W72 ! POLK KO hetero MSH-

OI   CVCL_4W73 ! POLK KO homo MSH-

OI   CVCL_M248 ! POLZ KO

OI   CVCL_M249 ! POLZ KO MSH

OI   CVCL_M250 ! POLZ L2618M

SX   Male

CA   Cancer cell line

//

ID   POLK F171A MSH-

AC   CVCL_4W71

DR   JCRB; JCRB1517

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 14

ST   D13S317: 9,13

ST   D16S539: 10,11

ST   D5S818: 11,12

ST   D7S820: 8,12

ST   TH01: 8,9

ST   TPOX: 8,10

ST   vWA: 15,16

DI   NCIt; C8644; B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_J376 ! POLH KO

OI   CVCL_M247 ! POLH KO MSH-

OI   CVCL_4W72 ! POLK KO hetero MSH-

OI   CVCL_4W73 ! POLK KO homo MSH-

OI   CVCL_M248 ! POLZ KO

OI   CVCL_M249 ! POLZ KO MSH

OI   CVCL_M250 ! POLZ L2618M

SX   Male

CA   Cancer cell line

//

ID   POLK KO hetero MSH-

AC   CVCL_4W72

DR   JCRB; JCRB1518

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 14

ST   D13S317: 9,13

ST   D16S539: 10,11

ST   D5S818: 11,12

ST   D7S820: 8,12

ST   TH01: 8,9

ST   TPOX: 8,10

ST   vWA: 16

DI   NCIt; C8644; B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_J376 ! POLH KO

OI   CVCL_M247 ! POLH KO MSH-

OI   CVCL_4W71 ! POLK F171A MSH-

OI   CVCL_4W73 ! POLK KO homo MSH-

OI   CVCL_M248 ! POLZ KO

OI   CVCL_M249 ! POLZ KO MSH

OI   CVCL_M250 ! POLZ L2618M

SX   Male

CA   Cancer cell line

//

ID   POLK KO homo MSH-

AC   CVCL_4W73

DR   JCRB; JCRB1514

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 14

ST   D13S317: 9,13

ST   D16S539: 10,11

ST   D5S818: 11,12

ST   D7S820: 8,12

ST   TH01: 8,9

ST   TPOX: 8,10

ST   vWA: 15,16

DI   NCIt; C8644; B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_J376 ! POLH KO

OI   CVCL_M247 ! POLH KO MSH-

OI   CVCL_4W71 ! POLK F171A MSH-

OI   CVCL_4W72 ! POLK KO hetero MSH-

OI   CVCL_M248 ! POLZ KO

OI   CVCL_M249 ! POLZ KO MSH

OI   CVCL_M250 ! POLZ L2618M

SX   Male

CA   Cancer cell line

//

ID   POLZ KO

AC   CVCL_M248

DR   JCRB; JCRB1488

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 14

ST   D13S317: 9,13

ST   D16S539: 9,11

ST   D5S818: 11,13

ST   D7S820: 8,12

ST   TH01: 8,9

ST   TPOX: 8,10

ST   vWA: 15,16

DI   NCIt; C8644; B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_J376 ! POLH KO

OI   CVCL_M247 ! POLH KO MSH-

OI   CVCL_4W71 ! POLK F171A MSH-

OI   CVCL_4W72 ! POLK KO hetero MSH-

OI   CVCL_4W73 ! POLK KO homo MSH-

OI   CVCL_M249 ! POLZ KO MSH

OI   CVCL_M250 ! POLZ L2618M

SX   Male

CA   Cancer cell line

//

ID   POLZ KO MSH

AC   CVCL_M249

DR   JCRB; JCRB1494

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 14

ST   D13S317: 9,13

ST   D16S539: 9,11

ST   D5S818: 11,13

ST   D7S820: 8,12

ST   TH01: 8,9

ST   TPOX: 8,10

ST   vWA: 15,16

DI   NCIt; C8644; B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_J376 ! POLH KO

OI   CVCL_M247 ! POLH KO MSH-

OI   CVCL_4W71 ! POLK F171A MSH-

OI   CVCL_4W72 ! POLK KO hetero MSH-

OI   CVCL_4W73 ! POLK KO homo MSH-

OI   CVCL_M248 ! POLZ KO

OI   CVCL_M250 ! POLZ L2618M

SX   Male

CA   Cancer cell line

//

ID   POLZ L2618M

AC   CVCL_M250

DR   JCRB; JCRB1490

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 14

ST   D13S317: 9,13

ST   D16S539: 9,11

ST   D5S818: 11,13

ST   D7S820: 8,12

ST   TH01: 8,9

ST   TPOX: 8,10

ST   vWA: 15,16

DI   NCIt; C8644; B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_J376 ! POLH KO

OI   CVCL_M247 ! POLH KO MSH-

OI   CVCL_4W71 ! POLK F171A MSH-

OI   CVCL_4W72 ! POLK KO hetero MSH-

OI   CVCL_4W73 ! POLK KO homo MSH-

OI   CVCL_M248 ! POLZ KO

OI   CVCL_M249 ! POLZ KO MSH

SX   Male

CA   Cancer cell line

//

ID   Pom2

AC   CVCL_6C24

SY   PoM2

RX   DOI=10.3390/foods1010040;

RX   PubMed=20444515;

OX   NCBI_TaxID=9823; ! Sus scrofa

CA   Finite cell line

//

ID   PomD-iPSC A10

AC   CVCL_IM67

DR   GEO; GSM674579

RX   PubMed=21926084;

CC   Characteristics: Homozygous for the GAA p.Asp645Glu mutation.

CC   Omics: Transcriptome analysis.

DI   NCIt; C84734; Glycogen storage disease type II

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IM68 ! PomD-iPSC A17

OI   CVCL_IM69 ! PomD-iPSC A25

CA   Induced pluripotent stem cell

//

ID   PomD-iPSC A17

AC   CVCL_IM68

DR   GEO; GSM674580

RX   PubMed=21926084;

CC   Characteristics: Homozygous for the GAA p.Asp645Glu mutation.

CC   Omics: Transcriptome analysis.

DI   NCIt; C84734; Glycogen storage disease type II

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IM67 ! PomD-iPSC A10

OI   CVCL_IM69 ! PomD-iPSC A25

CA   Induced pluripotent stem cell

//

ID   PomD-iPSC A25

AC   CVCL_IM69

DR   GEO; GSM674582

RX   PubMed=21926084;

CC   Characteristics: Homozygous for the GAA p.Asp645Glu mutation.

DI   NCIt; C84734; Glycogen storage disease type II

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IM67 ! PomD-iPSC A10

OI   CVCL_IM68 ! PomD-iPSC A17

CA   Induced pluripotent stem cell

//

ID   PomD-iPSC B03

AC   CVCL_IM70

DR   GEO; GSM674581

RX   PubMed=21926084;

CC   Omics: Transcriptome analysis.

DI   NCIt; C84734; Glycogen storage disease type II

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Induced pluripotent stem cell

//

ID   Porco Clawn iPSC

AC   CVCL_5G27

RX   PubMed=22889279;

RX   PubMed=23913699;

CC   Breed/subspecies: Clawn miniature.

OX   NCBI_TaxID=9823; ! Sus scrofa

CA   Induced pluripotent stem cell

//

ID   Porco Rosso-4 iPSC

AC   CVCL_5G28

RX   PubMed=22889279;

RX   PubMed=23913699;

CC   Breed/subspecies: [(Landrace x Large white) x Duroc] humanized Kusabira-Orange transgenic.

OX   NCBI_TaxID=9823; ! Sus scrofa

SX   Female

CA   Induced pluripotent stem cell

//

ID   Porco Rosso-6 iPSC

AC   CVCL_5G29

RX   PubMed=22889279;

RX   PubMed=23913699;

CC   Breed/subspecies: [(Landrace x Large white) x Duroc] humanized Kusabira-Orange transgenic.

OX   NCBI_TaxID=9823; ! Sus scrofa

SX   Female

CA   Induced pluripotent stem cell

//

ID   Porco Rosso-622-14 iPSC

AC   CVCL_5G30

RX   PubMed=23913699;

CC   Breed/subspecies: [(Landrace x Large white) x Duroc] humanized Kusabira-Orange transgenic.

OX   NCBI_TaxID=9823; ! Sus scrofa

CA   Induced pluripotent stem cell

//

ID   Porthos

AC   CVCL_2695

SY   PORTHOS

DR   CLO; CLO_0008478

DR   CLDB; cl3929

DR   ECACC; 93122323

RX   PubMed=1726925;

RX   PubMed=8514246;

OX   NCBI_TaxID=9823; ! Sus scrofa

CA   Finite cell line

//

ID   POS [Dog osteosarcoma]

AC   CVCL_L413

DR   BTO; BTO:0005399

RX   PubMed=7696411;

CC   Breed/subspecies: Mixed breed.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   POS [Human B-cell]

AC   CVCL_F579

SY   TER253

DR   IMGT/HLA; 11273

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   POS-1

AC   CVCL_0J71

RX   PubMed=12406567;

CC   Breed/subspecies: C3H.

DI   NCIt; C24021; Mouse osteosarcoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   Potelligent CHOK1SV

AC   CVCL_DR96

WW   http://www.lonza.com/custom-manufacturing/development-technologies/potelligent-chok1sv-technology.aspx

CC   Knockout cell: Method=ZFN; UniProtKB; G3HCE4; Fut8.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_DR95 ! CHOK1SV

SX   Female

CA   Spontaneously immortalized cell line

//

ID   POVD

AC   CVCL_Y194

DR   Cosmic; 1434970

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PP-9

AC   CVCL_Z843

SY   PP9

DR   PRIDE; PXD002115

RX   PubMed=11126533;

RX   PubMed=23773405;

RX   PubMed=26307495;

CC   Group: Insect cell line.

CC   Omics: Deep proteome analysis.

OX   NCBI_TaxID=29031; ! Phlebotomus papatasi

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   PP1084

AC   CVCL_5J49

RX   PubMed=8344493;

CC   Characteristics: Has a TP53 p.Arg273Cys mutation.

DI   NCIt; C2912; Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PP109

AC   CVCL_C233

SY   pp109

RX   PubMed=19002021;

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PP117

AC   CVCL_C234

SY   pp117

RX   PubMed=19002021;

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PP161

AC   CVCL_C235

SY   pp161

RX   PubMed=19002021;

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PP78

AC   CVCL_C236

SY   pp78

RX   PubMed=19002021;

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PP984

AC   CVCL_F007

DR   Cosmic; 931132

RX   PubMed=2052620;

RX   PubMed=9473234;

CC   Characteristics: Has a TP53 p.Arg273Cys mutation.

DI   NCIt; C2912; Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PPA00322IN

AC   CVCL_E185

WW   http://www.biologia.uniba.it/primates/cell_lines.html

CC   Group: Non-human primate cell line.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9597; ! Pan paniscus

SX   Male

CA   Transformed cell line

//

ID   PPA00378IN

AC   CVCL_E186

WW   http://www.biologia.uniba.it/primates/cell_lines.html

CC   Group: Non-human primate cell line.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9597; ! Pan paniscus

SX   Sex undetermined

CA   Transformed cell line

//

ID   PPC-1

AC   CVCL_4778

SY   Primary Prostate Carcinoma-1; Specimen P-3

DR   BTO; BTO:0001062

DR   ATCC; HTB-190

DR   BioSample; SAMN03151895

DR   ChEMBL-Cells; CHEMBL3307780

DR   ChEMBL-Targets; CHEMBL1626502

DR   Cosmic; 948074

DR   GEO; GSM91929

RX   PubMed=2016798;

RX   PubMed=2583869;

RX   PubMed=8616865;

RX   PubMed=12725112;

RX   PubMed=15486987;

RX   PubMed=20143388;

WW   http://capcelllines.ca/details.asp?id=171

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a PC-3 derivative (PubMed=20143388).

CC   Omics: Array-based CGH.

CC   Omics: Transcriptome analysis.

CC   Discontinued: ATCC; HTB-190; true.

CC   Derived from metastatic site: Bone.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11

ST   D16S539: 11

ST   D5S818: 13

ST   D7S820: 8,11

ST   TH01: 6,7

ST   TPOX: 8,9

ST   vWA: 17

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0035 ! PC-3

SX   Male

CA   Cancer cell line

//

ID   PPIA-/- Jurkat

AC   CVCL_1H23

SY   Jurkat CypA -/-

DR   NIH-ARP; 10095-136

RX   PubMed=11250896;

CC   Knockout cell: Method=Homologous recombination; HGNC; 9253; PPIA.

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0065 ! Jurkat

SX   Male

CA   Cancer cell line

//

ID   PPM-Mill

AC   CVCL_E110

SY   PPM Mill; PPMMill; Mill

RX   PubMed=22893632;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   PPM-Phi

AC   CVCL_V417

SY   Phi

RX   PubMed=22552293;

RX   PubMed=22893632;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   pPS1

AC   CVCL_AD95

RX   PubMed=21979046;

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   PPY00327IN

AC   CVCL_E190

WW   http://www.biologia.uniba.it/primates/cell_lines.html

CC   Group: Non-human primate cell line.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9601; ! Pongo abelii

SX   Sex undetermined

CA   Transformed cell line

//

ID   PPY00328IN

AC   CVCL_E191

WW   http://www.biologia.uniba.it/primates/cell_lines.html

CC   Group: Non-human primate cell line.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9601; ! Pongo abelii

SX   Sex undetermined

CA   Transformed cell line

//

ID   PPY00329IN

AC   CVCL_E192

WW   http://www.biologia.uniba.it/primates/cell_lines.html

CC   Group: Non-human primate cell line.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9601; ! Pongo abelii

SX   Female

CA   Transformed cell line

//

ID   PPY00330IN

AC   CVCL_E193

WW   http://www.biologia.uniba.it/primates/cell_lines.html

CC   Group: Non-human primate cell line.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9600; ! Pongo pygmaeus

SX   Sex undetermined

CA   Transformed cell line

//

ID   PPY00331IN

AC   CVCL_E194

WW   http://www.biologia.uniba.it/primates/cell_lines.html

CC   Group: Non-human primate cell line.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9600; ! Pongo pygmaeus

SX   Sex undetermined

CA   Transformed cell line

//

ID   Pr-111

AC   CVCL_Z948

SY   Pr111

RX   PubMed=11896566;

RX   PubMed=12235003;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: FVB/N.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   Pr-117

AC   CVCL_Z949

SY   Pr117

RX   PubMed=11896566;

RX   PubMed=12235003;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: FVB/N.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   Pr-14

AC   CVCL_Z950

SY   Pr14

RX   PubMed=9428383;

RX   PubMed=12235003;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: FVB/N.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   Pr-14C1

AC   CVCL_Z951

SY   Pr14C1

RX   PubMed=12235003;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: FVB/N.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_Z950 ! Pr-14

SX   Male

CA   Transformed cell line

//

ID   Pr-14C2

AC   CVCL_Z952

SY   Pr14C2

RX   PubMed=12235003;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: FVB/N.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_Z950 ! Pr-14

SX   Male

CA   Transformed cell line

//

ID   Pr-E-HNU9

AC   CVCL_Z573

RX   CelloPub=CLPUB00177;

CC   Group: Insect cell line.

OX   NCBI_TaxID=64459; ! Pieris rapae

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   PR-GTL-16

AC   CVCL_7696

RX   PubMed=21208906;

CC   Selected for resistance to: ChEBI; CHEBI:90197; PHA-665752.

CC   Derived from metastatic site: Liver.

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_7668 ! GTL-16

SX   Female

CA   Cancer cell line

//

ID   PR-Mel

AC   CVCL_7113

SY   PRMel

DR   BTO; BTO:0003789

DR   Cosmic; 1088702

DR   Cosmic; 1109801

DR   Cosmic; 1295341

DR   GEO; GSM276750

RX   PubMed=11121133;

RX   PubMed=12696065;

RX   PubMed=18384130;

CC   Omics: Transcriptome analysis.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   PR00002

AC   CVCL_2V04

DR   CLO; CLO_0017726

DR   Coriell; PR00002

RX   PubMed=16214744;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9600; ! Pongo pygmaeus

OI   CVCL_1G38 ! AG05252

SX   Male

CA   Finite cell line

//

ID   PR00003

AC   CVCL_2V05

DR   CLO; CLO_0017710

DR   Coriell; PR00003

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9597; ! Pan paniscus

SX   Male

CA   Finite cell line

//

ID   PR00011

AC   CVCL_2V06

DR   CLO; CLO_0017712

DR   Coriell; PR00011

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9545; ! Macaca nemestrina

SX   Female

CA   Finite cell line

//

ID   PR00013

AC   CVCL_2V07

DR   CLO; CLO_0017711

DR   Coriell; PR00013

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Discontinued: Coriell; PR00013; probable.

OX   NCBI_TaxID=9541; ! Macaca fascicularis

SX   Male

CA   Finite cell line

//

ID   PR00017

AC   CVCL_2V08

DR   CLO; CLO_0017714

DR   Coriell; PR00017

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=90387; ! Macaca leonina

SX   Female

CA   Finite cell line

//

ID   PR00019

AC   CVCL_2V09

DR   CLO; CLO_0017713

DR   Coriell; PR00019

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Discontinued: Coriell; PR00019; probable.

OX   NCBI_TaxID=9541; ! Macaca fascicularis

SX   Male

CA   Finite cell line

//

ID   PR00020

AC   CVCL_2V10

DR   CLO; CLO_0017716

DR   Coriell; PR00020

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Discontinued: Coriell; PR00020; probable.

OX   NCBI_TaxID=9541; ! Macaca fascicularis

SX   Male

CA   Finite cell line

//

ID   PR00024

AC   CVCL_2V11

DR   CLO; CLO_0017715

DR   Coriell; PR00024

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9545; ! Macaca nemestrina

SX   Male

CA   Finite cell line

//

ID   PR00030

AC   CVCL_2V12

DR   CLO; CLO_0017718

DR   Coriell; PR00030

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9545; ! Macaca nemestrina

SX   Female

CA   Finite cell line

//

ID   PR00033

AC   CVCL_2V13

DR   CLO; CLO_0017717

DR   Coriell; PR00033

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9555; ! Papio anubis

SX   Male

CA   Finite cell line

//

ID   PR00036

AC   CVCL_2V14

DR   CLO; CLO_0017719

DR   Coriell; PR00036

RX   PubMed=16326750;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9555; ! Papio anubis

OI   CVCL_2V15 ! PR00037

SX   Male

CA   Finite cell line

//

ID   PR00037

AC   CVCL_2V15

DR   CLO; CLO_0017872

DR   Coriell; PR00037

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9555; ! Papio anubis

OI   CVCL_2V14 ! PR00036

SX   Male

CA   Finite cell line

//

ID   PR00039

AC   CVCL_2V16

DR   CLO; CLO_0017874

DR   Coriell; PR00039

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9555; ! Papio anubis

SX   Male

CA   Finite cell line

//

ID   PR00041

AC   CVCL_DN72

DR   Coriell; PR00041

RX   PubMed=16214744;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Discontinued: Coriell; PR00041; probable.

OX   NCBI_TaxID=9555; ! Papio anubis

SX   Male

CA   Finite cell line

//

ID   PR00042

AC   CVCL_2V17

DR   CLO; CLO_0017875

DR   Coriell; PR00042

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9555; ! Papio anubis

SX   Male

CA   Finite cell line

//

ID   PR00045

AC   CVCL_2V18

DR   CLO; CLO_0017878

DR   Coriell; PR00045

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9555; ! Papio anubis

SX   Male

CA   Finite cell line

//

ID   PR00048

AC   CVCL_2V19

DR   CLO; CLO_0017868

DR   Coriell; PR00048

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=30611; ! Otolemur garnettii

SX   Female

CA   Finite cell line

//

ID   PR00049

AC   CVCL_2V20

DR   CLO; CLO_0017869

DR   Coriell; PR00049

RX   PubMed=16326750;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=30611; ! Otolemur garnettii

SX   Male

CA   Finite cell line

//

ID   PR00050

AC   CVCL_2V21

DR   CLO; CLO_0017870

DR   Coriell; PR00050

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=554167; ! Varecia variegata rubra

SX   Male

CA   Finite cell line

//

ID   PR00051

AC   CVCL_2V22

DR   CLO; CLO_0017871

DR   Coriell; PR00051

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9597; ! Pan paniscus

SX   Female

CA   Finite cell line

//

ID   PR00052

AC   CVCL_2V23

DR   Coriell; PR00052

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Discontinued: Coriell; PR00052; probable.

OX   NCBI_TaxID=9598; ! Pan troglodytes

SX   Female

CA   Finite cell line

//

ID   PR00053

AC   CVCL_2V24

DR   CLO; CLO_0017863

DR   Coriell; PR00053

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla

SX   Male

CA   Finite cell line

//

ID   PR00054

AC   CVCL_2V25

DR   CLO; CLO_0017865

DR   Coriell; PR00054

RX   PubMed=16214744;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9601; ! Pongo abelii

OI   CVCL_DP06 ! PR01003

SX   Male

CA   Finite cell line

//

ID   PR00055

AC   CVCL_2V26

DR   CLO; CLO_0017848

DR   Coriell; PR00055

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla

SX   Female

CA   Finite cell line

//

ID   PR00058

AC   CVCL_2V27

DR   CLO; CLO_0017846

DR   Coriell; PR00058

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9545; ! Macaca nemestrina

SX   Female

CA   Finite cell line

//

ID   PR00062

AC   CVCL_2V28

DR   CLO; CLO_0017847

DR   Coriell; PR00062

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9545; ! Macaca nemestrina

SX   Female

CA   Finite cell line

//

ID   PR00075

AC   CVCL_2V29

DR   CLO; CLO_0017842

DR   Coriell; PR00075

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla

SX   Female

CA   Finite cell line

//

ID   PR00077

AC   CVCL_2V30

DR   CLO; CLO_0017845

DR   Coriell; PR00077

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9545; ! Macaca nemestrina

SX   Female

CA   Finite cell line

//

ID   PR00092

AC   CVCL_2V31

DR   CLO; CLO_0017840

DR   Coriell; PR00092

RX   PubMed=16214744;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9597; ! Pan paniscus

SX   Female

CA   Transformed cell line

//

ID   PR00095

AC   CVCL_2V32

DR   CLO; CLO_0017841

DR   Coriell; PR00095

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=132548; ! Colobus guereza kikuyuensis

SX   Female

CA   Finite cell line

//

ID   PR00096

AC   CVCL_2V33

DR   CLO; CLO_0017838

DR   Coriell; PR00096

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=132548; ! Colobus guereza kikuyuensis

SX   Male

CA   Finite cell line

//

ID   PR00099

AC   CVCL_2V34

DR   CLO; CLO_0017839

DR   Coriell; PR00099

RX   PubMed=16326750;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=336983; ! Colobus angolensis palliatus

SX   Male

CA   Finite cell line

//

ID   PR00100

AC   CVCL_2V35

DR   CLO; CLO_0017836

DR   Coriell; PR00100

RX   PubMed=16214744;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=54135; ! Allenopithecus nigroviridis

SX   Male

CA   Finite cell line

//

ID   PR00101

AC   CVCL_2V36

DR   CLO; CLO_0017939

DR   Coriell; PR00101

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla

SX   Female

CA   Finite cell line

//

ID   PR00103

AC   CVCL_2V37

DR   CLO; CLO_0017938

DR   Coriell; PR00103

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla

SX   Female

CA   Finite cell line

//

ID   PR00105

AC   CVCL_2V38

DR   CLO; CLO_0017927

DR   Coriell; PR00105

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla

SX   Male

CA   Finite cell line

//

ID   PR00107

AC   CVCL_2V39

DR   CLO; CLO_0017928

DR   Coriell; PR00107

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla

SX   Male

CA   Finite cell line

//

ID   PR00108

AC   CVCL_2V40

DR   CLO; CLO_0017929

DR   Coriell; PR00108

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=336983; ! Colobus angolensis palliatus

SX   Female

CA   Finite cell line

//

ID   PR00111

AC   CVCL_DN73

DR   Coriell; PR00111

RX   PubMed=16214744;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Discontinued: Coriell; PR00111; probable.

OX   NCBI_TaxID=9597; ! Pan paniscus

SX   Male

CA   Finite cell line

//

ID   PR00112

AC   CVCL_2V41

DR   CLO; CLO_0017931

DR   Coriell; PR00112

RX   PubMed=16214744;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9544; ! Macaca mulatta

SX   Male

CA   Finite cell line

//

ID   PR00115

AC   CVCL_2V42

DR   CLO; CLO_0017932

DR   Coriell; PR00115

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9598; ! Pan troglodytes

SX   Male

CA   Finite cell line

//

ID   PR00119

AC   CVCL_2V43

DR   CLO; CLO_0017933

DR   Coriell; PR00119

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9447; ! Lemur catta

SX   Male

CA   Finite cell line

//

ID   PR00120

AC   CVCL_2V44

DR   CLO; CLO_0017934

DR   Coriell; PR00120

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9447; ! Lemur catta

SX   Female

CA   Finite cell line

//

ID   PR00122

AC   CVCL_2V45

DR   CLO; CLO_0017935

DR   Coriell; PR00122

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9455; ! Varecia variegata

SX   Female

CA   Finite cell line

//

ID   PR00123

AC   CVCL_2V46

DR   CLO; CLO_0017908

DR   Coriell; PR00123

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9455; ! Varecia variegata

SX   Male

CA   Finite cell line

//

ID   PR00124

AC   CVCL_2V47

DR   CLO; CLO_0017907

DR   Coriell; PR00124

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=34828; ! Eulemur mongoz

SX   Female

CA   Finite cell line

//

ID   PR00126

AC   CVCL_2V48

DR   CLO; CLO_0017905

DR   Coriell; PR00126

RX   PubMed=16214744;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9447; ! Lemur catta

SX   Male

CA   Finite cell line

//

ID   PR00127

AC   CVCL_2V49

DR   CLO; CLO_0017899

DR   Coriell; PR00127

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=87288; ! Eulemur macaco flavifrons

SX   Female

CA   Finite cell line

//

ID   PR00128

AC   CVCL_2V50

DR   CLO; CLO_0017900

DR   Coriell; PR00128

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=87288; ! Eulemur macaco flavifrons

SX   Male

CA   Finite cell line

//

ID   PR00129

AC   CVCL_2V51

DR   CLO; CLO_0017897

DR   Coriell; PR00129

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=34829; ! Eulemur rubriventer

SX   Female

CA   Finite cell line

//

ID   PR00130

AC   CVCL_2V52

DR   CLO; CLO_0017898

DR   Coriell; PR00130

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=34829; ! Eulemur rubriventer

SX   Male

CA   Finite cell line

//

ID   PR00131

AC   CVCL_2V53

DR   CLO; CLO_0017902

DR   Coriell; PR00131

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=554167; ! Varecia variegata rubra

SX   Female

CA   Finite cell line

//

ID   PR00132

AC   CVCL_2V54

DR   CLO; CLO_0017903

DR   Coriell; PR00132

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=554167; ! Varecia variegata rubra

SX   Female

CA   Finite cell line

//

ID   PR00133

AC   CVCL_2V55

DR   CLO; CLO_0017901

DR   Coriell; PR00133

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9509; ! Ateles geoffroyi

SX   Female

CA   Finite cell line

//

ID   PR00134

AC   CVCL_DN74

DR   Coriell; PR00134

RX   PubMed=16214744;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Discontinued: Coriell; PR00134; probable.

OX   NCBI_TaxID=9509; ! Ateles geoffroyi

SX   Female

CA   Transformed cell line

//

ID   PR00174

AC   CVCL_2V56

DR   CLO; CLO_0018370

DR   Coriell; PR00174

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=554167; ! Varecia variegata rubra

SX   Male

CA   Finite cell line

//

ID   PR00175

AC   CVCL_2V57

DR   CLO; CLO_0018377

DR   Coriell; PR00175

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9598; ! Pan troglodytes

SX   Male

CA   Finite cell line

//

ID   PR00198

AC   CVCL_2V58

DR   CLO; CLO_0018378

DR   Coriell; PR00198

RX   PubMed=16214744;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=54135; ! Allenopithecus nigroviridis

SX   Female

CA   Finite cell line

//

ID   PR00219

AC   CVCL_2V59

DR   CLO; CLO_0018375

DR   Coriell; PR00219

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9447; ! Lemur catta

SX   Female

CA   Finite cell line

//

ID   PR00220

AC   CVCL_2V60

DR   CLO; CLO_0018376

DR   Coriell; PR00220

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9447; ! Lemur catta

SX   Female

CA   Finite cell line

//

ID   PR00221

AC   CVCL_2V61

DR   CLO; CLO_0018373

DR   Coriell; PR00221

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9447; ! Lemur catta

SX   Female

CA   Finite cell line

//

ID   PR00222

AC   CVCL_2V62

DR   CLO; CLO_0018374

DR   Coriell; PR00222

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9447; ! Lemur catta

SX   Male

CA   Finite cell line

//

ID   PR00223

AC   CVCL_2V63

DR   CLO; CLO_0018371

DR   Coriell; PR00223

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9447; ! Lemur catta

SX   Female

CA   Finite cell line

//

ID   PR00224

AC   CVCL_2V64

DR   CLO; CLO_0018372

DR   Coriell; PR00224

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9447; ! Lemur catta

SX   Female

CA   Finite cell line

//

ID   PR00226

AC   CVCL_2V65

DR   CLO; CLO_0018359

DR   Coriell; PR00226

RX   PubMed=16214744;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9598; ! Pan troglodytes

SX   Male

CA   Finite cell line

//

ID   PR00227

AC   CVCL_2V66

DR   CLO; CLO_0018360

DR   Coriell; PR00227

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=34825; ! Propithecus verreauxi

SX   Female

CA   Finite cell line

//

ID   PR00228

AC   CVCL_2V67

DR   CLO; CLO_0018361

DR   Coriell; PR00228

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=31869; ! Daubentonia madagascariensis

SX   Female

CA   Finite cell line

//

ID   PR00230

AC   CVCL_2V68

DR   CLO; CLO_0018366

DR   Coriell; PR00230

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla

SX   Female

CA   Finite cell line

//

ID   PR00232

AC   CVCL_2V69

DR   CLO; CLO_0018367

DR   Coriell; PR00232

RX   PubMed=16214744;

RX   PubMed=16326750;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9568; ! Mandrillus leucophaeus

SX   Male

CA   Finite cell line

//

ID   PR00235

AC   CVCL_2V70

DR   CLO; CLO_0018368

DR   Coriell; PR00235

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9597; ! Pan paniscus

SX   Female

CA   Finite cell line

//

ID   PR00236

AC   CVCL_2V71

DR   CLO; CLO_0018369

DR   Coriell; PR00236

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9597; ! Pan paniscus

SX   Male

CA   Finite cell line

//

ID   PR00237

AC   CVCL_2V72

DR   CLO; CLO_0018362

DR   Coriell; PR00237

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9597; ! Pan paniscus

SX   Male

CA   Finite cell line

//

ID   PR00238

AC   CVCL_2V73

DR   CLO; CLO_0018363

DR   Coriell; PR00238

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9598; ! Pan troglodytes

SX   Male

CA   Finite cell line

//

ID   PR00239

AC   CVCL_2V74

DR   CLO; CLO_0018364

DR   Coriell; PR00239

RX   PubMed=16326750;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=43777; ! Pithecia pithecia

SX   Male

CA   Finite cell line

//

ID   PR00240

AC   CVCL_2V75

DR   CLO; CLO_0018365

DR   Coriell; PR00240

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=132548; ! Colobus guereza kikuyuensis

SX   Male

CA   Finite cell line

//

ID   PR00241

AC   CVCL_2V76

DR   CLO; CLO_0018351

DR   Coriell; PR00241

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=132548; ! Colobus guereza kikuyuensis

SX   Female

CA   Finite cell line

//

ID   PR00242

AC   CVCL_2V77

DR   CLO; CLO_0018349

DR   Coriell; PR00242

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=132548; ! Colobus guereza kikuyuensis

SX   Male

CA   Finite cell line

//

ID   PR00243

AC   CVCL_2V78

DR   CLO; CLO_0018350

DR   Coriell; PR00243

RX   PubMed=21878684;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9589; ! Hylobates pileatus

SX   Female

CA   Transformed cell line

//

ID   PR00244

AC   CVCL_2V79

DR   CLO; CLO_0018354

DR   Coriell; PR00244

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=1215604; ! Eulemur albifrons

SX   Male

CA   Finite cell line

//

ID   PR00245

AC   CVCL_2V80

DR   CLO; CLO_0018355

DR   Coriell; PR00245

RX   PubMed=16326750;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=1215604; ! Eulemur albifrons

SX   Male

CA   Finite cell line

//

ID   PR00247

AC   CVCL_2V81

DR   CLO; CLO_0018352

DR   Coriell; PR00247

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=47178; ! Eulemur fulvus collaris

SX   Female

CA   Finite cell line

//

ID   PR00251

AC   CVCL_2V82

DR   CLO; CLO_0018353

DR   Coriell; PR00251

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9597; ! Pan paniscus

SX   Male

CA   Transformed cell line

//

ID   PR00253

AC   CVCL_2V83

DR   CLO; CLO_0018357

DR   Coriell; PR00253

RX   PubMed=16214744;

RX   PubMed=16326750;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9601; ! Pongo abelii

SX   Male

CA   Transformed cell line

//

ID   PR00254

AC   CVCL_2V84

DR   CLO; CLO_0018358

DR   Coriell; PR00254

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=30603; ! Eulemur macaco macaco

SX   Female

CA   Finite cell line

//

ID   PR00255

AC   CVCL_2V85

DR   CLO; CLO_0018356

DR   Coriell; PR00255

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=47178; ! Eulemur fulvus collaris

SX   Male

CA   Finite cell line

//

ID   PR00257

AC   CVCL_2V86

DR   CLO; CLO_0018339

DR   Coriell; PR00257

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=13557; ! Hapalemur griseus

SX   Male

CA   Finite cell line

//

ID   PR00258

AC   CVCL_2V87

DR   CLO; CLO_0018340

DR   Coriell; PR00258

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=13557; ! Hapalemur griseus

SX   Female

CA   Finite cell line

//

ID   PR00259

AC   CVCL_2V88

DR   CLO; CLO_0018341

DR   Coriell; PR00259

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=554167; ! Varecia variegata rubra

SX   Male

CA   Finite cell line

//

ID   PR00260

AC   CVCL_2V89

DR   CLO; CLO_0018342

DR   Coriell; PR00260

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=132548; ! Colobus guereza kikuyuensis

SX   Male

CA   Finite cell line

//

ID   PR00261

AC   CVCL_2V90

DR   CLO; CLO_0018343

DR   Coriell; PR00261

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=132548; ! Colobus guereza kikuyuensis

SX   Male

CA   Finite cell line

//

ID   PR00262

AC   CVCL_2V91

DR   CLO; CLO_0018344

DR   Coriell; PR00262

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=132548; ! Colobus guereza kikuyuensis

SX   Male

CA   Finite cell line

//

ID   PR00265

AC   CVCL_DN75

DR   Coriell; PR00265

RX   PubMed=16214744;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Discontinued: Coriell; PR00265; probable.

OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla

SX   Male

CA   Transformed cell line

//

ID   PR00266

AC   CVCL_2V92

DR   CLO; CLO_0018345

DR   Coriell; PR00266

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=30603; ! Eulemur macaco macaco

SX   Male

CA   Finite cell line

//

ID   PR00267

AC   CVCL_2V93

DR   CLO; CLO_0018346

DR   Coriell; PR00267

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=30603; ! Eulemur macaco macaco

SX   Male

CA   Finite cell line

//

ID   PR00268

AC   CVCL_2V94

DR   CLO; CLO_0018347

DR   Coriell; PR00268

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=30603; ! Eulemur macaco macaco

SX   Male

CA   Finite cell line

//

ID   PR00269

AC   CVCL_2V95

DR   CLO; CLO_0018348

DR   Coriell; PR00269

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=30603; ! Eulemur macaco macaco

SX   Male

CA   Finite cell line

//

ID   PR00270

AC   CVCL_2V96

DR   CLO; CLO_0018338

DR   Coriell; PR00270

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=30603; ! Eulemur macaco macaco

SX   Male

CA   Finite cell line

//

ID   PR00273

AC   CVCL_2V97

DR   CLO; CLO_0018337

DR   Coriell; PR00273

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=34829; ! Eulemur rubriventer

SX   Female

CA   Finite cell line

//

ID   PR00275

AC   CVCL_2V98

DR   Coriell; PR00275

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=30608; ! Microcebus murinus

SX   Female

CA   Finite cell line

//

ID   PR00276

AC   CVCL_DN76

DR   Coriell; PR00276

RX   PubMed=16214744;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Discontinued: Coriell; PR00276; probable.

OX   NCBI_TaxID=9600; ! Pongo pygmaeus

SX   Female

CA   Transformed cell line

//

ID   PR00279

AC   CVCL_2V99

DR   CLO; CLO_0018336

DR   Coriell; PR00279

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla

SX   Female

CA   Finite cell line

//

ID   PR00280

AC   CVCL_2W00

DR   CLO; CLO_0018335

DR   Coriell; PR00280

RX   PubMed=21878684;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla

SX   Male

CA   Finite cell line

//

ID   PR00281

AC   CVCL_2W01

DR   CLO; CLO_0018334

DR   Coriell; PR00281

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=34825; ! Propithecus verreauxi

SX   Male

CA   Finite cell line

//

ID   PR00282

AC   CVCL_2W02

DR   CLO; CLO_0018333

DR   Coriell; PR00282

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=34825; ! Propithecus verreauxi

SX   Female

CA   Finite cell line

//

ID   PR00283

AC   CVCL_DP26

DR   Coriell; PR00283

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Discontinued: Coriell; PR00283; probable.

OX   NCBI_TaxID=100224; ! Cercopithecus lhoesti

SX   Male

CA   Finite cell line

//

ID   PR00285

AC   CVCL_2W03

DR   CLO; CLO_0018332

DR   Coriell; PR00285

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=87288; ! Eulemur macaco flavifrons

SX   Female

CA   Finite cell line

//

ID   PR00288

AC   CVCL_2W04

DR   CLO; CLO_0018331

DR   Coriell; PR00288

RX   PubMed=16214744;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=34828; ! Eulemur mongoz

SX   Female

CA   Finite cell line

//

ID   PR00289

AC   CVCL_2W05

DR   CLO; CLO_0018330

DR   Coriell; PR00289

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=34828; ! Eulemur mongoz

SX   Female

CA   Finite cell line

//

ID   PR00290

AC   CVCL_2W06

DR   CLO; CLO_0018329

DR   Coriell; PR00290

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9455; ! Varecia variegata

SX   Female

CA   Finite cell line

//

ID   PR00291

AC   CVCL_2W07

DR   CLO; CLO_0018328

DR   Coriell; PR00291

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=554167; ! Varecia variegata rubra

SX   Female

CA   Finite cell line

//

ID   PR00292

AC   CVCL_2W08

DR   CLO; CLO_0018327

DR   Coriell; PR00292

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=554167; ! Varecia variegata rubra

SX   Female

CA   Finite cell line

//

ID   PR00293

AC   CVCL_2W09

DR   CLO; CLO_0018324

DR   Coriell; PR00293

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=554167; ! Varecia variegata rubra

SX   Female

CA   Finite cell line

//

ID   PR00294

AC   CVCL_2W10

DR   CLO; CLO_0018323

DR   Coriell; PR00294

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=554167; ! Varecia variegata rubra

SX   Female

CA   Finite cell line

//

ID   PR00295

AC   CVCL_2W11

DR   CLO; CLO_0018326

DR   Coriell; PR00295

RX   PubMed=16214744;

RX   PubMed=16326750;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9495; ! Callimico goeldii

SX   Female

CA   Finite cell line

//

ID   PR00296

AC   CVCL_2W12

DR   CLO; CLO_0018325

DR   Coriell; PR00296

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=336983; ! Colobus angolensis palliatus

SX   Male

CA   Finite cell line

//

ID   PR00301

AC   CVCL_2W13

DR   CLO; CLO_0018320

DR   Coriell; PR00301

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla

SX   Male

CA   Finite cell line

//

ID   PR00302

AC   CVCL_2W14

DR   CLO; CLO_0018319

DR   Coriell; PR00302

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=34825; ! Propithecus verreauxi

SX   Male

CA   Finite cell line

//

ID   PR00303

AC   CVCL_2W15

DR   CLO; CLO_0018322

DR   Coriell; PR00303

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=30603; ! Eulemur macaco macaco

SX   Female

CA   Finite cell line

//

ID   PR00304

AC   CVCL_2W16

DR   CLO; CLO_0018321

DR   Coriell; PR00304

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=30603; ! Eulemur macaco macaco

SX   Female

CA   Finite cell line

//

ID   PR00306

AC   CVCL_2W17

DR   CLO; CLO_0018314

DR   Coriell; PR00306

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9447; ! Lemur catta

SX   Female

CA   Finite cell line

//

ID   PR00307

AC   CVCL_DP27

DR   Coriell; PR00307

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Discontinued: Coriell; PR00307; probable.

OX   NCBI_TaxID=554167; ! Varecia variegata rubra

SX   Female

CA   Finite cell line

//

ID   PR00316

AC   CVCL_2W18

DR   CLO; CLO_0018312

DR   Coriell; PR00316

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=40322; ! Eulemur fulvus fulvus

SX   Female

CA   Finite cell line

//

ID   PR00319

AC   CVCL_2W19

DR   CLO; CLO_0018311

DR   Coriell; PR00319

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=13514; ! Eulemur coronatus

SX   Female

CA   Finite cell line

//

ID   PR00320

AC   CVCL_2W20

DR   CLO; CLO_0018318

DR   Coriell; PR00320

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=13514; ! Eulemur coronatus

SX   Female

CA   Finite cell line

//

ID   PR00322

AC   CVCL_2W21

DR   CLO; CLO_0018317

DR   Coriell; PR00322

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=554167; ! Varecia variegata rubra

SX   Female

CA   Finite cell line

//

ID   PR00323

AC   CVCL_2W22

DR   CLO; CLO_0018316

DR   Coriell; PR00323

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=554167; ! Varecia variegata rubra

SX   Male

CA   Finite cell line

//

ID   PR00324

AC   CVCL_2W23

DR   CLO; CLO_0018315

DR   Coriell; PR00324

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=554167; ! Varecia variegata rubra

SX   Female

CA   Finite cell line

//

ID   PR00326

AC   CVCL_2W24

DR   CLO; CLO_0018306

DR   Coriell; PR00326

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=34825; ! Propithecus verreauxi

SX   Male

CA   Finite cell line

//

ID   PR00330

AC   CVCL_2W25

DR   CLO; CLO_0018304

DR   Coriell; PR00330

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=54180; ! Trachypithecus francoisi

SX   Female

CA   Finite cell line

//

ID   PR00331

AC   CVCL_2W26

DR   CLO; CLO_0018301

DR   Coriell; PR00331

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9447; ! Lemur catta

SX   Male

CA   Finite cell line

//

ID   PR00333

AC   CVCL_2W27

DR   CLO; CLO_0018292

DR   Coriell; PR00333

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=34828; ! Eulemur mongoz

SX   Female

CA   Finite cell line

//

ID   PR00334

AC   CVCL_2W28

DR   CLO; CLO_0018291

DR   Coriell; PR00334

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=34828; ! Eulemur mongoz

SX   Male

CA   Finite cell line

//

ID   PR00335

AC   CVCL_2W29

DR   CLO; CLO_0018295

DR   Coriell; PR00335

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=34828; ! Eulemur mongoz

SX   Male

CA   Finite cell line

//

ID   PR00336

AC   CVCL_2W30

DR   CLO; CLO_0018294

DR   Coriell; PR00336

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=40322; ! Eulemur fulvus fulvus

SX   Female

CA   Finite cell line

//

ID   PR00337

AC   CVCL_2W31

DR   CLO; CLO_0018297

DR   Coriell; PR00337

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=859984; ! Eulemur rufifrons

SX   Male

CA   Finite cell line

//

ID   PR00338

AC   CVCL_2W32

DR   Coriell; PR00338

RX   PubMed=16214744;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Discontinued: Coriell; PR00338; probable.

OX   NCBI_TaxID=34828; ! Eulemur mongoz

SX   Male

CA   Finite cell line

//

ID   PR00340

AC   CVCL_2W33

DR   CLO; CLO_0018296

DR   Coriell; PR00340

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=13557; ! Hapalemur griseus

SX   Female

CA   Finite cell line

//

ID   PR00341

AC   CVCL_2W34

DR   CLO; CLO_0018299

DR   Coriell; PR00341

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=34829; ! Eulemur rubriventer

SX   Male

CA   Finite cell line

//

ID   PR00342

AC   CVCL_2W35

DR   CLO; CLO_0018298

DR   Coriell; PR00342

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=47178; ! Eulemur fulvus collaris

SX   Male

CA   Finite cell line

//

ID   PR00344

AC   CVCL_2W36

DR   CLO; CLO_0018283

DR   Coriell; PR00344

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=87288; ! Eulemur macaco flavifrons

SX   Male

CA   Finite cell line

//

ID   PR00345

AC   CVCL_2W37

DR   CLO; CLO_0018281

DR   Coriell; PR00345

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=34828; ! Eulemur mongoz

SX   Male

CA   Finite cell line

//

ID   PR00357

AC   CVCL_2W38

DR   CLO; CLO_0018496

DR   Coriell; PR00357

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=859984; ! Eulemur rufifrons

SX   Male

CA   Finite cell line

//

ID   PR00366

AC   CVCL_2W39

DR   CLO; CLO_0018483

DR   Coriell; PR00366

RX   PubMed=16214744;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9597; ! Pan paniscus

SX   Female

CA   Transformed cell line

//

ID   PR00367

AC   CVCL_DN77

DR   Coriell; PR00367

RX   PubMed=16214744;

RX   PubMed=16326750;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Discontinued: Coriell; PR00367; probable.

OX   NCBI_TaxID=9597; ! Pan paniscus

SX   Female

CA   Transformed cell line

//

ID   PR00370

AC   CVCL_2W40

DR   Coriell; PR00370

RX   PubMed=16214744;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Discontinued: Coriell; PR00370; probable.

OX   NCBI_TaxID=34828; ! Eulemur mongoz

SX   Female

CA   Finite cell line

//

ID   PR00381

AC   CVCL_2W41

DR   CLO; CLO_0018484

DR   Coriell; PR00381

RX   PubMed=16214744;

RX   PubMed=21878684;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=61852; ! Nomascus gabriellae

SX   Male

CA   Transformed cell line

//

ID   PR00389

AC   CVCL_2W42

DR   CLO; CLO_0018485

DR   Coriell; PR00389

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=1215604; ! Eulemur albifrons

SX   Female

CA   Finite cell line

//

ID   PR00398

AC   CVCL_DN78

DR   Coriell; PR00398

RX   PubMed=16214744;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Discontinued: Coriell; PR00398; probable.

OX   NCBI_TaxID=9561; ! Mandrillus sphinx

SX   Male

CA   Transformed cell line

//

ID   PR00399

AC   CVCL_2W43

DR   CLO; CLO_0018486

DR   Coriell; PR00399

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9561; ! Mandrillus sphinx

SX   Male

CA   Finite cell line

//

ID   PR00400

AC   CVCL_2W44

DR   CLO; CLO_0018479

DR   Coriell; PR00400

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9598; ! Pan troglodytes

SX   Male

CA   Transformed cell line

//

ID   PR00408

AC   CVCL_DN79

DR   Coriell; PR00408

RX   PubMed=16214744;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Discontinued: Coriell; PR00408; probable.

OX   NCBI_TaxID=9544; ! Macaca mulatta

SX   Male

CA   Transformed cell line

//

ID   PR00418

AC   CVCL_2W45

DR   CLO; CLO_0018480

DR   Coriell; PR00418

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9544; ! Macaca mulatta

SX   Female

CA   Finite cell line

//

ID   PR00446

AC   CVCL_DN80

DR   Coriell; PR00446

RX   PubMed=16214744;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Discontinued: Coriell; PR00446; probable.

OX   NCBI_TaxID=9597; ! Pan paniscus

SX   Female

CA   Finite cell line

//

ID   PR00474

AC   CVCL_2W46

DR   CLO; CLO_0018481

DR   Coriell; PR00474

RX   PubMed=16214744;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=39432; ! Saimiri boliviensis boliviensis

SX   Male

CA   Finite cell line

//

ID   PR00485

AC   CVCL_2W47

DR   CLO; CLO_0018482

DR   Coriell; PR00485

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9530; ! Cercocebus torquatus

SX   Male

CA   Finite cell line

//

ID   PR00486

AC   CVCL_2W48

DR   CLO; CLO_0018487

DR   Coriell; PR00486

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=263448; ! Cercopithecus wolfi

SX   Female

CA   Finite cell line

//

ID   PR00488

AC   CVCL_DN81

DR   Coriell; PR00488

RX   PubMed=16214744;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Discontinued: Coriell; PR00488; probable.

OX   NCBI_TaxID=9600; ! Pongo pygmaeus

SX   Female

CA   Transformed cell line

//

ID   PR00494

AC   CVCL_2W49

DR   CLO; CLO_0018474

DR   Coriell; PR00494

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=40322; ! Eulemur fulvus fulvus

SX   Female

CA   Finite cell line

//

ID   PR00495

AC   CVCL_2W50

DR   Coriell; PR00495

RX   PubMed=16214744;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Discontinued: Coriell; PR00495; probable.

OX   NCBI_TaxID=9580; ! Hylobates lar

SX   Male

CA   Finite cell line

//

ID   PR00496

AC   CVCL_2W51

DR   CLO; CLO_0018472

DR   Coriell; PR00496

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9598; ! Pan troglodytes

SX   Male

CA   Transformed cell line

//

ID   PR00503

AC   CVCL_2W52

DR   CLO; CLO_0018465

DR   Coriell; PR00503

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=54600; ! Macaca nigra

SX   Female

CA   Finite cell line

//

ID   PR00512

AC   CVCL_DN82

DR   Coriell; PR00512

RX   PubMed=16214744;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Discontinued: Coriell; PR00512; probable.

OX   NCBI_TaxID=9598; ! Pan troglodytes

SX   Female

CA   Finite cell line

//

ID   PR00519

AC   CVCL_2W53

DR   CLO; CLO_0018466

DR   Coriell; PR00519

RX   PubMed=16214744;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=30609; ! Galago moholi

SX   Female

CA   Finite cell line

//

ID   PR00522

AC   CVCL_2W54

DR   Coriell; PR00522

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Discontinued: Coriell; PR00522; probable.

OX   NCBI_TaxID=9536; ! Cercopithecus hamlyni

SX   Male

CA   Finite cell line

//

ID   PR00524

AC   CVCL_2W55

DR   CLO; CLO_0018463

DR   Coriell; PR00524

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9597; ! Pan paniscus

SX   Male

CA   Finite cell line

//

ID   PR00525

AC   CVCL_2W56

DR   CLO; CLO_0018464

DR   Coriell; PR00525

RX   PubMed=16326750;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9519; ! Lagothrix lagotricha

SX   Female

CA   Finite cell line

//

ID   PR00527

AC   CVCL_2W57

DR   CLO; CLO_0018461

DR   Coriell; PR00527

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9535; ! Cercopithecus cephus

SX   Female

CA   Finite cell line

//

ID   PR00530

AC   CVCL_2W58

DR   CLO; CLO_0018462

DR   Coriell; PR00530

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=263448; ! Cercopithecus wolfi

SX   Female

CA   Finite cell line

//

ID   PR00531

AC   CVCL_2W59

DR   CLO; CLO_0018459

DR   Coriell; PR00531

RX   PubMed=16326750;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9535; ! Cercopithecus cephus

SX   Male

CA   Finite cell line

//

ID   PR00548

AC   CVCL_2W60

DR   CLO; CLO_0018460

DR   Coriell; PR00548

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9598; ! Pan troglodytes

SX   Female

CA   Transformed cell line

//

ID   PR00550

AC   CVCL_2W61

DR   CLO; CLO_0020703

DR   Coriell; PR00550

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=30586; ! Saguinus midas

SX   Male

CA   Finite cell line

//

ID   PR00551

AC   CVCL_2W62

DR   CLO; CLO_0020704

DR   Coriell; PR00551

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=30586; ! Saguinus midas

SX   Male

CA   Finite cell line

//

ID   PR00553

AC   CVCL_2W63

DR   CLO; CLO_0020705

DR   Coriell; PR00553

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=30601; ! Propithecus tattersalli

SX   Male

CA   Finite cell line

//

ID   PR00554

AC   CVCL_2W64

DR   CLO; CLO_0020706

DR   Coriell; PR00554

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=30586; ! Saguinus midas

SX   Male

CA   Finite cell line

//

ID   PR00559

AC   CVCL_2W65

DR   CLO; CLO_0020699

DR   Coriell; PR00559

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9557; ! Papio hamadryas

SX   Female

CA   Finite cell line

//

ID   PR00566

AC   CVCL_2W66

DR   CLO; CLO_0020700

DR   Coriell; PR00566

RX   PubMed=16214744;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=192857; ! Cercopithecus ascanius schmidti

SX   Male

CA   Finite cell line

//

ID   PR00573

AC   CVCL_DN83

DR   Coriell; PR00573

RX   PubMed=16214744;

RX   PubMed=16326750;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Discontinued: Coriell; PR00573; probable.

OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla

SX   Male

CA   Finite cell line

//

ID   PR00576

AC   CVCL_2W67

DR   CLO; CLO_0020701

DR   Coriell; PR00576

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9534; ! Chlorocebus aethiops

SX   Female

CA   Finite cell line

//

ID   PR00578

AC   CVCL_2W68

DR   CLO; CLO_0020702

DR   Coriell; PR00578

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9534; ! Chlorocebus aethiops

SX   Female

CA   Finite cell line

//

ID   PR00582

AC   CVCL_2W69

DR   CLO; CLO_0020688

DR   Coriell; PR00582

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9534; ! Chlorocebus aethiops

SX   Female

CA   Finite cell line

//

ID   PR00586

AC   CVCL_2W70

DR   CLO; CLO_0020686

DR   Coriell; PR00586

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9490; ! Saguinus oedipus

SX   Female

CA   Finite cell line

//

ID   PR00592

AC   CVCL_2W71

DR   CLO; CLO_0020690

DR   Coriell; PR00592

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9590; ! Symphalangus syndactylus

SX   Female

CA   Transformed cell line

//

ID   PR00594

AC   CVCL_2W72

DR   CLO; CLO_0020697

DR   Coriell; PR00594

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9590; ! Symphalangus syndactylus

SX   Female

CA   Transformed cell line

//

ID   PR00597

AC   CVCL_2W73

DR   CLO; CLO_0020698

DR   Coriell; PR00597

RX   PubMed=16214744;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9572; ! Colobus polykomos

SX   Male

CA   Finite cell line

//

ID   PR00598

AC   CVCL_2W74

DR   CLO; CLO_0020695

DR   Coriell; PR00598

RX   PubMed=16214744;

RX   PubMed=16326750;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9590; ! Symphalangus syndactylus

SX   Male

CA   Transformed cell line

//

ID   PR00603

AC   CVCL_2W75

DR   CLO; CLO_0020696

DR   Coriell; PR00603

RX   PubMed=21878684;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Discontinued: Coriell; PR00603; probable.

OX   NCBI_TaxID=9521; ! Saimiri sciureus

SX   Female

CA   Finite cell line

//

ID   PR00604

AC   CVCL_2W76

DR   CLO; CLO_0020693

DR   Coriell; PR00604

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=54180; ! Trachypithecus francoisi

SX   Male

CA   Finite cell line

//

ID   PR00605

AC   CVCL_2W77

DR   CLO; CLO_0020694

DR   Coriell; PR00605

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9598; ! Pan troglodytes

SX   Male

CA   Transformed cell line

//

ID   PR00608

AC   CVCL_2W78

DR   CLO; CLO_0020691

DR   Coriell; PR00608

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=255237; ! Cercocebus agilis

SX   Female

CA   Finite cell line

//

ID   PR00609

AC   CVCL_2W79

DR   CLO; CLO_0020692

DR   Coriell; PR00609

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=75566; ! Lophocebus aterrimus

SX   Male

CA   Finite cell line

//

ID   PR00612

AC   CVCL_2W80

DR   CLO; CLO_0020845

DR   Coriell; PR00612

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Discontinued: Coriell; PR00612; probable.

OX   NCBI_TaxID=9521; ! Saimiri sciureus

SX   Female

CA   Finite cell line

//

ID   PR00615

AC   CVCL_2W81

DR   CLO; CLO_0020826

DR   Coriell; PR00615

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9460; ! Cheirogaleus medius

SX   Female

CA   Finite cell line

//

ID   PR00616

AC   CVCL_2W82

DR   CLO; CLO_0020825

DR   Coriell; PR00616

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=75566; ! Lophocebus aterrimus

SX   Female

CA   Finite cell line

//

ID   PR00622

AC   CVCL_2W83

DR   CLO; CLO_0020824

DR   Coriell; PR00622

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla

SX   Male

CA   Finite cell line

//

ID   PR00623

AC   CVCL_2W84

DR   CLO; CLO_0020823

DR   Coriell; PR00623

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla

SX   Male

CA   Finite cell line

//

ID   PR00626

AC   CVCL_2W85

DR   CLO; CLO_0020822

DR   Coriell; PR00626

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=192857; ! Cercopithecus ascanius schmidti

SX   Female

CA   Finite cell line

//

ID   PR00627

AC   CVCL_2W86

DR   CLO; CLO_0020821

DR   Coriell; PR00627

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=37293; ! Aotus nancymaae

SX   Male

CA   Finite cell line

//

ID   PR00628

AC   CVCL_2W87

DR   Coriell; PR00628

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=37293; ! Aotus nancymaae

SX   Male

CA   Transformed cell line

//

ID   PR00631

AC   CVCL_2W88

DR   CLO; CLO_0020820

DR   Coriell; PR00631

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9470; ! Nycticebus coucang

SX   Male

CA   Finite cell line

//

ID   PR00632

AC   CVCL_2W89

DR   CLO; CLO_0020819

DR   Coriell; PR00632

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=57176; ! Aotus vociferans

SX   Male

CA   Finite cell line

//

ID   PR00634

AC   CVCL_2W90

DR   CLO; CLO_0020818

DR   Coriell; PR00634

RX   PubMed=16214744;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=192857; ! Cercopithecus ascanius schmidti

SX   Female

CA   Finite cell line

//

ID   PR00636

AC   CVCL_2W91

DR   CLO; CLO_0020817

DR   Coriell; PR00636

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=57176; ! Aotus vociferans

SX   Male

CA   Finite cell line

//

ID   PR00643

AC   CVCL_DN84

DR   Coriell; PR00643

RX   PubMed=16214744;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Discontinued: Coriell; PR00643; probable.

OX   NCBI_TaxID=9598; ! Pan troglodytes

SX   Male

CA   Transformed cell line

//

ID   PR00644

AC   CVCL_2W92

DR   CLO; CLO_0020855

DR   Coriell; PR00644

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9493; ! Callithrix pygmaea

SX   Female

CA   Finite cell line

//

ID   PR00648

AC   CVCL_2W93

DR   CLO; CLO_0020857

DR   Coriell; PR00648

RX   PubMed=16214744;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9600; ! Pongo pygmaeus

SX   Female

CA   Transformed cell line

//

ID   PR00650

AC   CVCL_2W94

DR   CLO; CLO_0020856

DR   Coriell; PR00650

RX   PubMed=21878684;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9600; ! Pongo pygmaeus

SX   Male

CA   Transformed cell line

//

ID   PR00652

AC   CVCL_2W95

DR   CLO; CLO_0020852

DR   Coriell; PR00652

RX   PubMed=16214744;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=61852; ! Nomascus gabriellae

SX   Female

CA   Transformed cell line

//

ID   PR00655

AC   CVCL_DN85

DR   Coriell; PR00655

RX   PubMed=16214744;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Discontinued: Coriell; PR00655; probable.

OX   NCBI_TaxID=33548; ! Colobus guereza

SX   Female

CA   Transformed cell line

//

ID   PR00657

AC   CVCL_2W96

DR   CLO; CLO_0020851

DR   Coriell; PR00657

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9598; ! Pan troglodytes

SX   Female

CA   Transformed cell line

//

ID   PR00660

AC   CVCL_DN86

DR   Coriell; PR00660

RX   PubMed=16214744;

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Discontinued: Coriell; PR00660; probable.

OX   NCBI_TaxID=9598; ! Pan troglodytes

SX   Female

CA   Transformed cell line

//

ID   PR00661

AC   CVCL_2W97

DR   CLO; CLO_0020854

DR   Coriell; PR00661

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9597; ! Pan paniscus

SX   Male

CA   Transformed cell line

//

ID   PR00663

AC   CVCL_2W98

DR   CLO; CLO_0020853

DR   Coriell; PR00663

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla

SX   Male

CA   Finite cell line

//

ID   PR00664

AC   CVCL_2W99

DR   Coriell; PR00664

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla

SX   Female

CA   Finite cell line

//

ID   PR00669

AC   CVCL_2X00

DR   CLO; CLO_0020849

DR   Coriell; PR00669

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla

SX   Male

CA   Finite cell line

//

ID   PR00671

AC   CVCL_2X01

DR   CLO; CLO_0020848

DR   Coriell; PR00671

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla

SX   Male

CA   Finite cell line

//

ID   PR00674

AC   CVCL_2X02

DR   CLO; CLO_0020850

DR   Coriell; PR00674

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=43780; ! Nasalis larvatus

SX   Male

CA   Finite cell line

//

ID   PR00677

AC   CVCL_2X03

DR   CLO; CLO_0020889

DR   Coriell; PR00677

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=881949; ! Saguinus fuscicollis nigrifrons

SX   Male

CA   Finite cell line

//

ID   PR00678

AC   CVCL_2X04

DR   CLO; CLO_0020888

DR   Coriell; PR00678

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=100224; ! Cercopithecus lhoesti

SX   Female

CA   Finite cell line

//

ID   PR00679

AC   CVCL_2X05

DR   CLO; CLO_0020887

DR   Coriell; PR00679

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=43780; ! Nasalis larvatus

SX   Female

CA   Finite cell line

//

ID   PR00680

AC   CVCL_2X06

DR   CLO; CLO_0020886

DR   Coriell; PR00680

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9519; ! Lagothrix lagotricha

SX   Female

CA   Finite cell line

//

ID   PR00707

AC   CVCL_2X07

DR   CLO; CLO_0020883

DR   Coriell; PR00707

CC   Group: Non-human primate cell line.

CC   From: Integrated Primate Biomaterials and Information Resource (IPBIR).

OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla

SX   Male

CA   Finite cell line

//


您正在向 biovector.net  发送关于产品 细胞株Cell Lines 88及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net 的询问

点击“立即发送”后,我们将在1个工作日内与您取得联系。